AS FILED WITH THE SECURITIES EXCHANGE COMMISSION ON February 5, 2008
REGISTRATION NO. 333-144787
U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549
AMENDMENT NO. 3
TO
FORM SB-2
REGISTRATION STATEMENT UNDER THE
SECURITIES ACT OF 1933
STRASBAUGH
(Name of small business issuer in its charter)
CALIFORNIA 3559 77-0057484
(State or other jurisdiction of (Primary Standard Industrial (I.R.S. Employer
incorporation or organization) Classification Code No.) Identification No.)
|
825 BUCKLEY ROAD, SAN LUIS OBISPO, CALIFORNIA 93401
(805) 541-6424
(Address and telephone number of principal executive offices
and principal place of business)
CHUCK SCHILLINGS
PRESIDENT AND CHIEF EXECUTIVE OFFICER
STRASBAUGH
825 BUCKLEY ROAD
SAN LUIS OBISPO, CALIFORNIA 93401
(805) 541-6424
(Name, address and telephone number of agent for service)
COPIES OF ALL CORRESPONDENCE TO:
LARRY A. CERUTTI, ESQ.
RUSHIKA KUMARARATNE, ESQ.
RUTAN & TUCKER, LLP
611 ANTON BOULEVARD, 14TH FLOOR
COSTA MESA, CALIFORNIA 92626
(714) 641-5100
APPROXIMATE DATE OF PROPOSED SALE TO THE PUBLIC: From time to time after this
registration becomes effective.
If any of the securities being registered on this form are to be offered on
a delayed or continuous basis pursuant to Rule 415 under the Securities Act of
1933, check the following box. |X|
If this form is filed to register additional securities for an offering
pursuant to Rule 462(b) under the Securities Act, please check the following box
and list the Securities Act registration number of the earlier effective
registration statement for the same offering. |__|
If this form is a post-effective amendment filed pursuant to Rule 462(c)
under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering. |__|
If this form is a post-effective amendment filed pursuant to Rule 462(d)
under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering. |__|
If the delivery of the prospectus is expected to be made pursuant to Rule
434, check the following box. |__|
Calculation of Registration Fee
========================================================================================================================
Proposed Maximum Proposed Maximum
Title of Each Class of Amount to be Offering Price Aggregate Offering Amount of
Securities to be Registered Registered(1) per Share(2) Price(2)(4) Registration Fee(4)
------------------------------------------------------------------------------------------------------------------------
Common stock, no par value 789,956(3) $2.00(2)(4) $1,579,912 $61.62
========================================================================================================================
|
(1) In the event of a stock split, stock dividend, anti-dilution adjustment or
similar transaction involving common stock of the registrant, in order to
prevent dilution, the number of shares registered shall be automatically
increased to cover the additional shares in accordance with Rule 416(a)
under the Securities Act.
(2) Estimated solely for the purpose of calculating the registration fee
pursuant to Rule 457(c) of the Securities Act of 1933, based on the
proposed initial offering price of $2.00 for the shares of common stock
offered for resale hereby.
(3) Represents 686,920 shares of common stock issuable upon conversion of
convertible preferred stock and 103,036 shares of common stock issuable
upon exercise of warrants.
(4) Calculated based on a estimate of the proposed maximum aggregate offering
price. A registration fee in the aggregate amount of $969.99 was paid with
the initial filing and Amendment No. 1 of this registration statement.
The Registrant hereby amends this registration statement on such date or dates
as may be necessary to delay its effective date until the Registrant shall file
a further amendment which specifically states that this registration statement
shall thereafter become effective in accordance with Section 8(a) of the
Securities Act of 1933 or until the registration statement becomes effective on
such date as the Commission, acting under Section 8(a), may determine.
The information in this prospectus is not complete and may be changed. The
selling security holders identified in this prospectus may not sell securities
under this prospectus until the registration statement of which this prospectus
is a part becomes effective.
SUBJECT TO COMPLETION, DATED February 5, 2008
PROSPECTUS
789,956 Shares
STRASBAUGH
Common Stock
This is a public offering of 789,956 shares of our common stock, including
an aggregate of 686,920 shares of our common stock underlying shares of
preferred stock and an aggregate of 103,036 shares of our common stock
underlying warrants. All shares are being offered for resale by selling security
holders identified in this prospectus. The selling security holders may, from
time to time, sell, transfer or otherwise dispose of any or all of their shares
of common stock on any stock exchange, market or trading facility on which the
shares are traded or quoted or in private transactions. These dispositions may
be at prevailing market prices at the time of sale, or at privately negotiated
prices. However, because there is no trading market in our common stock as of
the date of this prospectus, the selling security holders intend to sell any
shares in the public market at $2.00 per share until shares of our common stock
are traded on the OTC Bulletin Board. Once our common stock trades on the OTC
Bulletin Board, the selling security holders may sell their shares of common
stock in the manner set forth above and as described in "Plan of Distribution."
We will not receive any of the proceeds from the sale of shares by the selling
security holders.
Prices of our common stock currently are quoted on the Pink Sheets(R) under
the symbol "STRB." On January 28, 2008, the closing sale price for a share of
our common stock was $2.00.
Our principal offices are located at 825 Buckley Road, San Luis Obispo,
California 93401 and our telephone number is (805) 541-6424.
INVESTING IN OUR SHARES OF COMMON STOCK INVOLVES SUBSTANTIAL RISKS. SEE
"RISK FACTORS" BEGINNING ON PAGE 8 FOR FACTORS YOU SHOULD CONSIDER BEFORE BUYING
SHARES OF OUR COMMON STOCK.
NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES
COMMISSION HAS APPROVED OR DISAPPROVED OF THESE SECURITIES OR DETERMINED IF THIS
PROSPECTUS IS ACCURATE OR COMPLETE. ANY REPRESENTATION TO THE CONTRARY IS A
CRIMINAL OFFENSE.
The date of this prospectus is ____________, 2008.
TABLE OF CONTENTS
PAGE
----
PROSPECTUS SUMMARY...........................................................2
RISK FACTORS.................................................................8
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS............................18
USE OF PROCEEDS..............................................................18
DIVIDEND POLICY..............................................................18
PRICE RANGE OF COMMON STOCK..................................................19
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS.....................................................21
BUSINESS.....................................................................32
MANAGEMENT...................................................................49
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS...............................72
PRINCIPAL SHAREHOLDERS.......................................................76
SELLING SECURITY HOLDERS.....................................................80
PLAN OF DISTRIBUTION.........................................................86
DESCRIPTION OF CAPITAL STOCK.................................................88
LEGAL MATTERS................................................................93
EXPERTS......................................................................93
CHANGE IN CERTIFYING ACCOUNTANT..............................................93
WHERE YOU CAN FIND MORE INFORMATION..........................................94
INDEX TO FINANCIAL STATEMENTS................................................F-1
|
TO FULLY UNDERSTAND THIS OFFERING AND ITS CONSEQUENCES TO YOU, YOU
SHOULD READ THE FOLLOWING SUMMARY ALONG WITH THE MORE DETAILED INFORMATION AND
OUR FINANCIAL STATEMENTS AND THE NOTES TO THOSE STATEMENTS APPEARING ELSEWHERE
IN THIS PROSPECTUS. IN THIS PROSPECTUS, THE WORDS "WE," "US," "OUR" AND SIMILAR
TERMS REFER TO STRASBAUGH, A CALIFORNIA CORPORATION (FORMERLY, CTK WINDUP
CORPORATION), TOGETHER WITH ITS WHOLLY-OWNED OPERATING SUBSIDIARY, R. H.
STRASBAUGH, A CALIFORNIA CORPORATION (FORMERLY, STRASBAUGH), UNLESS THE CONTEXT
PROVIDES OTHERWISE.
OUR COMPANY
We develop, manufacture, market and sell an extensive line of precision
surfacing products, including polishing, grinding and precision optics tools and
systems, to customers in the semiconductor and silicon wafer fabrication, data
storage, light emitting diode, or LED, and precision optics markets worldwide.
Many of our products are used by our customers in the fabrication of integrated
circuits, commonly known as chips or semiconductors, and in the fabrication of
silicon wafers. Our customers include LG Electronics, Cree, Inc. and Western
Digital Corporation.
Within the semiconductor industry we focus our efforts on three markets
and applications: research and development, failure analysis and backgrinding.
The research and development market includes universities and research
institutes that have a need for lower-priced chemical mechanical planarization,
or CMP, and grinding tools. Failure analysis products are used by semiconductor
manufacturers to help determine the reasons why certain computer chips produced
from a single wafer do not meet expected specifications. Backgrinding products
are used to reduce silicon wafers from their original thickness at the end of
chip fabrication to a diminished thickness to allow for the final assembly of
the semiconductor devise.
Within the silicon wafer industry, we provide silicon wafer
manufacturers with polishing and grinding products. In addition, we also serve
several silicon wafer niche markets and applications, including
silicon-on-insulation, or SOI, wafers. SOI wafers are used to produce
sophisticated logic-integrated circuits.
Our CMP products are used within the data storage industry to polish
read-write heads used in disc drives. A number of our products are used in the
backgrinding step in the manufacturing of LED devices. In addition, several of
our products are used in the precision optics industry to grind, polish and lap
materials such as glass, crystals, ceramics, compound semiconductor materials,
metals and plastics to make lenses, prisms, displays, mirrors and other
products.
We market our products through a direct sales force in the United
States and Japan, and an international network of sales representatives and
distributors in Europe, China, Taiwan, South Korea, Israel and the Philippines.
OUR STRATEGY
The key elements of our business strategy include:
INCREASE OUR CURRENT MARKET PRESENCE AND SELECTIVELY PURSUE NEW
OPPORTUNITIES IN MAINSTREAM MARKETS. We intend to use our newly-developed
products to increase our current market share and selectively pursue new
opportunities in the mainstream semiconductor CMP and silicon wafer markets.
These products include NTREPID(TM), our advanced next-generation 300mm wafer
polisher, and NVISION, our newly-developed endpoint detection system.
2
CONTINUE TO FOCUS ON UNDERSERVED SEMICONDUCTOR NICHE MARKETS AND OFFER
HIGH VALUE PRODUCTS. With our comprehensive product line, we intend to continue
to look for semiconductor niche markets and new product applications where we
can quickly use our competencies to become a market leader. We believe that many
of our target customers seek high value products that combine quality,
excellence and reliability at prices competitive with other leading products
offered in the marketplace. We intend to continue to focus on high value product
offerings in niche markets by promoting and offering our products that are
affordable alternatives to higher-priced products offered by some of our
competitors.
EXPAND OUR PRESENCE IN CHINA. We intend to expand our marketing and
sales efforts in China. Our strategy to expand our presence in China is
comprised of two main elements. First, we intend to leverage our low price
advantage to become the equipment supplier of choice for Chinese companies that
acquire previous generation chip production lines from the West, where low
capital equipment cost is a key to profitability. This strategy utilizes our
existing product lines and sales representatives. Second, we intend to leverage
our technical capabilities, our new NTREPID(TM) CMP tool and our patent position
to partner with a China-based semiconductor and silicon wafer manufacturer to
assist the China-based partner in its pursuit of more mainstream semiconductor
CMP and silicon wafer fabrication applications in China and throughout the world
using our technology and products. Although both elements of our expansion
strategy are in the initial stages, they are beginning to show some success. For
example, our equipment is currently used by several Chinese companies that have
taken over outdated chip production lines formerly manufactured in the West. In
addition, on September 23, 2006 we entered into a non-binding Memorandum of
Understanding with the 45th Research Institute of China Electronic Technology
Corporation, or 45th Research Institute, located in China and funded by the
government of China, to enter into a joint venture to research, develop, design,
manufacture, sell and service within China advanced next-generation CMP
products. The Memorandum of Understanding was amended and restated on December
1, 2006. Discussions with the 45th Research Institute are in the formative
stages and no assurance can be given that we will be successful in entering into
a joint venture agreement with the 45th Research Institute upon the terms set
forth in the Memorandum of Understanding, or at all.
CONTINUE TO DEVELOP NEXT GENERATION PRODUCTS. We believe that our
future success is dependent on our ability to continue to develop next
generation products and technologies. For example, we are in the process of
designing a new optical end-point detection system for CMP products that will
allow this enabling technology to be implemented for the first time on the large
installed base of our competitors' CMP tools. Another example of our forward
thinking is the patents and prototypes we have for an advanced wafer grinding
tool.
PURSUE STRATEGIC TECHNOLOGY AND/OR PRODUCT ACQUISITIONS. We intend to
selectively pursue acquisitions of technology and/or products that enhance our
position in the markets in which we compete. We believe that because of our
distribution capabilities, strong sales organization and relationships with
long-standing customers, we are well positioned to take advantage of acquiring,
licensing or distributing other products or technology.
SHARE EXCHANGE TRANSACTION
On May 24, 2007, we completed a share exchange transaction, or Share
Exchange Transaction, with the shareholders of R. H. Strasbaugh, a California
corporation (formerly, Strasbaugh). Upon completion of the Share Exchange
Transaction, we acquired all of the issued and outstanding shares of capital
stock of R. H. Strasbaugh. In connection with the Share Exchange Transaction, we
issued an aggregate of 13,770,366 shares of our common stock to the shareholders
of R. H. Strasbaugh. Upon the closing of the Share Exchange Transaction the
former shareholders of R. H. Strasbaugh held approximately 97% of the issued and
outstanding shares of our common stock and the then current shareholders of CTK
Windup Corporation (now Strasbaugh) held approximately 3% of the issued and
outstanding shares of our common stock.
3
The Share Exchange Transaction has been accounted for as a
recapitalization of R. H. Strasbaugh with R. H. Strasbaugh being the accounting
acquiror. As a result, the historical financial statements of R. H. Strasbaugh
are now the historical financial statements of the legal acquiror, Strasbaugh.
Immediately prior to the consummation of the Share Exchange
Transaction, we amended and restated our articles of incorporation to effectuate
a 1-for-31 reverse split of our common stock, to change our name from CTK Windup
Corporation to Strasbaugh, to increase our authorized common stock from
50,000,000 shares to 100,000,000 shares, to increase our authorized preferred
stock from 2,000,000 shares to 15,000,000 shares (of which 5,909,089 shares have
been designated Series A Cumulative Redeemable Convertible Preferred Stock) and
to eliminate our Series A Participating Preferred Stock. On May 17, 2007, prior
to the filing of our amended and restated articles of incorporation, our
subsidiary amended its articles of incorporation to change its name from
Strasbaugh to R. H. Strasbaugh.
Upon the closing of the Share Exchange Transaction, our prior
directors, J. Michael Gullard, Bryant R. Riley, Bob D'Agostino and Robert J.
Gallagher, and our prior executive officer, J. Michael Gullard, resigned their
positions with Strasbaugh and a new slate of directors and executive officers
were appointed. See "Management" for a description of our current directors and
executive officers.
At the time of the closing of the Share Exchange Transaction, we were
not engaged in any active business operations. On March 10, 2005, our prior
board of directors approved a plan of dissolution of our company, or Plan of
Dissolution, and approved the solicitation of shareholder approval of the Plan
of Dissolution. Our shareholders approved the Plan of Dissolution on June 3,
2005 and on that date we completed the sale of substantially all of our assets
to Mimix Broadband, Inc., or Mimix. On January 17, 2007, our prior board of
directors preliminarily authorized the Share Exchange Transaction. On March 14,
2007, our shareholders approved the Share Exchange Transaction.
Prior to the sale of our assets to Mimix, we designed and manufactured
gallium arsenide, or GaAs, semiconductor components and GaAs-based subsystems
used in the transmission of voice, video and data over wireless communication
networks and systems. Our current business is comprised solely of the business
of R. H. Strasbaugh. See "Business--Company History."
SERIES A PREFERRED STOCK FINANCING
On May 24, 2007, immediately after the closing of the Share Exchange
Transaction, we entered into an agreement with 21 accredited investors for the
sale by us in a private offering of 5,909,089 shares of our Series A Cumulative
Redeemable Convertible Preferred Stock, or Series A Preferred Stock, at a
purchase price of $2.20 per share for total aggregate proceeds of $13 million.
We refer to this private offering in this prospectus as the Series A Preferred
Stock Financing. The Series A Preferred Stock ranks senior in liquidation and
dividend preferences to our common stock. Each share of Series A Preferred Stock
is convertible by the holder at an initial conversion price of $2.20 per share
such that one share of common stock would be issued for each share of Series A
Preferred Stock. The shares of Series A Preferred Stock are also subject to
forced conversion anytime after May 24, 2008, if the closing price of our common
stock exceeds 200% of the conversion price then in effect for 20 consecutive
trading days. The holders of Series A Preferred Stock vote together as a single
class with the holders of our other classes and series of voting stock on all
actions to be taken by our shareholders. On or after May 24, 2012 the holders of
then outstanding shares of our Series A Preferred Stock will be entitled to
redemption rights. See "Description of Capital Stock--Series A Preferred Stock"
for a more detailed description of the rights and preferences of the Series A
Preferred Stock.
4
CORPORATE INFORMATION
We are a California corporation that was incorporated on December 28,
1984 as AHJP Corporation. On January 8, 1985 we changed our name to Celeritek,
Inc. and on July 22, 2005 we changed our name to CTK Windup Corporation. On May
24, 2007, in connection with the Share Exchange Transaction, we changed our name
to Strasbaugh. Our wholly-owned operating subsidiary, R. H. Strasbaugh, is a
California corporation that commenced operations in 1948 as a sole
proprietorship prior to its incorporation in 1964. Our principal executive
offices are located at 825 Buckley Road, San Luis Obispo, California 93401. Our
telephone number is (805) 541-6424 and our Internet website is
www.strasbaugh.com. The content of our Internet website does not constitute a
part of this prospectus.
INFORMATION IN THIS PROSPECTUS
You should rely only on the information contained in this prospectus in
connection with this offering. We have not authorized anyone to provide you with
information that is different. The selling security holders are not making an
offer to sell these securities in any jurisdiction where the offer or sale is
not permitted. You should assume that the information appearing in this
prospectus is accurate only as of the date on the front cover of this
prospectus.
INDUSTRY AND MARKET DATA
Industry and market data used throughout this prospectus were obtained
from Laredo Technologies. We purchased a copy of the report prepared by Laredo
Technologies, portions of which were prepared solely for our use, and we have
received the consent of Laredo Technologies to use the data contained in the
report in this prospectus.
5
THE OFFERING
Common stock offered by the selling security holders... 789,956
Common stock outstanding prior to this offering........ 14,201,897
Common stock to be outstanding after this offering .... 14,991,853(1)
Use of Proceeds........................................ All proceeds of this offering will be received by selling
security holders for their own accounts. See "Use of Proceeds."
Risk Factors........................................... You should read the "Risk Factors" section beginning on page 8,
as well as other cautionary statements throughout this prospectus,
before investing in shares of our common stock.
|
(1) Represents 14,201,897 shares of common stock currently outstanding plus
686,920 shares of common stock underlying shares of Series A Preferred
Stock and 103,036 shares of common stock underlying warrants.
The number of shares of common stock being offered by the selling
security holders assumes the conversion of Series A Preferred Stock and exercise
of warrants whose underlying shares of common stock are covered by this
prospectus in exchange for 686,920 and 103,036 shares of common stock,
respectively, and the immediate resale of all those shares of common stock. The
number of shares of common stock that will be outstanding upon the completion of
this offering is based on the 14,201,897 shares outstanding as of February 1,
2008, and excludes the following:
o 2,000,000 shares of common stock reserved for issuance under our
2007 Share Incentive Plan, or 2007 Plan, of which options to
purchase 1,339,000 shares were outstanding as of that date, at a
weighted average exercise price of $1.71 per share; and
o any additional shares of common stock we may issue from time to
time after that date.
6
SUMMARY FINANCIAL INFORMATION
The following financial data should be read in conjunction with the
financial statements and related notes thereto and our "Management's Discussion
and Analysis or Plan of Operation" discussions, all of which are included
elsewhere in this prospectus.
The Share Exchange Transaction is treated as a recapitalization of R.
H. Strasbaugh for accounting purposes. As a result, the financial statements of
the accounting acquiror, R. H. Strasbaugh, will become the financial statements
of the legal acquiror, Strasbaugh. Therefore, the financial information
presented below and elsewhere in this prospectus for all periods prior to May
24, 2007 is the financial information of our accounting acquiror and
wholly-owned operating subsidiary, R. H. Strasbaugh. The financial information
presented below and elsewhere in this prospectus for periods after May 24, 2007
is the financial information of our consolidated operations.
The statement of operations data for the nine months ended September
30, 2007 and 2006 and the balance sheet data at September 30, 2007 are derived
from our unaudited condensed consolidated financial statements and related notes
thereto included elsewhere in this prospectus. The statements of operations data
for the years ended December 31, 2006 and 2005 and the balance sheet data at
December 31, 2006 are derived from our audited financial statements and related
notes thereto included elsewhere in this prospectus.
Nine Months Ended Year Ended
September 30, December 31,
--------------------------- -------------------------------
2007 2006 2005
(as restated)(1) 2006 (as restated)(2) (as restated)(2)
----------- ----------- ------------- -------------
(In thousands, except per share data)
STATEMENTS OF OPERATIONS DATA:
Net revenues ....................$ 16,561 $ 15,393 $ 23,035 $ 16,155
Cost of sales ................... 9,872 9,161 14,471 9,824
----------- ----------- ------------- -------------
Gross profit .................... 6,689 6,232 8,564 6,331
Operating expenses...>........... 6,179 4,688 6,563 6,247
----------- ----------- ------------- -------------
Income (loss) from operations.... 510 1,544 2,001 84
----------- ----------- ------------- -------------
Net income (loss) ...............$ 94 $ 975 $ 1,168 $ (365)
=========== =========== ============= =============
Basic income (loss) per share....$ 0.36 $ 0.07 $ 0.08 $ 0.03
Diluted income (loss)per share...$ 0.29 $ 0.05 $ 0.06 $ 0.03
Shares used in computing:
Basic income (loss) per share... 14,308 13,993 13,993 13,993
Diluted income (loss) per share. 19,638 18,573 18,573 13,993
September 30, 2007 December 31, 2006
(as restated)(1) (as restated)(2)
--------------- ---------------
BALANCE SHEET DATA: (In thousands)
Cash and cash equivalents .................. $ 3,013 $ 1,205
Investments in securities .................. $ 920 $ --
Working capital ............................ $ 10,297 $ 3,341
Total assets ............................... $ 16,384 $ 15,185
Total shareholders' equity ................. $ 1,493 $ 5,120
|
(1) For a discussion of the restatement of our financial statements for the
nine months ended September 30, 2007, please see "Note 13--Restatement of
Financials" in the Notes to Condensed Consolidated Financial Statements for
the Nine Months Ended September 30, 2007 (Unaudited ) beginning on page
F-31 of this prospectus.
(2) For a discussion of the restatement of our financial statements for the
years ended December 31, 2006 and 2005, please see "Note 15--Restatement of
Financial Statements" in the Notes to Financial Statements for the Years
Ended December 31, 2006 and 2005 beginning on Page F-58 of this prospectus.
7
RISK FACTORS
THE FOLLOWING SUMMARIZES MATERIAL RISKS THAT YOU SHOULD CAREFULLY
CONSIDER BEFORE YOU DECIDE TO BUY OUR COMMON STOCK IN THIS OFFERING. ANY OF THE
FOLLOWING RISKS, IF THEY ACTUALLY OCCUR, WOULD LIKELY HARM OUR BUSINESS,
FINANCIAL CONDITION AND RESULTS OF OPERATIONS. AS A RESULT, THE TRADING PRICE OF
OUR COMMON STOCK COULD DECLINE, AND YOU COULD LOSE THE MONEY YOU PAID TO BUY OUR
COMMON STOCK.
RISKS RELATING TO OUR BUSINESS
THE INDUSTRIES WITHIN WHICH WE COMPETE ARE CYCLICAL AND MAY EXPERIENCE
PERIODIC DOWNTURNS THAT MAY REDUCE CUSTOMER DEMAND FOR OUR PRODUCTS WHICH,
IN TURN, MAY HAVE AN ADVERSE IMPACT ON OUR RESULTS OF OPERATIONS, CASH
FLOWS AND FINANCIAL CONDITION.
We operate and compete within the semiconductor and semiconductor
equipment, silicon wafer and silicon wafer equipment, data storage, LED and
precision optics industries. These industries are cyclical and have historically
experienced periodic downturns, which have often resulted in a decrease in
demand for capital equipment. Commencing in the third quarter of 2007, we have
seen a marked downturn in many of the industries within which we operate and
compete. This current downturn has resulted in a reduction in demand for our
products which, in turn, will have an adverse impact on our results of
operations for 2007. A prolonged continuation of the current downturn in these
industries or any future downturn may have an adverse impact on our future
results of operations, cash flows and financial condition.
WE HAVE INCURRED LOSSES IN THE PAST AND WE MAY INCUR LOSSES IN THE FUTURE.
IF WE INCUR LOSSES IN THE FUTURE, WE WILL EXPERIENCE NEGATIVE CASH FLOW,
WHICH MAY HAMPER OUR OPERATIONS, MAY PREVENT US FROM EXPANDING OUR BUSINESS
AND MAY CAUSE OUR STOCK PRICE TO DECLINE.
We incurred net losses of $365,000, $775,000, $3.4 million and $3.7
million for the years ended December 31, 2005, 2004, 2003 and 2002,
respectively. Although we recorded net income of $94,000 for the nine months
ended September 30, 2007 and $1.2 million for the year ended December 31, 2006,
we expect to incur Losses for the year ended December 31, 2007 and we may incur
losses in future years due to, among other factors, instability in the
industries within which we operate, uncertain economic conditions worldwide or
lack of acceptance of our products in the marketplace. If we incur losses in the
future, it may make it difficult for us to raise additional capital to the
extent needed for our continued operations, particularly if we are unable to
maintain profitable operations in the future. Consequently, future losses will
result in negative cash flow, which may hamper current operations and may
prevent us from expanding our business. We may be unable to attain, sustain or
increase profitability on a quarterly or annual basis in the future. If we do
not attain, sustain or increase profitability, our stock price may decline.
THE INDUSTRIES WITHIN WHICH WE COMPETE ARE EXTREMELY COMPETITIVE. MANY OF
OUR COMPETITORS HAVE GREATER FINANCIAL AND OTHER RESOURCES AND GREATER NAME
RECOGNITION THAN WE DO AND ONE OR MORE OF THESE COMPETITORS COULD USE THEIR
GREATER FINANCIAL AND OTHER RESOURCES OR GREATER NAME RECOGNITION TO GAIN
MARKET SHARE AT OUR EXPENSE.
We believe that to remain competitive, we will require significant
financial resources in order to offer a broad range of products, to maintain
customer service and support centers worldwide and to invest in research and
cause a decline in our market share, sales and profitability. development. Many
of our existing and potential competitors, including Applied Materials, Inc.,
Novellus Systems, Inc. and Ebara Corporation, have substantially greater
financial resources, more extensive engineering, manufacturing, marketing and
customer service and support capabilities, larger installed bases of current
generation products, as well as greater name recognition than we do. As a
result, our competitors may be able to compete more aggressively and sustain
that competition over a larger period of time than we could. Our lack of
resources relative to many of our significant competitors may cause us to fail
to anticipate or respond adequately to new developments and other competitive
pressures. This failure could reduce our competitiveness and
8
WE DEPEND ON A SMALL NUMBER OF CUSTOMERS FOR A SIGNIFICANT PORTION OF OUR
TOTAL SALES. A REDUCTION IN BUSINESS FROM ANY OF THESE CUSTOMERS COULD
CAUSE A SIGNIFICANT DECLINE IN OUR NET REVENUES AND PROFITABILITY.
A significant portion of our total net revenues are generated from a
small number of customers. Our top five customers accounted for approximately
51% and 46% of our net revenues during 2006 and 2005, respectively, and 53% of
our net revenues during the first nine months of 2007. Two customers each
accounted for more than 10% of net revenues during 2006 and 2005. Although the
composition of the group comprising our largest customers may vary from year to
year, the loss of a significant customer or any reduction in orders by any
significant customer, including reductions due to market, economic or
competitive conditions in the industries in which we operate could cause a
significant decline in our net revenues and profitability. Our ability to
increase our net revenues in the future will depend, in part, upon our ability
to obtain orders from new customers, as well as the financial condition and
success of our existing customers and the general economy, which are largely
beyond our ability to control.
OUR POTENTIAL CUSTOMERS MAY NOT PURCHASE OUR PRODUCTS BECAUSE OF THEIR
SIGNIFICANT COST OR BECAUSE OUR POTENTIAL CUSTOMERS ARE ALREADY USING A
COMPETITOR'S PRODUCT WHICH, IN TURN, COULD CAUSE A DECLINE IN OUR SALES AND
PROFITABILITY.
A substantial investment is required to install and integrate capital
equipment into a semiconductor or silicon wafer production line. We believe that
once a manufacturer has selected a particular vendor's capital equipment, that
manufacturer generally relies upon that vendor's equipment for that specific
production line application and, to the extent possible, subsequent generations
of that vendor's systems. Accordingly, it may be extremely difficult to achieve
significant sales to a particular customer once that customer has selected
another vendor's capital equipment unless there are compelling reasons to do so,
such as significant performance or cost advantages. Any failure to gain access
and achieve sales to new customers will adversely affect the successful
commercial adoption of our products and could cause a decline in our sales and
profitability. Any significant order cancellations or order deferrals could
adversely affect our operating results.
OUR LACK OF LONG-TERM PURCHASE ORDERS AND COMMITMENTS COULD LEAD TO A RAPID
DECLINE IN OUR SALES AND PROFITABILITY.
Our customers issue purchase orders requesting products they desire to
purchase from us, and if we are able and willing to fill those orders, then we
fill them under the terms of the purchase orders. Accordingly, we cannot rely on
long-term purchase orders or commitments to protect us from the negative
financial effects of reduced demand for our products that could result from a
general economic downturn, from changes in the industries within which we
operate, including the entry of new competitors into the market, from the
introduction by others of new or improved technology, from an unanticipated
shift in the needs of our customers, or from other causes.
SOME OF OUR PRODUCT SALES CYCLES ARE LENGTHY, EXPOSING US TO THE RISKS OF
INVENTORY OBSOLESCENCE AND FLUCTUATIONS IN OPERATING RESULTS.
Sales of our products depend, in significant part, upon the decision of
a prospective customer to add new manufacturing capacity or to expand existing
manufacturing capacity, both of which typically involve a significant capital
commitment. Our products typically have a lengthy sales cycle, often six to
twelve months, during which time we may expend substantial funds and management
effort. Lengthy sales cycles subject us to risks of inventory obsolescence and
fluctuations in operating results over which we have little or no control.
Because technology changes rapidly, we may not be able to introduce our products
in a timely fashion.
PRODUCTS WITHIN THE INDUSTRIES IN WHICH WE OPERATE ARE SUBJECT TO RAPID
TECHNOLOGICAL CHANGES. IF WE FAIL TO ACCURATELY ANTICIPATE AND ADAPT TO
THESE CHANGES, THE PRODUCTS WE SELL WILL BECOME OBSOLETE, CAUSING A DECLINE
IN OUR SALES AND PROFITABILITY.
The industries within which we compete are subject to rapid
technological change and frequent new product introductions and enhancements
which often cause product obsolescence. We believe that our future success
depends on our ability to continue to enhance our existing products and their
process capabilities, and to develop and manufacture in a timely manner new
products with improved process capabilities. We may incur substantial
9
unanticipated costs to ensure product functionality and reliability early in its
products' life cycles. If we are not successful in the introduction and
manufacture of new products or in the development and introduction, in a timely
manner, of new products or enhancements to our existing products and processes
that satisfy customer needs and achieve market acceptance, our sales and
profitability will decline.
WE OBTAIN SOME OF THE COMPONENTS AND SUBASSEMBLIES INCLUDED IN OUR PRODUCTS
FROM A SINGLE SOURCE OR LIMITED GROUP OF SUPPLIERS, THE PARTIAL OR COMPLETE
LOSS OF WHICH COULD HAVE AN ADVERSE EFFECT ON OUR SALES AND PROFITABILITY.
We obtain some of the components and subassemblies for our products
from a single source or a limited group of suppliers. From time to time, we have
experienced temporary difficulties in receiving our orders from some of these
suppliers. Although we seek to reduce dependence on these sole and limited
source suppliers, the partial or complete loss of these sources could adversely
affect our sales and profitability and damage customer relationships by impeding
our ability to fulfill our customers' orders. Further, a significant increase in
the price of one or more of these components or subassemblies could adversely
affect our profit margins and profitability if no lower-priced alternative
source is available.
WE MANUFACTURE ALL OF OUR PRODUCTS AT A SINGLE FACILITY. ANY PROLONGED
DISRUPTION IN THE OPERATIONS OF THAT FACILITY WOULD RESULT IN A DECLINE IN
OUR SALES AND PROFITABILITY.
We manufacture all of our products in a facility located in San Luis
Obispo, California. Our manufacturing processes are highly complex, require
sophisticated and costly equipment and a specially designed facility. As a
result, any prolonged disruption in the operations of our manufacturing
facility, whether due to technical or labor difficulties, termination of our
month-to-month lease of this facility, destruction of or damage to this facility
as a result of an earthquake, fire or any other reason, would result in a
decline in our sales and profitability.
WE RELY UPON SALES REPRESENTATIVES AND DISTRIBUTORS FOR A SIGNIFICANT
PORTION OF OUR SALES. A DISRUPTION IN OUR RELATIONSHIP WITH ANY SALES
REPRESENTATIVE OR DISTRIBUTOR COULD CAUSE OUR SALES AND PROFITABILITY TO
DECLINE.
A significant portion of our sales outside of the United States are
made through sales representatives and distributors. The activities of these
sales representatives and distributors are not within our control, and they may
sell products manufactured by other manufacturers. In addition, in some
locations our sales representatives and distributors also provide field service
and support to our customers. A reduction in the sales efforts or financial
viability of these sales representatives and distributors, or a termination of
our relationship with these sales representatives and distributors, could cause
our sales and profitability to decline.
WE MAY NOT BE ABLE TO PROTECT OUR INTELLECTUAL PROPERTY OR OBTAIN LICENSES
FOR THIRD PARTIES' INTELLECTUAL PROPERTY AND, THEREFORE, WE MAY BE SUBJECT
TO ONE OR MORE INTELLECTUAL PROPERTY INFRINGEMENT CLAIMS WHICH MAY
ADVERSELY AFFECT OUR SALES, EARNINGS AND FINANCIAL RESOURCES.
Although we attempt to protect our intellectual property rights through
patents, copyrights, trade secrets and other measures, we may not be able to
protect our technology adequately, and competitors may be able to develop
similar technology independently. This may be especially true if we are
successful in entering into a joint venture relationship with the 45th Research
Institute or another joint venture partner located in China. Additionally,
patent applications that we may file may not be issued and foreign intellectual
property laws, including those of China, may not protect our intellectual
property rights. There is also a risk that patents licensed by or issued to us
will be challenged, invalidated or circumvented and that the rights granted
thereunder will not provide competitive advantages to us. Furthermore, others
may independently develop similar products, duplicate our products or design
around the patents licensed by or issued to us.
10
Litigation could result in substantial cost and diversion of effort by
us, which by itself could adversely affect our sales, earnings and financial
resources. Further, adverse determinations in such litigation could result in
our loss of proprietary rights, subject us to significant liabilities to third
parties, require us to seek licenses from third parties or prevent us from
manufacturing or selling our products. In addition, licenses under third
parties' intellectual property rights may not be available on reasonable terms,
if at all.
WE DEPEND ON THE SERVICES OF ALAN STRASBAUGH AND CHUCK SCHILLINGS, AND THE
LOSS OF EITHER OF THEM COULD ADVERSELY AFFECT OUR ABILITY TO ACHIEVE OUR
BUSINESS OBJECTIVES.
Our continued success depends in part upon the continued service of
Alan Strasbaugh, who is our Chairman of the Board, and Chuck Schillings, who is
our President and Chief Executive Officer. Each is critical to the overall
management of Strasbaugh as well as to the development of our technologies, our
culture and our strategic direction. For example, Alan Strasbaugh is a member of
our technology committee and provides expertise on the development of our
products, and Chuck Schillings is instrumental in developing and maintaining
close ties with our customer base. Although we have entered into employment
agreements with Messrs. Strasbaugh and Schillings, neither of these agreements
guarantees the service of the individual for a specified period of time. In
addition, we do not maintain "key-person" life insurance policies on Messrs.
Strasbaugh and Schillings. The loss of either Alan Strasbaugh or Chuck
Schillings could significantly delay or prevent the achievement of our business
objectives. Consequently, the loss of either Alan Strasbaugh or Chuck Schillings
could adversely affect our business, financial condition and results of
operations.
OUR FAILURE TO MANAGE OUR GROWTH EFFECTIVELY COULD PREVENT US FROM
ACHIEVING OUR GOALS.
Our strategy envisions a period of growth that may impose a significant
burden on our administrative and operational resources. The growth of our
business will require significant investments of capital and management's close
attention. Our ability to effectively manage our growth will require us to
substantially expand the capabilities of our administrative and operational
resources and to attract, train, manage and retain qualified management,
engineers and other personnel. We may be unable to do so. In addition, our
failure to successfully manage our growth could result in our sales not
increasing commensurately with our capital investments. If we are unable to
successfully manage our growth, we may be unable to achieve our goals.
WE ARE EXPOSED TO ADDITIONAL RISKS ASSOCIATED WITH INTERNATIONAL SALES AND
OPERATIONS.
International sales accounted for approximately 35% and 39% of our net
revenues during 2006 and 2005, respectively, and 61% of our net revenues during
the first nine months of 2007. Our international sales are subject to certain
risks, including the following:
o tariffs and other trade barriers;
o challenges in staffing and managing foreign operations and
providing prompt and effective support to our customers outside
the United States;
o difficulties in managing foreign distributors;
o governmental controls, either by the United States or other
countries, that restrict our business overseas or the import or
export of our products, or increase the cost of our operations;
o longer payment cycles and difficulties in collecting amounts
receivable outside of the United States;
o inadequate protection or enforcement of our intellectual property
and other legal rights in foreign jurisdictions;
o global or regional economic downturns; and
o geo-political instability, natural disasters, acts of war or
terrorism.
11
There can be no assurance that any of these factors will not have a
material adverse effect on our business, financial condition or results of
operations. In addition, each region in the global markets within which we
operate exhibits unique market characteristics that can cause capital equipment
investment patterns to vary significantly from period to period.
RISKS RELATING TO THIS OFFERING AND OWNERSHIP OF OUR COMMON STOCK
BECAUSE CERTAIN ACTIONS TAKEN BY OUR PRIOR BOARD OF DIRECTORS MAY HAVE BEEN
INCONSISTENT WITH THE PLAN OF DISSOLUTION APPROVED BY OUR SHAREHOLDERS AND
APPLICABLE PROVISIONS OF CALIFORNIA LAW, WE COULD BE SUBJECT TO SIGNIFICANT
LIABILITIES WHICH, IN TURN, COULD ADVERSELY AFFECT OUR FINANCIAL CONDITION.
On June 3, 2005, our shareholders approved the Plan of Dissolution and
thereby voluntarily elected to wind-up and dissolve Strasbaugh (formerly, CTK
Windup Corporation). Under the terms of the Plan of Dissolution, our activities
were to be limited to conducting our business only insofar as necessary for the
winding up of our company. Consequently, seeking shareholder approval of, and
entering into, the Share Exchange Transaction, may be viewed and ultimately
determined to be in conflict with the Plan of Dissolution and the disclosures we
made in our Proxy Statement filed with the Securities and Exchange Commission,
or SEC, on May 5, 2005 relating to the special meeting of our shareholders at
which we sought approval of the Plan of Dissolution. Although we believe that
the activities we conducted after our shareholders approved the Plan of
Dissolution were consistent with (i) the Plan of Dissolution, (ii) the
disclosures we made in our proxy statement, (iii) applicable provisions of
California law and (iv)our former board's fiduciary duties to our shareholders,
our shareholders and/or the Securities and Exchange Commission and/or the
California Department of Corporations may disagree with us. If that were to
happen, we may be subject to an action by our shareholders for acting in a
manner inconsistent with the Plan of Dissolution and/or for disseminating a
proxy statement that contained material misstatements. If it is determined that
disclosures contained in our proxy statement seeking approval of the Plan of
Dissolution were misleading and, as a result, violated federal and state proxy
rules, we may also be subject to fines and other unspecified relief imposed by
the SEC and/or the California Department of Corporations. The dollar amount of
any damages and/or fines and the costs associated with any potential shareholder
lawsuit or action by the SEC or the California Department of Corporations is
difficult for us to quantify, yet it could be significant. If it is significant,
our financial condition could be materially and adversely affected.
After our shareholders approved the Plan of Dissolution and before we
obtained shareholder approval for the Share Exchange Transaction, our former
board of directors declared and paid dividends to our shareholders. Under the
laws of the State of California, a corporation generally cannot revoke its
election to wind up and dissolve after distributing assets pursuant to the
corporation's election to wind up and dissolve. We believe that the dividends
were "extraordinary dividends" and not dividends made in connection with the
distribution of assets pursuant to our election to wind up and dissolve. A
contrary finding could mean that we did not have the power to revoke our
election to windup and dissolve, and consequently that we did not have the power
to enter in to the Share Exchange Transaction. Thus, we could potentially be
found to have violated the laws of the State of California and misrepresented to
our shareholders (including the former shareholders of R. H. Strasbaugh) that we
had the power to enter into the Share Exchange Transaction. If that were the
case, we could be subject to actions by the State of California and/or our
shareholders (including the former shareholders of R. H. Strasbaugh). One
outcome of such action or actions could be rescission of the Share Exchange
Transaction. We may also be required to indemnify the shareholders of R. H.
Strasbaugh for misrepresentations that we may have made. The dollar amount of
any damages and costs associated with any of these potential actions is
difficult for us to quantify, yet it could be significant. If it is significant,
our financial condition could be materially and adversely affected.
12
OUR COMMON STOCK PRICE HAS BEEN VOLATILE, WHICH COULD RESULT IN SUBSTANTIAL
LOSSES FOR INVESTORS PURCHASING SHARES OF OUR COMMON STOCK.
The market prices of securities of technology-based companies currently
are highly volatile. The market price of our common stock has fluctuated
significantly in the past. During 2006, the high and low closing bid prices of a
share of our common stock were $4.50 and $1.55, respectively (which prices
reflect the 1-for-31 reverse split of our common stock effected on May 24,
2007). On January 28, 2008, the last reported sale price of a share of our
common stock was $2.00. The market price of our common stock may continue to
fluctuate in response to the following factors, in addition to others, many of
which are beyond our control:
o conversion of our Series A Preferred Stock and exercise of our
warrants and the sale of their underlying common stock;
o changes in market valuations of similar companies and stock market
price and volume fluctuations generally;
o economic conditions specific to the industries within which we
operate;
o the timing of introduction of new systems and technology
announcements and releases and ability to transition between
product versions;
o changes in the timing of product orders due to unexpected delays
in the introduction of our products due to lifecycles of our
products ending earlier than expected or due to declines in market
acceptance of our products;
o delays in our introduction of new products or technological
innovations or problems in the functioning of our current or new
products or innovations;
o third parties' infringement of our intellectual property rights;
o changes in our pricing policies or the pricing policies of our
competitors;
o regulatory developments;
o fluctuations in our quarterly or annual operating results;
o additions or departures of key personnel; and
o future sales of our common stock or other securities.
The price at which you purchase shares of common stock may not be
indicative of the price of our stock that will prevail in the trading market.
You may be unable to sell your shares of common stock at or above your purchase
price, which may result in substantial losses to you. Moreover, in the past,
securities class action litigation has often been brought against a company
following periods of volatility in the market price of its securities. We may in
the future be the target of similar litigation. Securities litigation could
result in substantial costs and divert our management's attention and resources.
VOTING POWER OF A MAJORITY OF OUR COMMON STOCK IS HELD BY THREE
SHAREHOLDERS WHO, AS A RESULT, ARE ABLE TO CONTROL OR EXERCISE SIGNIFICANT
INFLUENCE OVER THE OUTCOME OF MATTERS TO BE VOTED ON BY OUR SHAREHOLDERS.
Alan Strasbaugh, our Chairman of the Board, Larry Strasbaugh, the
brother of Alan Strasbaugh, and Lloyd I. Miller III, have voting power equal to
approximately 60% of all votes eligible to be cast at a meeting of our
shareholders. As a result of their significant ownership interest, these
shareholders will be able to control or exercise significant influence with
respect to the election of directors, offers to acquire Strasbaugh and other
matters submitted to a vote of all of our shareholders.
13
SHARES OF OUR COMMON STOCK ELIGIBLE, OR TO BECOME ELIGIBLE, FOR PUBLIC SALE
COULD ADVERSELY AFFECT OUR STOCK PRICE AND MAKE IT DIFFICULT FOR US TO
RAISE ADDITIONAL CAPITAL THROUGH SALES OF EQUITY SECURITIES.
We cannot predict the effect, if any, that market sales of shares of
our common stock or the availability of shares of common stock for sale will
have on the market price prevailing from time to time. As of February 1, 2008,
we had outstanding 14,201,897 shares of common stock, of which approximately
13,770,366 shares were restricted under the Securities Act of 1933, as amended,
or Securities Act. As of February 1, 2008, we also had outstanding options,
warrants, and Series A Preferred Stock that were exercisable for or convertible
into approximately 8,519,886 shares of common stock. Sales of shares of our
common stock in the public market, or the perception that sales could occur,
could adversely affect the market price of our common stock. Any adverse effect
on the market price of our common stock could make it difficult for us to raise
additional capital through sales of equity securities at a time and at a price
that we deem appropriate.
THE CONVERSION OF OUR SERIES A PREFERRED STOCK AND THE EXERCISE OF
OUTSTANDING OPTIONS AND WARRANTS TO PURCHASE OUR COMMON STOCK COULD
SUBSTANTIALLY DILUTE YOUR INVESTMENT, IMPEDE OUR ABILITY TO OBTAIN
ADDITIONAL FINANCING, AND CAUSE US TO INCUR ADDITIONAL EXPENSES.
Under the terms of our Series A Preferred Stock and existing warrants
to purchase our common stock, and outstanding options to acquire our common
stock issued to employees and others, the holders are given an opportunity to
profit from a rise in the market price of our common stock that, upon the
conversion of our Series A Preferred Stock and the exercise of the warrants
and/or options, could result in dilution in the interests of our other
shareholders. The terms on which we may obtain additional financing may be
adversely affected by the existence and potentially dilutive impact of our
Series A Preferred Stock, options and warrants. In addition, holders of the
Series A Preferred Stock and warrants have registration rights with respect to
the common stock underlying such Series A Preferred Stock and warrants, the
registration of which will cause us to incur a substantial expense.
THE VOTING POWER AND VALUE OF YOUR INVESTMENT COULD DECLINE IF OUR SERIES A
PREFERRED STOCK AND WARRANTS ISSUED TO OUR INVESTORS ARE CONVERTED OR
EXERCISED AT A REDUCED PRICE DUE TO OUR ISSUANCE OF LOWER-PRICED SHARES
WHICH TRIGGER RIGHTS OF THE HOLDERS OF OUR SERIES A PREFERRED STOCK AND
WARRANTS TO RECEIVE ADDITIONAL SHARES OF OUR STOCK.
As part of our Series A Preferred Stock Financing, we issued a
significant amount of common stock warrants to our investors, the conversion or
exercise of which could have a substantial negative impact on the price of our
common stock and could result in a dramatic decrease in the value of your
investment. The initial conversion price of our Series A Preferred Stock and the
initial exercise price of our investor warrants will be subject to downward
anti-dilution adjustments in most cases, from time to time, where we issue
securities at a purchase, exercise or conversion price that is less than the
then-applicable conversion price of our Series A Preferred Stock or exercise
price of our investor warrants. Consequently, the voting power and value of your
investment in each such event would decline if our Series A Preferred Stock or
investor warrants are converted or exercised for shares of our common stock at
the new lower price as a result of sales of our securities made below the then
applicable conversion price of the Series A Preferred Stock and/or the exercise
price of the investor warrants.
14
THE MARKET PRICE OF OUR COMMON STOCK AND THE VALUE OF YOUR INVESTMENT COULD
SUBSTANTIALLY DECLINE IF OUR SERIES A PREFERRED STOCK, WARRANTS OR OPTIONS
ARE CONVERTED OR EXERCISED INTO SHARES OF OUR COMMON STOCK AND RESOLD INTO
THE MARKET, OR IF A PERCEPTION EXISTS THAT A SUBSTANTIAL NUMBER OF SHARES
WILL BE ISSUED UPON CONVERSION OR EXERCISE OF OUR SERIES A PREFERRED STOCK,
WARRANTS OR OPTIONS AND THEN RESOLD INTO THE MARKET.
If the conversion or exercise prices at which our Series A Preferred
Stock, warrants and options are converted or exercised are lower than the price
at which you made your investment, immediate dilution of the value of your
investment will occur. In addition, sales of a substantial number of shares of
common stock issued upon conversion or exercise of our Series A Preferred Stock,
warrants and options, or even the perception that such sales could occur, could
adversely affect the market price of our common stock. You could, therefore,
experience a substantial decline in the value of your investment as a result of
both the actual and potential conversion or exercise of our Series A Preferred
Stock, warrants or options.
BECAUSE WE ARE SUBJECT TO THE "PENNY STOCK" RULES, THE LEVEL OF TRADING
ACTIVITY IN OUR COMMON STOCK MAY BE REDUCED.
Our stock is quoted on the Pink Sheets(R) and constitutes "Penny
Stock." Broker-dealer practices in connection with transactions in Penny Stocks
are regulated by rules adopted by the SEC. Penny Stocks are generally equity
securities with a price per share of less than $5.00 (other than securities
registered on certain national exchanges). The Penny Stock rules require a
broker-dealer, prior to a transaction in Penny Stocks not exempt from the rules,
to deliver a standardized risk disclosure document that provides information
about Penny Stocks and the nature and level of risks in the Penny Stock market.
The broker-dealer must also provide the customer with current bid and offer
quotations for the Penny Stock, the compensation of the broker-dealer and the
salesperson in the transaction, and monthly accounting statements showing the
market value of each Penny Stock held in the customer's account. In addition,
the broker-dealer must make a special written determination that the Penny Stock
is a suitable investment for the purchaser and receive the purchaser's written
agreement to the transaction. These requirements may have the effect of reducing
the level of trading activity in a Penny Stock, such as our common stock, and
investors in our common stock may find it difficult to sell their shares.
BECAUSE OUR COMMON STOCK IS NOT LISTED ON A NATIONAL SECURITIES EXCHANGE,
YOU MAY FIND IT DIFFICULT TO DISPOSE OF OR OBTAIN QUOTATIONS FOR OUR COMMON
STOCK.
Our common stock is quoted on the Pink Sheets(R) under the symbol
"STRB." Because our stock is quoted on the Pink Sheets(R) rather than on a
national securities exchange, you may find it difficult to either dispose of, or
to obtain quotations as to the price of, our common stock.
FAILURE TO ACHIEVE AND MAINTAIN EFFECTIVE INTERNAL CONTROLS IN ACCORDANCE
WITH SECTION 404 OF THE SARBANES-OXLEY ACT OF 2002 COULD RESULT IN A
RESTATEMENT OF OUR FINANCIAL STATEMENTS, CAUSE INVESTORS TO LOSE CONFIDENCE
IN OUR FINANCIAL STATEMENTS AND OUR COMPANY AND HAVE A MATERIAL ADVERSE
EFFECT ON OUR BUSINESS AND STOCK PRICE.
We produce our financial statements in accordance with accounting
principles generally accepted in the United States, but our internal accounting
controls do not currently meet all standards applicable to companies with
publicly traded securities. Effective internal controls are necessary for us to
provide reliable financial reports to help mitigate the risk of fraud and to
operate successfully as a publicly traded company. As a public company, we will
be required to document and test our internal control procedures in order to
satisfy the requirements of Section 404 of the Sarbanes-Oxley Act of 2002, or
Section 404, which will require annual management assessments of the
effectiveness of our internal controls over financial reporting and a report by
our independent registered public accounting firm that addresses both
management's assessments and our internal controls. The requirement that we
provide management's assessment regarding internal control over financial
reporting and our auditor's attestation will apply to us starting with our
annual report for the year ending December 31, 2008.
15
In connection with its audits of our financial statements for the years
ended December 31, 2006 and 2005, our independent registered public accounting
firm, Windes & McClaughry Accountancy Corporation, or Windes, advised management
of the following matter that Windes considered to be a material weakness: The
current organization of our accounting department does not provide us with the
appropriate resources and adequate technical skills to accurately account for
and disclose our activities. Windes stated that this matter is evidenced by the
following issues: (i) we did not properly record the warrant issued to Agility
Capital, LLC, in connection with certain debt financing during the year ended
December 31, 2005, and subsequently restated our 2005 financial statements to
properly record the warrant as a debt discount, (ii) our closing procedures for
the years ended December 31, 2006 and 2005 were not adequate and resulted in
significant accounting adjustments for both years, (iii) our earnings per share
calculations for the years ended December 31, 2006 and 2005 were not accurate
and required adjustment, and (iv) we were unable to adequately perform the
financial reporting process as evidenced by a significant number of suggested
revisions and comments by Windes to our financial statements and related
disclosures for the years ended December 31, 2006 and 2005. As additional
evidence of this material weakness, we further restated our 2006 and 2005
financial statements and restated our financial statements for the nine months
ended September 30, 2007 to reverse the prior derecognition of certain
liabilities. In addition, we also restated our financial statements for the nine
months ended September 30, 2007 to properly accrue for certain stock-based
compensation expenses.
A material weakness is a control deficiency (within the meaning of the
Public Company Accounting Oversight Board Auditing Standard No. 2) or
combination of control deficiencies, that results in more than a remote
likelihood that a material misstatement of the annual or interim financial
statements will not be prevented or detected.
We are in the process of remediating the material weakness identified
above in order to help prevent and detect further errors in the financial
statement closing and reporting process. We are doing this by providing
additional training of our present staff, evaluating on an on-going basis the
effectiveness of that training and engaging the appropriate third party experts
in compliance, presentation and internal control evaluation. Additionally, we
are evaluating those areas which we may determine it necessary to hire in-house
personnel with appropriate experience and skills sets. We are also in the
process of installing additional software and IT capabilities which management
believes will improve reporting, audit trials and timeliness of those reports.
If these measures are insufficient to address the issues raised, or if we
discover additional internal control deficiencies, we may fail to meet reporting
requirements established by the SEC and our financial statements may contain
material misstatements and require restatement and our business and operating
results may be harmed.
The restatement of previously issued financial statements could also
expose us to legal risk. The defense of any such actions could cause the
diversion of management's attention and resources, and we could be required to
pay damages to settle such actions if any such actions are not resolved in our
favor. Even if resolved in our favor, such actions could cause us to incur
significant legal and other expenses. Moreover, we may be the subject of
negative publicity focusing on the financial statement inaccuracies and
resulting restatement and negative reactions from our shareholders, creditors or
others with which we do business. The occurrence of any of the foregoing could
harm our business and reputation and cause the price of our common stock to
decline.
As we prepare to comply with Section 404, we may identify significant
deficiencies or errors, that we may not be able to remediate in time to meet our
deadline for compliance with Section 404. Testing and maintaining internal
controls can divert our management's attention from other matters that are
important to our business. We may not be able to conclude on an ongoing basis
that we have effective internal controls over financial reporting in accordance
with Section 404 or our independent registered public accounting firm may not be
able or willing to issue a favorable assessment if we conclude that our internal
controls over financial reporting are effective. If either we are unable to
conclude that we have effective internal controls over financial reporting or
our independent registered public accounting firm is unable to provide us with
an unqualified report as required by Section 404, investors could lose
confidence in our reported financial information and our company, which could
result in a decline in the market price of our common stock, and cause us to
fail to meet our reporting obligations in the future, which in turn could impact
our ability to raise additional financing if needed in the future.
16
THE REQUIREMENTS OF BEING A PUBLIC COMPANY, INCLUDING COMPLIANCE WITH THE
REPORTING REQUIREMENTS OF THE SECURITIES EXCHANGE ACT OF 1934 AND THE
REQUIREMENTS OF THE SARBANES-OXLEY ACT OF 2002, MAY STRAIN OUR RESOURCES,
INCREASE OUR COSTS AND DISTRACT MANAGEMENT, AND WE MAY BE UNABLE TO COMPLY
WITH THESE REQUIREMENTS IN A TIMELY OR COST-EFFECTIVE MANNER.
As a public company, we will need to comply with laws, regulations and
requirements, certain corporate governance provisions of the Sarbanes-Oxley act
of 2002, related regulations of the SEC, and requirements of the principal
trading market upon which our common stock may trade, with which we are not
required to comply as a private company. As a result, we will incur significant
legal, accounting and other expenses that we did not incur as a private company.
Complying with these statutes, regulations and requirements will occupy a
significant amount of the time of our board of directors and management, will
require us to have additional finance and accounting staff, may make it more
difficult to attract and retain qualified officers and members of our board of
directors, particularly to serve on our audit committee, and make some
activities more difficult, time consuming and costly. We will need to:
o institute a more comprehensive compliance function;
o establish new internal policies, such as those relating to
disclosure controls and procedures and insider trading;
o design, establish, evaluate and maintain a system of internal
control over financial reporting in compliance with the
requirements of the Sarbanes-Oxley Act of 2002 and the related
rules and regulations of the SEC and the Public Company Accounting
Oversight Board;
o prepare and distribute periodic reports in compliance with our
obligations under the federal securities laws including the
Securities Exchange Act of 1934, or Exchange Act;
o involve and retain to a greater degree outside counsel and
accountants in the above activities; and
o establish an investor relations function.
If we are unable to accomplish these objectives in a timely and effective
fashion, our ability to comply with our financial reporting requirements and
other rules that apply to reporting companies could be impaired. If our finance
and accounting personnel insufficiently support us in fulfilling these
public-company compliance obligations, or if we are unable to hire adequate
finance and accounting personnel, we could face significant legal liability,
which could have a material adverse effect on our financial condition and
results of operations. Furthermore, if we identify any issues in complying with
those requirements (for example, if we or our independent registered public
accountants identified a material weakness or significant deficiency in our
internal control over financial reporting), we could incur additional costs
rectifying those issues, and the existence of those issues could adversely
affect, our reputation or investor perceptions of us.
In addition, we also expect that being a public company subject to
these rules and regulations will require us to modify our director and officer
liability insurance, and we may be required to accept reduced policy limits or
incur substantially higher costs to obtain the same or similar coverage. These
factors could also make it more difficult for us to attract and retain qualified
members of our board of directors, particularly to serve on our Audit Committee,
and qualified executive officers.
17
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
This prospectus contains forward-looking statements, including
statements concerning future conditions in the industries within which we
operate, and concerning our future business, financial condition, operating
strategies, and operational and legal risks. Words like "believe," "expect,"
"may," "will," "could," "seek," "estimate," "continue," "anticipate," "intend,"
"future," "plan" or variations of those terms and other similar expressions,
including their use in the negative, are used in this prospectus to identify
forward-looking statements. You should not place undue reliance on these
forward-looking statements, which speak only as to our expectations, as of the
date of this prospectus. These forward-looking statements are subject to a
number of risks and uncertainties, including those identified under "Risk
Factors" and elsewhere in this prospectus. Although we believe that the
expectations reflected in these forward-looking statements are reasonable,
actual conditions in the industries within which we operate, and actual
conditions and results in our business, could differ materially from those
expressed in these forward-looking statements. In addition, none of the events
anticipated in the forward-looking statements may actually occur. Any of these
different outcomes could cause the price of our common stock to decline
substantially. Except as required by law, we undertake no duty to update any
forward-looking statement after the date of this prospectus, either to conform
any statement to reflect actual results or to reflect the occurrence of
unanticipated events.
USE OF PROCEEDS
We will not receive any of the proceeds from the sale of the shares of
common stock offered under this prospectus by the selling security holders.
Rather, the selling security holders will receive those proceeds directly.
Upon exercise of the common stock warrants issued to the investors in
the Series A Preferred Stock Financing, the underlying shares of common stock of
which are offered for sale hereunder, we expect to receive aggregate proceeds of
approximately $249,347. We expect to use any cash proceeds from the exercise of
warrants for general working capital purposes.
DIVIDEND POLICY
Although we have declared cash dividends on our common stock in the
past, we currently anticipate that we will not declare or pay cash dividends on
our common stock in the foreseeable future. See "Price Range of Common Stock."
We will pay dividends on our common stock only if and when declared by
our board of directors. Our board of directors' ability to declare a dividend is
subject to restrictions imposed by California law. In determining whether to
declare dividends, the board of directors will consider these restrictions as
well as our financial condition, results of operations, working capital
requirements, future prospects and other factors it considers relevant. In
addition, our credit agreement with Silicon Valley Bank and the terms of our
Series A Preferred Stock restrict our ability to pay dividends to holders of our
common stock.
18
PRICE RANGE OF COMMON STOCK
Our common stock has been quoted on the Pink Sheets(R) under the symbol
"STRB" since May 25, 2007. Prior to May 24, 2007 and since July 11, 2005, our
common stock was quoted on the Pink Sheets(R) under the symbol "CLTK." Prior to
that date, our common stock traded on NASDAQ. The table below sets forth for the
quarters indicated, the reported high and low closing bid prices of our common
stock as reported on the Pink Sheets(R) . The prices shown reflect inter-dealer
quotations without retail markups, markdowns or commissions, and may not
necessarily represent actual transactions. The prices below also reflect the
1-for-31 reverse split of our common stock effected on May 24, 2007. As a result
of the Share Exchange Transaction, we changed our fiscal year end from March 31
to December 31.
HIGH LOW
------- -------
YEAR ENDED DECEMBER 31, 2006
First Quarter .................................... $ 4.50 $ 4.03
Second Quarter ................................... $ 4.34 $ 4.03
Third Quarter .................................... $ 4.34 $ 2.17
Fourth Quarter ................................... $ 2.48 $ 1.55
YEAR ENDING DECEMBER 31, 2007
First Quarter .................................... $ 2.48 $ 1.86
Second Quarter ................................... $ 2.52 $ 1.86
Third Quarter .................................... $ 2.35 $ 2.00
Fourth Quarter ................................... $ 2.35 $ 1.50
|
Various factors materially affect the comparability of the stock price
information presented in the above table. These factors relate primarily to the
announcement of the Share Exchange Transaction during the fourth quarter of 2006
and the consummation of the Share Exchange Transaction and the closing of the
Series A Preferred Stock Financing, both of which occurred during the second
quarter of 2007. See "Business - Company History."
Concurrent with the commencement of our common stock being quoted on
the Pink Sheets(R) on July 11, 2005, our transfer agent closed the transfer
books of our common stock. As a result, between July 11, 2005 and the closing of
the Share Exchange Agreement on May 24, 2007, our common stock was traded with
due bills attached. Prior to re-opening the transfer books for our common stock
on May 25, 2007, all of our stock transfer records were reconciled to accurately
reflect all trades of our common stock made between July 11, 2005 and May 24,
2007.
On June 24, 2005 and December 22, 2005, we paid an extraordinary cash
dividend of $0.62 and $0.12 per share of common stock, respectively, to our
common shareholders of record as of June 10, 2005 and July 22, 2005,
respectively.
As of February 1, 2008, we had 14,201,897 shares of common stock
outstanding held of record by approximately 155 shareholders. These holders of
record include depositories that hold shares of stock for brokerage firms which,
in turn, hold shares of stock for numerous beneficial owners. On January 28,
2008, the closing sale price of our common stock on the Pink Sheets(R) was $2.00
per share.
19
EQUITY COMPENSATION PLAN INFORMATION
The following table gives information about our common stock that may
be issued upon the exercise of options, warrants and rights under all of our
existing equity compensation plans as of December 31, 2007.
Number of securities
remaining available for
Number of securities to be Weighted-average future issuance under
issued upon exercise of exercise price of equity compensation plans
outstanding options, outstanding options, (excluding securities
Plan category warrants and rights warrants and rights reflected in column (a))
(a) (b) (c)
Equity compensation plans approved
by security holders............. 1,339,000 (1) $ 1.71 661,000 (2)
Equity compensation plans not
approved by security holders.... -- -- --
Total 1,339,000 661,000
|
(1) Represents shares of common stock underlying options that are outstanding
under our 2007 Plan. The material features of our 2007 Plan are described
below under the heading "Management-2007 Share Incentive Plan" and in Note
8 to our condensed consolidated financial statements for the nine months
ended September 30, 2007.
(2) Represents shares of common stock available for issuance under options
that may be issued under our 2007 Plan.
20
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following discussion and analysis should be read in conjunction
with our financial statements and notes to financial statements included
elsewhere in this prospectus. This prospectus and our financial statements and
notes to financial statements contain forward-looking statements, which
generally include the plans and objectives of management for future operations,
including plans and objectives relating to our future economic performance and
our current beliefs regarding revenues we might generate and profits we might
earn if we are successful in implementing our business strategies. The
forward-looking statements and associated risks may include, relate to or be
qualified by other important factors, including, without limitation:
o the projected growth or contraction in the industries within which
we operate;
o our business strategy for expanding, maintaining or contracting
our presence in these markets;
o anticipated trends in our financial condition and results of
operations; and
o our ability to distinguish ourselves from our current and future
competitors.
We do not undertake to update, revise or correct any forward-looking
statements.
Any of the factors described above or in the "Risk Factors" section
could cause our financial results, including our net income or loss or growth in
net income or loss to differ materially from prior results, which in turn could,
among other things, cause the price of our common stock to fluctuate
substantially.
OVERVIEW
We develop, manufacture, market and sell an extensive line of precision
surfacing products, including polishing, grinding and precision optics tools and
systems, to customers in the semiconductor and silicon wafer fabrication, data
storage, LED and precision optics markets worldwide. Many of our products are
used by our customers in the fabrication of semiconductors and silicon wafers.
Our net revenues increased by $1,168,000, or 8%, to $16,561,000 for the
nine months ended September 30, 2007 from $15,393,000 for the nine months ended
September 30, 2006. Our net income decreased to $94,000 for the first nine
months of 2007 from net income of $975,000 for the first nine months of 2006.
This increase in net revenues was primarily due to certain of our customers
expanding their manufacturing capacity, mostly in South Korea, during the first
six months of 2007, and a generally strong market during the first six months of
2007 in the industries in which we serve. The decrease in net income was
primarily due to a decline in net revenues during the third quarter. Commencing
the third quarter of 2007, we have seen a marked slowdown in chip sales. As a
result, the demand for manufacturing capacity and equipment sales is slowing
with it. We believe this trend of slower sales, and a decline in sales, will
continue and into 2008. This slowdown earnings will result in lower net revenue
for 2007 as compared to 2006 and an overall net loss for 2007.
SHARE EXCHANGE TRANSACTION
On May 24, 2007, we completed the Share Exchange Transaction with the
shareholders of R. H. Strasbaugh. Upon completion of the Share Exchange
Transaction, we acquired all of the issued and outstanding shares of capital
stock of R. H. Strasbaugh which resulted in a change in control of our company.
In connection with the Share Exchange Transaction, we issued an aggregate of
13,770,366 shares of our common stock to the shareholders of R. H. Strasbaugh.
The Share Exchange Transaction has been accounted for as a recapitalization of
R. H. Strasbaugh with R. H. Strasbaugh being the accounting acquiror. As a
result, the historical financial statements of R. H. Strasbaugh are now the
historical financial statements of the legal acquiror, Strasbaugh.
21
At the time of the closing of the Share Exchange Transaction, we were
not engaged in any active business operations. Our current business is comprised
solely of the business of our wholly-owned operating subsidiary, R. H.
Strasbaugh.
CRITICAL ACCOUNTING POLICIES
Our financial statements have been prepared in accordance with
accounting principles generally accepted in the United States. The preparation
of these financial statements requires us to make estimates and judgments that
affect the reported amounts of assets, liabilities, revenues and expenses, and
related disclosure of contingent assets and liabilities. We base our estimates
on historical experience and on various other assumptions that are believed to
be reasonable under the circumstances, the results of which form the basis of
making judgments about the carrying values of assets and liabilities that are
not readily apparent from other sources. Actual results may differ from these
estimates under different assumptions or conditions.
We believe that the following critical accounting policies, among
others, affect our more significant judgments and estimates used in the
preparation of our financial statements:
REVENUE RECOGNITION. We derive revenues principally from the sale of
tools, parts and services. We recognize revenue pursuant to Staff Accounting
Bulletin, or SAB, No. 104, "Revenue Recognition." Revenue is recognized when
there is persuasive evidence an arrangement exists, delivery has occurred or
services have been rendered, our price to the customer is fixed or determinable,
and collection of the related receivable is reasonably assured. Selling
arrangements may include contractual customer acceptance provisions and
installation of the product occurs after shipment and transfer of title. We
recognize revenue upon shipment of products or performance of services and defer
recognition of revenue for any amounts subject to acceptance until such
acceptance occurs. Provisions for the estimated future cost of warranty are
recorded at the time the products are shipped.
Generally, we obtain a non-refundable down-payment from the customer.
These fees are deferred and recognized as the tool is shipped. All sales
contract fees are payable no later than 60 days after delivery and payment is
not contingent upon installation. In addition, our tool sales have no right of
return, or cancellation rights. Tools are typically modified to some degree to
fit the needs of the customer and, therefore, once a purchase order has been
accepted by us and the manufacturing process has begun, there is no right to
cancel, return or refuse the order.
We have evaluated its arrangements with customers and revenue
recognition policies under Emerging Issues Task Force ("EITF") Issue No. 00-21,
"Accounting for Revenue Arrangements with Multiple Deliverables," and determined
that its components of revenue are separate units of accounting. Each unit has
value to the customer on a standalone basis, there is objective and reliable
evidence of the fair value of each unit, and there is no right to cancel, return
or refuse an order. Our revenue recognition policies for our specific units of
accounting are as follows:
22
o Tools - We recognize revenue once a customer has visited the
plant, signed off on the tool and the tool is completed and
shipped.
o Parts - We recognize revenue when the parts are shipped.
o Service - Revenue from maintenance contracts is deferred and
recognized over the life of the contract, which is generally one
to three years. Maintenance contracts are separate components of
revenue and not bundled with our tools. If a customer does not
have a maintenance contract, then the customer is billed for time
and material and we recognize revenue the after the service has
been completed.
o Upgrades - We offer a suite of products known as "enhancements"
which are generally comprised of one-time parts and/or software
upgrades to existing Strasbaugh and non-Strasbaugh tools. These
enhancements are not required for the tools to function, are not
part of the original contract and do not include any obligation to
provide any future upgrades. We recognize revenue once these
upgrades and enhancements are complete. Revenue is recognized on
equipment upgrades when we complete the installation of the parts
and/or software on the customer's equipment and the equipment is
accepted by the customer. The upgrade contracts cover a one-time
upgrade of a customer's equipment with new or modified parts
and/or software. After installation of the upgrade, we have no
further obligation on the contracts, other than standard warranty
provisions.
We install software into our tools. The software is used solely in
connection with operating the tools and is not sold, licensed or marketed
separately. The tools and software are fully functional when the tool is
completed, and after shipment the software is not updated for new versions that
may be subsequently developed and we have no additional obligations relative to
the software. However, software modifications may be included in tool upgrade
contracts. The revenue recognition requirements of Statement of Position ("SOP")
97-2, "Software Revenue Recognition," are met when there is persuasive evidence
an arrangement exists, the fee is fixed or determinable, collectibility is
probable and delivery and acceptance of the equipment has occurred, including
upgrade contracts for parts and/or software, to the customer.
Installation of a tool occurs after the tool is completed, tested,
formally accepted by the customer and shipped. We do not charge the customer for
installation nor recognize revenue for installation as it is an inconsequential
or perfunctory obligation and it is not considered a separate element of the
sales contract or unit of accounting. Regardless of whether we perform the
installation service there is no effect on the price or payment terms, there are
no refunds, and the tool may not be rejected by the customer. In addition,
installation is not essential to the functionality of the equipment because the
equipment is a standard product, installation does not significantly alter the
equipment's capabilities, and other companies are available to perform the
installation. Also, the fair value of the installation service has historically
been insignificant relative to our tools.
WARRANTY COSTS. Warranty reserves are provided by management based on
historical experience and expected future claims. Management believes that the
current reserves are adequate to meet any foreseeable contingencies with respect
to warranty claims.
23
ALLOWANCE FOR DOUBTFUL ACCOUNTS. We maintain allowances for doubtful
accounts for estimated losses resulting from the inability of our customers to
make required payments. The allowance for doubtful accounts is based on specific
identification of customer accounts and our best estimate of the likelihood of
potential loss, taking into account such factors as the financial condition and
payment history of major customers. We evaluate the collectibility of its
receivables at least quarterly. If the financial condition of our customers were
to deteriorate, resulting in an impairment of their ability to make payments,
additional allowances may be required. Management believes that our current
allowances for doubtful accounts are adequate to meet any foreseeable
contingencies.
INVENTORY. We write down our inventory for estimated obsolescence or
unmarketable inventory equal to the difference between the cost of inventory and
the estimated market value-based upon assumptions about future demand, future
pricing and market conditions. If actual future demand, future pricing or market
conditions are less favorable than those projected by management, additional
inventory write-downs may be required and the differences could be material.
Once established, write-downs are considered permanent adjustments to the cost
basis of the obsolete or unmarketable inventories.
VALUATION OF INTANGIBLES. From time to time, we acquire intangible
assets that are beneficial to our product development processes. We use our best
judgment based on the current facts and circumstances relating to our business
when determining whether any significant impairment factors exist.
DEFERRED TAXES. We record a valuation allowance to reduce the deferred
tax assets to the amount that is more likely than not to be realized. We have
considered estimated future taxable income and ongoing tax planning strategies
in assessing the amount needed for the valuation allowance. Based on these
estimates, all of our deferred tax assets have been reserved. If actual results
differ favorably from those estimates used, we may be able to realize all or
part of our net deferred tax assets.
LITIGATION. We account for litigation losses in accordance with
Statement of Financial Accounting Standards, or SFAS, No. 5, "Accounting for
Contingencies." Under SFAS No. 5, loss contingency provisions are recorded for
probable losses at management's best estimate of a loss, or when a best estimate
cannot be made, a minimum loss contingency amount is recorded. These estimates
are often initially developed substantially earlier than the ultimate loss is
known, and the estimates are refined each accounting period, as additional
information is known. Accordingly, we are often initially unable to develop a
best estimate of loss; therefore, the minimum amount, which could be zero, is
recorded. As information becomes known, either the minimum loss amount is
increased or a best estimate can be made, resulting in additional loss
provisions. Occasionally, a best estimate amount is changed to a lower amount
when events result in an expectation of a more favorable outcome than previously
expected. Due to the nature of current litigation matters, the factors that
could lead to changes in loss reserves might change quickly and the range of
actual losses could be significant, which could adversely affect our results of
operations and cash flows from operating activities.
SERIES A PREFERRED STOCK AND WARRANTS. We evaluate our Series a
Preferred Stock and warrants on an ongoing basis considering the provisions of
SFAS No. 150, "Accounting for Certain Financial Instruments with Characteristics
of Both Liabilities and Equity," which establishes standards for issuers of
financial instruments with characteristics of both liabilities and equity
related to the classification and measurement of those instruments. The Series A
Preferred Stock conversion feature and warrants are evaluated considering the
provisions of SFAS No. 133, "Accounting for Derivative Instruments and Hedging
Activities," which establishes accounting and reporting standards for derivative
instruments, including certain derivative instruments embedded in other
contracts, and for hedging activities, and EITF Issue No. 00-19, "Accounting for
Derivative Financial Instruments Indexed to, and Potentially Settled in, a
Company's Own Stock."
24
RESULTS OF OPERATIONS
The tables presented below, which compare our results of operations
from one period to another, present the results for each period, the change in
those results from one period to another in both dollars and percentage change,
and the results for each period as a percentage of net revenues. The columns
present the following:
o The first two data columns in each table show the absolute results
for each period presented.
o The columns entitled "Dollar Variance" and "Percentage Variance"
show the change in results, both in dollars and percentages. These
two columns show favorable changes as a positive and unfavorable
changes as negative. For example, when our net revenues increase
from one period to the next, that change is shown as a positive
number in both columns. Conversely, when expenses increase from
one period to the next, that change is shown as a negative in both
columns.
o The last two columns in each table show the results for each
period as a percentage of net revenues.
NINE MONTHS ENDED SEPTEMBER 30, 2007 (AS RESTATED) COMPARED TO NINE MONTHS ENDED SEPTEMBER 30, 2006
DOLLAR PERCENTAGE RESULTS AS A PERCENTAGE
VARIANCE VARIANCE OF NET REVENUES FOR THE
NINE MONTHS ENDED ------------- ------------- NINE MONTHS ENDED
SEPTEMBER 30, FAVORABLE FAVORABLE SEPTEMBER 30,
-------------------- ------------- ------------- ----------------
2007
(as restated) 2006 (UNFAVORABLE) (UNFAVORABLE) 2007 2006
-------- -------- ------------- ------------- ------ -----
(IN THOUSANDS)
Net revenues ................................ $ 16,561 $ 15,393 $ 1,168 8% 100% 100%
Cost of goods sold .......................... 9,872 9,161 (711) (8%) 60% 60%
-------- -------- ------------- ------------- ------ -----
Gross profit ................................ 6,689 6,232 457 7% 40% 40%
Selling, general and administrative
expenses .................................. 4,727 3,415 (1,312) (38%) 28% 22%
Research and development expenses ........... 1,452 1,273 (179) (14%) 9% 8%
-------- -------- ------------- ------------- ------ -----
Income from operations ...................... 510 1,544 (1,034) (67%) 3% 10%
Total other expense ......................... (344) (457) 113 25% (2%) (3%)
-------- -------- ------------- ------------- ------ -----
Income from operations before income
taxes ..................................... 166 1,087 (921) (85%) 1% 7%
Provision for income taxes .................. 72 112 40 36% -- 1%
-------- -------- ------------- ------------- ------ -----
Net income .................................. $ 94 $ 975 $ (881) (90%) 1% 6%
======== ======== ============= ============= ====== =====
|
NET REVENUES. The $1,168,000 increase in net revenues is due in large
part to shipments made to a single foreign customer in the first quarter of
2007, as well as generally improved market conditions within the semiconductor
and silicon wafer industries during the first half of 2007 as compared to the
first half of 2006. Because of a recent slowdown within the semiconductor and
silicon wafer industries, our customers are requiring additional time to make
final purchase decisions. As a result, we expect to report net revenues for 2007
in an amount less than we reported for 2006.
GROSS PROFIT. The $457,000 increase in gross profit was primarily due
to increased net revenues. Although the dollar amount of gross profit increased,
gross profit as a percentage of net revenues remained constant at approximately
40%. We anticipate that our gross profit margin will remain at approximately 40%
at the current level of net revenues.
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES. The $1,312,000 increase
in selling, general and administrative expenses was primarily due to an increase
in personnel by approximately 30 employees between the end of the first quarter
of 2006 and end of the first quarter of 2007, together with an increase in
commission expenses related to an increase in sales volume in the first three
quarters of 2007 as compared to the first three quarters 2006. This represented
a ramp-up of our production capabilities in late 2006 in anticipation, and
ultimate realization of, increased sales volume during the latter part of 2006
and through the first three quarters of 2007.
25
We expect that over the near term, our selling, general and
administration expenses will increase as a result of, among other things,
increased legal and accounting fees associated with increased corporate
governance activities in response to the Sarbanes-Oxley Act of 2002, recently
adopted rules and regulations of the SEC, the filing of a registration statement
with the SEC to register for resale the shares of common stock underlying our
Series A Preferred Stock and warrants issued in the Series A Preferred Stock
Financing, increased employee costs associated with planned staffing increases
and increased sales and marketing expenses.
RESEARCH AND DEVELOPMENT EXPENSES. The $179,000 increase in research
and development expense is considered nominal and represents mostly on-going
engineering improvements on existing product lines developed over the past five
years. We expect that research and development spending will continue to
increase during the remainder of 2007 and during 2008 as we explore new
developments in technology.
OTHER EXPENSE. The $113,000 decrease in other expense was primarily due
to a decrease in interest expense as a result of paying of certain indebtedness
with the proceeds from our Series A Preferred Stock Financing.
YEAR ENDED DECEMBER 31, 2006 (AS RESTATED) COMPARED TO THE YEAR ENDED
DECEMBER 31, 2005 (AS RESTATED)
RESULTS AS A PERCENTAGE
OF NET REVENUES FOR THE
YEAR ENDED DOLLAR PERCENTAGE YEAR ENDED
DECEMBER 31, VARIANCE VARIANCE DECEMBER 31,
------------------------- ------------- ----------- -------------------------------
2006 2005 FAVORABLE FAVORABLE 2006 2005
(AS RESTATED) (AS RESTATED) (UNFAVORABLE) (UNFAVORABLE) (AS RESTATED) (AS RESTATED)
----------- ----------- ------------- ----------- ------------- -------------
(IN THOUSANDS)
Net revenues ......................... $ 23,035 $ 16,155 $ 6,880 43% 100% 100%
Cost of sales ........................ 14,471 9,824 (4,647) (47%) 63% 61%
----------- ----------- ------------- ----------- ------------- -------------
Gross profit ......................... 8,564 6,331 2,233 35% 37% 39%
Selling, general and administrative
expenses ........................... 4,493 5,009 516 10% 20% 31%
Research and development expenses .... 2,070 2,322 252 11% 9% 14%
Gain from extinguishment of debt and -- (1,084) (1,084) 100% -- (7%)
loss on sale of property
and equipment....................... ----------- ----------- ------------- ----------- ------------- -------------
Income from operations ............... 2,001 84 1,917 2,282% 8% 4%
Total other expense .................. (754) (420) (335) (80%) (3%) (1%)
----------- ----------- ------------- ----------- ------------- -------------
Income (loss) from operations before
Income taxes ....................... 1,247 (336) 1,583 471% 5% (2%)
Provision for income taxes .... ...... 79 29 (50) (172%) -- --
----------- ----------- ------------- ----------- ------------- -------------
Net income (loss)..................... $ 1,168 $ (365) $ 1,533 420% 5% (2%)
=========== =========== ============= =========== ============= =============
|
NET REVENUES. The $6,880,000 increase in net revenues for 2006 was
primarily due to generally improved market conditions in the semiconductor and
silicon wafer industries, as well as multiple machine orders shipped to a key
customer in South Korea. We did not ship additional products at this level to
this key customer beyond the second quarter of 2007.
GROSS PROFIT. Although gross profit increased by $2,233,000 for 2006,
gross profit as a percentage of net revenues decreased to 37% for 2006 as
compared to 39% for 2005. The decrease in gross profit margin was primarily due
to product mix of lower margin tools resulting from the delivery of products
that were subject to purchase orders dated prior to the date when we increased
product prices in late 2006.
26
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES. The $516,000 decrease in
selling, general and administrative expenses was primarily due to cost saving
initiatives implemented late in 2005 and continued into 2006. A large part of
the cost savings initiatives included down-sizing the number of employees in
mid- to late-2005 and realizing those savings into 2006.
RESEARCH AND DEVELOPMENT EXPENSES. The $252,000 decrease in research
and development expenses was primarily due to a decision by management to reduce
the level of research and development expenses to those related to minor
upgrades and improvements and enhancements of developed products only, rather
than the research and development of new product lines.
GAIN FROM EXTINGUISHMENT OF DEBT AND LOSS FROM SALE OF PROPERTY AND
EQUIPMENT. Our 2005 results of operations include over $1,092,000 of net gains
in debt restructuring that we did not incur during 2006.
OTHER EXPENSE. The $335,000 increase in other expense was primarily due
to an increase in interest expense in 2006 as compared to 2005 resulting from an
increase in the level of purchases of parts and materials to facilitate the
increase in product shipments in 2006 as compared to 2005.
LIQUIDITY AND CAPITAL RESOURCES
During the nine months ended September 30, 2007, we funded our
operations primarily through net income of $94,000, our credit facility with
Silicon Valley Bank, our prior term loan with Agility Capital, LLC, or Agility,
and the net proceeds of approximately $11.1 million in connection with our
Series A Preferred Stock Financing described below. As of September 30, 2007, we
had working capital of $10,297,000 as compared to $3,341,000 at December 31,
2006. At September 30, 2007 and December 31, 2006 we had an accumulated deficit
of $26,807,000 and $26,901,000, respectively, and cash and cash equivalents of
$3,013,000 and $1,205,000 respectively.
Our current available capital resources consist primarily of
approximately $3,013,000 million in cash, and $920,000 in investments as of
September 30, 2007. This amount was primarily raised through the Series A
Preferred Stock Financing. We expect that our future available capital resources
will consist primarily of cash on hand, cash generated from our business, if
any, and future debt and/or equity financings, if any.
Cash used in operating activities for the nine month period ended
September 30, 2007 was $527,000, including net income of $94,000, depreciation
and amortization of $225,000 and non-cash interest expense of $113,000. Material
changes in asset and liabilities at September 30, 2007 as compared to December
31, 2006 that affected these results include:
o a net decrease in inventory of $372,000 (inventory represented 41%
of our total assets as of September 30, 2007);
o a net decrease in accrued expenses of $598,000 which includes
commissions payable in connection with shipments made during the
quarter ended March 31, 2007 and vacation and sick pay accruals;
o a net decrease in deferred revenue of $1,072,000; and
o a net decrease in accrued warrant of $450,000 due to the
repurchase of this warrant.
27
Cash used in investing activities totaled $1,040,000 for the nine
months ended September 30, 2007 as compared to $311,000 of cash used in
investing activities for the nine months ended September 30, 2006. Included in
the results for the nine months ended September 30, 2007 are the purchase of
$922,000 of investments in securities, $16,000 used in connection with the
purchase of property and equipment and net cash of $102,000 representing the
capitalized cost for intellectual property.
Cash provided by financing activities totaled $3,375,000 for the nine
months ended September 30, 2007 as compared to $602,000 for the nine months
ended September 30, 2006. This increase was most affected by the net issuance of
our Series A Preferred Stock of $11,122,000 offset by the repayment of notes
payable of $1,798,000, a decline in bank borrowings of $2,650,000, the
repurchase of common stock of $750,000 and the repurchase of participating
preferred stock of $3,000,000.
Prior to May 22, 2007, our Silicon Valley Bank credit facility provided
for a $3.5 million revolving line of credit secured by substantially all of our
assets. The amount of available borrowings under the facility was based upon 85%
of eligible accounts receivable. Interest was payable monthly. The interest rate
was variable and is adjusted monthly based on the prime rate plus 3.5% as to
$3.0 million of the facility (based on domestic accounts receivable) and the
prime rate plus 4% as to $500,000 of the facility (based on foreign accounts
receivable). On May 22, 2007, we entered into a Amendment to Loan and Security
Agreement with Silicon Valley Bank to increase the amount of our credit facility
to $7.5 million and to extend the term of the facility to August 18, 2007. On
September 6, 2007, we entered into another Amendment to Loan and Security
Agreement with Silicon Valley Bank to extend the term of the facility to October
16, 2007.
On December 4, 2007, we entered into two Loan and Security Agreements
with Silicon Valley Bank providing for a credit facility in the aggregate amount
of $7.5 million, or SVB Credit Facilities. The first component, or EXIM
Facility, provides for a two-year $2.5 million revolving line of credit, secured
by substantially all of our assets, that requires us to obtain a guarantee from
the Export Import Bank of the United States of the credit extensions under the
agreement before a credit extension will be made. The second component of the
SVB Credit Facility, or Non-EXIM Facility, is a two-year, revolving line of
credit secured by substantially all of our assets pursuant to which we can
borrow up to $7.5 million dollars less the principal balance borrowed under the
EXIM Facility. The guarantee from Export Import Bank of the United States must
be in full force and effect throughout the term of the EXIM Facility and so long
as any credit extensions under the EXIM Facility are outstanding. We will be in
default under the EXIM Facility if the EXIM guaranty ceases to be in full force
and effect as required by the Loan and Security Agreement applicable to the EXIM
Facility. Events of default under either of the SVB Credit Facilities will
constitute an event of default on the other SVB Credit Facility.
The SVB Credit Facilities are subject to various financial covenants,
applicable to us and our subsidiary, R.H. Strasbaugh, on a consolidated basis,
including the following: the ratio of certain assets to current liabilities,
measured on a monthly basis, must not be less than 1.0:1.0; and the ratio of
total liabilities less subordinated debt to tangible net worth plus subordinated
debt, measured on a monthly basis, must be not more than 0.60:1.0.
The Non-EXIM Facility is formula-based which generally provides that
the outstanding borrowings under the line of credit may not exceed an aggregate
of 85% of eligible accounts receivable and 30% of eligible inventory. The EXIM
Facility is also formula-based and provides that the outstanding borrowings
under the line of credit may not exceed an aggregate of 90% of eligible accounts
receivable and 50% of eligible inventory.
28
Interest on the SVB Credit Facilities is payable monthly. The interest
rate applicable to the SVB Credit Facilities is a variable per annum rate equal
to 0.75 percentage points above the prime rate as published by Silicon Valley
Bank. Upon the occurrence and during the continuation of an event of default,
the interest rate applicable to the outstanding balance under the SVB Credit
Facilities will increase by five percentage points above the per annum interest
rate that would otherwise be applicable.
Terms of the SVB Credit Facilities include commitment fees of $56,250
on the Non-EXIM Facility and $37,500 on the EXIM Facility. Both the EXIM
Facility and the Non-EXIM Facility are subject to an unused line fee of 0.25%
per annum, payable monthly, on any unused portion of the respective revolving
credit facility.
On May 24, 2007, our indebtedness to Agility in the amount of
approximately $761,799 was repaid in full. Additionally, on May 24, 2007, R. H.
Strasbaugh repurchased from Agility 771,327 shares of its common stock and a
warrant to purchase shares of its common stock for $750,000 and $450,000,
respectively.
On May 24, 2007, immediately after the closing of the Share Exchange
Transaction, we issued to 21 accredited investors in the Series A Preferred
Stock Financing an aggregate of 5,909,089 shares of our Series A Preferred Stock
at a purchase price of $2.20 per share and five-year investor warrants, or
Investor Warrants, to purchase an aggregate of 886,363 shares of common stock at
an exercise price of $2.42 per share, for total gross proceeds of $13,000,000.
The Investor Warrants are initially exercisable 180 days after May 24, 2007. We
paid cash placement agent fees and expenses of approximately $1.1 million and
issued five-year placement warrants, or Placement Warrants, to purchase 385,434
shares of common stock at an exercise price of $2.42 per share in connection
with the offering. Additional costs related to the financing include legal,
accounting and consulting fees that totaled approximately $400,000 through
September 30, 2007 and continue to be incurred in connection with various
securities filings and the registration statement described below.
We are obligated under a registration rights agreement related to the
Series A Preferred Stock Financing to file a registration statement with the
SEC, registering for resale shares of common stock underlying the Series A
Preferred Stock and shares of common stock underlying Investor Warrants, issued
in connection with the Series A Preferred Stock Financing. The registration
obligations require, among other things, that a registration statement be
declared effective by the SEC on or before October 6, 2007. Because we were
unable to have the initial registration statement declared effective by the SEC
by October 6, 2007, we are generally required to pay to each investor liquidated
damages equal to 1% of the amount paid by the investor for the underlying shares
of commons stock still owned by the investor on the date of the default and 1%
of the amount paid by the investor for the underlying shares of common stock
still owned by the investor on each monthly anniversary of the date of the
default that occurs prior to the cure of the default. However, we will not be
obligated to pay any liquidated damages with respect to any shares of common
stock not included on the registration statement as a result of limitations
imposed by the SEC relating to Rule 415 under the Securities Act. The maximum
aggregate liquidated damages payable to any investor will be equal to 10% of the
aggregate amount paid by the investor for the shares of our Series A Preferred
Stock. Accordingly, the maximum aggregate liquidation damages that we would be
required to pay under this provision is $1.3 million. We anticipate that we will
have sufficient cash available to pay these liquidated damages as required.
We believe that current and future available capital resources,
revenues generated from operations, and other existing sources of liquidity,
including the credit facility we have with Silicon Valley Bank and the remaining
proceeds we have from our Series A Preferred Stock Financing, will be adequate
to meet our anticipated working capital and capital expenditure requirements for
at least the next twelve months. If, however, our capital requirements or cash
flow vary materially from our current projections or if unforeseen circumstances
occur, we may require additional financing. Our failure to raise capital, if
needed, could restrict our growth, limit our development of new products or
hinder our ability to compete.
29
BACKLOG
As of September 30, 2007, we had a backlog of approximately $1.5
million. Our backlog includes firm non-cancelable customer commitments for 7
tools and approximately $545,000 in parts and upgrades. Management believes that
products in our backlog will be shipped by March 31, 2008.
EFFECTS OF INFLATION
The impact of inflation and changing prices has not been significant on
the financial condition or results of operations of either our company or our
operating subsidiary.
IMPACTS OF NEW ACCOUNTING PRONOUNCEMENTS
In December 2007, the Financial Accounting Standards Board, or FASB,
issued SFAS No. 141 (revised 2007), "Business Combinations," which replaces SFAS
No. 141. The statement retains the purchase method of accounting for
acquisitions, but requires a number of changes, including changes in the way
assets and liabilities are recognized in the purchase accounting. It also
changes the recognition of assets acquired and liabilities assumed arising from
contingencies, requires the capitalization of in-process research and
development at fair value, and requires the expensing of acquisition-related
costs as incurred. SFAS No. 141R is effective for us beginning July 1, 2009 and
will apply prospectively to business combinations completed on or after that
date.
In December 2007, the FASB issued SFAS No. 160, "Noncontrolling
Interests in Consolidated Financial Statements, an amendment of ARB 51," which
changes the accounting and reporting for minority interests. Minority interests
will be recharacterized as noncontrolling interests and will be reported as a
component of equity separate from the parent's equity, and purchases or sales of
equity interests that do not result in a change in control will be accounted for
as equity transactions. In addition, net income attributable to the
noncontrolling interest will be included in consolidated net income on the face
of the income statement and, upon a loss of control, the interest sold, as well
as any interest retained, will be recorded at fair value with any gain or loss
recognized in earnings. SFAS No. 160 is effective for us beginning July 1, 2009
and will apply prospectively, except for the presentation and disclosure
requirements, which will apply retrospectively. We are currently assessing the
potential impact that adoption of SFAS No. 160 would have on our financial
position, cash flows, or results of operations.
In February 2007, the FASB issued SFAS No. 159, "The Fair Value Option
for Financial Assets and Financial Liabilities," which permits entities to
choose to measure many financial instruments and certain other items at fair
value that are not currently required to be measured at fair value. SFAS No. 159
will apply to us on January 1, 2008. We are currently evaluating the impact of
adopting SFAS No. 159 on our financial position, cash flows, and results of
operations.
In December 2006, the FASB issued FASB Staff Position, or FSP, EITF
Issue No. 00-19-2, "Accounting for Registration Payment Arrangements." This FSP
specifies that the contingent obligation to make future payments or otherwise
transfer consideration under a registration payment arrangement, whether issued
as a separate agreement or included as a provision of a financial instrument or
other agreement, should be separately recognized and measured in accordance with
FASB Statement No. 5, "Accounting for Contingencies." As of September 30, 2007,
management believes it is probable that penalties under the agreement will be
incurred and accrued $62,000 of expense related to our registration rights
agreement calculated based on the terms of the agreement and the number of
shares included in this filing. Management is unable to determine if any
additional penalties may be incurred under the terms of the registration rights
agreement due to the restrictions imposed upon Strasbaugh by the SEC relating to
Rule 415 under the Securities Act.
In September 2006, the SEC issued SAB No. 108, "Considering the Effects
of Prior Year Misstatements When Quantifying Misstatements in Current Year
Financial Statements," which provides interpretive guidance on how the effects
of the carryover or reversal of prior year misstatements should be considered in
quantifying a current year misstatement. SAB No. 108 was effective for our
fiscal year ended December 31, 2006. The adoption of SAB No. 108 has not had a
material impact on our financial position, cash flows, or results of operations.
30
In September 2006, the FASB issued SFAS No. 157, "Fair Value
Measurements." SFAS No. 157 establishes a common definition for fair value to be
applied to GAAP guidance requiring use of fair value, establishes a framework
for measuring fair value, and expands disclosure about such fair value
measurements. SFAS No. 157 is effective for fiscal years beginning after
November 15, 2007. We are currently assessing the impact that SFAS No. 157 may
have on our financial position, cash flows, and results of operations.
In July 2006, the FASB released FASB Interpretation No. 48, "Accounting
for Uncertainty in Income Taxes," or FIN 48. FIN 48 provides guidance for how
uncertain tax positions should be recognized, measured, presented, and disclosed
in the financial statements. FIN 48 requires the evaluation of tax positions
taken in the course of preparing our tax returns to determine whether the tax
positions are "more-likely-than-not" of being sustained by the applicable tax
authority. Tax benefits of positions not deemed to meet the
"more-likely-than-not" threshold would be booked as a tax expense in the current
year and recognized as: a liability for unrecognized tax benefits; a reduction
of an income tax refund receivable; a reduction of deferred tax asset; an
increase in deferred tax liability; or a combination thereof. We adopted FIN 48
for the year ending December 31, 2007.
In February 2006, the FASB issued SFAS No. 155, "Accounting for Certain
Hybrid Financial Instruments," an amendment of SFAS No. 133, "Accounting for
Derivative Instruments and Hedging Activities," and SFAS No. 140, "Accounting
for Transfers and Servicing of Financial Assets and Extinguishments of
Liabilities." SFAS No. 155 permits fair value re-measurement for any hybrid
financial instrument that contains an embedded derivative that otherwise would
require bifurcation. SFAS No. 155 is effective for us for all financial
instruments acquired or issued after July 1, 2007. The adoption of SFAS No. 155
is not expected to have a material effect on our financial position, results of
operations or cash flows.
In May 2005, the FASB issued SFAS No. 154, "Accounting Changes and
Error Corrections," which replaces Accounting Principles Board, or APB, Opinion
No. 20, "Accounting Changes," and SFAS No. 3, "Reporting Accounting Changes in
Interim Financial Statements-An Amendment of APB Opinion No. 28." SFAS No. 154
provides guidance on the accounting for and reporting of accounting changes and
error corrections. It establishes retrospective application, or the latest
practicable date, as the required method for reporting a change in accounting
principle and the reporting of a correction of an error. SFAS No. 154 is
effective for accounting changes and corrections of errors made in fiscal years
beginning after December 15, 2005.
31
BUSINESS
OVERVIEW
We develop, manufacture, market and sell an extensive line of precision
surfacing products, including polishing, grinding and precision optics tools and
systems, to customers in the semiconductor and silicon wafer fabrication, data
storage, LED, and precision optics markets worldwide.
Many of our products are used by our customers in the fabrication of
integrated circuits, commonly known as chips or semiconductors, and in the
fabrication of silicon wafers. Most semiconductors are built on a silicon wafer
base and include a variety of circuit components that are connected by multiple
layers of wiring, or interconnects. To build a semiconductor, the components of
the semiconductor are first created on the surface of a silicon wafer by
performing a series of processes to deposit and selectively remove successive
film layers. After a series of steps designed to build the wiring portion of the
semiconductor through deposition and removal, a chemical mechanical
planarization, or CMP, step polishes the silicon wafer to achieve a flat
surface. Additional deposition, etch and CMP steps are then performed to build
up the layers of wiring needed to complete the interconnection of the circuit
elements to form the semiconductor. Through the use of CMP polishing products,
semiconductor manufacturers can increase the number of layers thereby reducing
the overall size of the semiconductor.
Over time, semiconductor manufacturers have migrated toward utilizing
increasingly larger wafers in chip production. While the predominate wafer size
used for volume production today is 200mm, a substantial number of advanced fabs
now use 300mm wafers, and the current trend continues toward the use of 300mm
wafers.
Our business and technologies have grown with this changing market. Our
equipment is configurable, and incorporates proprietary technology that we
believe results in higher yields for our manufacturing customers. Our newest
product, NTREPID(TM), is a next generation 300mm wafer polisher and CMP system.
Other new products include the NOVATION(R), a 300mm hybrid grinding tool;
NVISION(TM), an endpoint detection system for CMP wafer processes; and CMP
Enhancement(TM), an upgrade for older CMP systems.
We utilize our extensive patent portfolio and core technology platform
in designing and manufacturing each of our products for multiple market
applications, thereby expanding the market available for each product. Our
customers include some of the most well-established market participants such as
LG Electronics, Cree, Inc. and Western Digital Corporation. We have developed
our client base through a direct sales force in the United States and Japan, and
an international network of sales representatives and distributors in Europe,
China, Taiwan, South Korea, Israel and the Philippines.
COMPANY HISTORY
We are a California corporation that was incorporated on December 28,
1984 as AHJP Corporation. On January 8, 1985 we changed our name to Celeritek,
Inc. and on July 22, 2005, connection with the approval of a plan of dissolution
described below, we changed our name to CTK Windup Corporation. On May 24, 2007,
in connection with the Share Exchange Transaction described below, we changed
our name to Strasbaugh. Our wholly-owned operating subsidiary, R. H. Strasbaugh,
is a California corporation that commenced operations in 1948 as a sole
proprietorship prior to its incorporation in 1964.
32
On March 10, 2005, our prior board of directors approved a plan of
dissolution, or Plan of Dissolution, of our company and approved the
solicitation of shareholder approval of the Plan of Dissolution. Our
shareholders approved the Plan of Dissolution on June 3, 2005. As a result of
approval of the Plan of Dissolution and commencement of the wind up of our
company, (i) effective as of June 3, 2005 we completed the sale of substantially
all of our assets to Mimix Broadband, Inc., or Mimix, (ii) we voluntarily
delisted our common stock from NASDAQ effective July 11, 2005, (iii) our common
stock began trading on the Pink Sheets(R) on July 11, 2005, and (iv) our
transfer agent closed the transfer books for our common stock on July 11, 2005.
Because of our inability to liquidate our investment in NewGen Telcom Co., Ltd.,
our prior board of directors decided on August 25, 2005 to postpone our Plan of
Dissolution. See "Risk Factors--Risks Relating to This Offering and Ownership of
Our Common Stock."
During the fourth quarter of 2006, representatives of R.H. Strasbaugh
proposed the Share Exchange Transaction to our prior board of directors and on
December 5, 2006 the parties entered into a letter of intent regarding the Share
Exchange Transaction. On January 17, 2007, our prior board of directors
preliminarily authorized the Share Exchange Transaction and authorized our
officers to solicit from our shareholders their vote in favor of the Share
Exchange Transaction. In doing so, we prepared and distributed to all
shareholders a proxy statement seeking proxies in connection with the special
shareholders meeting that was to be held on March 14, 2007. On that date, our
shareholders approved the Share Exchange Transaction, thereby revoking our Plan
of Distribution. Subsequently, our prior board of directors approved and
ratified entering into and closing the Share Exchange Transaction. After
receiving both board and shareholder approval to enter into the Share Exchange
Transaction, we formally revoked the Plan of Dissolution pursuant to Section
1904(a) of the California Corporations Code and consummated the Share Exchange
Transaction. See "Risk Factors-Risks Relating to This Offering and Ownership of
our Common Stock."
On May 24, 2007, we completed the Share Exchange Transaction. Upon
completion of the Share Exchange Transaction, we acquired all of the issued and
outstanding shares of capital stock of R. H. Strasbaugh. The Share Exchange
Transaction has been accounted for as a recapitalization of R. H. Strasbaugh
with R. H. Strasbaugh being the accounting acquiror. Immediately prior to the
consummation of the Share Exchange Transaction, we amended and restated our
articles of incorporation to effectuate a 1-for-31 reverse split of our common
stock, to change our name from CTK Windup Corporation to Strasbaugh, to increase
our authorized common stock from 50,000,000 shares to 100,000,000 shares, to
increase our authorized preferred stock from 2,000,000 shares to 15,000,000
shares (of which 5,909,089 shares have been designated Series A Cumulative
Redeemable Convertible Preferred Stock) and to eliminate our Series A
Participating Preferred Stock. On May 17, 2007, prior to the filing of our
amended and restated articles of incorporation, our subsidiary amended its
articles of incorporation to change its name from Strasbaugh to R. H.
Strasbaugh.
Prior to the sale of our assets to Mimix, we designed and manufactured
GaAs semiconductor components and GaAs-based subsystems used in the transmission
of voice, video and data over wireless communication networks and systems. Our
current business is comprised solely of the business of R. H. Strasbaugh.
SEMICONDUCTOR AND SEMICONDUCTOR EQUIPMENT INDUSTRIES
Over the past twenty years, the semiconductor industry has grown
rapidly as a result of increasing demand for personal computers, the expansion
of the Internet and the telecommunications industry, and the emergence of new
applications in consumer electronics. Nonetheless, the semiconductor industry
has historically been cyclical, with periods of rapid expansion followed by
periods of over-capacity. According to a March 2006 report issued by Laredo
Technologies, or Laredo Technologies Report, worldwide semiconductor revenue in
2005 was $227.5 billion, an increase of 6.8% from 2004.
33
Several technological trends currently characterize the semiconductor
industry, including the increasing density of the integrated circuit, transition
from aluminum wiring to copper wiring as the primary conductive material in
semiconductor devices, transition from traditional insulating films made of
silicon oxide to insulators with a low dielectric constant, or "low-k," and the
move to larger 300mm wafer sizes due to the potential manufacturing cost
advantages of these larger wafers.
The semiconductor equipment industry is highly competitive and
characterized by rapid technological advancements. The pace of technological
change in the semiconductor fabrication equipment industry is rapid, with
customers continually moving to smaller critical dimensions and larger wafer
sizes and adopting new materials for fabricating semiconductors. Existing
technology can sometimes be adapted to the new requirements, but some of these
requirements may create the need for an entirely different technical approach.
The rapid pace of technological change has created opportunities for existing
companies that can gain market acceptance of their next generation products.
A company's ability to compete in this industry primarily depends on
its ability to market its technology, continually improve its products,
processes and services, and maintain its ability to develop new products that
meet constantly evolving customer requirements. The significant indicators of
potential success in this industry include a product's technical capability,
productivity and cost-effectiveness, and the level of technical service and
support that accompanies the product.
SEMICONDUCTOR CMP
CMP systems are designed to carry out an integral step in the
semiconductor fabrication process. After deposition steps are performed to
deposit various layers of film onto a silicon wafer, and etching steps are
utilized to selectively remove certain materials, CMP steps are carried out. CMP
tools polish the surface of the silicon wafer to create a planar (or flat)
surface before moving on to subsequent manufacturing steps. This process of
creating a flat surface is critical, as it allows subsequent steps to occur with
greater accuracy and enables film layers to build up with minimal height
variation.
CMP has evolved into the technology of choice for planarizing among
semiconductor manufacturers since it was first developed in the mid-1980s. It is
now a key enabling process for the manufacturing of semiconductor devices.
According to the Laredo Technologies Report, CMP equipment revenues in 2005 were
$1.2 billion, an 8.9% decrease from 2004. We believe that demand for CMP
equipment is driven by the overall growth in chip consumption, the transition to
300mm wafers, and the increasing number of CMP processing steps needed to
produce ever smaller chip geometries.
We believe that another growth driver for the CMP market is the
emergence of China as a major manufacturer and consumer of semiconductors. We
believe that China currently consumes approximately 20% of the world's
semiconductor production and that this consumption will rise to more than 50% by
2015.
34
SEMICONDUCTOR NICHE MARKETS
Within the semiconductor industry, we focus on serving three small, but
growing, niche markets and applications: research and development, failure
analysis and backgrinding.
RESEARCH AND DEVELOPMENT
The research and development market consists of customers who need CMP
and grinding tools for the development of new semiconductor products. This
market includes universities, research institutes, device manufacturers and
early development technology companies that are working on the next generation
products and technologies.
FAILURE ANALYSIS
Failure analysis is a process that is integral to the success and
profitability of any semiconductor manufacturing company. The number of "good"
computer chips produced from a single wafer can be anywhere from 50% to over 90%
of the total number of chips produced. Failure analysis equipment helps to
determine what causes this yield loss, and is utilized to quickly find a
solution. The two main processes in failure analysis for which we provide
products are "de-construction" and "wafer thinning." The deconstruction process
utilizes a polishing process to remove the various conducting and insulating
layers on the front side of a wafer to expose underlying faults. The second
process, which we call "whole wafer super-thinning," utilizes both polishing and
grinding processes to thin wafers from the base side. The super-thinned and
nearly transparent wafer is then mounted to a glass substrate for support.
Selected circuits can be powered up from the front side of the wafer and their
thermal (infrared) profile inspected by viewing through the back side of the
wafer. The failure analysis market is currently in a major expansion phase, as
old and labor-intensive methods are being replaced by new and highly automated
ones, creating a new opportunity for equipment manufacturers.
BACKGRINDING
Backgrinding is the conventional method for reducing wafers from their
original thickness at the end of chip fabrication to a diminished thickness
suitable for final packaging of die after dicing. Packaging is the final step of
chip fabrication, during which the semiconductor devise is fully assembled.
Dicing is a process of reducing a wafer containing multiple identical integrated
circuits into dice, with each die containing only one of those circuits. These
dice are the component parts of semiconductors. Backgrinding is important not
only because it ultimately allows for thinner chips, but also because it
improves a chip's ability to dissipate heat by shortening the heat transfer
path, thereby allowing the semiconductor devices to operate at high power
levels. We believe that the needs of chip fabricators for backgrinding equipment
will increase in the near future due to the move within the industry toward
thinner chips, as well as the fact that backgrinding is now finding a new
application in the manufacturing of 3-D stacked chips. These 3-D stacked chips
increase the density and performance of semiconductor devices by extending the
area available for chip structure to more than one level of silicon. These new
chips will require the development of advanced wafer grinding and polishing
tools, which we are currently working to develop.
SILICON WAFER AND SILICON WAFER EQUIPMENT INDUSTRY
Silicon wafers are the prime building blocks for almost all
semiconductor integrated circuits. The quality of an integrated circuit is
highly dependent upon the quality of the silicon prime wafer it is built on. All
silicon wafers must meet stringent specifications, including purity grade, high
dimensional accuracy and good surface integrity. Manufacturing wafers to conform
to these high standard requires sophisticated equipment that is constantly
evolving and being replaced to meet the demands of the next generation of
wafers.
35
A typical and simplified process for manufacturing a semiconductor chip
wafer involves generating a cylinder-shaped silicon ingot that is sliced into
rough silicon wafers. The wafers undergo various process steps, including
lapping, edge-grinding and polishing steps to create the desired wafer flatness,
surface finish and edge profile characteristics. Our products perform the final
polishing process step prior to the wafers being cleaned and packaged.
The silicon wafer equipment market is growing to keep pace with the
increasing number of chips required by the world's markets. We believe that
growth is being driven by the transition to 300mm wafers and the new
manufacturing methodologies needed to produce silicon wafers suitable for
ever-shrinking chip geometries. An additional growth driver for the silicon
wafer equipment industry is the emergence of China as the most cost effective
location for silicon wafer fabrication facilities. While some pre-existing
equipment will be re-used as silicon wafer fabrication facilities are moved from
Japan, Taiwan, the United States and Germany to China, the move will also create
an opportunity for market participants to re-equip facilities in those countries
with new, state-of-the-art equipment.
SILICON WAFER NICHE MARKETS
In addition to the overall silicon wafer industry, we also serve
several niche markets and applications, including SOI, within this broad
industry. SOI wafers are used to produce the most sophisticated logic-integrated
circuits, including microprocessors, high power devices and
micro-electromechanical systems, or MEMS, components for sensors and actuators.
SOI wafers are manufactured by bonding together two silicon wafers separated by
an insulating layer, usually silicon dioxide. They are difficult to produce and
require more processing steps than typical silicon wafers.
Another niche market for wafer fabrication equipment is in the
production of compound semiconductor wafers and LEDs. Compound-semiconductor
wafers are used in the manufacture of high performance chips for special
applications and opto-electronic devices such as light sensors and light
emitting devices such as LEDs. LEDs are also manufactured using other wafer-form
substrates, such as sapphire and silicon carbide. These materials are difficult
to process and require special grinding and polishing tools. We currently
produce a range of products that can be utilized in the fabrication of both
compound-semiconductor wafers and LEDs. We believe that these niche markets
represent a very attractive target market for our product offerings.
DATA STORAGE INDUSTRY
Management estimates the global data storage market, including the
hardware market and companion services, to be in excess of $70 billion. The
demand for increased data storage capacity is driven by the increasing quantity
and diversity of information that is created and managed digitally. As data
storage hardware, software, and transmission networks continue to deliver
improved cost/performance, new and expanded applications have emerged that more
efficiently support critical business processes.
Within the data storage market, the growing demand for disc drives is
focused on two areas:
o CONSUMER ELECTRONICS. Increasingly, high-performance computing and
communications functions and disc drives are being incorporated
into consumer electronics devices. For example, many of today's
digital video recorders, digital music players, video game
consoles and advanced television set-top boxes now incorporate
high performance computing functions and disk drives. In addition,
36
faster connections to the Internet and increased broadband
capacity have led to consumers downloading greater amounts of data
than ever before, expanding the market for disc drives for use in
new consumer and entertainment appliances. The adoption and rapid
growth of the use of disc drives in these applications will be
facilitated by the development of low-cost disc drives that meet
the pricing requirements of the consumer electronics market.
o MOBILE COMPUTING. We believe that the mobile computing market will
grow faster than any other personal computer segment, as price and
performance continue to improve and notebook computers become an
attractive alternative to desktop computers. Notebook systems are
also becoming progressively more desirable to consumers as the
need for mobility increases and wireless adoption continues to
advance.
New applications for hard disk storage technology, as well as market
growth in China and other Asian markets, are factors that have contributed to a
strong growth spurt in this industry. These new applications require more
sophisticated manufacturing processes and methods than previously existed. As a
consequence of this growth and demand for more sophisticated products, older
manufacturing methods are being phased out in favor of more efficient and
advanced technologies such as CMP. CMP polishing steps used in manufacturing of
semiconductors are now used almost universally for the production of the
read-write heads used in these drives. Our products are used to perform these
CMP polishing steps.
LED INDUSTRY
An LED is a semiconductor device that emits incoherent narrow spectrum
light and the effect is considered a form of electroluminescence. LEDs can emit
light in the infrared, visible or ultraviolet spectrums and are rapidly
replacing incandescent and fluorescent lamps in a multitude of applications.
LEDs are fabricated on wafers utilizing process steps similar to semiconductor
chip fabrication. Rather than using a silicon wafer as the substrate, harder
wafer materials such as silicon carbide and sapphire are used in the fabrication
of LEDs. Our products perform the backgrinding step to reduce wafer thickness
prior to the wafers being diced into individual LED devices. We believe that the
lower cost of manufacturing LEDs, their vastly extended life, and their energy
efficiency will fuel this trend toward LEDs into the foreseeable future.
PRECISION OPTICS INDUSTRY
We believe that the demand for optical-based components is growing
rapidly. These components are utilized in a wide variety of products, including
DVD players, digital cameras, and night vision equipment. In addition, optical
devices are currently being used in many applications in the telecommunications
industry. We make a wide variety of tools which grind and polish materials such
as glass, crystals, ceramics, compound semiconductor materials, metals, and
plastics to make lenses, prisms, displays, mirrors and other products. Although
it is difficult to quantify total market size, optics has become, and will
continue to serve as, a source of stable and substantial revenue and growth for
us. Growth drivers for the optics industry include the increased demand for
consumer electronics, the need for more sophisticated tools, the introduction of
semiconductor manufacturing technology to the field of optics, and opportunities
in China.
37
OUR COMPETITIVE STRENGTHS
We believe the following strengths serve as a foundation for our
strategy:
o QUALITY, EXCELLENCE AND RELIABILITY. Over the years, we have
manufactured what we believe to be high quality products that are
robust, reliable and long-lasting. For example, NTEGRITY(TM), our
first generation CMP tool developed in 1991, is still being sold
today and maintains a large installed base.
o HIGHLY CONFIGURABLE AND FLEXIBLE TOOLS. We focus on developing
tools that are flexible for our customers, rather than wafer size
specific tools. All of our tools are capable of processing
multiple wafer sizes, in multiple configurations. For example, our
new NTREPID(TM) CMP tool is unique in the semiconductor industry
in its ability to convert from 200mm to 300mm wafer processing
capability in a matter of hours. This flexibility and
configurability has enabled us to serve a wider variety of markets
and product applications with just a single tool.
o PRODUCT DEVELOPMENT IN PARTNERSHIP WITH CUSTOMERS. To compete
against much larger competitors, we have historically partnered
with our customers to develop products that fit their needs. For
example, we recently partnered with Cree, Inc. to develop a new
grinding machine specifically focused on the emerging LED market,
after larger industry players showed little interest in helping
Cree develop a machine that would meet their requirements. Working
with Cree, we developed a machine with what we believe to be
significant technological advantages over other tools. We are now
established as a preferred vendor for Cree, which in turn has
provided us with additional opportunities with other customers.
o INNOVATIVE TECHNOLOGY APPLICATIONS AND PRODUCT OPTIONS. With a
focus on building cutting edge tools, we have developed a host of
advanced technologies that have allowed us to differentiate our
products from those of our competitors. These technologies include
the SMARTPAD(R) optical endpoint detection system for CMP, the
NOVATION(R) sub-aperture grinder/polisher, and variable input
pneumatic retaining ring (ViPRR(TM)) and membrane wafer carrier
technologies. All of these technologies are protected by multiple
patents, pending patents and trade secrets.
o NEXT GENERATION TOOLS. We have developed next generation tools for
over 50 years. By utilizing our proprietary technology and working
closely with customers, we have developed several new next
generation tools that are just now being introduced into the
market. The NTREPID(TM), our next generation 300mm automatic CMP
tool and wafer polisher, incorporates a host of new technologies
and features a highly configurable and efficient design. We
believe that NTREPID(TM) is a cost effective product given its low
cost of ownership and a high throughput for its small footprint.
Our other next-generation tools include NOVATION(R), NVISION(TM),
CMP Enhancement(TM), and a prototype 300mm wafer grinder, which
has been used for advanced product development by one of the
world's foremost chip manufacturers.
OUR STRATEGY
The primary elements of our business strategy include:
INCREASE OUR CURRENT MARKET PRESENCE AND SELECTIVELY PURSUE NEW
OPPORTUNITIES IN MAINSTREAM MARKETS. We intend to use our newly-developed
products to increase our current market share and selectively pursue new
opportunities in the mainstream semiconductor CMP and silicon wafer markets.
These products include NTREPID, our advanced next-generation 300mm wafer
polisher, and NVISION, our newly-developed endpoint detection system.
38
CONTINUE TO FOCUS ON UNDERSERVED SEMICONDUCTOR NICHE MARKETS AND OFFER
HIGH VALUE PRODUCTS. With a comprehensive product line, we intend to continue to
look for semiconductor niche markets and new product applications where we can
quickly use our competencies to become a market leader. We believe that many of
our target customers seek high value products that combine quality, excellence
and reliability at prices competitive with other leading products offered in the
marketplace. We intend to continue to focus on high value product offerings by
promoting and offering our products that are affordable alternatives to
higher-priced products offered by some of our competitors.
EXPAND OUR PRESENCE IN CHINA. We intend to expand our marketing and
sales efforts in China. Our strategy to expand our presence in China is
comprised of two main elements. First, we intend to leverage our low price
advantage to become the equipment supplier of choice for Chinese companies that
acquire outdated chip production lines from the West, where low capital
equipment cost is a key to profitability. This strategy utilizes our existing
product lines and sales representatives. Second, we intend to leverage our
technical capabilities, our new NTREPID(TM) CMP tool and our patent position to
partner with a China-based semiconductor and silicon wafer manufacturer to
assist the China-based partner in its pursuit of more mainstream semiconductor
CMP and silicon wafer fabrication applications in China and throughout the world
using our technology and products. Although both elements of our expansion
strategy are in the initial stages, they are beginning to show some success. For
example, our equipment is currently used by several Chinese companies that have
taken over outdated chip production lines formerly manufactured in the West. In
addition, on December 1, 2006, we entered into a non-binding Memorandum of
Understanding with the 45th Research Institute, an agency funded by the
government of China, to enter into a joint venture to research, develop, design,
manufacture, sell and service within China advanced next-generation CMP
products. Discussions with the 45th Research Institute are in the formative
stages and no assurance can be given that we will be successful in entering into
a joint venture agreement with the 45th Research Institute upon the terms set
forth in the Memorandum of Understanding, or at all.
CONTINUE TO DEVELOP NEXT GENERATION PRODUCTS. We believe that our
future success is dependent on our ability to continue to develop next
generation products and technologies. For example, we are in the process of
designing a new optical end-point detection system for CMP products that will
allow this key enabling technology to be implemented for the first time on the
large installed base of our competitors' CMP tools. Another example of our
forward thinking is the patents and prototypes we have for an advanced wafer
grinding tool.
PURSUE STRATEGIC TECHNOLOGY AND/OR PRODUCT ACQUISITIONS. We intend to
selectively pursue acquisitions of technology and/or products that enhance our
position in the markets in which we compete. We believe that because of our
distribution capabilities, strong sales organization and relationships with
long-standing customers, we are well positioned to take advantage of acquiring,
licensing or distributing other products or technology.
PRODUCTS AND SERVICES
We have a comprehensive product line of polishing, grinding and optics
tools that serve a wide range of markets and product applications. We have built
a core competency designing innovative and quality manufacturing tools that
provide high-yield cost-effective solutions to our customers.
nTREPID(TM)
Our newest product offering , nTREPID(TM), is a next generation 300mm
wafer polisher. nTREPID(TM) is designed to meet the needs of customers in
several market segments, including semiconductor CMP and silicon wafer
fabrication, data storage, and SOI. We believe this system has a much larger
market potential than nTEGRITY(TM), our previous generation product.
39
nTREPID(TM) is a highly configurable polishing system that combines a
proven rotary polishing platform and advanced carrier technology in a low-cost,
compact footprint. We believe that it is a highly reliable system with the
potential to provide customers with higher yields. nTREPID(TM) takes elements
from our nHANCE(R) 300mm research and development CMP system and earlier 300mm
production technologies. It is the culmination of CMP technologies developed at
Strasbaugh over the past 15 years. The tool is available in several
configurations to best suit the needs of semiconductor and silicon wafer
fabrication. In addition, nTREPID(TM) supports a range of wafer sizes up to
300mm and easily converts from 200mm to 300mm in four hours. It supports serial
or parallel processing for one, two or three table polishing processes.
nTREPID(TM) also utilizes our ViPRR(TM) carrier technology, which will keep this
tool competitive through the 90nm and 65nm technology nodes to 45nm and beyond.
After a successful beta introduction, the first production version of
nTREPID(TM) was shipped during the first quarter of 2007. We also plan to
demonstrate a number of nTREPID(TM) tools for strategic customers throughout the
world. nTREPID(TM) currently sells for between $1.2 million and $2.5 million
depending on the market applications. Sales of nTREPID(TM) for the first nine
months of 2007 totaled approximately $1.4 million.
nOVATION(R)
We believe that nOVATION(R) is the only system capable of performing
the whole wafer super-thinning process, a new means of thinning and polishing
the backside silicon of a semiconductor wafer. Instead of isolating and
preparing an individual die, nOVATION(R) prepares the entire surface of the
wafer at once, which reduces sample preparation time from weeks to days. After
successful beta testing at two locations, the world's largest semiconductor
company recently adopted nOVATION(R) as its preferred wafer polisher for this
application. nOVATION(R) currently sells for approximately $450,000. We have not
made any sales of this product since 2004.
nVISION(TM)
nVISION(TM) is a newly developed endpoint detection system designed to
control semiconductor and SOI CMP wafer processes for the newest generation
integrated circuits. nVISION(TM) combines multiple endpoint capabilities,
optical signal, spindle motor current, table motor current and pad temperature,
into one system. Using our proprietary SMARTPAD(R) technology, we believe
nVISION(TM) is a key technological breakthrough for endpoint detection systems
with the potential for use on most major brand CMP tools. Our first order for
the production version nVISION(TM) system was shipped in the first quarter of
2007. nVISION(TM) currently sells for approximately $200,000. We have not made
any sales of this product since 2004.
CMP Enhancement(TM)
CMP Enhancement(TM) uses our ViPRR(TM) wafer carrier technology that
has applications on the approximately 1,000-tool installed base of Integrated
Process Equipment Corporation, or IPEC, and Speedfam CMP tools. Wafer carriers
are a key enabling technology in CMP machines and account for a large portion of
what differentiates one CMP tool from another. We believe that CMP
Enhancement(TM) significantly improves process performance, increases yields
through reduced edge exclusion and greater uniformity control, and extends the
useful life of a customer's tools. CMP Enhancement(TM) offers the additional
benefit of demonstrating our advanced CMP technology, positioning our new
nTREPID(TM) system as a possible successor to these older tools. After extensive
evaluation by a customer, we received our first large multi-quantity IPEC
version CMP Enhancement(TM) order in 2005. We introduced and received our first
Speedfam version order in early 2006. CMP Enhancement(TM) currently sells for
approximately $75,000. Sales of CMP Enhancement(TM) were approximately $1.2
million in 2005. We have not made any sales since 2005.
40
nTEGRITY(TM)
With over 300 tools in use by high-production semiconductor fabrication
facilities throughout the world, our nTEGRITY(TM) 200mm CMP system has a proven
record of adaptability and reliability. We believe that nTEGRITY(TM) is the
leading choice for the demanding data storage industry and for emerging
applications such as SOI, LED and MEMS. For applications not requiring an
integrated cleaner, we believe that nTEGRITY(TM) provides the highest throughput
per dollar of capital cost and the highest throughput per square foot of clean
room space of any CMP tool currently available. Introduced in 1991, nTEGRITY(TM)
currently sells for approximately $650,000 to $1,500,000. Sales of nTEGRITY(TM)
were approximately $1.5 million, $1.6 million and $1.9 million for 2005, 2006
and the first nine months of 2007, respectively.
nFINITY(R)
nFINITY(R) is a high yield, 200mm wax mount silicon wafer polisher.
With over 180 tools installed worldwide, nFINITY(R) continues to be one of our
top sellers due to its ability to produce superior wafer flatness, low cost of
ownership, consistent wafer-to-wafer process performance and reliability. This
product was introduced in 1997. nFINITY(R) currently sells for approximately
$580,000 to $1,000,000. Sales of nFINITY(R) were approximately $3.6 million,
$4.3 million and $5.2 million for 2005, 2006 and the first nine months of 2007,
respectively.
nGENUITY(TM)
nGENUITY(TM) is a wafer grinder use for the precision grinding of
smaller substrates used in most emerging wafer-based applications, including
semiconductor, photonics, compound semiconductor, MEMS, optics, and other
applications. With advanced technical features, such as cassette to cassette
wafer handling, force adaptive grinding, closed loop thickness control, and
automatic spindle height setup, nGENUITY(TM) delivers advanced process control
to emerging industries at what we believe to be highly competitive prices.
Introduced in 1987, nGENUITY(TM) currently sells for approximately $211,000 to
$325,000. Sales of nGENUITY(TM) were approximately $98,000, $565,000 and
$265,000 for 2005, 2006 and the first nine months of 2007, respectively.
nTELLECT(R)
nTELLECT(R) is a high volume production wafer grinding tool combining
process precision with a robust design. nTELLECT(R) is used for demanding
applications, such as SOI and the grinding of hard substrates that cannot be
efficiently processed by other designs. Among the hard materials this tool can
process is silicon carbide, the emerging substrate for production of the latest
generation of LEDs. nTELLECT(R) is also used for grinding extremely brittle
compound semiconductor materials used in the photonics market. Introduced in
1994, nTELLECT(R) currently sells for approximately $540,000. Sales of
nTELLECT(R) were approximately $758,000, $3.3 million and $1,135,500 for 2005,
2006 and the first nine months of 2007, respectively.
nSPIRE(TM)
nSPIRE(TM) is an economical CMP tool for 75mm to 200mm research and
development, failure analysis, and low volume production. This tool is used in
universities, research institutes, and early development technology companies.
nSPIRE(TM) provides wafer carrier technology and process control in laboratory
size packages. We believe that nSPIRE(TM) sales will increase as more photonic,
telecom, MEMS and other advanced products move to wafer-based production.
Introduced in 1995, nSPIRE(TM) currently sells for approximately $250,000. Sales
of nSPIRE(TM) were approximately $105,000, $195,000 and $211,000 for 2005, 2006
and the first nine months of 2007, respectively.
41
nHANCE(R)
We believe that nHANCE(R) is one of the most sophisticated
300mm-capable research and development and low volume production CMP system in
the world. Unlike some of its competitors, this tool is capable of matching or
exceeding the process precision of full 300mm production CMP tools costing $4
million or more. nHANCE(R) is used by consumables manufacturers developing the
slurries and pads used in today's most advanced silicon wafer facilities. It is
also being used for sample preparation for failure analysis. Introduced in 2000,
nHANCE(R) currently sells for approximately $450,000. Our last sales of this
product, totaling approximately $875,000, occurred in 2005.
nCOMPASS(R)
nCOMPASS(R) is a robust wafer edge profiling tool that has established
a position in the rapidly growing application of SOI and other types of bonded
wafer production. It is a simple wafer processing platform, with high throughput
and a flexible control system, which can be readily adapted to new applications.
nCOMPASS(R) recently beat all competitors for a high precision edge profiling
application on a new generation of glass-based bonded wafers. Introduced in 1986
and completely updated in 2002, nCOMPASS(R) currently sells for approximately
$270,000. Sales of this product were approximately $350,000 during 2006. We did
not make any sales in 2005 or during the first nine months of 2007.
OPTICS PRODUCTS
We offer a full line of optical polishing (nFOCUS(TM)), ring lapping
(nGAUGE(TM)), continuous pitch polishing (nSPEC(TM)) and curve generator
(nLIGHTEN(TM)) tools. We have sold over 12,000 optical tools and we believe that
we have the world's most comprehensive product line. We also believe that our
optical tools provide more sophisticated and full-featured controls, precise and
reliable performance and long tool life than those of our competitors. These
products currently sell for between approximately $10,000 and $500,000. Sales of
these products were approximately $575,000, $990,000 and $535,000 for 2005, 2006
and the first nine months of 2007, respectively.
SERVICE, PARTS AND CONSUMABLES
Our large installed equipment base provides us with a source of
recurring service, parts and consumables revenues. We have an international
network of field service engineers and we provide a variety of different service
options, and tailor service requirements to meet the needs of each customer. A
one-year warranty covering parts and labor is included with each new tool. When
designing custom service plans, we can provide as much or as little as the
customer requires. For example, service plans range from on-site field service
engineers to regularly scheduled maintenance with technical support available 24
hours per day, 7 days a week. Many customers contract for regularly scheduled
maintenance programs in which our service engineers calibrate, adjust and clean
their tools at regular intervals. Typically running between $20,000 and $100,000
per year, service plans are negotiated with the customer depending upon the type
of machine and the level of service requested. We also have a 24-hour service
line to field any emergency calls.
42
With a large installed base of tools, we also enjoy a sizable parts and
consumables business. Service, parts and consumables accounted for approximately
$5.8 million in revenues for the nine months ended September 30, 2007, or 35% of
net revenues. Parts include valves, pulleys, belts, motors, joints, carriers and
any of the thousands of parts used in our tools. Parts are purchased in three
different ways: spare parts kits that include the most commonly needed parts for
each machine; single parts as needed; and by consignment at customer facilities.
Consumables include wafer retaining rings, wafer films, shims, conditioning
discs and other parts of the system that typically wear out in conjunction with
wafer processing. Consumables sales are made on a recurring basis and are
generally more predictable than spare parts sales.
CUSTOMERS
We maintain long-standing relationships with our core customers. Our
main customers include leading semiconductor device manufacturers, silicon wafer
manufacturers, data storage companies, and a multitude of smaller customers in
multiple niche markets. With over 850 distinct customers in the last five years
and over 700 tools installed, we have a large, active and diverse customer base.
Our top five customers accounted for 51% and 46% of net revenues during 2006 and
2005, respectively. Two customers each accounted for more than 10% of net
revenues during 2006 and 2005. Our customers purchase our products by issuing
purchase orders from time to time. We do not have long-term purchase orders or
commitments with our customers. As a result, our customers may terminate their
relationship with us at any time.
Within the semiconductor industry, we have a large installed base of
tools at companies such as Western Digital Corporation, NEC Corporation,
Altis-IBM and United Microelectronics Corporation. In addition to these market
leaders, we have a large number of second- and third-tier specialty customers,
including Freescale and On Semiconductor, that prefer lower prices, better
service and more customized solutions. We also sell a significant number of
tools to testing laboratories and research and development facilities at large
device manufacturers, as well as university research laboratories.
In the silicon wafer industry, we sell to silicon wafer manufacturers
that perform the front-end polishing of the wafer before selling it to device
manufactures. In this industry, our largest customers include LG International
and MEMC Electronic Materials, Inc. In the LED industry, we sell to the market
leaders of high-end devices, including Cree, Inc. In the data storage industry,
our customers, Seagate, Hitachi and Headway, are markets leaders in
manufacturing disk drives and memory applications. In the optics industry, we
have been manufacturing and selling machines to thousands of customers since
1948. Optics tools are sold to a wide variety of customers and industries,
including aerospace, defense, optical labs, research institutions and medical
applications. Additionally, our two distributors, Euris (Europe) and Yokogawa
(Japan), are also significant customers.
SALES AND MARKETING
Our sales and marketing strategy focuses on establishing Strasbaugh as
the premier provider of polishing and grinding equipment by developing long-term
relationships with our active customer base. A key competitive advantage of our
sales process lies within our customer-focused approach. We frequently
collaborate with our leading customers to refine existing product lines and
design new innovations to meet their specific requirements.
With a wide variety of markets served and product applications, we
target markets where we can be a market leader, such as data storage, LED and
precision optics. In mainstream markets, such as semiconductor CMP and silicon
wafer, we target applications where we can be the more customer-focused,
low-cost alternative to larger competitors with more expensive tools.
43
We utilize a direct sales force for sales in the United States and
Japan who are employees of Strasbaugh and who are paid a base salary plus
commission. In the United States, our sales professionals sell equipment by
geographic region - Eastern, Southern and Western United States. Another sales
professional focuses exclusively on optics worldwide. With an average of eight
years' tenure at Strasbaugh, sales professionals are extremely knowledgeable
about our products and the markets in which we sell. Our Vice President of
Worldwide Sales and Marketing is responsible for managing our direct sales
professionals and international network of representatives and distributors.
Outside of the United States and Japan, we rely on a highly technical
and sophisticated network of sales representatives and distributors. Sales in
Europe are handled by a distributor that has worked with us for ten years. Sales
in China, Taiwan, South Korea and the rest of Asia are handled by
representatives who have also worked with us for many years. Both distributors
and sales representatives offer our full line of products. Distributors purchase
products directly from us at our domestic retail price and then mark up their
prices for sales in Europe. Our sales representatives are paid a commission of
12% - 15% of the total amount of sales made by each such sales representative.
Neither our distributors, sales representatives nor the ultimate end users of
our products have return or exchange rights with respect to our products. Also,
we do not offer any further sales incentives such as advertising or exclusivity
charges or a right of return. Our distributors and sales representatives may
enter into maintenance contracts with their customers and the particular
distributor or sales representative will pay us directly for time and material
should our employees be used to provide maintenance services.
Our sales professionals, sales representatives and distributors strive
to develop close relationships with current and prospective customers. We
maintain constant contact with customers to assess their needs and to update
them on the latest product developments. In addition, our sales professionals
regularly attend national and international trade and technical shows to stay
abreast of industry trends and foster deeper relationships with customers. After
contact has been initiated with a potential client, we conduct a variety of
meetings and presentations to introduce our products and services. Typically,
customers will be provided with price quotations, tool and process
specifications, and product demonstrations before an order is produced.
COMPETITION
Substantial competition exists for our products. Competitors range from
small companies that compete with us with a single product and/or in a single
region to global companies with multiple product lines. We believe that our
strong competitive position is based on our ability to successfully provide
products and services that address customer requirements.
SEMICONDUCTOR CMP
Applied Materials and Ebara are the market leaders in mainstream
semiconductor CMP products. The remaining market is divided among several
smaller companies. We have traditionally focused on CMP niche and specialty
applications in which Applied Materials does not concentrate or materially
participate. However, the launch of NTREPID(TM) provides us with the opportunity
to compete on a technical basis in the significantly larger mainstream
semiconductor CMP market. In this market, we plan to focus on non-copper CMP
applications where Ebara has a leading market share and avoid competing directly
with Applied Materials, which focuses on copper applications.
44
SEMICONDUCTOR NICHE MARKET AND APPLICATIONS
Within our small niche markets and applications, we face competition
from a variety of companies. In failure analysis, we face competition from other
manufacturers of semi-automated CMP tools, including Logitech and MAT, Inc.
Logitech and MAT, Inc. tools are designed to compete against nSPIRE(TM) and
nHANCE(R), which are CMP tools adapted to this application. In response to our
competition, we developed a next generation tool specifically for failure
analysis, nOVATION(R). Currently, we are not aware of any competition for
nOVATION(R).
Our main competition in backgrinding is Disco Corporation, with what we
believe to be an estimated 80% market share, followed by two other Japanese
companies, Okamoto and Accretech. Although, we have sold both nTELLECT(R) and
nGENUITY(TM) grinders for this application, we avoid these older mainstream
applications and focus our efforts on growth markets where we can have a leading
position or a differentiated technology.
SILICON WAFER FABRICATION AND NICHE MARKETS
In silicon wafer fabrication and niche markets, our primary competition
is from Lapmaster and Peter Wolters (now owned by Novellus). We believe that our
nTREPID(TM) polisher is a generation ahead of the tools offered by these
competitors.
SOI/MEMS
We have been successful in marketing our nTEGRITY(TM) product to
smaller customers in the SOI market, but have not able to gain wide acceptance
with the larger companies that require newer technologies unavailable on
nTEGRITY(TM), such as integrated cleaning, 300mm-capable wafer grinding and
optical endpoint detection. The first installation of our new nVISION(TM)
optical endpoint tool was to a major SOI producer and the launch of nTREPID(TM)
will provide the other technical innovations required to compete in this market.
MEMS are mostly low volume applications where there is no need for
sophisticated high volume production tools. We face competition in this market
primarily from de-commissioned Integrated Process Equipment Corp. CMP tools.
LED
In the LED market, our main competition comes from Disco Corporation
for the sale of grinders. We have developed a market-leading position with
respect to Disco Corporation and others by anticipating a shift to silicon
carbide as a substrate for the production of LED devices. Cree, Disco
Corporation, Okamoto and Accretech are attempting to enter this market with
adaptations of the same grinders they use for semiconductor backgrinding.
DATA STORAGE
Our main competitors in the data storage market are Applied Materials
and Ebara. However, these companies have not adapted their products to the
particularly demanding polishing requirements of this market. We believe that
lower-tiered CMP equipment companies do not have the technology to compete
effectively in this market.
OPTICS
Our optics products face competition from lower quality and cheaper
tools from Asia, as well as from products offered by small family-owned
businesses.
45
MANUFACTURING
Our headquarters are located approximately 185 miles south of San Jose
in San Luis Obispo, California. We lease a 135,000 square foot building
partially owned by Alan Strasbaugh our Chairman of the Board and major
shareholder. The facility is comprised of approximately 106,000 square feet of
manufacturing space, including 11,600 square feet of clean assembly space and
1,200 square feet of clean rooms (60% Class 100, 40% Class 10). All of our
manufacturing is completed at these facilities with full ability for design,
fabrication, assembly and distribution requiring a minimal amount of
outsourcing. We estimate that current manufacturing capacity provides us with
the ability to substantially increase sales with only the addition of personnel
and relatively little capital equipment expenditures. We estimate that the
facilities, machinery and equipment will support annual net revenues of
approximately $100 million.
PRODUCT DEVELOPMENT
Product development is spearheaded by our senior management and our
intellectual property committee, which evaluates the development of new products
and new market applications for existing products. For example, the NSPIRE(TM)
and NHANCE(R) were first introduced into the market as high performance CMP
tools for research and development applications. To widen the application of
these tools, we developed a new process called "whole wafer deconstruct" and
launched these tools into the failure analysis market reusing existing
technology for a completely new application.
Between 2002 and 2005, we increased our research and development budget
to continue the development of leading next generation tools and technologies.
We spent over $10 million in product development and research and development
during this period. The result was the development of three new major tools
(NTREPID(TM), NOVATION(R), AND NVISION(TM)) and one system upgrade (CMP
Enhancement(TM)). We believe that these products will be fully accepted into the
market. These products are now beginning to generate revenue, and we believe
that they will comprise a significant portion of our future revenue.
In addition, our engineering team is currently developing the 7AG, a
new modular 300mm-capable wafer grinder that has the capability to bring
grinding into front-end-of-line semiconductor manufacturing for the first time.
The prototype of this tool has been used for several months by the world's
foremost chip manufacturer to demonstrate a new chip manufacturing methodology
that has the potential to expand the market for wafer grinding tools. The 7AG
was also designed to be highly competitive for next generation industry
requirements in other industries, such as silicon wafer, solar cell, LED and
advanced chip packaging.
INTELLECTUAL PROPERTY
We believe that we have a broad intellectual property portfolio. We
primarily own intellectual property protecting the design features or operating
methods for tools manufactured by us for polishing or grinding semiconductor and
silicon wafers. Our portfolio consists of 123 trade secrets and processes, 70
issued patents, 12 licensed patents, and 45 patents pending. Our ten most
important patents were issued between June 1995 and July 2007. The duration of
these patents runs until between June 2012 and August 2024. The duration of our
entire patent portfolio also runs until between June 2012 and August 2024. With
customers worldwide, we have received international patents covering Japan,
China, Taiwan, Europe, Korea and Singapore.
In 2000, as part of a capital infusion by Lam Research Corporation, or
Lam, into R. H. Strasbaugh, we sold certain intellectual property to Lam, or Lam
Intellectual Property, for $4 million and concurrently entered into a License
Agreement with Lam. Pursuant to the terms of the License Agreement, for the
duration of the License Agreement, which is perpetual unless terminated as
described below, Lam granted to us a non-exclusive, royalty-free worldwide
46
license to use, upgrade, or modify the Lam Intellectual Property in industries
that develop, design, make, use, sell, repair or service semiconductor
processing equipment used in the fabrication of integrated circuits. These
industries are collectively referred to in this prospectus as the Semiconductor
Processing Equipment Industry. Additionally, pursuant to the License Agreement,
Lam granted to us an irrevocable, perpetual, exclusive, royalty-free worldwide
license to use the Lam Intellectual Property in any industry except the
Semiconductor Processing Equipment Industry. The License Agreement may be
terminated upon either party breaching a material provision of the License
Agreement, ceasing to do business, ceasing to carry on as a going concern or
becoming insolvent. The licensed intellectual property originally consisted of 6
issued patents, 9 patent applications and 19 internal disclosures related to
CMP. At this time 12 patents have been issued and licensed back to us.
TRADEMARKS
Our trademarks are filed and/or registered for a series of product
names, all beginning with the letter "n." We currently have six registered
trademarks, five trademarks and one trademark with a filed application for
registration.
EMPLOYEES
As of February 1, 2008, we employed 81 full and part-time employees.
None of our employees are represented by labor unions, and there have not been
any work stoppages at our facilities. We generally consider our relationships
with our employees to be satisfactory.
FACILITIES
Our corporate headquarters is located approximately 185 miles south of
San Jose in San Luis Obispo, California. We operate out of a 135,000 square foot
building located in a small industrial park. The facility is made up of
approximately 106,000 square feet of manufacturing space, including 11,600
square feet of clean assembly space and 1,200 square feet of cleanroom space
(60% Class 100, 40% Class 10). The building is jointly owned by Alan Strasbaugh
and his former wife, April Paletsas, with each owning an undivided one-half
interest in the property, and leased to R. H. Strasbaugh, on a month-to-month
basis, at $84,000 per month. During 2005, 2006 and the first nine months of
2007, our total lease costs were $955,780, $1,000,280 and $756,000,
respectively.
LEGAL PROCEEDINGS
On December 1, 2006, a complaint on joinder for declaratory relief was
filed by April Paletsas requesting that we be joined to a matter in the San Luis
Obispo Superior Court involving Alan Strasbaugh and his former wife, April
Paletsas. The Court issued an order allowing our subsidiary, R. H. Strasbaugh to
be joined, and management intends to vigorously defend this lawsuit. Ms.
Palatses is requesting a declaration by the Court that R. H. Strasbaugh is
required to install a new roof on the leased facilities in San Luis Obispo under
the repair and maintenance covenants of the lease covering our corporate
facilities, between Alan Strasbaugh and Ms. Paletsas, as landlords, and R. H.
Strasbaugh, as lessee. The case is currently pending in the discovery stage and
Ms. Palates has filed a motion for Summary Judgment seeking to establish R. H.
Strasbaugh's liability to replace the roof. We are currently unable to evaluate
the likelihood of an unfavorable result or the range of potential loss. However,
we plan to vigorously defend this action and we believe that all of our defenses
are meritorious.
47
On or about August 15, 2006, John Rzezuski filed a complaint in the
Commonwealth of Massachusetts Superior Court against R. H. Strasbaugh alleging
negligence and breach of implied warranty. Mr. Rzezuski alleges that he was
injured while using a product we designed, manufactured and sold to Mr.
Rzezuski's employer. Mr. Rzezuski demands a judgment in an amount sufficient to
compensate him for his losses and damages but does not allege with specificity
his injuries or the relief sought. We are unable to reasonably estimate a
potential range of loss and, further, we believe that the possibility of any
payment is remote. Our insurance carrier has assumed the defense of this action.
INTERNET WEBSITE
Our Internet website is www.strasbaugh.com. The content of our Internet
website does not constitute a part of this prospectus.
48
MANAGEMENT
DIRECTORS AND EXECUTIVE OFFICERS
Our directors and executive officers as of February 1, 2008 are as
follows:
NAME AGE POSITIONS HELD
---- --- --------------
Alan Strasbaugh (1)......... 59 Chairman of the Board
Chuck Schillings............ 48 President and Chief Executive Officer
Richard Nance............... 59 Executive Vice President and Chief
Financial Officer
Michael Kirkpatrick......... 50 Director of Sales and Marketing
Allan Paterson.............. 56 Vice President of Business Development
Wesley Cummins (1).......... 30 Director
David Porter (1) (2)........ 65 Director
John Givens................. 45 Director
-----------------
|
(1) Member of our Compensation Committee and Nominating and Corporate Governance
Committee.
(2) Member of our Audit Committee
ALAN STRASBAUGH has served as our Chairman of the Board since May 2007
and as Chairman of the Board of our operating subsidiary, R. H. Strasbaugh,
since 1978. Mr. Strasbaugh also served as R. H. Strasbaugh's Chief Executive
Officer from 1988 to 1998. Prior to that, he served as the Director of
Operations of R. H. Strasbaugh for 10 years. Mr. Strasbaugh has been awarded
eight United States patents related to semiconductor manufacturing. Mr.
Strasbaugh is also employed by us as a technical advisor. Mr. Strasbaugh holds a
B.S. degree in Mechanical Engineering from California Polytechnic State
University, Pomona.
CHUCK SCHILLINGS has served as our President and Chief Executive
Officer since May 2007 and as President and Chief Executive Officer of our
operating subsidiary, R. H. Strasbaugh, since 2005. Mr. Schillings also served
as a member of the board of directors of R. H. Strasbaugh between February 2003
and May 2007. From 2001 to 2004, Mr. Schillings was engaged in real estate
development and was President and director of a not-for-profit organization he
co-founded. From 1995 to 2001, he held several sales and marketing management
positions at R. H. Strasbaugh. Mr. Schillings holds an M.S.B.A. degree in
International Business from San Francisco State University and a B.S. degree in
Business Finance with an Economics minor from San Diego State University.
RICHARD NANCE has served as our Executive Vice President and Chief
Financial Officer since May 2007 and as Chief Financial Officer and Vice
President - Finance of R. H. Strasbaugh since 2002. Prior to that, Mr. Nance was
the Chief Financial Officer of Greentrac, a privately held software company. He
has worked as a chief financial officer for both public and private companies
involved in software technology, manufacturing and international sales and
distribution. Mr. Nance is a licensed Certified Public Accountant with prior
experience as a National Bank Examiner with the United States Comptroller of the
Currency, a commercial banker, and has over 13 years of experience in business
consulting, strategic planning and advisory services. Mr. Nance holds a B.B.A.
degree in Banking and Finance from North Texas State University, a B.S. degree
in Accounting from Central State University of Oklahoma and memberships in the
American Institute of CPAs and the California Society of CPAs.
49
MICHAEL A. KIRKPATRICK has served as Director of Sales and Marketing of
R. H. Strasbaugh since 2004 and of Strasbaugh since May 2007. Mr. Kirkpatrick is
responsible for the worldwide sales and marketing of all of our products. During
his 15 years of employment at R. H. Strasbaugh, Mr. Kirkpatrick has served as
United States Sales Manager and General Manager for R. H. Strasbaugh's data
storage business and has been actively involved in its CMP program. Mr.
Kirkpatrick helped pioneer the application of CMP to the read/write head
fabrication process. During his career at R. H. Strasbaugh, Mr. Kirkpatrick has
been personally responsible for over $100 million in semiconductor equipment
sales. He holds a B.S. degree in Business Administration and Marketing from
California Polytechnic State University, San Luis Obispo, California.
ALLAN PATERSON has served as Vice President of Business Development of
R. H. Strasbaugh since 1995 and of Strasbaugh since May 2007 and is responsible
for new product identification and the development of marketing and business
development strategies. Mr. Paterson has over 25 years of experience in domestic
and international business, marketing and sales development. His experience
includes being responsible for sales, marketing and customer support for high
technology companies in Europe, Israel and in the United States. Mr. Patterson
has been awarded two United States patents related to semiconductor
manufacturing. Mr. Paterson holds a Higher National Diploma in Electrical
Technology from Cleveland College in the United Kingdom.
WESLEY CUMMINS has served as a member of our board of directors since
May 2007. Mr. Cummins is President of B. Riley and Co. Inc., an NASD-registered
broker-dealer, where he oversees the firm's investment banking, sales and
trading and research. From July of 2006 through September 10, 2007, Mr. Cummins
spearheaded the firm's initiative to grow the financial advisory and capital
raising services to middle publicly traded companies as Director of Capital
Markets of B. Riley and Co. Inc. Mr. Cummins joined B. Riley's Research
Department in February 2002 and was promoted to Director of Research in January
2003. During his tenure, he grew B. Riley's research coverage to more than 100
companies in the following sectors: retail, semiconductors, technology hardware,
software, IT services, communications, media and healthcare. While Director of
Research, Mr. Cummins was ranked No. 1 in the 2004 Forbes.com/StarMine-North
American Analyst Survey in the Best Stock Picker category for the Communications
Equipment sector. Prior to joining B. Riley, Mr. Cummins worked at Needham &
Company and at Kennedy Capital Management. He holds a B.S.B.A. degree from
Washington University in St. Louis. Mr. Cummins also currently serves as a
Director for Flight Safety Technologies (AMEX: FLT) and Davidson Optronics.
DAVID PORTER has served as a member of our board of directors since May
2007. Prior to his retirement on January 1, 2000, Mr. Porter was employed at
Ford Motor Company for thirty-six years. During his retirement, Mr. Porter has
served on the Board of Directors of the San Luis Obispo Botanical Gardens and as
the chairperson of the Gardens of Exploration Task Force and is a private
investor. Mr. Porter's education includes an Executive Business Program at the
University of Michigan and an A.B. in Chinese History from Stanford University.
JOHN GIVENS has served as a member of our board of directors since
November 2007. Dr. Givens is President of Innovative Materials Group, Inc. and
CMP Solutions, Ltd. which he founded in 1999 and 2002, respectively. Dr. Givens
has focused his career on the innovation and development of materials and
processes necessary to enable integrated circuit fabrication. His industrial
experience includes Vice President of Engineering for Thomas West, Inc., with a
focus on CMP pad material development and process implementation, and CMP
Section Manager for VLSI Technology with the responsibilities of CMP
manufacturability and process strategy. Dr. Givens received his B.S. in
Metallurgical Engineering, M.S. in Metallurgical Engineering and Ph.D. in
Materials Science & Engineering from the University of Illinois at Urbana -
Champaign.
50
COMPOSITION OF THE BOARD OF DIRECTORS
Our board of directors has responsibility for our overall corporate
governance and meets regularly throughout the year. Our bylaws provide that our
board of directors may fix the exact number of directors between four and seven.
Our board of directors has fixed the number of directors at five. We currently
have one vacancy on the board of directors. Our Nominating and Corporate
Governance Committee has commenced a search for one additional independent
director.
Our directors are elected annually and hold office until the next
annual meeting of shareholders, until their successors are elected or until
their earlier death, resignation or removal. Our directors are kept informed of
our business through discussions with our executive officers, by reviewing
materials provided to them and by participating in meetings of our board of
directors and its committees.
For so long as our shares of Series A Preferred Stock remain
outstanding, the holders of at least a majority of our issued and outstanding
shares of Series A Preferred Stock are entitled to nominate one member of our
board of directors. In addition, the holders of at least a majority of our
issued and outstanding shares of Series A Preferred Stock are entitled to
nominate a second member of our board of directors for successive one-year-terms
upon the accumulation of accrued and unpaid dividends for three or more
six-month periods or our failure to comply with the covenants or agreements set
forth in our articles of incorporation. The right to nominate a second director
will terminate upon the cure of the defaults creating the right to nominate a
second director. The holders of Series A Preferred Stock have nominated Wesley
Cummins as a member of our board of directors.
Our executive officers are appointed by and serve at the discretion of
our board of directors. There are no family relationships among our executive
officers and directors.
As discussed below, we have adopted procedures by which shareholders
may elect nominees to our board of directors.
CORPORATE GOVERNANCE
Our board of directors believes that good corporate governance is
paramount to ensure that Strasbaugh is managed for the long-term benefit of our
shareholders. Our board of directors has adopted corporate governance guidelines
that guide its actions with respect to, among other things, the composition of
the board of directors and its decision making processes, board of directors
meetings and involvement of management, the board of director's standing
committees and procedures for appointing members of the committees, and its
performance evaluation for our Chief Executive Officer.
Our board of directors has adopted a Code of Ethics and Corporate
Conduct that applies to all of our directors, officers and employees and an
additional Code of Business Ethics that applies to our Chief Executive Officer
and senior financial officers. The Codes of Ethics, as applied to our principal
executive officer, principal financial officer and principal accounting officer
constitutes our "code of ethics" within the meaning of Section 406 of the
Sarbanes-Oxley Act of 2002.
51
We intend to satisfy the disclosure requirement under Item 5.05 of Form
8-K relating to amendments to or waivers from provisions of these codes that
relate to one or more of the items set forth in Item 406(b) of Regulation S-B,
by describing on our Internet website, located at http://www.strasbaugh.com,
within four business days following the date of a waiver or a substantive
amendment, the date of the waiver or amendment, the nature of the amendment or
waiver, and the name of the person to whom the waiver was granted.
Information on our Internet website is not, and shall not be deemed to
be, a part of this prospectus or incorporated into any other filings we make
with the SEC.
DIRECTOR INDEPENDENCE
Our corporate governance guidelines provide that after a phase in
period a majority of the board of directors and all members of the Audit,
Compensation and Nominating and Corporate Governance Committees of the board of
directors will be independent. Our corporate governance guidelines provide a
phase in period such that we have 12 months from the date that this registration
statement is declared effective by the SEC, or Effective Date, to comply with
the requirement that a majority of our board of directors be independent. If we
lose compliance anytime after the 12 month phase in period, our corporate
governance guidelines provides a cure period to regain compliance if non
compliance is a result of a vacancy or a director ceasing to be independent due
to circumstances beyond their control.
On an annual basis, each director and executive officer is obligated to
complete a Director and Officer Questionnaire that requires disclosure of any
transactions with Strasbaugh in which a director or executive officer, or any
member of his or her immediate family, have a direct or indirect material
interest. Following completion of these questionnaires, the board of directors,
with the assistance of the Nominating and Corporate Governance Committee, makes
an annual determination as to the independence of each director using the
current standards for "independence" established by the SEC and NASDAQ Market
Place Rules, additional criteria set forth in our corporate governance
guidelines and consideration of any other material relationship a director may
have with Strasbaugh.
In July 2007, the board of directors determined that all directors
(other than Mr. Givens) are independent under these standards, except for Mr.
Strasbaugh, who serves as our Chairman of the Board and Mr. Cummins, who is
employed by B. Riley and Co. Inc. In November 2007, our board of directors
determined that Mr. Givens is independent under these standards. See "Certain
Relationships and Related Transactions" below.
SHAREHOLDER COMMUNICATIONS WITH OUR BOARD OF DIRECTORS
Our board of directors has implemented a process by which shareholders
may send written communications directly to the attention of our board of
directors or any individual member of our board of directors. David Porter, the
Chairman of our Audit Committee, is responsible for monitoring communications
from shareholders and providing copies of such communications to the other
directors as he considers appropriate. Communications will be forwarded to all
directors if they relate to substantive matters and include suggestions or
comments that Mr. Porter considers to be important for the directors to
consider. Shareholders who wish to communicate with our board of directors can
write to David Porter, The Board of Directors, Strasbaugh, 825 Buckley Road, San
Luis Obispo, California 93401.
52
COMMITTEES OF THE BOARD OF DIRECTORS
Our board of directors has established standing Audit, Compensation and
Nominating and Corporate Governance Committees. Each committee has a written
charter that is reviewed annually and revised as appropriate.
AUDIT COMMITTEE
Our Audit Committee selects our independent auditors, reviews the
results and scope of the audit and other services provided by our independent
auditors, and reviews our financial statements for each interim period and for
our year end.
Our Audit Committee operates pursuant to a charter approved by our
board of directors and our Audit Committee, according to the rules and
regulations of the SEC. Our Audit Committee Charter provides that after a phase
in period our Audit Committee must consist of at least three independent
members. Our Audit Committee Charter provides a phase in period such that our
Audit Committee must be comprised of (i) at least one independent member on the
Effective Date; (ii) a majority of independent members within 90 days of the
Effective Date; and (iii) all independent directors within 12 months of the
Effective Date. If we lose compliance anytime after the 12-month phase in
period, our Audit Committee Charter provides a cure period to regain compliance
with the independence requirements if the non compliance is a result of one
vacancy or a one director ceasing to be independent due to circumstances beyond
their control.
David Porter is the only member of our Audit Committee. Our board of
directors has determined that Messrs. Porter and Givens are "independent" under
our Corporate Governance Guidelines, and the Nasdaq Marketplace Rules and that
each satisfies the other requirements under SEC rules regarding audit committee
membership. We currently do not have a director that (i) qualifies as an "audit
committee financial expert" under applicable SEC rules and regulations governing
the composition of the Audit Committee, and (ii) satisfies the "financial
sophistication" requirements of the NASDAQ Marketplace Rules.
COMPENSATION COMMITTEE
Our Compensation Committee is responsible for establishing and
administering our overall policies on compensation and the compensation to be
provided to our executive officers, including, among other things, annual
salaries and bonuses, stock options, stock grants, other stock-based awards, and
other incentive compensation arrangements. In addition, the Compensation
Committee reviews the philosophy and policies behind the salary, bonus and stock
compensation arrangements for all other employees. Although our Compensation
Committee makes all compensation decisions as to our executive officers, our
Chief Executive Officer makes recommendations to our Compensation Committee
regarding compensation for the other named executive officers. Our Compensation
Committee has the authority to administer our 2007 Share Incentive Plan with
respect to grants to executive officers and directors, and also has authority to
make equity awards under our 2007 Share Incentive Plan to all other eligible
individuals. However, our board of directors may retain, reassume or exercise
from time to time the power to administer our 2007 Share Incentive Plan. Equity
awards made to members of the Compensation Committee must be authorized and
approved by a disinterested majority of our board of directors.
The Compensation Committee evaluates both performance and compensation
to ensure that the total compensation paid to our executive officers is fair,
reasonable and competitive so that we can attract and retain superior employees
in key positions. The Compensation Committee believes that compensation packages
offered to our executives, including the named executive officers, should
include both cash and equity-based compensation that reward performance as
measured against established goals. The Compensation Committee has the authority
to retain consultants, and other advisors and in furtherance of the foregoing
objectives.
53
Our Compensation Committee operates pursuant to a charter approved by
our board of directors and our Compensation Committee. Our Compensation
Committee Charter provides that, after a phase in period, our Compensation
Committee must consist of at least three independent members. Our Compensation
Committee Charter provides a phase in period such that our Compensation
Committee must be comprised of (i) at least one independent member on the
Effective Date; (ii) a majority of independent members within 90 days of the
Effective Date; and (iii) all independent directors within 12 months of the
Effective Date. If we lose compliance anytime after the 12-month phase in
period, our Compensation Committee Charter provides a cure period to regain
compliance with the independence requirements if the non compliance is a result
of one vacancy or a one director ceasing to be independent due to circumstances
beyond their control.
Our Compensation Committee consists of Messrs. Porter, Strasbaugh and
Cummins. Mr. Porter acts as Chairman of our Compensation Committee. Our board of
directors has determined that Mr. Porter is "independent" under the current
NASDAQ Marketplace Rules.
NOMINATING AND CORPORATE GOVERNANCE COMMITTEE
Our Nominating and Corporate Governance Committee selects nominees for
our board of directors. The Nominating and Corporate Governance Committee will
consider candidates for director recommended by any shareholder that is the
beneficial owner of shares representing more than 1% of the then-outstanding
shares of our common stock and who has beneficially owned those shares for at
least one year. The Nominating and Corporate Governance Committee will evaluate
those recommendations by applying its regular nominee criteria and considering
the additional information described in the Nominating and Corporate Governance
Committee's below-referenced charter. Shareholders that desire to recommend
candidates for the board of directors for evaluation may do so by contacting
Strasbaugh in writing, identifying the potential candidate and providing
background and other relevant information. Our Nominating and Corporate
Governance Committee utilizes a variety of methods for identifying and
evaluating nominees for director. Candidates may also come to the attention of
the Nominating and Corporate Governance Committee through current members of our
board of directors, professional search firms and other persons. In evaluating
potential candidates, our Nominating and Corporate Governance Committee will
take into account a number of factors, including, among others, the following:
o the candidate's independence from management;
o whether the candidate has relevant business experience;
o judgment, skill, integrity and reputation;
o existing commitments to other businesses;
o corporate governance background;
o financial and accounting background, to enable the committee to
determine whether the candidate would be suitable for Audit
Committee membership; and
o the size and composition of our board of directors.
54
Our Nominating and Corporate Governance Committee operates pursuant to
a charter approved by our board of directors and our Nominating and Corporate
Governance Committee. Our Nominating and Corporate Governance Charter provides
that, after a phase in period, our Nominating and Corporate Governance must
consist of at least three independent members. Our Nominating and Corporate
Governance Charter provides a phase in period such that our Nominating and
Corporate Governance Committee must be comprised of (i) at least one independent
member on the Effective Date; (ii) a majority of independent members within 90
days of the Effective Date; and (iii) all independent directors within 12 months
of the Effective Date. If we lose compliance anytime after the 12-month phase in
period, our Nominating and Corporate Governance Charter provides a cure period
to regain compliance with the independence requirements if the non compliance is
a result of one vacancy or a one director ceasing to be independent due to
circumstances beyond their control.
Our Nominating and Corporate Governance Committee consists of Messrs.
Porter, Strasbaugh and Cummins. Mr. Porter acts as chairman of our Nominating
and Corporate Governance Committee. Our board of directors has determined that
Mr. Porter is "independent" under the NASDAQ Marketplace Rules.
COMPENSATION OF DIRECTORS
We use a combination of cash and stock-based incentive compensation to
attract and retain qualified candidates to serve on our board of directors. In
setting the compensation of directors, we consider the significant amount of
time that members of the board of directors spend in fulfilling their duties to
Strasbaugh as well as the experience level we require to serve on our board of
directors. The board of directors, through its Compensation Committee, annually
reviews the compensation and compensation policies for members of the board of
directors. In recommending director compensation, the Compensation Committee is
guided by three goals:
o compensation should fairly pay directors for work required in a
company of our size and scope;
o compensation should align directors' interests with the long-term
interests of our shareholders; and
o the structure of the compensation should be clearly disclosed to
our shareholders.
Each of our directors is paid $12,000 per year for serving on the board
of directors. The Chairman of the Audit Committee, Compensation Committee and
Nominating and Corporate Governance Committee is paid an additional $12,000,
$4,000 and $2,000 per year, respectively, for serving in such capacity.
Directors who serve (but do not chair) on the Audit Committee, Compensation
Committee and Nominating and Corporate Governance Committee are paid an
additional $3,000, $2,000 and $1,000 per year, respectively, for serving in such
capacity. On May 24, 2007, each of our directors (other than Mr. Givens) was
issued options to purchase 18,000 shares of our common stock pursuant to our
2007 Share Incentive Plan. In addition, directors are reimbursed for certain
reasonable documented expenses in connection with attendance at meetings of our
board of directors and its committees. Employee directors do not receive
compensation in connection with their service as directors.
55
DIRECTOR COMPENSATION TABLE
The following table summarizes for the twelve months ended December 31,
2007, the compensation awarded to or paid to, or earned by, our current
directors. The following table also summarizes for the twelve months ended
December 31, 2007, the compensation awarded to or paid to, or earned by, the
former members of our board of directors. Our former directors, J. Michael
Gullard, Bryant Riley, Bob D'Agostino, and Robert Gallagher, resigned as members
of our board of directors in connection with the Share Exchange Transaction that
was consummated on May 24, 2007. Our former directors, Dana Ditmore and Gary
Meek, resigned as members of our board of directors on June 21, 2007 and July 7,
2007, respectfully, due to personal reasons.
Fees Earned or Option All Other
Paid in Cash Awards Compensation Total
Name ($) ($)(1) ($) ($)
---------------------------- -------------- ------------ ------------ -------------
Alan Strasbaugh 7,500 692(2) 80,277(3) 88,469
David Porter 15,000 692(2) -- 15,692
Wesley Cummins 7,500 692(2) -- 8,192
John Givens -- -- 1,000(4) 1,000
Dana Ditmore ................... -- 692(5) -- 692
Former Board Member
Gary Meek -- 692(6) -- 692
Former Board Member
J. Michael Gullard.............. -- -- 25,000(7) 25,000
Former Board Member
Bryant R. Riley................. -- -- -- --
Former Board Member
Robert J. Gallagher............. 10,000 -- -- 10,000
Former Board Member
Bob D'Agostino.................. 10,000 -- -- 10,000
Former Board Member
__________
|
(1) The amount reflected in this column is the compensation cost we recognized
for financial statement reporting purposes during 2007 under SFAS No.
123(R). The fair value of each grant is estimated on the date of grant
using the Black-Scholes option-pricing model with the following
weighted-average assumptions for 2007:
Dividend yield......................................... 0%
Expected volatility.................................... 48.1%
Risk-free interest rates............................... 4.81%
Expected option life (in years)........................ 6.5
Weighted-average exercise price per common share....... $1.71
|
(2) The director was granted an option to purchase 18,000 shares of our common
stock on May 24, 2007, which option remained outstanding on December 31,
2007. The stock option vests pursuant to a three year vesting schedule,
whereby 33% of the option becomes exercisable on May 24, 2008, 33% of the
option becomes exercisable on May 24, 2009 and 34% becomes exercisable on
May 24, 2010. The option expires on May 24, 2017.
(3) Includes $79,231 of base salary paid to Mr. Alan Strasbaugh pursuant to
the terms of his Employment Agreement dated May 24, 2007.
(4) Represents payments made for consulting services during the year ended
December, 31 2007.
(5) Mr. Ditmore was granted an option to purchase 18,000 shares of our common
stock on May 24, 2007. The entire option lapsed when Mr. Ditmore resigned
on June 21, 2007. Vesting was pursuant to a three year vesting schedule,
whereby 33% of the option would have been exercisable on May 24, 2008, 33%
of the option would have been exercisable on May 24, 2009 and 34% of the
option would have been exercisable on May 24, 2010. Had it not lapsed, the
option would have expired on May 24, 2017.
56
(6) Mr. Meek was granted an option to purchase 18,000 shares of our common
stock on May 24, 2007. The entire option lapsed when Mr. Meek resigned on
July 7, 2007. Vesting was pursuant to a three year vesting schedule,
whereby 33% of the option would have been exercisable on May 24, 2008, 33%
of the option would have been exercisable on May 24, 2009 and 34% of the
option would have been exercisable on May 24, 2010. Had it not lapsed, the
option would have expired on May 24, 2017.
(7) Represents base salary paid to Mr. Gullard for his services as our Chief
Executive Officer from January 1, 2007 until his resignation on May 24,
2007.
COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION
No member of our board of directors has a relationship that would
constitute an interlocking relationship with executive officers and directors of
another entity.
COMPENSATION OF EXECUTIVE OFFICERS
SUMMARY COMPENSATION TABLE
The following table shows for the twelve months ended December 31, 2006
and December 31, 2007, the compensation awarded to or paid to, or earned by, our
former Chief Executive Officer, J. Michael Gullard, who was our only executive
officer from January 1, 2006 to May 24, 2007. Mr. Gullard resigned his positions
in connection with the Share Exchange Transaction that was consummated on May
24, 2007. The following table also shows for the fiscal years ended December 31,
2006 and December 31, 2007, the compensation awarded or paid to, or earned by,
our current Chief Executive Officer and two most highly compensated executive
officers, or named executive officers.
Option All other
Year Salary Bonus Awards Compensation Total
Name and Principal Position ($) ($) ($) ($)(1) ($) ($)
------------------------------------ ------ -------- --------- ---------- ------------- ------------
J. Michael Gullard.................. 2006 50,000 -- -- -- 50,000
Former President and Chief Executive 2007 25,000 -- -- -- 25,000
Officer(2)
Chuck Schillings.................... 2006 192,577 50,000 -- -- 242,577
President and Chief Executive Officer 2007 226,603 50,000 7,692 3,318(4) 287,614
of Strasbaugh and R. H.
Strasbaugh(3)
Richard Nance....................... 2006 135,911 15,000 -- -- 150,911
Chief Financial Officer of Strasbaugh 2007 190,325 30,000 10,230 230,555
and R. H. Strasbaugh(3)
Allan Paterson...................... 2006 95,192 -- -- 3,269(4) 98,461
Vice President of Business 2007 167,576 -- 7,692 1,904(4) 177,172
Development of Strasbaugh and
R. H. Strasbaugh(3)
Michael Kirkpatrick................. 2006 96,292 -- -- 106,434(5) 202,726
Director of Sales and Marketing of 2007 100,138 -- -- 94,245(6) 194,383
Strasbaugh and R. H. Strasbaugh
__________
|
(1) The amount reflected in this column is the compensation cost we recognized
for financial statement reporting purposes during 2007 under SFAS No.
123(R). The fair value of each grant is estimated on the date of grant
using the Black-Scholes option-pricing model with the following
weighted-average assumptions for 2007:
Dividend yield.............................................. 0%
Expected volatility......................................... 48.1%
Risk-free interest rates.................................... 4.81%
Expected option life (in years)............................. 6.5
Weighted-average exercise price per common share............ $1.71
|
(2) Mr. Gullard resigned as our chief executive officer on May 24, 2007.
57
(3) Amounts for 2006 represent compensation received for services provided as
an executive officer of R. H. Strasbaugh. Amounts for 2007 represent
compensation received for services provided as an executive officer of
Strasbaugh and R. H. Strasbaugh.
(4) Represents our contributions to the employee's 401(k) plan.
(5) Includes $103,130 in commissions that we paid to Mr. Kirkpatrick in 2006.
(6) Includes $90,750 in commissions that we paid to Mr. Kirkpatrick in 2007.
EMPLOYMENT AGREEMENTS
EXECUTIVE EMPLOYMENT AGREEMENTS DATED MAY 24, 2007 WITH EACH OF CHUCK
SCHILLINGS AND RICHARD NANCE
The Executive Employment Agreements with Mr. Schillings and Mr. Nance
provide for a three-year term and automatic one-year renewals thereafter, unless
either the employee or Strasbaugh provides written notice to the other at least
90 days prior to the expiration of the then-current term.
Mr. Schillings is to be employed as our President and Chief Executive
Officer and is to receive an annual base salary of $245,000 during the first
12-month period that his agreement is in effect, after which our Compensation
Committee may, in its sole discretion, increase Mr. Schillings' annual base
salary. Further, Mr. Schillings is eligible for an annual cash bonus, based upon
performance criteria to be established by the board, of up to 40% of his annual
base salary. On May 24, 2007, Mr. Schillings was issued options to purchase an
aggregate of 200,000 shares of our common stock pursuant to our 2007 Share
Incentive Plan.
Mr. Nance is to be employed as our Chief Financial Officer and is to
receive an annual base salary of $200,000 during the first 12-month period that
his agreement is in effect, after which our Compensation Committee may, in its
sole discretion, increase Mr. Nance's annual base salary. Further, Mr. Nance is
eligible for an annual cash bonus, based upon performance criteria to be
established by the Board, of up to 35% of his annual base salary. On May 24,
2007, Mr. Nance was issued options to purchase an aggregate of 266,000 shares of
our common stock pursuant to our 2007 Share Incentive Plan.
We are required to provide each of Messrs. Schillings and Nance certain
benefits, to the extent we offer them, including the right to participate in our
employee medical, dental, life and disability insurance plans, and any
additional compensation, benefit, pension, stock option, stock purchase, and
401(k) plans. We are also required to provide Mr. Schillings with five weeks of
paid vacation per year and Mr. Nance with three weeks of paid vacation per year.
Each of Messrs. Schillings and Nance are also entitled to reimbursement
for all reasonable business expenses incurred in the performance of their
services under the Executive Employment Agreements, including expenditures for
entertainment, gifts, cellular telephone expenses, and travel.
If the employment relationship with Mr. Schillings or Mr. Nance is
terminated (a) by us or the employee upon 90 days' written notice, (b) by us for
due cause, or (c) by the employee upon 30 days' written notice or by the
employee breaching his employment agreement by refusing to continue his
employment and failing to give the requisite 90 days' written notice, all
compensation and benefits shall cease as of the date of termination, other than:
(i) those benefits that are provided by retirement and benefit plans and
programs specifically adopted and approved by us for the employee that are
earned and vested by the date of termination; (ii) employee's pro rata annual
salary through the date of termination; (iii) any restricted stock awards which
have vested as of the date of termination pursuant to the terms of the agreement
granting the awards; and (iv) accrued vacation as required by California law.
If the employment relationship is terminated due to incapacity or death
of the employee, the employee or his estate or legal representative, will be
entitled to (i) those benefits that are provided by retirement and benefits
plans and programs specifically adopted and approved by us for his benefit that
are earned and vested at the date of termination, (ii) a prorated incentive
bonus for the fiscal year in which incapacity or death occurs, and, (iii) even
though no longer employed by us, the employee shall continue to receive the
annual salary compensation for six months following the date of termination,
offset, however, by any payments received by the employee as a result of any
disability insurance maintained by us for his benefit.
58
If the employment relationship is terminated by the employee for good
reason or by us upon written notice, then the employee shall be entitled to (i)
his salary in effect as of the date of termination through the end of the month
during which the termination occurs plus credit for any vacation earned but not
taken, (ii) six months of base salary, (iii) a prorated incentive bonus for the
fiscal year during which termination occurs and (iv) maintain, at our expense,
all medical and life insurance to which he was entitled immediately prior to the
date of termination for a period not to exceed 12 months.
The term "good reason" is defined in each of the Executive Employment
Agreements as (i) a general assignment by us for the benefit of creditors or
filing by us of a voluntary bankruptcy petition or the filing against us of any
involuntary bankruptcy which remains undismissed for 30 days or more or if a
trustee, receiver or liquidator is appointed, (ii) any material changes in the
employee's titles, duties or responsibilities without his express written
consent, or (iii) the employee is not paid the compensation and benefits
required under the Executive Employment Agreement.
The term "due cause" is defined in each of the Executive Employment
Agreements as (i) any intentional misapplication by the employee of Strasbaugh
funds or other material assets, or any other act of dishonesty injurious to
Strasbaugh committed by the employee; or (ii) the employee's conviction of (a) a
felony or (b) a crime involving moral turpitude; or (iii) the employee's use or
possession of any controlled substance or chronic abuse of alcoholic beverages,
which use or possession the board reasonably determines renders the employee
unfit to serve in his capacity as a senior executive of Strasbaugh; or (iv) the
employee's breach, nonperformance or nonobservance of any of the terms of his
employment agreement with us, including but not limited to the employee's
failure to adequately perform his duties or comply with the reasonable
directions of the board; but notwithstanding anything in the foregoing
subsections (iii) or (iv) to the contrary, we may not terminate the employee
unless our board of directors first provides the employee with a written
memorandum describing in detail how his performance thereunder is not
satisfactory and the employee is given a reasonable period of time (not less
than 30 days) to remedy the unsatisfactory performance related by the board of
directors to the employee in that memorandum. A determination of whether the
employee has satisfactorily remedied the unsatisfactory performance shall be
promptly made by a majority of the disinterested directors of the board (or the
entire board, but not including the employee, if there are no disinterested
directors) at the end of the period provided to the employee for remedy, and the
board's determination shall be final.
EMPLOYMENT AGREEMENT DATED MAY 24, 2007 WITH ALAN STRASBAUGH
The Employment Agreement with Mr. Strasbaugh provides for a five-year
term and renewal based upon mutual agreement. For providing services to
Strasbaugh as a technical advisor, Mr. Strasbaugh is to receive an annual base
salary of $100,000.
We are required to provide Mr. Strasbaugh with certain benefits, to the
extent we offer them, including the right to participate in our employee
medical, dental, life and disability insurance plans. Additionally, Mr.
Strasbaugh is eligible for holiday and vacation pay in accordance with our
employment policies. Mr. Strasbaugh is also entitled to reimbursement for all
reasonable business expenses incurred on behalf of Strasbaugh, including
expenditures for travel.
The Employment Agreement with Mr. Strasbaugh may only be terminated for
"cause," or upon disability or death. Upon termination on death, Mr.
Strasbaugh's estate will be entitled to receive a payment equal to 60 days of
Mr. Strasbaugh's base salary.
The term "cause" is defined in the Employment Agreement as (i) any act
of personal dishonesty, including, but not limited to, any intentional
misapplication of Strasbaugh's funds or other property, or action resulting in
personal gain to the employee at the expense of Strasbaugh; or (ii) employee's
regular neglect of his duties or Employee's gross negligence or willful
misconduct in the performance of his duties; or (iii) disobedience of a lawful
and reasonable order or directive given to employee by our board of directors
and within the scope of employee's duties that is not cured within ten (10) days
59
after receiving written notice from us; or (iv) employee's participation in a
criminal activity or in an activity involving moral turpitude that has a
material adverse effect (the report in the public media of conduct described in
this subparagraph (iv), above, shall be deemed to cause a material adverse
effect on Strasbaugh); or (v) employee's misappropriation or disclosure to
others in competition with us any of our confidential information, including
investment prospects, analysis or advice, customer lists, plans or other
property interests of Strasbaugh.
OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END
The following table sets forth information about outstanding equity
awards held by our former chief executive officer, J. Michael Gullard, and our
named executive officers as of December 31, 2007.
Option Awards
------------------------------------------------------------------
Number of Number of
Securities Securities
Underlying Underlying
Unexercised Unexercised
Options Options Option Option
(#) (#) Exercise Expiration
Name Exercisable Unexercisable Price ($) Date
---------------------- ------------- --------------- ------------- ------------
J. Michael Gullard -- -- -- --
Chuck Schillings -- 200,000(1) 1.71 5/24/27
Richard Nance -- 266,000(1) 1.71 5/24/17
Allan Paterson -- 200,000(1) 1.71 5/24/17
Michael Kirkpatrick -- -- -- --
______________
(1) The stock option was granted on May 24, 2007 and vests pursuant to a three
year vesting schedule, whereby 33% of the option becomes exercisable on
May 24, 2008, 33% of the option becomes exercisable on May 24, 2009 and
34% becomes exercisable on May 24, 2010.
|
2007 SHARE INCENTIVE PLAN
Our 2007 Share Incentive Plan, or 2007 Plan, is intended to promote
Strasbaugh's interests by providing eligible persons in our service with the
opportunity to acquire a proprietary or economic interest, or otherwise increase
their proprietary or economic interest, in us as an incentive for them to remain
in such service and render superior performance during such service. The 2007
Plan consists of two equity-based incentive programs, the Discretionary Grant
Program and the Stock Issuance Program. Principal features of each program are
summarized below. Our Compensation Committee is in the process of amending our
2007 Plan to conform to provisions of Internal Revenue Code Section 409A. We
expect to complete these amendments prior to the effectiveness of the
Registration Statement of which this prospectus is a part.
ADMINISTRATION
The Compensation Committee of our board of directors has the exclusive
authority to administer the Discretionary Grant and Stock Issuance Programs with
respect to option grants, restricted stock awards, restricted stock units, stock
appreciation rights, direct stock issuances and other stock-based awards, or
equity awards, made to executive officers and non-employee board members, and
also has the authority to make equity awards under those programs to all other
eligible individuals. However, our board of directors may retain, reassume or
exercise from time to time the power to administer those programs. Equity awards
made to members of the Compensation Committee must be authorized and approved by
a disinterested majority of our board of directors.
The term "plan administrator," as used in this summary, means the
Compensation Committee or our board of directors, to the extent either entity is
acting within the scope of its administrative jurisdiction under the 2007 Plan.
60
SHARE RESERVE
Initially, 2,000,000 shares of common stock are authorized for issuance
under the 2007 Plan. The 2007 Plan was adopted by our board of directors on
February 9, 2007 and approved by our shareholders on March 14, 2007. As of
February 1, 2008, options to purchase 1,339,000 shares of common stock were
issued and outstanding under the 2007 Plan.
No participant in the 2007 Plan may be granted equity awards for more
than 500,000 shares of common stock per calendar year. Shareholder approval of
this proposal constitutes approval of the 500,000 share limitation for purposes
of Internal Revenue Code Section 162(m). This share-limitation is intended to
assure that any deductions to which we would otherwise be entitled, either upon
the exercise of stock options or stock appreciation rights granted under the
Discretionary Grant Program with an exercise price per share equal to the fair
market value per share of our common stock on the grant date or upon the
subsequent sale of the shares purchased under those options, will not be subject
to the $1.0 million limitation on the income tax deductibility of compensation
paid per covered executive officer imposed under Internal Revenue Code Section
162(m). In addition, shares issued under the Stock Issuance Program may qualify
as performance-based compensation that is not subject to the Internal Revenue
Code Section 162(m) limitation, if the issuance of those shares is approved by
the Compensation Committee and the vesting is tied solely to the attainment of
the corporate performance milestones discussed below in the summary description
of that program.
The shares of common stock issuable under the 2007 Plan may be drawn
from shares of our authorized but unissued shares or from shares reacquired by
us, including shares repurchased on the open market. Shares subject to any
outstanding equity awards under the 2007 Plan that expire or otherwise terminate
before those shares are issued will be available for subsequent awards. Unvested
shares issued under the 2007 Plan and subsequently repurchased by us at the
option exercise or direct issue price paid per share, pursuant to our repurchase
rights under the 2007 Plan, will be added back to the number of shares reserved
for issuance under the 2007 Plan and will be available for subsequent
reissuance.
If the exercise price of an option under the 2007 Plan is paid with
shares of common stock, then the authorized reserve of common stock under the
2007 Plan will be reduced only by the net number of new shares issued under the
exercised stock option. If shares of common stock otherwise issuable under the
2007 Plan are withheld in satisfaction of the withholding taxes incurred in
connection with the issuance, exercise or vesting of an equity award, then the
number of shares of common stock available for issuance under the 2007 Plan will
be reduced only by the net number of shares issued pursuant to that equity
award. The withheld shares will not reduce the share reserve. Upon the exercise
of any stock appreciation right granted under the 2007 Plan, the share reserve
will only be reduced by the net number of shares actually issued upon exercise,
and not by the gross number of shares as to which the stock appreciation right
is exercised.
As soon as practicable following shareholder approval of the 2007 Plan
and the effectiveness of a registration statement to be filed by us with the SEC
registering our common stock under the Exchange Act, we intend to register the
issuance of our securities under the 2007 Plan on Form S-8 under the Securities
Act.
ELIGIBILITY
Officers, employees, non-employee directors, and consultants and
independent advisors who are under written contract and whose securities issued
pursuant to the 2007 Plan could be registered on Form S-8, all of whom are in
our service or the service of any parent or subsidiary of ours, whether now
existing or subsequently established, are eligible to participate in the
Discretionary Grant and Stock Issuance Programs.
VALUATION
The fair market value per share of our common stock on any relevant
date under the 2007 Plan will be deemed to be equal to the closing selling price
per share of our common stock at the close of regular hours trading on the Pink
Sheets(R) or the OTC Bulletin Board on that date, as the price is reported by
the National Association of Securities Dealers. If there is no closing selling
price for our common stock on the date in question, the fair market value will
be the closing selling price on the last preceding date for which a quotation
exists.
61
DISCRETIONARY GRANT PROGRAM
The plan administrator has complete discretion under the Discretionary
Grant Program to determine which eligible individuals are to receive equity
awards under that program, the time or times when those equity awards are to be
made, the number of shares subject to each award, the time or times when each
equity award is to vest and become exercisable, the maximum term for which the
equity award is to remain outstanding and the status of any granted option as
either an incentive stock option or a non-statutory option under the federal tax
laws.
STOCK OPTIONS. Each granted option will have an exercise price per
share determined by the plan administrator, provided that the exercise price
will not be less than 85% or 100% of the fair market value of a share on the
grant date in the case of non-statutory or incentive options, respectively. No
granted option will have a term in excess of ten years. Incentive options
granted to an employee who beneficially owns more than 10% of our outstanding
common stock must have exercise prices not less than 110% of the fair market
value of a share on the grant date and a term of not more than five years
measured from the grant date. Options generally will become exercisable in one
or more installments over a specified period of service measured from the grant
date. However, options may be structured so that they will be immediately
exercisable for any or all of the option shares. Any unvested shares acquired
under immediately exercisable options will be subject to repurchase, at the
exercise price paid per share, if the optionee ceases service with us prior to
vesting in those shares.
An optionee who ceases service with us other than due to misconduct
will have a limited time within which to exercise outstanding options for any
shares for which those options are vested and exercisable at the time of
cessation of service. The plan administrator has complete discretion to extend
the period following the optionee's cessation of service during which
outstanding options may be exercised (but not beyond the expiration date) and/or
to accelerate the exercisability or vesting of options in whole or in part.
Discretion may be exercised at any time while the options remain outstanding,
whether before or after the optionee's actual cessation of service.
STOCK APPRECIATION RIGHTS. The plan administrator has the authority to
issue the following three types of stock appreciation rights under the
Discretionary Grant Program:
o Tandem stock appreciation rights, which provide the holders with
the right, upon approval of the plan administrator, to surrender
their options for an appreciation distribution in an amount equal
to the excess of the fair market value of the vested shares of
common stock subject to the surrendered option over the aggregate
exercise price payable for those shares.
o Standalone stock appreciation rights, which allow the holders to
exercise those rights as to a specific number of shares of common
stock and receive in exchange an appreciation distribution in an
amount equal to the excess of the fair market value on the
exercise date of the shares of common stock as to which those
rights are exercised over the aggregate base price in effect for
those shares. The base price per share may not be less than the
fair market value per share of the common stock on the date the
standalone stock appreciation right is granted, and the right may
not have a term in excess of ten years.
o Limited stock appreciation rights, which may be included in one or
more option grants made under the Discretionary Grant Program to
executive officers or directors who are subject to the short-swing
profit liability provisions of Section 16 of the Exchange Act.
Upon the successful completion of a hostile takeover for more than
50% of our outstanding voting securities or a change in a majority
of our board as a result of one or more contested elections for
board membership over a period of up to 36 consecutive months,
each outstanding option with a limited stock appreciation right
may be surrendered in return for a cash distribution per
surrendered option share equal to the excess of the fair market
value per share at the time the option is surrendered or, if
greater and the option is a non-statutory option, the highest
price paid per share in the transaction, over the exercise price
payable per share under the option.
62
Payments with respect to exercised tandem or standalone stock
appreciation rights may, at the discretion of the plan administrator, be made in
cash or in shares of common stock. All payments with respect to exercised
limited stock appreciation rights will be made in cash. Upon cessation of
service with us, the holder of one or more stock appreciation rights will have a
limited period within which to exercise those rights as to any shares as to
which those stock appreciation rights are vested and exercisable at the time of
cessation of service. The plan administrator will have complete discretion to
extend the period following the holder's cessation of service during which his
or her outstanding stock appreciation rights may be exercised and/or to
accelerate the exercisability or vesting of the stock appreciation rights in
whole or in part. Discretion may be exercised at any time while the stock
appreciation rights remain outstanding, whether before or after the holder's
actual cessation of service.
REPRICING. The plan administrator has the authority, with the consent
of the affected holders, to effect the cancellation of any or all outstanding
options or stock appreciation rights under the Discretionary Grant Program and
to grant in exchange one or more of the following: (i) new options or stock
appreciation rights covering the same or a different number of shares of common
stock but with an exercise or base price per share not less than the fair market
value per share of common stock on the new grant date or (ii) cash or shares of
common stock, whether vested or unvested, equal in value to the value of the
cancelled options or stock appreciation rights. The plan administrator also has
the authority with or, if the affected holder is not subject to the short-swing
profit liability of Section 16 under the Exchange Act, then without, the consent
of the affected holders, to reduce the exercise or base price of one or more
outstanding stock options or stock appreciation rights to the then current fair
market value per share of common stock or to issue new stock options or stock
appreciation rights with a lower exercise or base price in immediate
cancellation of outstanding stock options or stock appreciation rights with a
higher exercise or base price.
STOCK ISSUANCE PROGRAM
Shares of common stock may be issued under the Stock Issuance Program
for valid consideration under the California Corporations Code as the plan
administrator deems appropriate, including cash, past services or other
property. In addition, restricted shares of common stock may be issued pursuant
to restricted stock awards that vest in one or more installments over the
recipient's period of service or upon attainment of specified performance
objectives. Shares of common stock may also be issued under the program pursuant
to restricted stock units or other stock-based awards that entitle the
recipients to receive the shares underlying those awards upon the attainment of
designated performance goals, the satisfaction of specified service requirements
and/or upon the expiration of a designated time period following the vesting of
those awards or units, including without limitation, a deferred distribution
date following the termination of the recipient's service with us.
The plan administrator will have complete discretion under the Stock
Issuance Program to determine which eligible individuals are to receive equity
awards under the program, the time or times when those equity awards are to be
made, the number of shares subject to each equity award, the vesting schedule to
be in effect for the equity award and the consideration, if any, payable per
share. The shares issued pursuant to an equity award may be fully vested upon
issuance or may vest upon the completion of a designated service period and/or
the attainment of pre-established performance goals.
63
To assure that the compensation attributable to one or more equity
awards under the Stock Issuance Program will qualify as performance-based
compensation that will not be subject to the $1.0 million limitation on the
income tax deductibility of the compensation paid per covered executive officer
imposed under Internal Revenue Code Section 162(m), the Compensation Committee
will also have the discretionary authority to structure one or more equity
awards under the Stock Issuance Program so that the shares subject to those
particular awards will vest only upon the achievement of certain pre-established
corporate performance goals. Goals may be based on one or more of the following
criteria: (i) return on total shareholders' equity; (ii) net income per share;
(iii) net income or operating income; (iv) earnings before interest, taxes,
depreciation, amortization and stock-based compensation costs, or operating
income before depreciation and amortization; (v) sales or revenue targets; (vi)
return on assets, capital or investment; (vii) cash flow; (viii) market share;
(ix) cost reduction goals; (x) budget comparisons; (xi) implementation or
completion of projects or processes strategic or critical to our business
operations; (xii) measures of customer satisfaction; (xiii) any combination of,
or a specified increase in, any of the foregoing; and (xiv) the formation of
joint ventures, research and development collaborations, marketing or customer
service collaborations, or the completion of other corporate transactions
intended to enhance our revenue or profitability or expand our customer base;
provided, however, that for purposes of items (ii), (iii) and (vii) above, the
Compensation Committee may, at the time the equity awards are made, specify
certain adjustments to those items as reported in accordance with generally
accepted accounting principles in the United States, or GAAP, which will exclude
from the calculation of those performance goals one or more of the following:
certain charges related to acquisitions, stock-based compensation, employer
payroll tax expense on certain stock option exercises, settlement costs,
restructuring costs, gains or losses on strategic investments, non-operating
gains, certain other non-cash charges, valuation allowance on deferred tax
assets, and the related income tax effects, purchases of property and equipment,
and any extraordinary non-recurring items as described in Accounting Principles
Board Opinion No. 30 or its successor, provided that those adjustments are in
conformity with those reported by us on a non-GAAP basis. In addition,
performance goals may be based upon the attainment of specified levels of our
performance under one or more of the measures described above relative to the
performance of other entities and may also be based on the performance of any of
our business groups or divisions thereof or any parent or subsidiary.
Performance goals may include a minimum threshold level of performance below
which no award will be earned, levels of performance at which specified portions
of an award will be earned, and a maximum level of performance at which an award
will be fully earned. The Compensation Committee may provide that, if the actual
level of attainment for any performance objective is between two specified
levels, the amount of the award attributable to that performance objective shall
be interpolated on a straight-line basis.
The plan administrator will have the discretionary authority at any
time to accelerate the vesting of any and all shares of restricted stock or
other unvested shares outstanding under the Stock Issuance Program. However, no
vesting requirements tied to the attainment of performance objectives may be
waived with respect to shares that were intended at the time of issuance to
qualify as performance-based compensation under Internal Revenue Code Section
162(m), except in the event of certain involuntary terminations or changes in
control or ownership.
Outstanding restricted stock units or other stock-based awards under
the Stock Issuance Program will automatically terminate, and no shares of common
stock will actually be issued in satisfaction of those awards, if the
performance goals or service requirements established for those awards are not
attained. The plan administrator, however, will have the discretionary authority
to issue shares of common stock in satisfaction of one or more outstanding
restricted stock units or other stock-based awards as to which the designated
performance goals or service requirements are not attained. However, no vesting
requirements tied to the attainment of performance objectives may be waived with
respect to awards that were intended at the time of issuance to qualify as
performance-based compensation under Internal Revenue Code Section 162(m),
except in the event of certain involuntary terminations or changes in control or
ownership.
64
GENERAL PROVISIONS
ACCELERATION. If a change in control occurs, each outstanding equity
award under the Discretionary Grant Program will automatically accelerate in
full, unless (i) that award is assumed by the successor corporation or otherwise
continued in effect, (ii) the award is replaced with a cash retention program
that preserves the spread existing on the unvested shares subject to that equity
award (the excess of the fair market value of those shares over the exercise or
base price in effect for the shares) and provides for subsequent payout of that
spread in accordance with the same vesting schedule in effect for those shares,
or (iii) the acceleration of the award is subject to other limitations imposed
by the plan administrator. In addition, all unvested shares outstanding under
the Discretionary Grant and Stock Issuance Programs will immediately vest upon
the change in control, except to the extent our repurchase rights with respect
to those shares are to be assigned to the successor corporation or otherwise
continued in effect or accelerated vesting is precluded by other limitations
imposed by the plan administrator. Each outstanding equity award under the Stock
Issuance Program will vest as to the number of shares of common stock subject to
that award immediately prior to the change in control, unless that equity award
is assumed by the successor corporation or otherwise continued in effect or
replaced with a cash retention program similar to the program described in
clause (ii) above or unless vesting is precluded by its terms. Immediately
following a change in control, all outstanding awards under the Discretionary
Grant Program will terminate and cease to be outstanding except to the extent
assumed by the successor corporation or its parent or otherwise expressly
continued in full force and effect pursuant to the terms of the change in
control transaction.
The plan administrator will have the discretion to structure one or
more equity awards under the Discretionary Grant and Stock Issuance Programs so
that those equity awards will vest in full either immediately upon a change in
control or in the event the individual's service with us or the successor entity
is terminated (actually or constructively) within a designated period following
a change in control transaction, whether or not those equity awards are to be
assumed or otherwise continued in effect or replaced with a cash retention
program.
A change in control will be deemed to have occurred if, in a single
transaction or series of related transactions:
(i) any person (as that term is used in Section 13(d) and 14(d) of the
Exchange Act), or persons acting as a group, other than a trustee or fiduciary
holding securities under an employment benefit program, is or becomes a
beneficial owner (as defined in Rule 13-3 under the Exchange Act), directly or
indirectly of securities representing 51% or more of the combined voting power
of our company, or
(ii) there is a merger, consolidation, or other business combination
transaction of us with or into an other corporation, entity or person, other
than a transaction in which the holders of at least a majority of the shares of
our voting capital stock outstanding immediately prior to such transaction
continue to hold (either by such shares remaining outstanding or by their being
converted into shares of voting capital stock of the surviving entity) a
majority of the total voting power represented by the shares of voting capital
stock of our company (or the surviving entity) outstanding immediately after the
transaction, or
(iii) all or substantially all of our assets are sold.
65
SHAREHOLDER RIGHTS AND OPTION TRANSFERABILITY. The holder of an option
or stock appreciation right will have no shareholder rights with respect to the
shares subject to that option or stock appreciation right unless and until the
holder exercises the option or stock appreciation right and becomes a holder of
record of shares of common stock distributed upon exercise of the award.
Incentive options are not assignable or transferable other than by will or the
laws of inheritance following the optionee's death, and during the optionee's
lifetime, may only be exercised by the optionee. However, non-statutory options
and stock appreciation rights may be transferred or assigned during the holder's
lifetime to one or more members of the holder's family or to a trust established
for the benefit of the holder and/or one or more family members or to the
holder's former spouse, to the extent the transfer is in connection with the
holder's estate plan or pursuant to a domestic relations order.
A participant will have certain shareholder rights with respect to
shares of common stock issued to the participant under the Stock Issuance
Program, whether or not the participant's interest in those shares is vested.
Accordingly, the participant will have the right to vote the shares and to
receive any regular cash dividends paid on the shares, but will not have the
right to transfer the shares prior to vesting. A participant will not have any
shareholder rights with respect to the shares of common stock subject to
restricted stock units or other stock-based awards until the awards vest and the
shares of common stock are actually issued. However, dividend-equivalent units
may be paid or credited, either in cash or in actual or phantom shares of common
stock, on outstanding restricted stock units or other stock-based awards,
subject to terms and conditions the plan administrator deems appropriate.
CHANGES IN CAPITALIZATION. If any change is made to the outstanding
shares of common stock by reason of any recapitalization, stock dividend, stock
split, combination of shares, exchange of shares or other change in corporate
structure effected without our receipt of consideration, appropriate adjustments
will be made to (i) the maximum number and/or class of securities issuable under
the 2007 Plan, (ii) the maximum number and/or class of securities for which any
one person may be granted equity awards under the 2007 Plan per calendar year,
(iii) the number and/or class of securities and the exercise price or base price
per share in effect under each outstanding option or stock appreciation right,
and (iv) the number and/or class of securities subject to each outstanding
restricted stock unit or other stock-based award under the 2007 Plan and the
cash consideration, if any, payable per share. All adjustments will be designed
to preclude any dilution or enlargement of benefits under the 2007 Plan and the
outstanding equity awards thereunder.
SPECIAL TAX ELECTION. Subject to applicable laws, rules and
regulations, the plan administrator may permit any or all holders of equity
awards to utilize any or all of the following methods to satisfy all or part of
the federal and state income and employment withholding taxes to which they may
become subject in connection with the issuance, exercise or vesting of those
equity awards:
STOCK WITHHOLDING: The election to have us withhold, from the
shares otherwise issuable upon the issuance, exercise or vesting of an
equity award, a portion of those shares with an aggregate fair market
value equal to the percentage of the withholding taxes (not to exceed
100%) designated by the holder and make a cash payment equal to the
fair market value directly to the appropriate taxing authorities on the
individual's behalf.
STOCK DELIVERY: The election to deliver to us certain shares
of common stock previously acquired by the holder (other than in
connection with the issuance, exercise or vesting that triggered the
withholding taxes) with an aggregate fair market value equal to the
percentage of the withholding taxes (not to exceed 100%) designated by
the holder.
66
SALE AND REMITTANCE: The election to deliver to us, to the
extent the award is issued or exercised for vested shares, through a
special sale and remittance procedure pursuant to which the optionee or
participant will concurrently provide irrevocable instructions to a
brokerage firm to effect the immediate sale of the purchased or issued
shares and remit to us, out of the sale proceeds available on the
settlement date, sufficient funds to cover the withholding taxes we are
required to withhold by reason of the issuance, exercise or vesting.
AMENDMENT, SUSPENSION AND TERMINATION
Our board of directors may suspend or terminate the 2007 Plan at any
time. Our board of directors may amend or modify the 2007 Plan, subject to any
required shareholder approval. Shareholder approval will be required for any
amendment that materially increases the number of shares available for issuance
under the 2007 Plan, materially expands the class of individuals eligible to
receive equity awards under the 2007 Plan, materially increases the benefits
accruing to optionees and other participants under the 2007 Plan or materially
reduces the price at which shares of common stock may be issued or purchased
under the 2007 Plan, materially extends the term of the 2007 Plan, expands the
types of awards available for issuance under the 2007 Plan, or as to which
shareholder approval is required by applicable laws, rules or regulations.
Unless sooner terminated by our board, the 2007 Plan will terminate on
the earliest to occur of: (i) February 9, 2017; (ii) the date on which all
shares available for issuance under the 2007 Plan have been issued as
fully-vested shares; and (iii) the termination of all outstanding equity awards
in connection with certain changes in control or ownership.
FEDERAL INCOME TAX CONSEQUENCES
The following discussion summarizes income tax consequences of the 2007
Plan under current federal income tax law and is intended for general
information only. In addition, the tax consequences described below are subject
to the limitations of Internal Revenue Code Section 162(m), as discussed in
further detail below. Other federal taxes and foreign, state and local income
taxes are not discussed, and may vary depending upon individual circumstances
and from locality to locality.
OPTION GRANTS. Options granted under the 2007 Plan may be either
incentive stock options, which satisfy the requirements of Internal Revenue Code
Section 422, or non-statutory stock options, which are not intended to meet
those requirements. The federal income tax treatment for the two types of
options differs as follows:
INCENTIVE STOCK OPTIONS. No taxable income is recognized by
the optionee at the time of the option grant, and, if there is no
disqualifying disposition at the time of exercise, no taxable income is
recognized for regular tax purposes at the time the option is
exercised, although taxable income may arise at that time for
alternative minimum tax purposes equal to the excess of the fair market
value of the purchased shares at the time over the exercise price paid
for those shares.
The optionee will recognize taxable income in the year in
which the purchased shares are sold or otherwise made the subject of
certain dispositions. For federal tax purposes, dispositions are
divided into two categories: qualifying and disqualifying. A qualifying
disposition occurs if the sale or other disposition is made more than
two years after the date the option for the shares involved in the sale
or disposition was granted and more than one year after the date the
option was exercised for those shares. If either of these two
requirements is not satisfied, a disqualifying disposition will result.
67
Upon a qualifying disposition, the optionee will recognize
long-term capital gain in an amount equal to the excess of the amount
realized upon the sale or other disposition of the purchased shares
over the exercise price paid for the shares. If there is a
disqualifying disposition of the shares, the excess of the fair market
value of those shares on the exercise date over the exercise price paid
for the shares will be taxable as ordinary income to the optionee. Any
additional gain or any loss recognized upon the disposition will be
taxable as a capital gain or capital loss.
If the optionee makes a disqualifying disposition of the
purchased shares, we will be entitled to an income tax deduction, for
our taxable year in which the disposition occurs, equal to the excess
of the fair market value of the shares on the option exercise date over
the exercise price paid for the shares. If the optionee makes a
qualifying disposition, we will not be entitled to any income tax
deduction.
NON-STATUTORY STOCK OPTIONS. No taxable income is recognized
by an optionee upon the grant of a non-statutory option. The optionee
will, in general, recognize ordinary income, in the year in which the
option is exercised, equal to the excess of the fair market value of
the purchased shares on the exercise date over the exercise price paid
for the shares, and we will be required to collect certain withholding
taxes applicable to the income from the optionee.
We will be entitled to an income tax deduction equal to the
amount of any ordinary income recognized by the optionee with respect
to an exercised non-statutory option. The deduction will in general be
allowed for our taxable year in which the ordinary income is recognized
by the optionee.
If the shares acquired upon exercise of the non-statutory
option are unvested and subject to repurchase in the event of the
optionee's cessation of service prior to vesting in those shares, the
optionee will not recognize any taxable income at the time of exercise
but will have to report as ordinary income, as and when our repurchase
right lapses, an amount equal to the excess of the fair market value of
the shares on the date the repurchase right lapses over the exercise
price paid for the shares. The optionee may elect under Internal
Revenue Code Section 83(b) to include as ordinary income in the year of
exercise of the option an amount equal to the excess of the fair market
value of the purchased shares on the exercise date over the exercise
price paid for the shares. If a timely Internal Revenue Code Section
83(b) election is made, the optionee will not recognize any additional
income as and when the repurchase right lapses.
STOCK APPRECIATION RIGHTS. No taxable income is recognized upon receipt
of a stock appreciation right. The holder will recognize ordinary income in the
year in which the stock appreciation right is exercised, in an amount equal to
the excess of the fair market value of the underlying shares of common stock on
the exercise date over the base price in effect for the exercised right, and we
will be required to collect certain withholding taxes applicable to the income
from the holder.
We will be entitled to an income tax deduction equal to the amount of
any ordinary income recognized by the holder in connection with the exercise of
a stock appreciation right. The deduction will in general be allowed for our
taxable year in which the ordinary income is recognized by the holder.
DIRECT STOCK ISSUANCES. Stock granted under the 2007 Plan may include
issuances such as unrestricted stock grants, restricted stock grants and
restricted stock units. The federal income tax treatment for such stock
issuances are as follows:
68
UNRESTRICTED STOCK GRANTS. The holder will recognize ordinary
income in the year in which shares are actually issued to the holder.
The amount of that income will be equal to the fair market value of the
shares on the date of issuance, and we will be required to collect
certain withholding taxes applicable to the income from the holder.
We will be entitled to an income tax deduction equal to the
amount of ordinary income recognized by the holder at the time the
shares are issued. The deduction will in general be allowed for our
taxable year in which the ordinary income is recognized by the holder.
RESTRICTED STOCK GRANTS. No taxable income is recognized upon
receipt of stock that qualifies as performance-based compensation
unless the recipient elects to have the value of the stock (without
consideration of any effect of the vesting conditions) included in
income on the date of receipt. The recipient may elect under Internal
Revenue Code Section 83(b) to include as ordinary income in the year
the shares are actually issued an amount equal to the fair market value
of the shares. If a timely Internal Revenue Code Section 83(b) election
is made, the holder will not recognize any additional income when the
vesting conditions lapse and will not be entitled to a deduction in the
event the stock is forfeited as a result of failure to vest.
If the holder does not file an election under Internal Revenue
Code Section 83(b), he will not recognize income until the shares vest.
At that time, the holder will recognize ordinary income in an amount
equal to the fair market value of the shares on the date the shares
vest. We will be required to collect certain withholding taxes
applicable to the income of the holder at that time.
We will be entitled to an income tax deduction equal to the
amount of ordinary income recognized by the holder at the time the
shares are issued, if the holder elects to file an election under
Internal Revenue Code Section 83(b), or we will be entitled to an
income tax deduction at the time the vesting conditions occur, if the
holder does not elect to file an election under Internal Revenue Code
Section 83(b).
RESTRICTED STOCK UNITS. No taxable income is recognized upon
receipt of a restricted stock unit award. The holder will recognize
ordinary income in the year in which the shares subject to that unit
are actually issued to the holder. The amount of that income will be
equal to the fair market value of the shares on the date of issuance,
and we will be required to collect certain withholding taxes applicable
to the income from the holder.
We will be entitled to an income tax deduction equal to the
amount of ordinary income recognized by the holder at the time the
shares are issued. The deduction will in general be allowed for our
taxable year in which the ordinary income is recognized by the holder.
DEDUCTIBILITY OF EXECUTIVE COMPENSATION
We anticipate that any compensation deemed paid by us in connection
with disqualifying dispositions of incentive stock option shares or the exercise
of non-statutory stock options or stock appreciation rights with exercise prices
or base prices equal to or greater than the fair market value of the underlying
shares on the grant date will qualify as performance-based compensation for
purposes of Internal Revenue Code Section 162(m) and will not have to be taken
into account for purposes of the $1.0 million limitation per covered individual
on the deductibility of the compensation paid to certain executive officers.
Accordingly, all compensation deemed paid with respect to those options or stock
appreciation rights should remain deductible without limitation under Internal
Revenue Code Section 162(m). However, any compensation deemed paid by us in
connection with shares issued under the Stock Issuance Program will be subject
to the $1.0 million limitation on deductibility per covered individual, except
to the extent the vesting of those shares is based solely on one or more of the
performance milestones specified above in the summary of the terms of the Stock
Issuance Program.
69
ACCOUNTING TREATMENT
Pursuant to the accounting standards established by Statement of
Financial Accounting Standards No. 123R, Share-Based Payment, or SFAS 123R, we
are required to recognize all share-based payments, including grants of stock
options, restricted stock units and employee stock purchase rights, in our
financial statements effective January 1, 2006. Accordingly, stock options that
are granted to our employees and non-employee board members will have to be
valued at fair value as of the grant date under an appropriate valuation
formula, and that value will have to be charged as stock-based compensation
expense against our reported GAAP earnings over the designated vesting period of
the award. Similar option expensing will be required for any unvested options
outstanding on January 1, 2006, with the grant date fair value of those unvested
options to be expensed against our reported earnings over the remaining vesting
period. For shares issuable upon the vesting of restricted stock units awarded
under the 2007 Plan, we will be required to expense over the vesting period a
compensation cost equal to the fair market value of the underlying shares on the
date of the award. If any other shares are unvested at the time of their direct
issuance, the fair market value of those shares at that time will be charged to
our reported earnings ratably over the vesting period. This accounting treatment
for restricted stock units and direct stock issuances will be applicable whether
vesting is tied to service periods or performance goals. The issuance of a
fully-vested stock bonus will result in an immediate charge to our earnings
equal to the fair market value of the bonus shares on the issuance date.
Stock options and stock appreciation rights granted to non-employee
consultants will result in a direct charge to our reported earnings based on the
fair value of the grant measured on the vesting date of each installment of the
underlying shares. Accordingly, the charge will take into account the
appreciation in the fair value of the grant over the period between the grant
date and the vesting date of each installment comprising that grant.
INTERESTS OF RELATED PARTIES
The 2007 Plan provides that our officers, employees, non-employee
directors, and certain consultants and independent advisors will be eligible to
receive awards under the 2007 Plan.
As discussed above, we may be eligible in certain circumstances to
receive a tax deduction for certain executive compensation resulting from awards
under the 2007 Plan that would otherwise be disallowed under Internal Revenue
Code Section 162(m).
POSSIBLE ANTI-TAKEOVER EFFECTS
Although not intended as an anti-takeover measure by our board of
directors, one of the possible effects of the 2007 Plan could be to place
additional shares, and to increase the percentage of the total number of shares
outstanding, or to place other incentive compensation, in the hands of the
directors and officers of Strasbaugh. Those persons may be viewed as part of, or
friendly to, incumbent management and may, therefore, under some circumstances
be expected to make investment and voting decisions in response to a hostile
takeover attempt that may serve to discourage or render more difficult the
accomplishment of the attempt.
70
In addition, options or other incentive compensation may, in the
discretion of the plan administrator, contain a provision providing for the
acceleration of the exercisability of outstanding, but unexercisable,
installments upon the first public announcement of a tender offer, merger,
consolidation, sale of all or substantially all of our assets, or other
attempted changes in the control of Strasbaugh. In the opinion of our board,
this acceleration provision merely ensures that optionees under the 2007 Plan
will be able to exercise their options or obtain their incentive compensation as
intended by our board of directors and shareholders prior to any extraordinary
corporate transaction which might serve to limit or restrict that right. Our
board of directors is, however, presently unaware of any threat of hostile
takeover involving Strasbaugh.
INDEMNIFICATION OF DIRECTORS AND OFFICERS
Our articles of incorporation provide that the liability of our
directors for monetary damages shall be eliminated to the fullest extent
permissible under California law. This is intended to eliminate the personal
liability of a director for monetary damages in an action brought by or in the
right of Strasbaugh for breach of a director's duties to Strasbaugh or our
shareholders except for liability:
o for acts or omissions that involve intentional misconduct or a
knowing and culpable violation of law;
o for acts or omissions that a director believes to be contrary to
the best interests of Strasbaugh or our shareholders or that
involve the absence of good faith on the part of the director;
o for any transaction for which a director derived an improper
personal benefit;
o for acts or omissions that show a reckless disregard for the
director's duty to Strasbaugh or our shareholders in circumstances
in which the director was aware, or should have been aware, in the
ordinary course of performing a director's duties, of a risk of
serious injury to Strasbaugh or our shareholders;
o for acts or omissions that constitute an unexcused pattern of
inattention that amounts to an abdication of the director's duty
to Strasbaugh or our shareholders; and
o for engaging in transactions described in the California
Corporations Code or California case law that result in liability,
or approving the same kinds of transactions.
Our articles of incorporation also provide that we are authorized to
provide indemnification to our agents, as defined in Section 317 of the
California Corporations Code, through our bylaws or through agreements with such
agents or both, for breach of duty to us and our shareholders, in excess of the
indemnification otherwise permitted by Section 317 of the California
Corporations Code, subject to the limits on such excess indemnification set
forth in Section 204 of the California Corporations Code. Our bylaws also
authorize us to purchase and maintain insurance on behalf of any of our
directors or officers against any liability asserted against that person in that
capacity, whether or not we would have the power to indemnify that person under
the provisions of the California Corporations Code. We have entered and expect
to continue to enter into agreements to indemnify our directors and officers as
determined by our board of directors. These agreements provide for
indemnification of related expenses including attorneys' fees, judgments, fines
and settlement amounts incurred by any of these individuals in any action or
proceeding. We believe that these bylaw provisions and indemnification
agreements are necessary to attract any retain qualified persons as directors
and officers. We also maintain directors' and officers' liability insurance.
Our bylaws provide for indemnification of our officers, directors,
employees, and other agents to the extent and under the circumstances permitted
by California law. In all cases where indemnification is permitted by the
bylaws, a determination to indemnify such person must be made when ordered by a
court and must be made in a specific case upon a determination that
indemnification is required or proper in the circumstances. Such determination
must be made:
71
o by our board of directors by a majority vote of a quorum
consisting of directors who were not parties to the action, suit
or proceeding which is the subject of the request for
indemnification; or
o if such a quorum is not obtainable, or, even if obtainable, a
majority vote of a quorum of disinterested directors so directs,
by independent legal counsel in a written opinion; or
o by a majority of our shareholders.
The limitation of liability and indemnification provisions in our
articles of incorporation and bylaws may discourage shareholders from bringing a
lawsuit against our directors for breach of their fiduciary duty. They may also
reduce the likelihood of derivative litigation against our directors and
officers, even though an action, if successful, might benefit us and other
shareholders. Furthermore, a shareholder's investment may be adversely affected
to the extent that we pay the costs of settlement and damage awards against
directors and officers as required by these indemnification provisions. At
present, there is no pending litigation or proceeding involving any of our
directors, officers or employees regarding which indemnification is sought, and
we are not aware of any threatened litigation that may result in claims for
indemnification.
Insofar as indemnification for liabilities under the Securities Act may
be permitted to our directors, officers and controlling persons pursuant to the
foregoing provisions, or otherwise, we have been informed that in the opinion of
the SEC such indemnification is against public policy as expressed in the
Securities Act and is, therefore, unenforceable.
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
POLICY REGARDING RELATED PARTY TRANSACTIONS
We recognize that related party transactions present a heightened risk
of conflicts of interest and in connection with this offering, have adopted a
policy to which all related party transactions shall be subject. Pursuant to the
policy, the Audit Committee of our board of directors will review the relevant
facts and circumstances of all related party transactions, including, but not
limited to, whether the transaction is on terms comparable to those that could
be obtained in arm's-length dealings with an unrelated third party and the
extent of the related party's interest in the transaction. Pursuant to the
policy, no director may participate in any approval of a related party
transaction to which he or she is a related party.
The Audit Committee will then, in its sole discretion, either approve
or disapprove the transaction. If advance Audit Committee approval of a
transaction is not feasible, the transaction may be preliminarily entered into
by management, subject to ratification of the transaction by the Audit Committee
at the Audit Committee's next regularly scheduled meeting. If at that meeting
the Audit Committee does not ratify the transaction, management shall make all
reasonable efforts to cancel or annul such transaction.
Certain types of transactions, which would otherwise require individual
review, have been preapproved by the Audit Committee. These types of
transactions include, for example, (i) compensation to an officer or director
where such compensation is required to be disclosed in our proxy statement, (ii)
transactions where the interest of the related party arises only by way of a
directorship or minority stake in another organization that is a party to the
transaction and (iii) transactions involving competitive bids or fixed rates.
72
SHARE EXCHANGE TRANSACTION
Pursuant to the Share Exchange Transaction we issued to the
shareholders of R. H. Strasbaugh an aggregate of 13,770,366 shares of our common
stock in exchange for the same number of R. H. Strasbaugh's common stock. The
1:1 exchange ratio was determined by arms-length negotiations between Strasbaugh
(formerly, CTK Windup Corporation) and R. H. Strasbaugh (formerly, Strasbaugh)
and was not based on any particular valuation or other financial data with
respect to either company or a comparison of comparable companies or
transactions.
In connection with the Share Exchange Transaction we issued to (i) Alan
Strasbaugh, the Chairman of our board of directors, 7,518,295 shares of our
common stock in exchange for 7,518,295 shares of common stock of R. H.
Strasbaugh held by Alan Strasbaugh; (ii) Chuck Schillings, our President and
Chief Executive Officer, 848,508 shares of our common stock in exchange for
848,508 shares of common stock of R. H. Strasbaugh held by Mr. Schillings; (iii)
Larry Strasbaugh, the brother of Alan Strasbaugh, 2,616,712 shares of our common
stock in exchange for 2,616,712 shares of common stock of R. H. Strasbaugh held
by Larry Strasbaugh; (iv)Thomas Walsh 1,272,783 shares of our common stock in
exchange for 1,272,783 shares of common stock of R. H. Strasbaugh held by Mr.
Walsh; and (v) Michael Kirkpatrick, our Director of Sales and Marketing, 848,508
shares of our common stock in exchange for 848,508 shares of common stock of R.
H. Strasbaugh held by Mr. Kirkpatrick. As a result of the Share Exchange
Transaction each of Mr. Alan Strasbaugh, Mr. Schillings, Mr. Larry Strasbaugh,
Mr. Walsh and Mr. Kirkpatrick became the beneficial owners of more than 5% of
our common stock. Except for Mr. Walsh, none of the shareholders of R. H.
Strasbaugh acquired the shares they exchanged within two years prior to May 24,
2007. On February 6, 2007, Mr. Walsh acquired 548,865 shares of R. H. Strasbaugh
common stock upon exercise of an option to purchase shares of R.H. Strasbaugh's
common stock that was originally granted several years ago and extended on April
10, 2006, at an exercise price of $0.07 per share.
EMPLOYMENT AGREEMENTS
We are or have been a party to employment and compensation arrangements
with related parties, as more particularly described above under the headings
"Compensation of Executive Officers," "Employment Agreements" and "Compensation
of Directors."
INDEMNIFICATION AGREEMENTS
We have entered into an indemnification agreement with each of our
directors and executive officers. The indemnification agreements and our
certificate of incorporation and bylaws require us to indemnify our directors
and officers to the fullest extent permitted by California law.
FACILITIES LEASE
Our corporate headquarters, in San Luis Obispo, is jointly owned by
Alan Strasbaugh and his former wife, April Paletsas, with each owning an
undivided one-half interest in the property, and leased to R. H. Strasbaugh, on
a month-to-month basis, at $84,000 per month. During 2005, 2006 and the first
nine months of 2007 our total lease costs were $955,780, $1,000,280 and
$756,000, respectively. Alan Strasbaugh is the chairman of our board of
directors, the chairman of the board of directors of R. H. Strasbaugh and an
employee of Strasbaugh.
73
REPAYMENT OF LOANS
On May 31, 2007, R. H. Strasbaugh made a payment of $746,776 to the
Chairman of our board of directors, Alan Strasbaugh, and thereby paid in full
all obligations under the Straight Commercial Promissory Note dated February 12,
2002, or Note, by and between R. H. Strasbaugh and Mr. Strasbaugh. R. H.
Strasbaugh issued the Note to Mr. Alan Strasbaugh in the principal amount of
$852,262, which amount represented the amount of past due rent, and the note
bore interest at the prime rate of interest rate plus 1.0%.
On May 24, 2007, R. H. Strasbaugh made a payment of $761,799 to
Agility, then a beneficial owner of 6.9% of the then issued and outstanding
shares of common stock of R. H. Strasbaugh, and thereby paid in full all
obligations under the Loan Agreement dated September 23, 2005, and amended from
time to time, by and between R. H. Strasbaugh and Agility. R. H. Strasbaugh
borrowed an initial principal amount of $1,650,000 under the Loan Agreement. The
loan was payable in a lump-sum payment of $150,000 due March 1, 2007, with the
remainder payable in monthly installments of $55,000 including interest at 12%
and the remaining balance due September 2007.
SERIES A PREFERRED STOCK FINANCING
On May 24, 2007, we issued to Lloyd I. Miller, III 1,000,000 shares of
our Series A Preferred Stock at a price of $2.20 per share, for an aggregate
purchase price of $2,200,000. On the same date, we also issued to Milfam II L.P.
1,000,000 shares of our Series A Preferred Stock at a price of $2.20 per share,
for an aggregate purchase price of $2,200,000. Lloyd I. Miller, III has the
power to vote or dispose of the shares held by Milfam II L.P. On May 30, 2007,
Lloyd I. Miller, III waived the 4.99% conversion limitation with respect to the
shares of Series A Preferred Stock and Investor Warrants held by him and Milfam
II L.P. Thus, the waiver was effective as of July 30, 2007 and both Mr. Miller
and Milfam II L.P. are beneficial owners of more than 5% of our common stock.
In connection with the Series A Preferred Stock Financing, we issued a
Placement Warrant to purchase 385,434 shares of our common stock to our
placement agent B. Riley and Co. Inc., as compensation for services rendered as
placement agent in the Series A Preferred Stock Financing. B. Riley and Co. Inc.
assigned portions of its Placement Warrant to the following, each of whom is
either an employee of B. Riley and Co. Inc. or an affiliate of an employee of B.
Riley and Co. Inc: Bryant Riley, Michael C. Munck, Kenneth W. Tang, The Donnelly
Revocable Living Trust, The Guardi Family Trust, Thomas John Kelleher and Mary
Meighan Kelleher as trustees of The Kelleher Family Trust Established January
18, 2007, Wesley Cummins, Shane Pavitt, Knut Grevle, Pete Benedict and Wyatt
Carr. B. Riley and Co. Inc. currently holds a Placement Warrant to purchase
138,756 shares of our common stock.
Pursuant to an assignment from B. Riley and Co. Inc. of its Placement
Warrant to purchase 385,434 shares of our common stock, we issued a Placement
Warrant to purchase 18,345 shares of our common stock to Mr. Bryant Riley, a
former member of our board of directors and a selling security holder.
Additionally, as an investor in the Series A Preferred Stock Financing, we
issued to Mr. Riley 772,727 shares of our Series A Preferred Stock and an
Investor Warrant to purchase 115,909 shares of our common stock. Mr. Riley
shares the power to vote or dispose of the shares beneficially owned by B. Riley
and Co. Inc. with the management of B. Riley and Co. Inc.
Pursuant to an assignment from B. Riley and Co. Inc. of its Placement
Warrant to purchase 385,434 shares of our common stock, we issued a Placement
Warrant to purchase 48,198 shares of our common stock to Wesley Cummins, a
member of our board of directors.
74
Both Mr. Riley and Mr. Cummins, in their capacity as employees of B.
Riley and Co. Inc., provided investment banking services to us in connection
with the Series A Preferred Stock Financing. B. Riley has represented to us that
the assignments made to both Mr. Riley and Mr. Cummins were in consideration of
services rendered by Mr. Riley and Mr. Cummins, respectively, as employees of B.
Riley and Co. Inc., in connection with the investment banking services B. Riley
provided us in connection with the Series A Preferred Stock Financing.
Additionally, both Mr. Riley and Mr. Cummins have represented to us that they
received the Placement Warrants assigned to them by B. Riley in the ordinary
course of business as transaction-based compensation for investment banking
services.
On May 24, 2007, the closing price of our common stock on the Pink
Sheets(R) was $0.055 per share. On that same date, we effected a 1-for-31
reserve stock split. As a result of the reverse stock split, the effective per
share closing price on May 24, 2007 was $1.71.
STOCK OPTIONS
On May 24, 2007, each of our directors (other than Mr. Givens) were
issued options to purchase 18,000 shares of our common stock pursuant to our
2007 Share Incentive Plan.
REPURCHASE OF PREFERRED STOCK
On May 24, 2007, R. H. Strasbaugh, our wholly-owned subsidiary,
repurchased from Lam Research Corporation, then a beneficial owner of 21.2% of
the then issued and outstanding shares of common stock of R. H. Strasbaugh,
4,087,980 shares of R. H. Strasbaugh's convertible preferred stock held by Lam
Research Corporation for $3,000,000. Prior to the repurchase, Lam Research
Corporation held all of the then issued and outstanding shares Convertible
Preferred Stock of R. H. Strasbaugh.
REPURCHASE OF COMMON STOCK AND WARRANTS
On May 24, 2007, R. H. Strasbaugh repurchased from Agility, then a
beneficial owner of 6.9% of the then issued and outstanding shares of common
stock of R. H. Strasbaugh, 771,327 shares of common stock of R. H. Strasbaugh,
and a warrant to purchase shares of R. H. Strasbaugh common stock, each held by
Agility for $750,000 and $450,000, respectively. Pursuant to the warrant that
was repurchased, Agility had the right to purchase 4.1% of R. H. Strasbaugh's
issued stock, on a fully diluted basis, at anytime between September 23, 2005
and September 23, 2015 at an exercise price of $0.01 per share.
75
PRINCIPAL SHAREHOLDERS
The following table sets forth information with respect to the
beneficial ownership of our voting stock as of February 1, 2008, the date of the
table, by:
o each person known by us to beneficially own more than 5% of the
outstanding shares any class of our voting stock;
o each of our directors;
o each of our current executive officers identified at the beginning
of the "Management" section of this prospectus and our former
Chief Executive Officer, Michael J. Gullard; and
o all of our directors and executive officers as a group.
Beneficial ownership is determined in accordance with the rules of the
SEC, and includes voting or investment power with respect to the securities. To
our knowledge, except as indicated by footnote, and subject to community
property laws where applicable, the persons named in the table below have sole
voting and investment power with respect to all shares of voting stock shown as
beneficially owned by them. Except as indicated in the discussion of the
beneficial ownership limitations on the Series A Preferred Stock below and
except as indicated by footnote, all shares of common stock underlying
derivative securities, if any, that are currently exercisable or convertible or
are scheduled to become exercisable or convertible for or into shares of common
stock within 60 days after the date of the table are deemed to be outstanding
for the purpose of calculating the percentage ownership of each listed person or
group but are not deemed to be outstanding as to any other person or group.
Percentage of beneficial ownership of our common stock is based on 14,201,897
shares of common stock outstanding as of the date of the table. Percentage of
beneficial ownership of our Series A Preferred Stock is based on 5,909,089
shares of Series A Preferred Stock outstanding as of the date of the table.
The terms of the Series A Preferred Stock and the Investor Warrants
held by the selling security holders prohibit conversion of the Series A
Preferred Stock or exercise of the Investor Warrants to the extent that such
conversion or exercise would result in a holder, together with its affiliates,
beneficially owning in excess of 4.99% of our outstanding shares of common
stock. A holder may waive these 4.99% beneficial ownership limitations upon
61-days' prior written notice to us. Also, these beneficial ownership
limitations do not preclude a holder from exercising an Investor Warrant,
converting Series A Preferred Stock or selling the shares underlying Investor
Warrants or Series A Preferred Stock in stages over time where each stage does
not cause the holder and its affiliates to beneficially own shares in excess of
the 4.99% limitation amount.
The address of each of the following shareholders, unless otherwise
indicated below, is c/o Strasbaugh, 825 Buckley Road, San Luis Obispo,
California 93401. Messrs. Schillings, Nance, Kirkpatrick and Paterson are
executive officers of Strasbaugh. Messrs. Alan Strasbaugh, Porter, Cummins and
Givens are directors of Strasbaugh. Larry Strasbaugh is the brother of Alan
Strasbaugh.
76
AMOUNT AND
NATURE OF
BENEFICIAL PERCENT
NAME OF BENEFICIAL OWNER TITLE OF CLASS OWNERSHIP OF CLASS
----------------------------------------------------- ------------------ ------------ --------
Alan Strasbaugh...................................... Common 7,518,491(1) 52.94%
Chuck Schillings..................................... Common 848,508 5.97%
Richard Nance........................................ Common -- --
David Porter......................................... Common -- --
Wesley Cummins....................................... Common 48,198(2) *
John Givens.......................................... Common -- --
Allan Paterson....................................... Common -- --
Michael A. Kirkpatrick............................... Common 848,508 5.97%
J. Michael Gullard................................... Common 2,045 *
Larry Strasbaugh..................................... Common 2,616,712 18.43%
Thomas A. Walsh...................................... Common 1,272,783 8.96%
Lloyd I. Miller, III ................................ Common 2,309,528(3) 14.00%
Series A Preferred 2,000,000(4) 33.85%
Milfam II L.P. ...................................... Common 1,155,629(5) 7.53%
Series A Preferred 1,000,000 16.92%
Harvey SMidCap Fund LP............................... Common 745,894(6) 4.99%
Series A Preferred 1,186,363 20.08%
James Schwartz ...................................... Common 745,894(7) 4.99%
Series A Preferred 1,363,636(8) 23.08%
Jeffrey Moskowitz.................................... Common 745,894(7) 4.99%
Series A Preferred 1,363,636(8) 23.08%
Bryant Riley......................................... Common 735,262(9) 4.99%
Series A Preferred 772,727 13.08%
The Robert A Lichtenstein & Annette
Lichtenstein Revocable Trust......................... Common 522,727(10) 3.55%
Series A Preferred 454,545 7.69%
Kayne Anderson Capital Income Partners (QP), LP...... Common 418,183(11) 2.86%
Series A Preferred 363,637 6.15%
Richard A. Kayne..................................... Common 627,274(12) 4.23%
Series A Preferred 545,455(13) 9.23%
John P. Francis...................................... Common 365,910(14) 2.51%
Series A Preferred 318,182(15) 5.38%
All directors and executive officers
as a group (8 persons)............................... Common 9,263,705 65.23%
|
* Less than 1%.
(1) Includes 196 shares of common stock held by Mr. Strasbaugh's wife. (2)
Represents shares underlying a Placement Warrant. (3) Includes 2,045 shares of
outstanding common stock, 1,000,000 shares
underlying Series A Preferred Stock and 150,000 shares underlying
Investor Warrants held directly by Lloyd I. Miller, III. Also includes
1,155,629 shares of common stock represented in this table as
beneficially owned by Milfam II L.P. Further, includes the following
shares of common stock over which Mr. Miller has the sole power to vote
or dispose of: 109 shares held by the Catherine C. Miller - Irrevocable
Trust Agreement; 109 shares held by the Kimberly S. Miller - Irrevocable
Trust Agreement; 48 shares held by Milfam LLC; 48 shares held by Lloyd I.
77
Miller, IV and 209 shares held by Alexandra B. Miller. Also includes the
following shares of common stock over which Mr. Miller has shared power
to vote or dispose of: 622 shares held by the Trust A-4 - Lloyd I.
Miller; 661 shares held by Trust C - Lloyd I. Miller and 48 shares held
by the Lloyd Crider - Irrevocable Trust Agreement. On May 30, 2007, Mr.
Miller waived the 4.99% beneficial ownership limitation applicable to the
Series A Preferred Stock and Investor Warrants held by himself and Milfam
II L.P. The address for Lloyd I. Miller, III is 4550 Gordon Drive,
Naples, Florida 34102.
(4) Includes 1,000,000 shares of Series A Preferred Stock owned by Mr. Miller
and 1,000,000 shares of Series A Preferred stock represented in this
table as held by Milfam II L.P.
(5) Represents 5,629 shares of outstanding common stock, 1,000,000 shares
underlying Series A Preferred Stock and 150,000 shares underlying
Investor Warrants. Mr. Lloyd I. Miller, III has the power to vote or
dispose of the shares beneficially held by Milfam II L.P. Milfam LLC is
the general partner of Milfam II L.P. and Lloyd I. Miller, III is the
manager of Milfam LLC. On May 30, 2007, Mr. Miller waived the 4.99%
beneficial ownership limitation applicable to the Series A Preferred
Stock and Investor Warrants held by Milfam II LP. The address for Milfam
II L.P. is c/o Lloyd I. Miller, III, 4550 Gordon Drive, Naples, Florida
34102.
(6) Represents 745,894 shares underlying Series A Preferred Stock and
Investor Warrants. The number of shares beneficially owned is limited to
4.99% of our outstanding common stock pursuant to the terms of the Series
A Preferred Stock and Investor Warrants. If beneficial ownership
limitations had not been in effect, the Harvey SMidCap Fund LP would have
beneficially owned a total of 1,364,317 shares of common stock, or 8.76%
of our outstanding common stock, representing 1,186,363 shares underlying
Series A Preferred Stock and 177,954 shares underlying Investor Warrants.
Power to vote or dispose of the shares beneficially owned by Harvey
SMidCap Fund LP is held by Harvey Partners LLC. The individuals
authorized to act on behalf of Harvey Partners LLC in the voting and
disposition of the shares are James Schwartz and Jeffrey Moskowitz. The
address for Harvey SMidCap Fund LP is 350 Madison Avenue, 8th Floor, New
York, New York 10017.
(7) Represents shares underlying Series A Preferred Stock and Investor
Warrants held by Harvey SMidCap Fund LP and Harvey SMidCap Offshore Fund
LTD. The number of shares beneficially owned is limited to 4.99% of our
outstanding common stock pursuant to the terms of the Series A Preferred
Stock and Investor warrants. If beneficial ownership limitations had not
been in effect, Mr. Schwartz and Mr. Moskowitz would each have
beneficially owned a total of 1,568,181 shares underlying the Series A
Preferred Stock and Investor Warrants held by Harvey SMidcap Fund LP and
Harvey SMidcap Offshore Fund LTD, or 8.76% of our outstanding common
stock, representing 1,186,363 shares underlying Series A Preferred Stock
and 177,954 shares underlying Investor Warrants held by Harvey SMidCap
Fund LP and 177,273 shares underlying Series A Preferred Stock and 26,591
shares underlying Investor Warrants held by Harvey SMidCap Offshore Fund
LTD. Harvey Partners LLC holds the power to vote or dispose of the shares
beneficially owned by Harvey SMidCap Fund LP and Harvey SMidCap Offshore
Fund LTD. Mr. Schwartz and Mr. Moskowitz are each authorized to act alone
on behalf of Harvey Partners LLC. The address for Mr. Schwartz and Mr.
Moskowitz is 350 Madison Avenue, 8th Floor, New York, New York 10017.
(8) Represents 1,186,363 shares of Series A Preferred Stock held by Harvey
SMidCap Fund LP and 177,273 shares of Series A Preferred Stock held
Harvey SMidCap Offshore Fund LTD. Harvey Partners LLC holds the power to
vote or dispose of the shares beneficially owned by Harvey SMidCap Fund
LP and Harvey SMidCap Offshore Fund LTD. Mr. Schwartz and Mr. Moskowitz
are each authorized to act alone on behalf of Harvey Partners LLC.
(9) Includes 2,045 shares of outstanding common stock held by Bryan and
Carleen Riley JTWROS, 18,345 shares underlying Placement Warrants and
532,818 shares underlying both Series A Preferred Stock and Investor
Warrants held by Mr. Riley. Also includes 21,761 shares of common stock
and 138,756 shares underlying Placement Warrants held by B. Riley and Co.
Inc. Mr. Riley has shared power to vote or dispose of the shares held by
B. Riley and Co. Inc. Additionally includes the following shares of
common stock over which Mr. Riley has the sole power to vote or dispose
of: 322 shares held by BR Investco, LLC; 112 shares held by B. Riley and
Co. Retirement Trust; 738 shares held by Investment Advisory Client; and
78
20,365 shares held by Riley Investment Partners Master Fund, L.P. The
number of shares beneficially owned is limited to 4.99% of the
outstanding common stock of the Company pursuant to the terms of the
Series A Preferred Stock and Investor warrants. If beneficial ownership
limitations had not been in effect, the selling security holder would
have beneficially owned a total of 1,229,836 shares of common stock, or
7.99% of our outstanding common stock, which includes 772,727 shares
underlying the Series A Preferred Stock and 115,909 shares underlying
Investor Warrants. The address for Mr. Riley is c/o Riley Investment
Management LLC, 11100 Santa Monica Boulevard, Suite 800, Los Angeles,
California 90025.
(10) Represents 454,545 shares underlying Series A Preferred Stock and 68,182
shares underlying Investor Warrants. The individuals authorized to act on
behalf of The Robert A Lichtenstein & Annette Lichtenstein Revocable
Trust in the voting and disposition of the shares are Robert A
Lichtenstein and Annette Lichtenstein, trustees of The Robert A
Lichtenstein & Annette Lichtenstein Revocable Trust. The address for The
Robert A Lichtenstein & Annette Lichtenstein Revocable Trust is 4573 Tara
Drive, Encino, California 91316.
(11) Represents 363,637 shares underlying Series A Preferred Stock and 54,546
shares underlying Investor Warrants. Power to vote or dispose of the
shares is held by Kayne Anderson Capital Advisors, LP, the General
Partner of Kayne Anderson Capital Income Partners (QP), LP and Kayne
Anderson Investment Management, Inc., the investment advisor to Kayne
Anderson Capital Income Partners (QP), LP. Richard A. Kayne is authorized
to act on behalf of Kayne Anderson Capital Advisors, LP as its chief
executive officer and on behalf of Kayne Anderson Investment Management,
Inc. as its chief executive officer. The address for Kayne Anderson
Capital Income Partners (QP), LP is 350 Madison Avenue, 8th Floor, New
York, New York 10017.
(12) Includes 136,364 shares underlying Series A Preferred Stock and 45,454
shares underlying Investor Warrants held by Kayne Anderson Income
Partners, LP and 20,455 shares underlying Series A Preferred Stock and
6,818 shares underlying Investor Warrants held by Kayne Anderson Capital
Income Fund, Ltd. Also includes the 418,183 shares of common stock
represented in this table as beneficially owned by Kayne Anderson Capital
Income Partners (QP), LP. Power to vote or dispose of the shares is held
by Kayne Anderson Capital Advisors, LP, the General Partner of the three
affiliated entities and Kayne Anderson Investment Management, Inc., the
investment advisor to the three affiliated entities. Mr. Kayne is
authorized to act on behalf of Kayne Anderson Capital Advisors, LP as its
chief executive officer and on behalf of Kayne Anderson Capital Advisors,
LP as its chief executive officer. The address for Mr. Kayne is c/o Kayne
Anderson Capital Advisors, LP, 1800 Avenue of the Stars, 2nd Floor, Los
Angeles, California 90067.
(13) Represents 136,364 shares underlying Series A Preferred Stock held by
Kayne Anderson Income Partners, LP, 20,455 shares underlying Series A
Preferred Stock held by Kayne Anderson Capital Income Fund, Ltd. and
363,637 shares underlying Series A Preferred Stock held by Kayne Anderson
Capital Income Partners (QP), LP.
(14) Represents 159,091 shares underlying Series A Preferred Stock and 23,864
shares underlying Investor Warrants held by Catalysis Offshore, Ltd. and
159,091 shares underlying Series A Preferred Stock and 23,864 shares
underlying Investor Warrants held by Catalysis Partners, LLC. Power to
vote or dispose of the shares is held by Francis Capital Management, LLC.
Mr. Francis is authorized to act on behalf of Francis Capital Management,
LLC in the voting and disposition of the shares. The address for Mr.
Francis is 429 Santa Monica Boulevard, Suite 320, Santa Monica,
California 90401.
(15) Represents 159,091 shares underlying Series A Preferred Stock held by
Catalysis Offshore, Ltd. and 159,091 shares underlying Series A Preferred
Stock and held by Catalysis Partners, LLC.
79
SELLING SECURITY HOLDERS
SELLING SECURITY HOLDER TABLE
This prospectus covers the offer and sale by the selling security
holders of up to an aggregate of 789,956 shares of common stock, consisting of
686,920 shares underlying Series A Preferred Stock and 103,036 shares underlying
Investor Warrants. The following table sets forth, to our knowledge, certain
information about the selling security holders as of February 1, 2008, the date
of the table, based on information furnished to us by the selling security
holders. Except as indicated in the footnotes or description of the Series A
Preferred Stock Financing following the table, each selling security holder has
indicated to us that it is acting individually, not as a member of a group, and
none of the selling security holders or their affiliates has held any position
or office or had any other material relationship with us in the past three
years. The shares of common stock being offered under this prospectus may be
offered for sale from time to time during the period the registration statement
of which this prospectus is a part remains effective, by or for the accounts of
the selling security holders listed below.
Beneficial ownership is determined in accordance with the rules of the
SEC, and includes voting or investment power with respect to the securities. To
our knowledge, except as indicated by footnote, and subject to community
property laws where applicable, the persons named in the table below have sole
voting and investment power with respect to all shares of common stock shown as
beneficially owned by them. Except as indicated in the discussion of the
beneficial ownership limitations on the Series A Preferred Stock below and
except as indicated by footnote, all shares of common stock underlying
derivative securities, if any, that are currently exercisable or convertible or
are scheduled to become exercisable or convertible for or into shares of common
stock within 60 days after the date of the table are deemed to be outstanding
for the purpose of calculating the percentage ownership of each listed person or
group but are not deemed to be outstanding as to any other person or group.
Percentage of beneficial ownership is based on 14,201,897 shares of common stock
as of the date of the table. Shares shown as beneficially owned after the
offering assume that all shares being offered are sold.
The terms of the Series A Preferred Stock and the Investor Warrants
held by the selling security holders prohibit conversion of the Series A
Preferred Stock or exercise of the Investor Warrants to the extent that such
conversion or exercise would result in a holder, together with its affiliates,
beneficially owning in excess of 4.99% of our outstanding shares of common
stock. A holder may waive these 4.99% beneficial ownership limitations upon
61-days' prior written notice to us. Also, these beneficial ownership
limitations do not preclude a holder from exercising Investor Warrants,
converting Series A Preferred Stock or selling the shares underlying Investor
Warrants or Series A Preferred Stock in stages over time where each stage does
not cause the holder and its affiliates to beneficially own shares in excess of
the 4.99% limitation amount.
We issued to B. Riley and Co. Inc., a NASD-registered broker-dealer and
the our placement agent, a warrant to purchase 385,434 shares of the our common
stock as compensation for services rendered as placement agent in the Series A
Preferred Stock Financing. Subsequent to its receipt of the Placement Warrant,
B. Riley and Co. Inc. assigned portions of its Placement Warrant to several of
its employees or affiliates of its employees, including the following selling
security holders: Bryant Riley, Michael C. Munck and Kenneth W. Tang.
In addition to being a selling security holder, Bryant Riley previously
served on our board of directors. Wesley Cummins, who currently serves on our
board of directors, was also assigned Placement Warrants by B. Riley and Co.
Inc. Both Mr. Riley and Mr. Cummins, in their capacity as employees of B. Riley
and Co. Inc., provided investment banking services to us in connection with the
Series A Preferred Stock Financing. B. Riley and Co. Inc. has represented to us
that the assignments made to both Mr. Riley and Mr. Cummins were in
consideration of services rendered by Mr. Riley and Mr. Cummins, respectively,
as employees of B. Riley and Co. Inc., in connection with the investment banking
services B. Riley and Co. Inc. provided us in connection with the Series A
Preferred Stock Financing. Additionally, both Mr. Riley and Mr. Cummins have
represented to us that they received the warrants assigned to them by B. Riley
and Co. Inc. in the ordinary course of business as transaction-based
compensation for investment banking services.
80
SHARES OF
SHARES OF COMMON STOCK
COMMON STOCK BENEFICIALLY OWNED
BENEFICIALLY SHARES OF AFTER OFFERING (1)
NAME OF OWNED COMMON STOCK -----------------------
BENEFICIAL OWNER PRIOR TO OFFERING BEING OFFERED NUMBER PERCENTAGE
------------------------------------------- ----------------- ------------- --------- ----------
Lloyd I. Miller, III....................... 2,309,528 (2) 133,685 (3) 2,175,843 13.29%
Milfam II L.P.............................. 1,155,629 (4) 133,685 (5) 1,021,944 6.72%
Harvey SMidCap Fund LP..................... 745,894 (6) 158,599 (7) 745,894 4.99%
Bryant Riley**............................. 735,262 (8) 103,302 (9) 735,262 4.99%
The Robert A Lichtenstein & Annette
Lichtenstein Revocable Trust............. 522,727 (10) 60,766 (11) 461,961 3.15%
Kayne Anderson Capital Income Partners
(QP), LP................................. 418,183 (12) 48,613 (13) 369,570 2.54%
Catalysis Offshore, Ltd.................... 182,955 (14) 21,268 (15) 161,687 1.13%
PTR Fund L.P............................... 130,681 (16) 15,191 (17) 115,490 *
Jonathan Stanton Company................... 130,681 (18) 15,191 (19) 115,490 *
Palm Beach Trading......................... 52,273 (20) 6,077 (21) 46,196 *
Newport Micro Fund II, LLC................. 52,273 (22) 6,077 (23) 46,196 *
Spector & Bennett Profit Sharing Plan...... 26,136 (24) 3,038 (25) 23,098 *
Nanci S. Munck............................. 26,136 (26) 3,038 (27) 23,098 *
Michael C. Munck**......................... 29,471 (28) 3,038 (29) 26,433 *
Mike Crawford**............................ 26,136 (30) 3,038 (31) 23,098 *
Kenneth W. Tang**.......................... 37,143 (32) 3,038 (33) 34,105 *
R. Gregg Hillman........................... 26,136 (34) 3,038 (35) 23,098 *
Harvey SMidCap Offshore Fund LTD........... 203,864 (36) 23,699 (37) 180,165 1.25%
Kayne Anderson Income Partners, LP......... 52,272 (38) 6,077 (39) 46,195 *
Kayne Anderson Capital Income Fund, Ltd.... 156,819 (40) 18,230 (41) 138,589 *
Catalysis Partners, LLC.................... 182,955 (42) 21,268 (43) 161,687 1.13%
_____________
|
* Less than 1.00%
** Each of these selling security holders have represented to us that they
are not acting as an underwriter in this offering, and they have received
the Series A Preferred Stock and/or Investor Warrants whose underlying
shares are offered under this prospectus in the ordinary course of
business, that at the time of such receipt, they had no agreement or
understanding, directly or indirectly, with any person to distribute the
Series A Preferred Stock and/or Investor Warrants or the shares underlying
the Series A Preferred Stock and/or Investor Warrants.
(1) Assumes all shares being offered under this prospectus are sold. The
percentage of share ownership indicated is based on 14,201,897 shares of
our common stock outstanding as of February 1, 2008.
(2) Includes 2,045 shares of outstanding common stock, 1,000,000 shares
underlying Series A Preferred Stock and 150,000 shares underlying Investor
Warrants held directly by Lloyd I. Miller, III. Also includes all the
shares represented in this column as held by Milfam II L.P. Further
includes an additional 523 shares held by the Catherine C. Miller -
Irrevocable Trust Agreement; the Kimberly S. Miller - Irrevocable Trust
Agreement; Milfam LLC; Lloyd I. Miller, IV and Alexandra B. Miller over
which Mr. Miller reports sole voting and dispositive power and 1,331
shares held by Trust A-4 - Lloyd I. Miller; Trust C - Lloyd I. Miller; and
Lloyd Crider - Irrevocable Trust Agreement over which Mr. Miller reports
shared voting and dispositive power. Lloyd I. Miller, III was a director
of the Company from May 28, 2003 to June 10, 2005. On May 30, 2007, Mr.
Miller waived the 4.99% conversion limitation applicable to the Series A
Preferred Stock held by himself and Milfam II L.P. effective as of July
30, 2007.
(3) Represents 116,248 shares underlying Series A Preferred Stock and 17,437
shares underlying Investor Warrants.
(4) Represents 5,629 shares of outstanding common stock, 1,000,000 shares
underlying Series A Preferred Stock and 150,000 shares underlying Investor
Warrants. Mr. Lloyd I. Miller, III, also a selling security holder, has
the power to vote or dispose of the shares beneficially owned by Milfam II
L.P. On May 30, 2007, Mr. Miller waived the 4.99% conversion limitation
applicable to the Series A Preferred held by Milfam II LP effective as of
July 30, 2007.
(5) Represents 116,248 shares underlying Series A Preferred Stock and 17,437
shares underlying Investor Warrants.
81
(6) Represents 745,894 shares underlying Series A Preferred Stock and Investor
Warrants. The number of shares beneficially owned is limited to 4.99% of
the our outstanding common stock pursuant to the terms of the Series A
Preferred Stock and Investor Warrants. If beneficial ownership limitations
had not been in effect, Harvey SMidCap Fund LP would have beneficially
owned a total of 1,364,317 shares of our common stock, or 8.76% of our
outstanding common stock, representing 1,186,363 shares underlying Series
A Preferred Stock and 177,954 shares underlying Investor Warrants. Power
to vote or dispose of the shares beneficially owned by Harvey SMidCap Fund
LP is held by Harvey Partners LLC. The individuals authorized to act on
behalf of Harvey Partners LLC in the voting and disposition of the shares
are James Schwartz and Jeffrey Moskowitz the partners of Harvey Partners
LLC. Mr. Schwartz and Mr. Moskowitz are each authorized to act alone on
behalf of Harvey Partners LLC. Mr. Schwartz and Mr. Moskowitz also have
the authority to act on behalf of Harvey Partners LLC in the voting and
disposition of the shares held by selling security holder Harvey SMidCap
Offshore Fund LTD.
(7) Represents 137,912 shares underlying Series A Preferred Stock and 20,687
shares underlying Investor Warrants.
(8) Includes 2,045 shares of outstanding common stock held by Bryan and
Carleen Riley JTWROS, 18,345 shares underlying Placement Warrants and
532,818 shares underlying both Series A Preferred Stock and Investor
Warrants held by Mr. Riley. Also includes 21,761 shares of outstanding
common stock and 138,756 shares underlying a Placement Warrant held by
selling security holder B. Riley and Co. Inc. Mr. Riley has shared power
to vote or dispose of the shares held by B. Riley and Co. Inc.
Additionally includes the following shares of common stock over which Mr.
Riley has the sole power to vote or dispose of: 322 shares held by BR
Investco, LLC; 112 shares held by B. Riley and Co. Retirement Trust; 738
shares held by Investment Advisory Client; and 20,365 shares held by Riley
Investment Partners Master Fund, L.P. The number of shares beneficially
owned is limited to 4.99% of our outstanding common stock pursuant to the
terms of the Series A Preferred Stock and Investor Warrants. If beneficial
ownership limitations had not been in effect, the selling security holder
would have beneficially owned a total of 1,229,836 shares of common stock,
or 7.99% of our outstanding common stock, which includes 772,727 shares
underlying the Series A Preferred Stock and 115,909 shares underlying
Investor Warrants. Mr. Riley served on our Board of Directors from May 28,
2003 to May 24, 2007.
(9) Represents 89,828 shares underlying Series A Preferred Stock and 13,474
shares underlying Investor Warrants.
(10) Represents 454,545 shares underlying Series A Preferred Stock and 68,182
shares underlying Investor Warrants. The individuals authorized to act on
behalf of The Robert A Lichtenstein & Annette Lichtenstein Revocable Trust
in the voting and disposition of the shares are Robert A Lichtenstein and
Annette Lichtenstein as its trustees.
(11) Represents 52,840 shares underlying Series A Preferred Stock and 7,926
shares underlying Investor Warrants.
(12) Represents 363,637 shares underlying Series A Preferred Stock and 54,546
shares underlying Investor Warrants. Power to vote or dispose of the
shares beneficially owned by Kayne Anderson Capital Income Partners (QP),
LP is held by Kayne Anderson Capital Advisors, LP, the General Partner of
Kayne Anderson Capital Income Partners (QP), LP and Kayne Anderson
Investment Management, Inc., the investment advisor to Kayne Anderson
Capital Income Partners (QP), LP. Richard A. Kayne is authorized to act on
behalf of Kayne Anderson Capital Advisors, LP and Kayne Anderson
Investment Management, Inc. as the chief executive officer of both
entities. Richard A. Kayne also beneficially owns the shares held by
selling security holders Kayne Anderson Income Partners, LP and Kayne
Anderson Capital Income Fund, Ltd.
(13) Represents 42,272 shares underlying Series A Preferred Stock and 6,341
shares underlying Investor Warrants.
(14) Represents 159,091 shares underlying Series A Preferred Stock and 23,864
shares underlying Investor Warrants. Power to vote or dispose of the
shares beneficially owned by Catalysis Offshore, Ltd. is held by Francis
Capital Management, LLC. The individual authorized to act on behalf of
Francis Capital Management, LLC in the voting and disposition of the
shares is its managing member John P. Francis. John P. Francis also has
the authority to act on behalf of Francis Capital Management, LLC in the
voting and disposition of the shares held by selling security holder
Catalysis Partners, LLC.
(15) Represents 18,494 shares underlying Series A Preferred Stock and 2,774
shares underlying Investor Warrants.
(16) Represents 113,636 shares underlying Series A Preferred Stock and 17,045
shares underlying Investor Warrants. Power to vote or dispose of the
shares beneficially owned by PTR Fund L.P. is held by Mr. Patrick Gaynor
as president of PTR Fund L.P.
(17) Represents 13,210 shares underlying Series A Preferred Stock and 1,981
shares underlying Investor Warrants.
82
(18) Represents 113,636 shares underlying Series A Preferred Stock and 17,045
shares underlying Investor Warrants. Power to vote or dispose of the
shares beneficially owned by Jonathan Stanton Company is held by Jonathan
Axelrod as president of Jonathan Stanton Company.
(19) Represents 13,210 shares underlying Series A Preferred Stock and 1,981
shares underlying Investor Warrants.
(20) Represents 45,455 shares underlying Series A Preferred Stock and 6,818
shares underlying Investor Warrants. Power to vote or dispose of the
shares beneficially owed by Palm Beach trading is held by Edward Pierot as
president of Palm Beach Trading.
(21) Represents 5,284 shares underlying Series A Preferred Stock and 793 shares
underlying Investor Warrants.
(22) Represents 45,455 shares underlying Series A Preferred Stock and 6,818
shares underlying Investor Warrants. Power to vote or dispose of the
shares beneficially owned by Newport Micro Fund II, LLC is held by J.
Scott Liolios as Investment Manager. J. Scott Liolios is licensed with a
NASD-registered broker-dealer.
(23) Represents 5,284 shares underlying Series A Preferred Stock and 793 shares
underlying Investor Warrants.
(24) Represents 22,727 shares underlying Series A Preferred Stock and 3,409
shares underlying Investor Warrants. The individual authorized to act on
behalf of Spector & Bennett Profit Sharing Plan in the voting and
disposition of the shares is Ross A. Spector as trustee.
(25) Represents 2,642 shares underlying Series A Preferred Stock and 396 shares
underlying Investor Warrants.
(26) Represents 22,727 shares underlying Series A Preferred Stock and 3,409
shares underlying Investor Warrants.
(27) Represents 2,642 shares underlying Series A Preferred Stock and 396 shares
underlying Investor Warrants.
(28) Represents 22,727 shares underlying Series A Preferred Stock, 3,409 shares
underlying Investor Warrants and 3,335 shares underlying Placement
Warrants. Mr. Munck is employed by B. Riley and Co. Inc.
(29) Represents 2,642 shares underlying Series A Preferred Stock and 396 shares
underlying Investor Warrants.
(30) Represents 22,727 shares underlying Series A Preferred Stock and 3,409
shares underlying Investor Warrants. Mr. Crawford is employed by Riley
Investment Management, an affiliate of B. Riley and Co. Inc.
(31) Represents 2,642 shares underlying Series A Preferred Stock and 396 shares
underlying Investor Warrants.
(32) Represents 22,727 shares underlying Series A Preferred Stock, 3,409 shares
underlying Investor Warrants and 11,007 shares underlying Placement
Warrants. Mr. Tang is employed by B. Riley and Co. Inc.
(33) Represents 2,642 shares underlying Series A Preferred Stock and 396 shares
underlying Investor Warrants.
(34) Represents 22,727 shares underlying Series A Preferred Stock and 3,409
shares underlying Investor Warrants. Mr. Hillman is a research analyst at
First Wilshire Securities Management, Inc., a NASD-registered
broker-dealer.
(35) Represents 2,642 shares underlying Series A Preferred Stock and 396 shares
underlying Investor Warrants.
(36) Represents 177,273 shares underlying Series A Preferred Stock and 26,591
shares underlying Investor Warrants. Power to vote or dispose of the
shares beneficially owned by Harvey S. MidCap Offshore Fund LTD. is held
by Harvey Partners LLC. The individuals authorized to act on behalf of
Harvey Partners LLC in the voting and disposition of the shares are its
partners James Schwartz and Jeffrey Moskowitz. Mr. Schwartz and Mr.
Moskowitz are each authorized to act alone on behalf of Harvey Partners
LLC. Mr. Schwartz and Mr. Moskowitz also have the authority to act on
behalf of Harvey Partners LLC in the voting and disposition of the shares
held by selling security holder Harvey SMidCap Fund LP.
(37) Represents 20,608 shares underlying Series A Preferred Stock and 3,091
shares underlying Investor Warrants.
(38) Represents 45,454 shares underlying Series A Preferred Stock and 6,818
shares underlying Investor Warrants. Power to vote or dispose of the
shares beneficially owned by Kayne Anderson Income Partners, LP is held by
Kayne Anderson Capital Advisors, LP, the General Partner of Kayne Anderson
Income Partners, LP and Kayne Anderson Investment Management, Inc., the
investment advisor to Kayne Anderson Income Partners, LP. Richard A. Kayne
is authorized to act on behalf of Kayne Anderson Capital Advisors, LP and
Kayne Anderson Investment Management, Inc. as the chief executive officer
of both entities. Richard A. Kayne also beneficially owns the shares held
by selling security holders Kayne Anderson Capital Income Partners (QP),
LP and Kayne Anderson Capital Income Fund, Ltd.
(39) Represents 5,284 shares underlying Series A Preferred Stock and 793 shares
underlying Investor Warrants.
83
(40) Represents 136,364 shares underlying Series A Preferred Stock and 20,455
shares underlying Investor Warrants. Power to vote or dispose of the
shares beneficially owned by Kayne Anderson Capital Income Fund, Ltd. is
held by Kayne Anderson Capital Advisors, LP, the General Partner of Kayne
Anderson Capital Income Fund, Ltd. and Kayne Anderson Investment
Management, Inc., the investment advisor to Kayne Anderson Capital Income
Fund, Ltd. Richard A. Kayne is authorized to act on behalf of Kayne
Anderson Capital Advisors, LP and Kayne Anderson Investment Management,
Inc. as the chief executive officer of both entities. Richard A. Kayne
also beneficially owns the shares held by selling security holders Kayne
Anderson Capital Income Partners (QP), LP and Kayne Anderson Income
Partners, LP.
(41) Represents 15,852 shares underlying Series A Preferred Stock and 2,378
shares underlying Investor Warrants.
(42) Represents 159,091 shares underlying Series A Preferred Stock and 23,864
shares underlying Investor Warrants. Power to vote or dispose of the
shares beneficially owned by Catalysis Partners, LLC is held by Francis
Capital Management, LLC. The individual authorized to act on behalf of
Francis Capital Management, LLC in the voting and disposition of the
shares is its managing member John P. Francis. John P. Francis also has
the authority to act on behalf of Francis Capital Management, LLC in the
voting and disposition of the shares held by selling security holder
Catalysis Offshore, Ltd.
(43) Represents 18,494 shares underlying Series A Preferred Stock and 2,774
shares underlying Investor Warrants.
PRIVATE PLACEMENT THROUGH WHICH THE SELLING SECURITY HOLDERS OBTAINED BENEFICIAL
OWNERSHIP OF THE OFFERED SHARES
OVERVIEW
All of the shares of common stock being offered under this prospectus
are issuable upon the conversion of Series A Preferred Stock and exercise of
Investor Warrants that were issued in the Series A Preferred Stock Financing.
The descriptions of the agreements discussed below are qualified by reference to
the complete text of those agreements, which are attached as exhibits to the
registration statement of which this prospectus is a part.
On May 24, 2007, we entered into a securities purchase agreement with
21 accredited investors in connection with a private placement transaction
providing for, among other things, our issuance of 5,909,089 shares of our
Series A Preferred Stock and five-year Investor Warrants to purchase up to an
aggregate of 886,363 shares of our common stock. The Investor Warrants have an
exercise price of $2.42 per share and are scheduled to become exercisable on
November 20, 2007. We received aggregate gross proceeds of $13 million from the
investors for our issuance of the Series A Preferred Stock and Investor
Warrants. We also entered into a registration rights agreement with the
investors that require us to register the shares of common stock underlying the
Series A Preferred Stock and Investor Warrants with the SEC.
B. Riley and Co. Inc., an NASD-registered broker-dealer, acted as
placement agent in connection with the Series A Preferred Stock Financing. We
paid to B. Riley and Co. Inc. cash placement agent fees and expenses of
approximately $1.1 million and issued to B. Riley and Co. Inc. a five-year
Placement Warrant to purchase an aggregate of 385,434 shares of our common
stock. B. Riley and Co. Inc. assigned portions of its Placement Warrant to
purchase 385,434 shares of our common stock to the following, each of whom is
either an employee of B. Riley and Co. Inc. or an affiliate of an employee of B.
Riley and Co. Inc.: Bryant Riley, Michael C. Munck, Kenneth W. Tang, The
Donnelly Revocable Living Trust, The Guardi Family Trust, Thomas John Kelleher
and Mary Meighan Kelleher as trustees of The Kelleher Family Trust Established
January 18, 2007, Wesley Cummins, Shane Pavitt, Knut Grevle, Pete Benedict and
Wyatt Carr. The Placement Warrants have an exercise price of $2.42 per share and
are currently exercisable. Our engagement agreement with B. Riley and Co. Inc.
requires us to register the shares of common stock underlying the Placement
Warrants.
84
REGISTRATION RIGHTS AGREEMENT
We were obligated under a registration rights agreement related to the
Series A Preferred Stock Financing to file, on or before July 23, 2007, a
registration statement with the SEC, registering for resale shares of common
stock underlying the Series A Preferred Stock and shares of common stock
underlying Investor Warrants, issued in connection with the Series A Preferred
Stock Financing. If we (i) do not file the registration statement within the
time period prescribed, or (ii) fail to file with the SEC a request for
acceleration in accordance with Rule 461 under the Securities Act within five
trading days of the date that we are notified by the SEC that the registration
statement will not be "reviewed," or is not subject to further review, or (iii)
the registration statement filed or required to be filed under the registration
rights agreement is not declared effective by the SEC on or before October 6,
2007, then in addition to any other rights the holders of such securities may
have under the registration statement or under applicable law, on each such date
that we breach our obligations and on each monthly anniversary of each such date
(if have not cured the breach by such date) until the applicable event is cured,
we are required to pay to each such holder an amount in cash, as partial
liquidated damages and not as a penalty, equal to 1% of the aggregate purchase
price paid by such holder in connection with the Series A Preferred Stock
Financing relating to the purchase and sale of such securities then held by such
holder. However, we will not be obligated to pay any liquidated damages with
respect to any shares of common stock not included on the registration statement
as a result of limitations imposed by the SEC relating to Rule 415 under the
Securities Act. If we fail to pay any partial liquidated damages in full within
seven days after the date payable, we are required to pay interest thereon at a
rate of 10% per annum (or such lesser maximum amount that is permitted to be
paid by applicable law) to such holder, accruing daily from the date such
partial liquidated damages are due until such amounts, plus all such interest
thereon, are paid in full. The partial liquidated damages are to apply on a
daily pro-rata basis for any portion of a month prior to the cure of an Event.
The total liquidated damages payable by us for our failure to meet these filing
and effectiveness requirements are capped at $1.3 million.
The registration rights agreement also provides that after the initial
registration statement is declared effective by the SEC, we are required to file
one or more additional registration statements for the resale of the remaining
common stock underlying the Series A Preferred Stock and the common stock
underlying the warrants if, at the time the initial registration statement is
declared effective, such registration statement covers less than 6,795,452
shares of common stock. In addition, the registration rights agreement provides
for customary piggy-back registration rights whereby certain holders of shares
of our common stock, or warrants to purchase shares of our common stock, can
cause us to register such shares for resale in connection with our filing of a
registration statement with the SEC to register shares in another offering. The
registration rights agreement also contains customary representations and
warranties, covenants and limitations. The Investor Warrants and the Placement
Warrants contain customary anti-dilution provisions for stock splits, stock
dividends and the like and contain a net exercise cashless exercise feature that
will permit the warrants to be exercised for a net number of shares using the
spread between the warrant exercise price and the average of the closing sale
prices for the five trading days immediately prior to the exercise of the
warrant as payment for a reduced number of common shares. Use of the cashless
exercise feature by the investors is limited to times when after 180 days after
the issuance of the warrant a valid resale prospectus is not then available for
use by the investors.
LIMITATIONS ON CONVERSION AND EXERCISABILITY
The Series A Preferred Stock and Investor Warrants contain provisions
limiting the exercise of the Investor Warrants and conversion of the Series A
Preferred Stock to the extent necessary to insure that following the exercise or
conversion, as the case may be, the total number of shares of common stock then
beneficially owned by the holder and its affiliates and others whose beneficial
ownership would be aggregated with the holder's for purposes of Section 13(d) of
the Exchange Act does not exceed 4.99% of the total number of then issued and
outstanding shares of our common stock (including for such purpose the shares of
85
common stock issuable upon such exercise). The 4.99% beneficial ownership
limitations may be waived upon 61 days' notice. The beneficial ownership
limitations do not preclude a holder from exercising Investor Warrants,
converting Series A Preferred Stock or selling the shares underlying Investor
Warrants or Series A Preferred Stock in stages over time where each stage does
not cause the holder and its affiliates to beneficially own shares in excess of
the limitation amount.
INDEMNIFICATION AND OTHER MATTERS
We have registered for resale under this prospectus the shares of
common stock underlying the Series A Preferred Stock and the shares of common
stock underlying the Investor Warrants and the Placement Warrants. The
securities purchase agreement, registration rights agreement and placement agent
arrangements contain various indemnification provisions in connection with the
offering and registration of the shares and warrants. There are no material
relationships between us or our affiliates and any of the investors or placement
agent, except that (i) Wesley Cummins, a member of our board of directors, is
President of B. Riley and Co. Inc., our placement agent in the Series A
Preferred Stock Financing, (ii) Bryant Riley, a former member of our board of
directors, is the chairman of the board of B. Riley and Co. Inc., (iii) we have
entered into an engagement agreement with B. Riley and Co. Inc. whereby B. Riley
and Co. Inc. may provide certain on-going investment banking services to
Strasbaugh, and (iv) each of Lloyd I. Miller, III and Milfam II L.P. became a
beneficial owner of more than 5% of our outstanding common stock in connection
with the waiver, on May 30, 2007, by each of Lloyd I. Miller and Milfam II L.P.
of the 4.99% beneficial ownership limitation applicable to the Series A
Preferred Stock and Investor Warrants.
DIVIDEND PAYMENT ON SERIES A PREFERRED STOCK
We paid the first semi-annual dividend that accrued on our Series A
Preferred Stock on December 31, 2007, an aggregate of approximately $632,548, to
the holders of our Series A Preferred Stock. Thus, each of our selling security
holders that owns shares of our Series A Preferred Stock received a dividend
equal $0.107 per share of the Series A Preferred Stock that such selling
security holder held on December 31, 2007.
PLAN OF DISTRIBUTION
The selling security holders may, from time to time, sell any or all of
their shares of common stock on any stock exchange, market or trading facility
on which the shares are traded or quoted in private transactions. These sales
may be at prevailing market prices at the time of sale, or at privately
negotiated prices. However, because there is no trading market in our common
stock as of the date of this prospectus, the selling security holders intend to
sell any shares in the public market at $2.00 per share until shares of our
common stock are traded on the OTC Bulletin Board. Once our common stock trades
on the OTC Bulletin Board, the selling security holders may use any one or more
of the following methods when selling shares:
o ordinary brokerage transactions and transactions in which the
broker-dealer solicits purchasers;
o block trades in which the broker-dealer will attempt to sell the
shares as agent but may position and resell a portion of the block
as principal to facilitate the transaction;
o purchases by a broker-dealer as principal and resale by the
broker-dealer for its account;
o an exchange distribution in accordance with the rules of the
applicable exchange;
o privately negotiated transactions;
o short sales;
o broker-dealers may agree with the selling security holders to sell
a specified number of such shares at a stipulated price per share;
86
o a combination of any such methods of sale; and
o any other method permitted pursuant to applicable law.
The selling security holders may also sell shares under Rule 144 under
the Securities Act, if available, rather than under this prospectus.
Broker-dealers engaged by the selling security holders may arrange for
other brokers-dealers to participate in sales. Broker-dealers may receive
commissions or discounts from the selling security holders (or, if any
broker-dealer acts as agent for the purchaser of shares, from the purchaser) in
amounts to be negotiated. The selling security holders do not expect these
commissions and discounts to exceed what is customary in the types of
transactions involved. Any profits on the resale of shares of common stock by a
broker-dealer acting as principal might be deemed to be underwriting discounts
or commissions under the Securities Act. Discounts, concessions, commissions and
similar selling expenses, if any, attributable to the sale of shares will be
borne by a selling security holder. The selling security holders may agree to
indemnify any agent, dealer or broker-dealer that participates in transactions
involving sales of the shares if liabilities are imposed on that person under
the Securities Act.
The selling security holders may from time to time pledge or grant a
security interest in some or all of the shares of common stock owned by them
and, if they default in the performance of their secured obligations, the
pledgees or secured parties may offer and sell the shares of common stock from
time to time under this prospectus after we have filed a supplement to this
prospectus under Rule 424(b)(3) or other applicable provision of the Securities
Act supplementing or amending the list of selling security holders to include
the pledgee, transferee or other successors in interest as selling stockholders
under this prospectus.
The selling security holders also may transfer the shares of common
stock in other circumstances, in which case the transferees, pledgees or other
successors in interest will be the selling beneficial owners for purposes of
this prospectus and may sell the shares of common stock from time to time under
this prospectus after we have filed a supplement to this prospectus under Rule
424(b)(3) or other applicable provision of the Securities Act supplementing or
amending the list of selling security holders to include the pledgee, transferee
or other successors in interest as selling security holders under this
prospectus.
The selling security holders and any broker-dealers or agents that are
involved in selling the shares of common stock may be deemed to be
"underwriters" within the meaning of the Securities Act in connection with such
sales. In such event, any commissions received by such broker-dealers or agents
and any profit on the resale of the shares of common stock purchased by them may
be deemed to be underwriting commissions or discounts under the Securities Act.
We are required to pay all fees and expenses incident to the
registration of the shares of common stock. We have agreed to indemnify the
selling security holders against certain losses, claims, damages and
liabilities, including liabilities under the Securities Act.
The selling security holders have advised us that they have not entered
into any agreements, understandings or arrangements with any underwriters or
broker-dealers regarding the sale of their shares of common stock, nor is there
an underwriter or coordinating broker acting in connection with a proposed sale
of shares of common stock by any selling security holder. If we are notified by
any selling security holder that any material arrangement has been entered into
with a broker-dealer for the sale of shares of common stock, if required, we
will file a supplement to this prospectus. If the selling security holders use
this prospectus for any sale of the shares of common stock, they will be subject
to the prospectus delivery requirements of the Securities Act.
The anti-manipulation rules of Regulation M under the Exchange Act may
apply to sales of our common stock and activities of the selling security
holders.
87
DESCRIPTION OF CAPITAL STOCK
Our authorized capital stock consists of 100,000,000 shares of common
stock, no par value per share, and 15,000,000 shares of preferred stock, no par
value per share. Of the 15,000,000 shares designated preferred stock, 5,909,089
shares have been designated Series A Preferred Stock. As of February 1, 2008,
there were 14,201,897 shares of common stock issued and outstanding and
5,909,089 shares of Series A Preferred Stock issued and outstanding. The
following description of our capital stock does not purport to be complete and
should be reviewed in conjunction with our articles of incorporation and our
bylaws.
COMMON STOCK
All outstanding shares of common stock are, and the common stock to be
issued upon conversion of the Series A Preferred Stock and exercise of warrants
and resold by the selling security holders in this offering will be, fully paid
and nonassessable. The following summarizes the rights of holders of our common
stock:
o each holder of common stock is entitled to one vote per share on
all matters to be voted upon generally by the shareholders;
however, in voting for directors at a meeting of shareholders,
shares may be voted cumulatively for persons whose names have been
placed in nomination prior to the voting for the election of
directors, but only if a shareholder present at the meeting gives
notice at the meeting, prior to the voting for the election of
directors, of his or her intention to vote cumulatively;
o subject to preferences that may apply to shares of preferred stock
outstanding, including the Series A Preferred Stock, the holders
of common stock are entitled to receive lawful dividends as may be
declared by our board of directors, see "Dividend Policy";
o upon our liquidation, dissolution or winding up, the holders of
shares of common stock are entitled to receive a pro rata portion
of all our assets remaining for distribution after satisfaction of
all our liabilities and the payment of any liquidation preference
of any outstanding preferred stock, including the Series A
Preferred Stock;
o there are no redemption or sinking fund provisions applicable to
our common stock; and
o there are no preemptive or conversion rights applicable to our
common stock.
PREFERRED STOCK
Our board of directors is authorized to issue from time to time,
without shareholder authorization, in one or more designated series, any or all
of our authorized but unissued shares of preferred stock with any dividend,
redemption, conversion and exchange provision as may be provided in that
particular series.
The rights of the holders of our common stock will be subject to, and
may be adversely affected by, the rights of the holders of any preferred stock
that may be issued in the future. Issuance of a new series of preferred stock,
while providing desirable flexibility in connection with possible acquisitions
and other corporate purposes, could have the effect of entrenching our board of
directors and making it more difficult for a third-party to acquire, or
discourage a third-party from acquiring, a majority of our outstanding voting
stock. We have no present plans to issue any shares of or to designate any
additional series of preferred stock.
88
SERIES A PREFERRED STOCK
Our Series A Preferred Stock ranks senior in liquidation and dividend
preferences to our common stock. Holders of Series A Preferred Stock will be
entitled to semi-annual cumulative dividends payable in arrears in cash in an
amount equal to 8% per annum of the purchase price per share of the Series A
Preferred Stock. The holders of Series A Preferred Stock have a liquidation
preference over the holders of our common stock equivalent to the purchase price
per share of the Series A Preferred Stock, as adjusted, plus any accrued and
unpaid dividends on the Series A Preferred Stock. A liquidation will be deemed
to occur upon the happening of customary events, including transfer of all or
substantially all of our capital stock or assets, or in the event of a merger,
consolidation, share exchange, reorganization or other transaction or series of
related transactions, unless holders of 66 2/3% of the Series A Preferred Stock
vote affirmatively in favor of or otherwise consent to such transaction.
The holders of the Series A Preferred Stock have conversion rights
initially equivalent to one share of common stock for each share of Series A
Preferred Stock. Each share of Series A Preferred Stock is convertible by the
holder at any time after its initial issuance at a conversion price equal to
$2.20 per share. The conversion price is subject to customary antidilution
adjustments. In addition, antidilution adjustments are to occur in the event
that we issue equity securities at a price equivalent to less than $2.20 per
share, including derivative securities convertible into equity securities (on an
as-converted or as-exercised basis). Certain specified issuances of securities
will not result in antidilution adjustments, which are referred to as
Anti-Dilution Excluded Securities, including (i) securities issued to our
employees, officers, consultants, or directors under any option plan, agreement
or other arrangement duly adopted by us, the issuance of which is approved by
the Compensation Committee, (ii) the Series A Preferred Stock and any common
stock issued upon conversion of the Series A Preferred Stock, (iii) securities
issued upon conversion or exercise of any derivative securities outstanding on
May 24, 2007, and (iv) securities issued in connection with a stock split, stock
dividend, combination, reorganization, recapitalization or other similar event
for which adjustment to the conversion price of the Series A Preferred Stock is
already made. The shares of Series A Preferred Stock are also subject to forced
conversion anytime after May 24, 2008, only if the closing price of our common
stock exceeds 200% of the conversion price then in effect for 20 consecutive
trading days. The forced conversion is to be based upon the conversion ratio as
last adjusted. No shares of Series A Preferred Stock will be subject to forced
conversion unless the shares of common stock issued or issuable to the holders
upon conversion of the Series A Preferred Stock are registered for resale with
the SEC and eligible for trading on the New York Stock Exchange, the American
Stock Exchange, the NASDAQ Global market, the NASDAQ Capital market, the OTC
Bulletin Board or the Pink Sheets(R). Accrued but unpaid dividends on the Series
A Preferred Stock are to be paid in cash upon any conversion of the Series A
Preferred Stock. In addition, the Company is required at all times to reserve
and keep available out of its authorized but unissued shares of Common Stock,
for the purpose of effecting the conversion of shares of Series A Preferred
Stock issued or issuable to the holders, such number of shares of Common Stock
as shall from time to time be sufficient to effect the conversion of all
outstanding shares of Series A Preferred Stock.
The holders of Series A Preferred Stock are entitled to certain buy-in
rights if we fail to deliver the shares of common stock underlying the Series A
Preferred Stock (whether or not such shares of common stock are covered by an
effective registration statement under the Securities Act) by the third business
day after the date on which the Series A Preferred Stock is converted. The
buy-in rights apply if after such third business day, but prior to cure by us,
the holder purchases (in an open market transaction or otherwise) shares of our
common stock to deliver in satisfaction of a sale by the holder of common stock
that the holder anticipated receiving from us upon conversion of the Series A
Preferred Stock.
90
As described more fully in the financial statements accompanying this
prospectus, in determining the accounting treatment for the Series A Preferred
Stock, management has considered the fact that we have adequate authorized and
unissued shares of common stock to cover the maximum number of shares that could
be required to be issued upon conversion of the Series A Preferred Stock and
upon exercise of outstanding warrants, and that we are required by our
agreements with our investors to maintain sufficient authorized and unissued
shares for such purposes at all times. Management also controls the events and
actions necessary for us to meet these requirements at all times, as well as the
requirements to share-settle the Series A Preferred Stock due to the ability to
deliver unregistered shares to satisfy the instruments.
The holders of Series A Preferred Stock vote together as a single class
with the holders of our other classes and series of voting stock on all actions
to be taken by our shareholders. Each share of Series A Preferred Stock entitles
the holder to the number of votes equal to the number of shares of our common
stock into which each share of Series A Preferred Stock is convertible, subject
to the 4.99% limitation described below. In addition, the holders of Series A
Preferred Stock are afforded numerous customary protective provisions with
respect to certain actions that may only be approved by holders of a majority of
the shares of Series A Preferred Stock. These protective provisions include
limitations on:
o the increase or decrease of the number of authorized shares of
Series A Preferred Stock;
o increase or decrease of the number of authorized shares of other
capital stock;
o generally any actions that have an adverse effect on the rights
and preferences of the Series A Preferred Stock;
o the authorization, creation or sale of any securities senior to or
on parity with the Series A Preferred Stock as to voting,
dividend, liquidation or redemption rights, including subordinated
debt;
o the authorization, creation or sale of any securities junior to
the Series A Preferred Stock as to voting, dividend, liquidation
or redemption rights, including subordinated debt, other than our
common stock;
o the authorization, creation or sale of any shares of Series A
Preferred Stock other than the shares of Series A Preferred Stock
authorized, created and sold pursuant to the Securities Purchase
Agreement dated May 24, 2007;
o the declaration or payment of any dividends or distributions on
our capital stock in a cumulative amount in excess of the
dividends and distributions paid on the Series A Preferred Stock
in accordance with our articles of incorporation;
o authorizing or effecting the voluntary liquidation, dissolution,
recapitalization, reorganization or winding up of our business;
and
o the purchase, redemption or acquisition of any of our capital
stock other than Series A Preferred Stock, or any warrants or
other rights to subscribe for or to purchase, or any options for
the purchase of, our capital stock or securities convertible into
or exchangeable for our capital.
91
For so long as our shares of Series A Preferred Stock remain
outstanding, the holders of at least a majority of our issued and outstanding
shares of Series A Preferred Stock are entitled to nominate one member of our
board of directors. In addition, the holders of at least a majority of our
issued and outstanding shares of Series A Preferred Stock are entitled to
nominate a second member of our board of directors for successive one-year-terms
upon the accumulation of accrued and unpaid dividends for three or more
six-month periods or our failure to comply with the covenants or agreements set
forth in our articles of incorporation. The right to nominate a second director
will terminate upon the cure of the defaults creating the right to nominate a
second director. The holders of Series A Preferred Stock have nominated Wesley
Cummins as a member of our board of directors.
On or after May 24, 2012, the holders of our then outstanding shares of
Series A Preferred Stock, if any, will be entitled to redemption rights. The
redemption price is equal to the per-share purchase price of the Series A
Preferred Stock, which is subject to adjustment as discussed above and in our
articles of incorporation, plus any accrued but unpaid dividends. The redemption
price must be paid in immediately available funds. If the funds legally
available to us for the payment of the redemption price of the Series A
Preferred Stock is not sufficient to redeem all of the shares of the Series A
Preferred Stock required to be redeemed on any date, then shares of Series A
Preferred Stock are to be redeemed on a pro rata basis from the holders of the
Series A Preferred Stock in proportion to the number of shares of Series A
Preferred Stock held by them. If all of the shares of Series A Preferred Stock
to be redeemed are not redeemed in full, all rights in respect of such shares of
Series A Preferred Stock that have not been redeemed, including the right to
receive the applicable redemption price, plus accrued and unpaid dividends, will
continue to be outstanding. The exercise by the holders of the option to redeem
any shares of Series A Preferred Stock which were not redeemed may be rescinded
by such holders at any time following the date established for such redemption
by written notice to Strasbaugh.
The Series A Preferred Stock contain provisions prohibiting the
conversion of the Series A Preferred Stock to the extent that such conversion
would result in the holder, together with its affiliates, beneficially owning in
excess of 4.99% of our outstanding shares of common stock. The holder may waive
this 4.99% limitation upon 61-days' prior written notice to us. Additionally,
these limitations do not preclude a holder from converting Series A Preferred
Stock and selling shares of common stock underlying the Series A Preferred Stock
in stages over time where each stage does not cause the holder and its
affiliates to beneficially own shares of common stock in excess of the 4.99%
limitation amount.
The Series A Preferred Stock could have the effect of delaying,
deferring and discouraging another party from acquiring control of Strasbaugh.
WARRANTS
As of February 1, 2008, we had outstanding warrants to purchase
1,271,797 shares of our common stock at exercise prices equaling $2.42 per
share. These outstanding warrants consist of five-year Investor Warrants to
purchase an aggregate of 886,363 shares of common stock and five-year Placement
Warrants to purchase an aggregate of 385,434 shares of common stock. The
Placement Warrants and Investor Warrants are exercisable through May 24, 2012.
The holders of Investor Warrants and Placement Warrants are entitled to
certain buy-in rights if we fail to deliver the shares of common stock
underlying the Investor Warrants and Placement Warrants (whether or not such
shares of common stock are covered by an effective registration statement under
the Securities Act) by the third business day after the date on which the
Investor Warrants and Placement Warrants are exercised. The buy-in rights apply
if after such third business day, but prior to cure by us, the holder purchases
(in an open market transaction or otherwise) shares of our common stock to
deliver in satisfaction of a sale by the holder of common stock that the holder
anticipated receiving from us upon exercise of the Investor Warrants and
Placement Warrants.
91
The Investor Warrants contain provisions prohibiting the conversion to
the extent that such conversion would result in the holder, together with its
affiliates, beneficially owning in excess of 4.99% of our outstanding shares of
common stock. The holder may waive this 4.99% limitation upon 61-days' prior
written notice to us. Additionally, these limitations do not preclude a holder
from exercising Investor Warrants and selling shares of common stock underlying
the Investor Warrants in stages over time where each stage does not cause the
holder and its affiliates to beneficially own shares of common stock in excess
of the 4.99% limitation amount.
OPTIONS
As of February 1, 2008, we had outstanding options to purchase
1,339,000 shares of our common stock at exercise prices equaling $1.71 per share
issued pursuant to our 2007 Plan. For a detailed description of our 2007 Plan
see "Management - 2007 Share Incentive Plan."
REGISTRATION RIGHTS
The holders of our Series A Preferred Stock and warrants are entitled
to rights with respect to the registration of their shares under the Securities
Act. These registration rights are described in "Selling Security Holders."
ANTI-TAKEOVER EFFECTS OF CALIFORNIA LAW AND OUR ARTICLES OF INCORPORATION AND
BYLAWS
Certain provisions of California law, our articles of incorporation and
our bylaws contain provisions that could have the effect of delaying, deferring
and discouraging another party from acquiring control of us. These provisions,
which are summarized below, are expected to discourage coercive takeover
practices and inadequate takeover bids. These provisions are also designed to
encourage persons seeking to acquire control of us to first negotiate with our
board of directors. We believe that the benefits of increased protection of our
potential ability to negotiate with an unfriendly or unsolicited acquiror
outweigh the disadvantages of discouraging a proposal to acquire us because
negotiation of these proposals could result in an improvement of their terms.
The ability to authorize undesignated preferred stock makes it possible
for our board of directors to issue preferred stock with voting or other rights
or preferences that could impede the success of any attempt to acquire us. These
provisions may have the effect of deferring hostile takeovers or delaying
changes in control or management of Strasbaugh. In addition, the Series A
Preferred Stock could have the effect of delaying, deferring and discouraging
another party from acquiring control of Strasbaugh. Also, pursuant to our
articles of incorporation, the holders of at least a majority of our issued and
outstanding shares of Series A Preferred Stock have the right to nominate one
member of our board of directors. In addition, at least a majority of our issued
and outstanding shares of Series A Preferred Stock have the right to nominate a
second member of our board of directors upon the happening of certain events.
The provisions of California law, our articles of incorporation and our
bylaws could have the effect of discouraging others from attempting hostile
takeovers and, as a consequence, they may also inhibit temporary fluctuations in
the market price of our common stock that often result from actual or rumored
hostile takeover attempts. These provisions may also have the effect of
preventing changes in our management. It is possible that these provisions could
make it more difficult to accomplish transactions that stockholders may
otherwise deem to be in their best interests.
92
TRANSFER AGENT AND REGISTRAR
The transfer agent and registrar for our common stock is Computershare.
Its telephone number is (781) 575-2879.
LEGAL MATTERS
The validity of the shares of common stock offered under this
prospectus will be passed upon by Rutan & Tucker, LLP, Costa Mesa, California.
EXPERTS
Windes & McClaughry Accountancy Corporation, or Windes, independent
registered public accounting firm, has audited R. H. Strasbaugh's balance sheet
as of December 31, 2006, and related statements of income, changes in
shareholders' equity and cash flows for each of the two years in the period
ended December 31, 2006, as set forth in their report. We have included our
financial statements in the prospectus and elsewhere in the registration
statement in reliance on Windes' report, given on their authority as experts in
accounting and auditing.
CHANGE IN CERTIFYING ACCOUNTANT
The Share Exchange Transaction between Strasbaugh (formerly, CTK Windup
Corporation) and R. H. Strasbaugh (formerly Strasbaugh) is treated as a
recapitalization of R. H. Strasbaugh for accounting purposes. As a result, the
financial statements of the accounting acquiror, R. H. Strasbaugh, will become
the financial statements of the legal acquiror, Strasbaugh. Because the
independent registered public accounting firm that audited R. H. Strasbaugh's
financial statements, Windes, is different from the independent registered
public accounting firm that has been auditing our financial statements, Mark
Bailey & Company Ltd., or Mark Bailey, the rules and regulations of the SEC
provide that there has been a change in our independent registered public
accounting firm.
Effective May 24, 2007, we dismissed Mark Bailey as our independent
registered public accounting firm. Effective the same date, we appointed Windes
as our independent registered public accounting firm. We have not consulted with
Windes in the past regarding the application of accounting principles to a
specified transaction or the type of audit opinion that might be rendered on our
financial statements. The decision to change our independent registered public
accounting firm was approved by our Audit Committee.
The report issued by Mark Bailey in connection with the audit of our
(CTK Windup Corporation) balance sheet as of December 31, 2006 did not contain
an adverse opinion or a disclaimer of opinion, nor was such report qualified or
modified as to uncertainty, audit scope, or accounting principles. In connection
with its audit of our (CTK Windup Corporation) balance sheet as of December 31,
2006, we had no disagreements with Mark Bailey on any matters of accounting
principles or practices, financial statement disclosure, or audit scope or
procedure, which disagreements, if not resolved to the satisfaction of Mark
Bailey would have caused Mark Bailey to make a reference thereto in their report
on the financial statements for such period.
Pursuant to Item 304(a)(3) of Regulation S-B, we have requested that
Mark Bailey furnish us with a letter addressed to the SEC stating whether or not
Mark Bailey agrees with the above statements. A copy of this letter, dated July
12, 2007, is included as an exhibit to the registration statement of which this
prospectus is a part.
93
WHERE YOU CAN FIND MORE INFORMATION
We have filed with the SEC a registration statement on Form SB-2 under
the Securities Act, and the rules and regulations promulgated under the
Securities Act, with respect to the common stock offered under this prospectus.
This prospectus, which constitutes a part of the registration statement, does
not contain all of the information contained in the registration statement and
the exhibits and schedules to the registration statement. Many of the contracts
and documents described in this prospectus are filed as exhibits to the
registration statements and you may review the full text of such contracts and
documents by referring to such exhibits.
For further information with respect to us and the common stock offered
under this prospectus, reference is made to the registration statement and its
exhibits and schedules. The registration statement, including its exhibits and
schedules, may be inspected without charge at the Public Reference Room
maintained by the SEC at 100 F Street N.E., Washington, D.C. 20549. Copies of
such documents may be obtained from the SEC upon the payment of the charges
prescribed by the SEC. The public may obtain information on the operation of the
Public Reference Room by calling the SEC at 1-800-SEC-0330.
The SEC maintains an Internet web site that contains reports, proxy and
information statements and other information regarding issuers, such as us, that
file electronically with the SEC. The SEC's Internet website address is
http://www.sec.gov. Our Internet website address is http://www.strasbaugh.com.
All trademarks or trade names referred to in this prospectus are the
property of their respective owners.
94
STRASBAUGH AND SUBSIDIARY
INDEX TO FINANCIAL STATEMENTS
Page
----
Condensed Consolidated Balance Sheets as of September 30, 2007 (unaudited) and
December 31, 2006.......................................................................................F-2
Condensed Consolidated Statements of Income for the Nine Months Ended
September 30, 2007 and 2006 (unaudited).................................................................F-3
Condensed Consolidated Statements of Cash Flows for the Nine Months Ended
September 30, 2007 and 2006 (unaudited).................................................................F-4
Condensed Consolidated Statement of Redeemable Convertible Preferred Stock and
Shareholders' Equity for the Nine Months Ended September 30, 2007 (unaudited)...........................F-5
Notes to Condensed Consolidated Financial Statements for the Nine Months Ended
September 30, 2007 (unaudited)..........................................................................F-6
Report of Independent Registered Public Accounting Firm......................................................F-32
Balance Sheet as of December 31, 2006........................................................................F-33
Statements of Income for the Years Ended December 31, 2006 and 2005..........................................F-34
Statements of Changes in Shareholders' Equity for the Years Ended
December 31, 2006 and 2005..............................................................................F-35
Statements of Cash Flows for the Years Ended December 31, 2006 and 2005......................................F-36
Notes to Financial Statements for the Years Ended December 31, 2006 and 2005.................................F-37
F-1
|
STRASBAUGH AND SUBSIDIARY
CONDENSED CONSOLIDATED BALANCE SHEETS
AS OF SEPTEMBER 30, 2007 (UNAUDITED)
AND DECEMBER 31, 2006
(IN THOUSANDS, EXCEPT SHARE AND PER SHARE DATA)
ASSETS
SEPTEMBER 30, DECEMBER 31,
2007 2006
(as restated) (as restated)
------------ ------------
(unaudited)
CURRENT ASSETS
Cash and cash equivalents $ 3,013 $ 1,205
Accounts receivable, net of allowance for doubtful accounts of $43
at September 30, 2007 and December 31, 2006 3,317 4,251
Investments in securities 147 --
Inventories 6,742 7,114
Prepaid expenses 322 338
Short-term deposits 45 48
------------ ------------
13,586 12,956
------------ ------------
PROPERTY, PLANT, AND EQUIPMENT 1,739 1,949
------------ ------------
OTHER ASSETS
Investments in securities 773 --
Capitalized intellectual property, net of accumulated amortization
of $9 at September 30, 2007 and $11 at December 31, 2006 286 192
Long-term deposits -- 88
------------ ------------
1,059 280
------------ ------------
TOTAL ASSETS $ 16,384 $ 15,185
============ ============
LIABILITIES, REDEEMABLE CONVERTIBLE PREFERRED STOCK AND SHAREHOLDERS' EQUITY
CURRENT LIABILITIES
Line of credit $ -- $ 2,650
Notes payable, current portion 100 1,785
Accounts payable 717 1,038
Accrued expenses 2,343 2,941
Deferred revenue 129 1,201
------------ ------------
3,289 9,615
------------ ------------
NONCURRENT LIABILITIES
Accrued warrant -- 450
------------ ------------
-- 450
------------ ------------
COMMITMENTS AND CONTINGENCIES (Notes 7, 8, 9 and 10)
REDEEMABLE CONVERTIBLE PREFERRED STOCK
Redeemable convertible preferred stock ("Series A"), no par value, aggregate
preference in liquidation $13,103, 15,000,000 shares authorized, 5,909,089
shares issued and outstanding at September 30, 2007, zero outstanding at
December 31, 2006 11,602 --
------------ ------------
SHAREHOLDERS' EQUITY
Preferred stock ("Participating"), no par value, 5,769,736 shares authorized,
4,087,980 shares issued and outstanding at December 31, 2006, zero
outstanding at September 30, 2007 -- 8,595
Common stock, no par value, 100,000,000 shares authorized, 14,201,897 issued
and outstanding at September 30, 2007: 50,000,000 shares
authorized, 13,992,828 shares issued and outstanding at December 31, 2006 56 17
Additional paid-in capital 28,246 23,409
Accumulated other comprehensive loss (2) --
Accumulated deficit (26,807) (26,901)
------------ ------------
1,493 5,120
------------ ------------
TOTAL LIABILITIES, REDEEMABLE CONVERTIBLE PREFERRED STOCK AND SHAREHOLDERS' EQUITY $ 16,384 $ 15,185
============ ============
The accompanying notes are an integral part of these
statements.
F-2
|
STRASBAUGH AND SUBSIDIARY
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2007 AND 2006 (UNAUDITED)
(IN THOUSANDS, EXCEPT PER SHARE DATA)
NINE MONTHS ENDED
SEPTEMBER 30,
2007
(as restated) 2006
------------- ------------
(unaudited)
REVENUES
Tools $ 10,716 $ 6,217
Parts and Service 5,845 9,176
------------ ------------
NET REVENUES 16,561 15,393
------------ ------------
COST OF SALES
Tools 6,486 4,587
Parts and Service 3,386 4,574
------------ ------------
TOTAL COST OF SALES 9,872 9,161
------------ ------------
GROSS PROFIT 6,689 6,232
------------ ------------
OPERATING EXPENSES
Selling, general and administrative expenses 4,727 3,415
Research and development 1,452 1,273
------------ ------------
6,179 4,688
------------ ------------
INCOME FROM OPERATIONS 510 1,544
------------ ------------
OTHER INCOME (EXPENSE)
Rental income -- 136
Interest income 56 1
Interest expense (330) (584)
Other expense, net (70) (10)
------------ ------------
(344) (457)
------------ ------------
INCOME BEFORE PROVISION FOR INCOME TAXES 166 1,087
PROVISION FOR INCOME TAXES 72 112
------------ ------------
NET INCOME $ 94 $ 975
============ ============
NET INCOME PER COMMON SHARE
Basic $ 0.36 $ 0.07
============ ============
Diluted $ 0.29 $ 0.05
============ ============
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING
Basic 14,308 13,993
============ ============
Diluted 19,638 18,573
============ ============
The accompanying notes are an integral part of these statements.
F-3
|
STRASBAUGH AND SUBSIDIARY
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR NINE MONTHS ENDED SEPTEMBER 30, 2007 AND 2006 (UNAUDITED)
(IN THOUSANDS)
NINE MONTHS ENDED
SEPTEMBER 30,
2007
(as restated) 2006
------------- ------------
(unaudited)
CASH FLOWS FROM OPERATING ACTIVITIES
Net income $ 94 $ 975
Adjustments to reconcile net income
to net cash from operating activities:
Depreciation and amortization 225 282
Amortization of intellectual property 9 8
Noncash interest expense 113 (113)
Stock based compensation 60 7
Changes in assets and liabilities:
Accounts receivable 934 (1,382)
Inventories 372 (2,739)
Prepaid expenses 16 59
Deposits 91 9
Accounts payable (321) 946
Accrued expenses (598) 240
Deferred revenue (1,072) 966
Accrued warrant (450) 55
------------ ------------
Net Cash Used In Operating Activities (527) (687)
------------ ------------
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in securities (922) --
Purchase of property and equipment (16) (135)
Capitalized cost for intellectual property (102) (176)
------------ ------------
Net Cash Used In Investing Activities (1,040) (311)
------------ ------------
CASH FLOWS FROM FINANCING ACTIVITIES
Net change in line of credit (2,650) 512
Bank overdraft -- 175
Borrowings on notes payable -- 525
Repayment of notes payable (1,798) (610)
Repurchase of participating preferred stock (3,000) --
Issuance of conditionally redeemable convertible preferred stock 11,122 --
Issuance of warrants 350 --
Proceeds from stock options exercised 38 --
Proceeds from issuance of shares in share exchange transaction 63 --
Repurchase of common stock (750) --
------------ ------------
Net Cash Provided By Financing Activities 3,375 602
------------ ------------
NET CHANGE IN CASH AND CASH EQUIVALENTS 1,808 (396)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD 1,205 681
------------ ------------
CASH AND CASH EQUIVALENTS, END OF PERIOD $ 3,013 $ 285
============ ============
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Cash paid for:
Interest $ 203 $ 377
============ ============
Income taxes $ 18 $ 59
============ ============
Fair value accretion on conditionally redeemable
convertible preferred stock $ 113 $ --
============ ============
Preferred stock dividend $ 367 $ --
============ ============
Unrealized loss on investments in securities $ 2 $ --
============ ============
The accompanying notes are an integral part of these
statements.
F-4
|
STRASBAUGH AND SUBSIDIARY
CONDENSED CONSOLIDATED STATEMENT OF REDEEMABLE CONVERTIBLE PREFERRED STOCK
AND SHAREHOLDERS EQUITY FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2007 (UNAUDITED)
(IN THOUSANDS, EXCEPT SHARE DATA)
TOTAL
ACCUMULATED SHAREHOLDERS'
REDEEMABLE OTHER EQUITY AND
CONVERTIBLE COMPRE- REDEEMABLE
PREFERRED STOCK COMMON STOCK PREFERRED STOCK ADDITIONAL HENSIVE CONVERTIBLE
------------------ ------------------- -------------------- PAID-IN INCOME ACCUMULATED PREFERRED
SHARES AMOUNT SHARES AMOUNT SHARES AMOUNT CAPITAL (LOSS) DEFICIT STOCK
--------- ------- ---------- ------ ---------- ------- -------- ------ -------- --------
BALANCE, DECEMBER 31, 2006
(as restated) -- $ -- 13,992,828 $ 17 4,087,980 $ 8,595 $ 23,409 $ -- $(26,901) $ 5,120
Comprehensive income:
Net income (as restated) -- -- -- -- -- -- -- -- 94 94
Other comprehensive loss:
Unrealized loss of
investments, net of
tax of $0 -- -- -- -- -- -- -- (2) -- (2)
--------
Total comprehensive income -- -- -- -- -- -- -- -- -- 92
--------
Repurchase of
participating preferred
stock for $3,000 -- -- -- -- (4,087,980) $(8,595) 5,595 -- -- (3,000)
Issuance of common stock
to CTK, net of issuance
costs of $300 -- -- 431,531 1 -- -- 62 -- -- 63
Sale of Series A
redeemable convertible
preferred stock, net
of issuance costs of
$1,878 5,909,089 11,122 -- -- -- -- -- -- -- 11,122
Fair value of warrants
issued (Note 9) -- -- -- -- -- -- 350 -- -- 350
Repurchase of common stock -- -- (771,327) -- -- -- (750) -- -- (750)
Issuance of common stock
from exercise of options -- -- 548,865 38 -- -- -- -- -- 38
Stock-based compensation
expense -- -- -- -- -- -- 60 -- -- 60
Accretion of redeemable
convertible preferred
stock -- 113 -- -- -- -- (113) -- -- --
Preferred stock dividend -- 367 -- -- -- -- (367) -- -- --
--------- ------- ---------- ------ ---------- ------- -------- ------ -------- --------
BALANCE, SEPTEMBER 30,
2007 (as restated) 5,909,089 $11,602 14,201,897 $ 56 -- $ -- $ 28,246 $ (2) $(26,807) $ 13,095
========= ======= ========== ====== ========== ======= ======== ====== ======== ========
The accompanying notes are an integral part of
these statements.
F-5
|
STRASBAUGH AND SUBSIDIARY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2007 (UNAUDITED)
NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
ORGANIZATION AND DESCRIPTION OF BUSINESS
The condensed consolidated financial statements include the accounts of
Strasbaugh, a California corporation formerly known as CTK Windup Corporation
("Strasbaugh"), and its wholly-owned subsidiary, R. H. Strasbaugh, a California
corporation ("R. H. Strasbaugh," and together with Strasbaugh, the "Company").
All material inter-company accounts and transactions have been eliminated in the
consolidation.
The Company designs and manufactures precision surfacing systems and solutions
for the global semiconductor, electronics, precision optics, and aerospace
industries. Products are sold to customers throughout the United States, Europe,
and Asia and Pacific Rim countries.
SHARE EXCHANGE TRANSACTION
On May 24, 2007, Strasbaugh completed a share exchange transaction (the "Share
Exchange Transaction") with R. H. Strasbaugh, a California corporation formerly
known as Strasbaugh ("R. H. Strasbaugh"). Upon completion of the Share Exchange
Transaction, Strasbaugh acquired all of the issued and outstanding shares of R.
H. Strasbaugh's capital stock. In connection with the Share Exchange
Transaction, Strasbaugh issued an aggregate of 13,770,366 shares of its common
stock to R. H. Strasbaugh's shareholders. The Share Exchange Transaction has
been accounted for as a recapitalization of R. H. Strasbaugh with R. H.
Strasbaugh being the accounting acquiror. As a result, the historical financial
statements of R. H. Strasbaugh will be the financial statements of the legal
acquiror, Strasbaugh (formerly known as CTK Windup Corporation).
Immediately prior to the consummation of the Share Exchange Transaction, CTK
Windup Corporation amended and restated its articles of incorporation to
effectuate a 1-for-31 reverse split of its common stock, to change its name from
CTK Windup Corporation to Strasbaugh, to increase its authorized common stock
from 50,000,000 shares to 100,000,000 shares, to increase its authorized
preferred stock from 2,000,000 shares to 15,000,000 shares (of which 5,909,089
shares have been designated Series A Cumulative Redeemable Convertible Preferred
Stock (the "Series A Preferred Stock")) and to eliminate its Series A
Participating Preferred Stock. On May 17, 2007, prior to the filing of CTK
Windup Corporation's amended and restated articles of incorporation, the
Company's subsidiary, R. H. Strasbaugh (then known as Strasbaugh), amended its
articles of incorporation to change its name from Strasbaugh to R. H.
Strasbaugh.
BASIS OF PRESENTATION
The accompanying unaudited condensed consolidated financial statements have been
prepared in accordance with the rules and regulations of the Securities and
Exchange Commission ("Commission") and therefore do not include all information
and footnotes necessary for a complete presentation of the financial position,
results of operations and cash flows in conformity with accounting principles
generally accepted in the United States of America.
F-6
STRASBAUGH AND SUBSIDIARY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2007 (UNAUDITED)
NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
BASIS OF PRESENTATION (CONTINUED)
The unaudited condensed consolidated financial statements do, however, reflect
all adjustments, consisting of only normal recurring adjustments, which are, in
the opinion of management, necessary to state fairly the financial position as
of September 30, 2007 and the results of operations and cash flows for the
related interim periods ended September 30, 2007 and 2006. However, these
results are not necessarily indicative of results for any other interim period
or for the year. It is suggested that the accompanying condensed consolidated
financial statements be read in conjunction with the Company's audited financial
statements included elsewhere in this prospectus.
RECLASSIFICATIONS
Certain prior period balances have been reclassified for consistency with the
current presentation.
ESTIMATES AND ASSUMPTIONS
The preparation of financial statements in accordance with accounting principles
generally accepted in the United States of America requires management to make
estimates and assumptions that affect the reported amounts of assets and
liabilities, the disclosure of contingent assets and liabilities at the date of
the financial statements, the reported amounts of increases and decreases in net
assets from operations during the reporting period. Actual results could differ
from those estimates and those differences could be material. Significant
estimates include the fair value of the Company's common stock and the fair
value of options and warrants to purchase common stock, and depreciation and
amortization.
CORRECTION OF PRIOR PERIOD ERROR
In September 2006, the SEC issued Staff Accounting Bulletin ("SAB") No. 108
"Considering the Effects of Prior Year Misstatements when Quantifying
Misstatements in Current Year Financial Statements." SAB No. 108 provides
interpretive guidance on how the effects of the carryover or reversal of prior
year misstatements should be considered in quantifying a current year
misstatement. The SEC staff believes that registrants should quantify errors
using both a balance sheet and income statement approach and evaluate whether
either approach results in quantifying a misstatement that, when all relevant
quantitative and qualitative factors considered, is material. The Company
adopted SAB No. 108 for its fiscal year ended December 31, 2006.
Subsequent to the issuance of the December 31, 2006 financial statements, the
Company discovered an error in its interest expense account which affected its
2005 and 2006 fiscal years. In the first quarter of fiscal 2007 the Company
recorded additional interest expense to correct the cumulative impact of the
error which amounted to $56,000 at December 31, 2006.
F-7
STRASBAUGH AND SUBSIDIARY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2007 (UNAUDITED)
NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
CORRECTION OF PRIOR PERIOD ERROR (CONTINUED)
As a result of this error, interest expense was understated by period as
follows:
Year Ended December 31, 2005: $ 12,000
Nine Months Ended September 30, 2006: $ 30,000
Three Months Ended December 31, 2006: $ 14,000
|
The error resulted from an incorrect compounding of interest on the outstanding
principal and interest payable on a related party note. The Company considered
the relative quantitative and qualitative aspects of the computational error in
determining materiality. In evaluating the cumulative impact of $56,000 on the
December 31, 2006 income statement and balance sheet, the Company considered an
offsetting unrecorded difference of $34,000 related to inventory pricing errors
that arose in 2006.
The inventory pricing errors were detected in 2007 during the audit of the
Company's 2006 financial statements. The error of $34,000 is the extrapolated
total impact on inventory of smaller errors discovered in an audit sample of
price tests of the December 31, 2006 inventory balance. The total inventory
pricing error is less than 3% of the 2006 net income and is considered
insignificant to the results of operations and the overall financial statements.
Further, because the error is an extrapolation of sample errors, identifying
individual items to adjust prices is not possible, however, inventory prices are
adjusted periodically in the normal course of operations. Accordingly, the
inventory pricing errors were considered insignificant and no adjustment of the
fiscal 2006 or interim 2007 financial statements was considered necessary.
The net impact of the interest expense and inventory pricing errors on the 2006
net income was $22,000. The Company believes the impact of the known errors in
the 2006 and 2005 financial statements are insignificant and that the financial
statements are not required to be restated. In addition, disclosure of the
correction of the prior period error in interest expense in the 2007 interim
financial statements is considered appropriate rather than restating prior
period balances, because the impact of the correction is not considered
significant to the Company's expected annual results or to the trend in earnings
in 2007.
In analyzing the proper disposition of the errors, the Company also considered
the provisions of Accounting Principles Board ("APB") Opinion No. 28, "Interim
Financial Reporting." In accordance with APB No. 28, in determining materiality
for the purpose of reporting the cumulative effect of an accounting change or
correction of an error, amounts should be related to the estimated income for
the full fiscal year and also to the effect on the trend of earnings. Changes
that are material with respect to an interim period but not material with
respect to the estimated income for the full fiscal year or to the trend of
earnings should be separately disclosed in the interim period.
CONCENTRATIONS OF CREDIT RISK
The Company sells its products on credit terms, performs ongoing credit
evaluations of its customers, and maintains an allowance for potential credit
losses. During the nine months ended September 30, 2007 and 2006, the Company's
top 10 customers accounted for 69% and 53% of net revenues, respectively. Sales
to major customers (over 10%) as a percentage of net revenues were 40% and 12%,
for the nine months ended September 30, 2007 and 2006, respectively.
F-8
STRASBAUGH AND SUBSIDIARY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2007 (UNAUDITED)
NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
CONCENTRATIONS OF CREDIT RISK (CONTINUED)
A decision by a significant customer to substantially decrease or delay
purchases from the Company, or the Company's inability to collect receivables
from these customers, could have a material adverse effect on the Company's
financial condition and results of operations. As of September 30, 2007 the
amount due from the major customers (over 10%) discussed above represented 40%
of total accounts receivable.
SEGMENT INFORMATION
The Company's results of operations for the nine months ended September 30, 2007
and 2006, represent a single segment referred to as global semiconductor and
semiconductor equipment, silicon wafer and silicon wafer equipment, LED, data
storage and precision optics industries. Export sales represent approximately
61% and 32% of sales for the nine months ended September 30, 2007 and 2006,
respectively.
The geographic breakdown of the Company's sales was as follows:
SEPTEMBER 30,
2007 2006
-------- --------
United States 39% 68%
Europe 25% 4%
Asia and Pacific Rim countries 36% 28%
|
The geographic breakdown of the Company's accounts receivable was as follows:
SEPTEMBER 30,
2007
-------------
United States 37%
Europe 30%
Asia and Pacific Rim countries 33%
|
INVESTMENTS IN SECURITIES
The Company considers all highly liquid debt instruments purchased with a
maturity of three months or less to be cash equivalents. The Company determines
the appropriate classification of its investments in debt and equity securities
at the time of purchase and reevaluates such determinations at each
balance-sheet date. Debt securities are classified as held to maturity when the
Company has the positive intent and ability to hold the securities to maturity.
Debt securities for which the Company does not have the intent or ability to
hold to maturity are classified as available for sale. Held-to-maturity
securities are recorded as either short term or long term on the Balance Sheet
based on contractual maturity date and are stated at amortized cost. Marketable
securities that are bought and held principally for the purpose of selling them
in the near term are classified as trading securities and are reported at fair
value, with unrealized gains and losses recognized in earnings. Debt and
marketable equity securities not classified as held to maturity or as trading,
are classified as available for sale, and are carried at fair market value, with
the unrealized gains and losses, net of tax, included in the determination of
comprehensive income and reported in shareholders' equity.
F-9
STRASBAUGH AND SUBSIDIARY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2007 (UNAUDITED)
NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
INVESTMENTS IN SECURITIES (CONTINUED)
The fair value of substantially all securities is determined by quoted market
prices. At September 30, 2007, the short-term investments held to maturity
include certificates of deposits maturing in over 90 days and less than one
year. The Company's other investments have maturity dates generally from 2 to 10
years, are classified as available for sale and are included in non-current
assets because the investments will likely be sold prior to maturity, however,
they will likely be held over one year from the balance sheet date. The Company
had no realized gains or losses on sales of securities in 2007 or 2006. The
Company had no investments in securities at September 30, 2006. The Company's
unrealized losses on investments at September 30, 2007 totaled $2,000.
Investments in securities at September 30, 2007 were as follows:
UNREALIZED
AGGREGATE GAIN
FAIR VALUE COST BASIS (LOSS)
----------- ----------- ----------
Certificates of Deposit $ 147,000 $ 147,000 $ --
US government debt securities 500,000 501,000 (1,000)
Corporate debt securities 173,000 174,000 (1,000)
Municipal debt securities 100,000 100,000 --
----------- ----------- ----------
920,000 922,000 (2,000)
Investments, current 147,000 147,000 --
----------- ----------- ----------
Investments, non-current $ 773,000 $ 775,000 $ (2,000)
=========== =========== ==========
|
ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)
Comprehensive income consists of net income and other gains and losses affecting
shareholders' equity that, under generally accepted accounting principles are
excluded from net income. For the nine months ended September 30, 2007, the
Company's accumulated other comprehensive loss consisted of unrealized losses on
investments. There were no items of accumulated other comprehensive loss for the
nine months ended September 30, 2006.
REVENUE RECOGNITION
The Company derives revenues principally from the sale of tools, parts and
services. The Company recognizes revenue pursuant to SAB No. 104, "Revenue
Recognition." Revenue is recognized when there is persuasive evidence an
arrangement exists, delivery has occurred or services have been rendered, the
Company's price to the customer is fixed or determinable, and collection of the
related receivable is reasonably assured. Selling arrangements may include
contractual customer acceptance provisions and installation of the product
occurs after shipment and transfer of title. The Company recognizes revenue upon
shipment of products or performance of services and defers recognition of
revenue for any amounts subject to acceptance until such acceptance occurs.
Provisions for the estimated future cost of warranty are recorded at the time
the products are shipped.
F-10
STRASBAUGH AND SUBSIDIARY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2007 (UNAUDITED)
NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
REVENUE RECOGNITION (CONTINUED)
Generally, the Company obtains a non-refundable down-payment from the customer.
These fees are deferred and recognized as the tool is shipped. All sales
contract fees are payable no later than 60 days after delivery and payment is
not contingent upon installation. In addition, the Company's tool sales have no
right of return, or cancellation rights. Tools are typically modified to some
degree to fit the needs of the customer and, therefore, once a purchase order
has been accepted by the Company and the manufacturing process has begun, there
is no right to cancel, return or refuse the order.
The Company has evaluated its arrangements with customers and revenue
recognition policies under Emerging Issues Task Force ("EITF") Issue No. 00-21,
"Accounting for Revenue Arrangements with Multiple Deliverables," and determined
that its components of revenue are separate units of accounting. Each unit has
value to the customer on a standalone basis, there is objective and reliable
evidence of the fair value of each unit, and there is no right to cancel, return
or refuse an order. The Company's revenue recognition policies for its specific
units of accounting are as follows:
o Tools - The Company recognizes revenue once a customer has
visited the plant, signed off on the tool and the tool is
completed and shipped.
o Parts - The Company recognizes revenue when the parts are
shipped.
o Service - Revenue from maintenance contracts is deferred and
recognized over the life of the contract, which is generally
one to three years. Maintenance contracts are separate
components of revenue and not bundled with our tools. If a
customer does not have a maintenance contract, then the
customer is billed for time and material and the Company
recognizes revenue the after the service has been completed.
o Upgrades - The Company offers a suite of products known as
"enhancements" which are generally comprised of one-time parts
and/or software upgrades to existing Strasbaugh and
non-Strasbaugh tools. These enhancements are not required for
the tools to function, are not part of the original contract
and do not include any obligation to provide any future
upgrades. The Company recognizes revenue once these upgrades
and enhancements are complete. Revenue is recognized on
equipment upgrades when the Company completes the installation
of the upgrade parts and/or software on the customer's
equipment and the equipment is accepted by the customer. The
upgrade contracts cover a one-time upgrade of a customer's
equipment with new or modified parts and/or software. After
installation of the upgrade, the Company has no further
obligation on the contracts, other than standard warranty
provisions.
F-11
STRASBAUGH AND SUBSIDIARY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2007 (UNAUDITED)
NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
REVENUE RECOGNITION (CONTINUED)
The Company includes software in its tools. Software is considered an incidental
element of the tooling contracts and only minor modifications which are
incidental to the production effort may be necessary to meet customer
requirements. The software is used solely in connection with operating the tools
and is not sold, licensed or marketed separately. The tools and software are
fully functional when the tool is completed, and after shipment, the software is
not updated for new versions that may be subsequently developed and, the Company
has no additional obligations relative to the software. However, software
modifications may be included in tool upgrade contracts. The revenue recognition
requirements of Statement of Position ("SOP") 97-2, "Software Revenue
Recognition," are met when there is persuasive evidence an arrangement exists,
the fee is fixed or determinable, collectibility is probable and delivery and
acceptance of the equipment has occurred, including upgrade contracts for parts
and/or software, to the customer.
Installation of a tool occurs after the tool is completed, tested, formally
accepted by the customer and shipped. The Company does not charge the customer
for installation nor recognize revenue for installation as it is an
inconsequential or perfunctory obligation and it is not considered a separate
element of the sales contract or unit of accounting. If the Company does not
perform the installation service there is no effect on the price or payment
terms, there are no refunds, and the tool may not be rejected by the customer.
In addition, installation is not essential to the functionality of the equipment
because the equipment is a standard product, installation does not significantly
alter the equipment's capabilities, and other companies are available to perform
the installation. Also, the fair value of the installation service has
historically been insignificant relative to the Company's tools.
STOCK BASED COMPENSATION
In December 2004, the Financial Accounting Standards Board ("FASB") issued SFAS
No. 123 (revised 2004), "Share-Based Payment," ("SFAS No. 123(R)"), which is a
revision of SFAS No. 123, "Accounting for Stock Issued to Employees." SFAS No.
123(R) supersedes APB Opinion No. 25, "Accounting for Stock Issued to Employees"
and amends SFAS No. 95, "Statement of Cash Flows." Generally, the approach in
SFAS No.123(R) is similar to the approach described in SFAS No. 123. However,
SFAS No. 123(R) requires all share-based payments to employees, including grants
of employee stock options, to be recognized in the income statement based on
their fair values. Pro forma disclosure is no longer an alternative.
SFAS No. 123(R) also established accounting requirements for measuring,
recognizing and reporting share-based compensation, including income tax
considerations. One such change was the elimination of the minimum value method,
which under SFAS No. 123 permitted the use of zero volatility when performing
Black-Scholes valuations. Under SFAS No. 123(R), companies are required to use
expected volatilities derived from the historical volatility of the company's
stock, implied volatilities from traded options on the company's stock and other
factors. SFAS No. 123(R) also requires the benefits of tax deductions in excess
of recognized compensation cost to be reported as a financing cash flow, rather
than as an operating cash flow as required under previous accounting literature.
F-12
STRASBAUGH AND SUBSIDIARY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2007 (UNAUDITED)
NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
STOCK BASED COMPENSATION (CONTINUED)
The provisions of SFAS No. 123(R) were effective for and adopted by the Company
as of January 1, 2006. Prior to the adoption, the Company was using the
intrinsic-value accounting for stock based compensation pursuant to APB Opinion
No. 25. Required pro forma information was presented under the fair value method
using a Black-Scholes option-pricing model pursuant to SFAS No. 123. The
adoption of SFAS No. 123(R) was made using the prospective application method.
Under this method, the statement applies to new awards and awards modified,
repurchased or cancelled after the required effective date. Additionally,
compensation cost for the portion of awards for which the requisite service has
not been rendered that are outstanding as of effective date shall be recognized
as the requisite service is rendered. The adoption of SFAS No. 123(R) did not
have a significant impact on the Company's results of operations, income taxes
or earnings per share.
EARNINGS PER SHARE
Basic net income per share is computed by dividing net income available to
common stockholders by the weighted average number of outstanding common shares
for the period. Diluted net income per share is computed by using the treasury
stock method and dividing net income available to common stockholders plus the
effect of assumed conversions (if applicable) by the weighted average number of
outstanding common shares after giving effect to all potential dilutive common
stock, including options, warrants, common stock subject to repurchase and
convertible preferred stock, if any.
For the nine months ended September 30, 2007, in accordance with EITF Topic
D-53: "Computation of Earnings Per Share for a Period That Includes a Redemption
or an Induced Conversion of a Portion of a Class of Preferred Stock," the
computation of net income available to common shareholders includes the excess
of the carrying value of the Company's preferred stock repurchased during the
period over its carrying value.
F-13
STRASBAUGH AND SUBSIDIARY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2007 (UNAUDITED)
NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
EARNINGS PER SHARE (CONTINUED)
Reconciliations of the numerator and denominator used in the calculation of
basic and diluted net income per common share are as follows:
FOR THE NINE MONTHS ENDED
SEPTEMBER 30,
--------------------------
2007
(as restated) 2006
------------ -----------
Numerator:
Net income $ 94,000 $ 975,000
Preferred stock accretion (113,000) --
Preferred stock dividend (367,000) --
Excess of carrying value of preferred stock over cash paid
upon redemption 5,595,000 --
------------ -----------
Net income available to common shareholders - basic 5,209,000 975,000
Adjustment to net income for assumed conversions 480,000 39,000
------------ -----------
Net income available to common shareholders - diluted $ 5,689,000 $ 1,014,000
============ ===========
Denominator:
Shares outstanding, beginning 13,992,828 13,992,828
Weighted-average shares issued 314,680 --
------------ -----------
Weighted-average shares outstanding--basic 14,307,508 13,992,828
------------ -----------
Effect of dilutive securities
Weighted-average preferred stock outstanding 4,955,175 4,087,979
Weighted-average warrants outstanding (Notes 6 and 9) 304,103 491,748
Weighted-average options outstanding 71,154 --
------------ -----------
5,330,432 4,579,727
------------ -----------
Weighted-average shares outstanding--diluted 19,637,940 18,572,555
============ ===========
|
Warrants to purchase 1,271,797 shares of common stock as of September 30, 2007
and stock options to purchase approximately 1,452,205 and 663,521 shares of
common stock as of September 30, 2007 and 2006, respectively, were outstanding
but not included in the computation of diluted earnings per common share because
the exercise prices were greater than the average market price of the common
stock, and therefore, the effects on dilutive earnings per common share would
have been anti-dilutive.
F-14
STRASBAUGH AND SUBSIDIARY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2007 (UNAUDITED)
NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
INCOME TAXES AND DEFERRED INCOME TAXES
Income taxes are provided for the effects of transactions reported in the
financial statements and consist of taxes currently due plus deferred taxes
related primarily to differences between the basis of certain assets and
liabilities for financial and income tax reporting. Deferred taxes are
classified as current or noncurrent depending on the classification of the
assets and liabilities to which they relate. Deferred taxes arising from
temporary differences that are not related to an asset or liability are
classified as current or noncurrent, depending on the periods in which the
temporary differences are expected to reverse. A valuation allowance is
established when necessary to reduce deferred tax assets if it is more likely
than not that all, or some portion of, such deferred tax assets will not be
realized.
SERIES A PREFERRED STOCK AND WARRANTS
The Company evaluates its Series A Preferred Stock and Warrants (as defined in
Note 9) on an ongoing basis considering the provisions of SFAS No. 150,
"Accounting for Certain Financial Instruments with Characteristics of Both
Liabilities and Equity," which establishes standards for issuers of financial
instruments with characteristics of both liabilities and equity related to the
classification and measurement of those instruments The Series A Preferred Stock
conversion feature and Warrants are evaluated considering the provisions of SFAS
No. 133, "Accounting for Derivative Instruments and Hedging Activities," which
establishes accounting and reporting standards for derivative instruments,
including certain derivative instruments embedded in other contracts, and for
hedging activities, and considering EITF Issue No. 00-19, "Accounting for
Derivative Financial Instruments Indexed to, and Potentially Settled in, a
Company's Own Stock."
NEW ACCOUNTING PRONOUNCEMENTS
In December 2007, FASB issued SFAS No. 141 (revised 2007), "Business
Combinations," which replaces SFAS No. 141. The statement retains the purchase
method of accounting for acquisitions, but requires a number of changes,
including changes in the way assets and liabilities are recognized in the
purchase accounting. It also changes the recognition of assets acquired and
liabilities assumed arising from contingencies, requires the capitalization of
in-process research and development at fair value, and requires the expensing of
acquisition-related costs as incurred. SFAS No. 141R is effective for the
Company beginning July 1, 2009 and will apply prospectively to business
combinations completed on or after that date.
In December 2007, the FASB issued SFAS No. 160, "Noncontrolling Interests in
Consolidated Financial Statements, an amendment of ARB 51," which changes the
accounting and reporting for minority interests. Minority interests will be
recharacterized as noncontrolling interests and will be reported as a component
of equity separate from the parent's equity, and purchases or sales of equity
interests that do not result in a change in control will be accounted for as
equity transactions. In addition, net income attributable to the noncontrolling
interest will be included in consolidated net income on the face of the income
statement and, upon a loss of control, the interest sold, as well as any
interest retained, will be recorded at fair value with any gain or loss
recognized in earnings. SFAS No. 160 is effective for the Company beginning July
1, 2009 and will apply prospectively, except for the presentation and disclosure
requirements, which will apply retrospectively. Management is currently
assessing the potential impact that the adoption of SFAS No. 160 would have on
the Company's financial position, cash flows, or results of operations.
F-15
STRASBAUGH AND SUBSIDIARY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2007 (UNAUDITED)
NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
NEW ACCOUNTING PRONOUNCEMENTS (CONTINUED)
In July 2006, the FASB issued Financial Accounting Standards Interpretation No.
48 ("FIN No. 48"), "Accounting for Uncertainty in Income Taxes," which clarifies
the accounting for uncertainty in income taxes recognized in an enterprise's
financial statements in accordance with SFAS No. 109. FIN No. 48 prescribes a
recognition and measurement method of a tax position taken or expected to be
taken in a tax return. FIN No. 48 also provides guidance on derecognition,
classification, interest and penalties, accounting in interim periods,
disclosures and transitions. The Company adopted the provisions of FIN No. 48
effective January 1, 2007. In accordance with FIN No. 48, the Company recognizes
any interest and penalties related to unrecognized tax benefits in income tax
expense should they exist. The application of FIN No. 48 had no effect on the
Company's financial position, operating income or cash flows for the period
ended September 30, 2007.
NOTE 2 - INVENTORIES
Inventories consist of the following:
SEPTEMBER 30,
2007
-------------
Parts and raw materials $ 7,002,000
Work-in-process 2,575,000
Finished goods 81,000
-------------
9,658,000
Inventory reserves (2,916,000)
-------------
$ 6,742,000
=============
|
NOTE 3 - PROPERTY, PLANT AND EQUIPMENT
Property, plant and equipment consist of the following:
SEPTEMBER 30,
2007
-------------
Buildings and improvements $ 2,198,000
Shop and lab equipment 5,689,000
Transportation equipment 165,000
Furniture and fixtures 1,110,000
Computer equipment 2,317,000
-------------
11,479,000
Less: accumulated depreciation and amortization 9,740,000
-------------
$ 1,739,000
=============
|
Depreciation expense totaled approximately $217,000 and $271,000 for the nine
months ended September 30, 2007 and 2006, respectively.
F-16
STRASBAUGH AND SUBSIDIARY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2007 (UNAUDITED)
NOTE 4 - LINE OF CREDIT
The Company has a line of credit agreement ("Loan Agreement") and guaranty
agreement ("Exim Agreement") with a bank through February 2007. The agreements
are secured by substantially all of the Company's assets. The borrowing amount
under the agreements is based on eligible accounts receivable. The agreements
allow the Company to borrow up to $3 million at the prime rate (7.75% at
September 30, 2007) plus 3.5% under the Loan Agreement and $500,000 at the prime
rate plus 4% under the Exim Agreement. In addition, the Company must pay the
bank an administrative fee of 0.5% of the face amount of each receivable when
first financed under both of the agreements. Both agreements include
affirmative, negative and financial covenants. The notes payable to the majority
stockholder were subordinated to these agreements (See Note 5). During the three
months ended March 31, 2007, the Company renewed the agreements through May 18,
2007. In May 2007, the Company entered into an Amendment to Loan and Security
Agreement to increase the Company's credit line from $3.5 million to $7.5
million and to extend the term to August 18, 2007. On September 6, 2007, the
Company entered into another Amendment to Loan and Security Agreement to extend
the term of the credit facility to October 16, 2007. At September 30, 2007, the
availability under the credit facility was approximately $3.5 million and there
was no balance outstanding.
On December 4, 2007, the Company entered into two Loan and Security Agreements
with Silicon Valley Bank providing for a credit facility in the aggregate amount
of $7.5 million. (See Note 14 - Subsequent Events.)
NOTE 5 - NOTES PAYABLE
The Company had a note payable to Agility Capital, LLC ("Agility"), which was
secured by substantially all of the Company's assets. The note was payable in
monthly installments of $55,000 including interest at 12%, with the balance due
in September 2007. The note was paid in full in May 2007.
In addition, the Company had a subordinated unsecured note payable to a majority
stockholder which was payable in monthly interest-only payments at the prime
rate plus 1%. The note was originally due in February 2007 and was subsequently
extended until June 2007. The outstanding balance on the note and the unpaid
accrued interest totaling approximately $747,000 was paid in full in May 2007.
The Company had unsecured notes payable totaling $100,000 at September 30, 2007.
NOTE 6 - AGILITY WARRANT
During 2005, the Company issued a warrant (Note 6) to Agility (the "Agility
Warrant"), in connection with a financing transaction. Pursuant to APB No. 14,
the fair value of the warrant was allocated as a discount to the new debt. The
values for each security were determined separately, based on their values at
the time of issuance, and the debt discount was computed by comparing the value
attributed to the debt securities with the face value of the debt. The discount
was initially recorded at its fair value of $391,000. Amortization of the
discount totaled approximately $0 and $167,000 for the nine months ended
September 30, 2007 and 2006, respectively.
The Agility Warrant allowed the holder to purchase up to 4.1% of the Company's
equity on a fully-diluted basis at $0.01 per share. If the Company had repaid
the note payable prior to June 17, 2006, the warrant would have decreased to
2.1% of the Company's equity on a fully-diluted basis. The agreement also
allowed the Company to call the warrant for $225,000 on or before June 17, 2006,
which was not done. If the Company did not receive at least $5 million of net
proceeds from the sale or issuance of its equity securities on or before
September 16, 2007, Agility could have required the Company to purchase the
warrant in cash for $450,000. The shares underlying the warrant vested upon
issuance and the warrant was to expire in September 2017.
The Company accounted for this warrant under EITF Issue No. 00-19 and,
accordingly, the warrant was carried at its estimated fair value. The warrant
was repurchased by the Company in May 2007 for its carrying value of $450,000.
The changes in the fair value of the warrant during the nine months ended
September 30, 2007 and 2006 totaled $0 and $39,000, respectively, and were
included in other expenses.
F-17
STRASBAUGH AND SUBSIDIARY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2007 (UNAUDITED)
NOTE 7 - COMMITMENTS AND CONTINGENCIES
LEASE COMMITMENTS
The Company leases its manufacturing and sales facility from the chairman of the
company, who is the majority stockholder, and his former spouse. This 15-year
lease agreement commenced on May 1, 1990 and ended on April 30, 2005. Under the
original terms of the lease, the Company paid monthly lease payments and was
liable for all property taxes, insurance, repairs and maintenance. The lease
also provided for periodic adjustments in minimum lease payments based upon the
CPI. Effective May 1, 2005, the Company exercised the holdover provision within
the lease agreement for its manufacturing and sales facility when it did not
elect to execute an automatic five-year extension but remained in possession of
the premises. The holdover provision within the lease agreement allows the
Company to remain the tenant on a month-to-month basis under the terms that
existed at the end of the original lease term, as defined. The holdover
provision remains valid as long as the Company remains in possession and makes
timely monthly rent payments. The monthly rent is currently $84,000.
The Company has other minor (less than $10,000 annually) noncancelable operating
leases through 2009.
SUBLEASE AGREEMENT
In March 2005, the Company entered into a sublease agreement with an unrelated
third party to lease approximately 9,000 square feet of office space and 11,200
square feet of warehouse space. The lease commenced in April 2005 and was
scheduled to terminate in March 2008. The sublease agreement was terminated in
November 2006. Rental income totaled $0 and $136,000 for the nine months ended
September 30, 2007 and 2006, respectively.
LITIGATION
During the year ended December 31, 2006, the Company entered into a legal
dispute with its co-landlord, who is the former spouse of the major stockholder,
of its current facility regarding the Company's potential liability for capital
repairs. The Company is presently unable to evaluate the likelihood of an
unfavorable result in this dispute or the range of potential loss. However,
management intends to vigorously defend against this case and believes that all
of its defenses are meritorious.
On or about August 15, 2006, a complaint was filed in the Commonwealth of
Massachusetts Superior Court against R. H. Strasbaugh alleging negligence and
breach of implied warranty. The claimant alleges that he was injured while using
a product the Company designed, manufactured and sold to his employer. The
claimant demands a judgment in an amount sufficient to compensate him for his
losses and damages but does not allege with specificity his injuries or the
relief sought. As of the date of these financial statements, management is
unable to reasonably estimate a potential range of loss and, further, believes
that the possibility of any payment is remote. The Company's insurance carrier
has assumed the defense of this action.
The Company is subject to various lawsuits and claims with respect to such
matters as product liabilities, employment matters and other actions arising out
of the normal course of business. While the effect on future financial results
is not subject to reasonable estimation because considerable uncertainty exists,
in the opinion of Company counsel, the ultimate liabilities resulting from such
lawsuits and claims will not materially affect the financial condition or
results of operations.
F-18
STRASBAUGH AND SUBSIDIARY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2007 (UNAUDITED)
NOTE 8 - STOCK COMPENSATION PLANS
1998 AMENDED RESTATED STOCK OPTION PLAN - R. H. STRASBAUGH
Under R. H. Strasbaugh's 1998 Amended Restated Stock Option Plan (the "1998
Plan"), as amended, 1,400,000 shares of R. H. Strasbaugh's common stock are
available for issuance, pursuant to which employees are eligible to receive
stock options. The 1998 Plan is administered by the board of directors of R. H.
Strasbaugh. No compensation expense has been recorded in the accompanying
condensed consolidated financial statements related to the 1998 Plan for the
nine months ended September 30, 2007 and 2006 respectively.
The status of the 1998 Plan is summarized below:
AVERAGE INTRINSIC
SHARES PRICE VALUE
---------- ----------- ---------
Outstanding at January 1, 2006 296,470 $ 5.50 --
Forfeited (183,265) $ 5.50 --
----------
Outstanding at September 30, 2006 113,205 $ 5.50 --
==========
Outstanding at December 31, 2006 113,205 $ 5.50 --
==========
Outstanding at September 30, 2007 113,205 $ 5.50 --
==========
Exercisable at September 30, 2007 113,205 $ 5.50 --
==========
|
At September 30, 2007, the weighted average remaining life of these options was
1.25 years.
2000 STOCK OPTION AGREEMENT - R. H. STRASBAUGH
During 2000, the board of directors of R. H. Strasbaugh granted options to
purchase 1,646,557 shares of R. H. Strasbaugh common stock at an exercise price
of $.07 per share to four vice presidents. The options are subject to a number
of restrictions as defined in the agreement, including a buy-sell provision with
R. H. Strasbaugh. The options expire ten years from the date of issuance and
automatically cancel 30 days after termination, as defined in the agreements.
The status of the options under this plan is summarized below:
AVERAGE INTRINSIC
SHARES PRICE VALUE
---------- ----------- ---------
Outstanding at January 1, 2006 548,866 $ 0.07 --
Expired (548,866) $ 0.07 --
Granted April 10, 2006 548,866 $ 0.07 --
----------
Outstanding at September 30, 2006 548,866 $ 0.07 --
==========
Outstanding at December 31, 2006 548,866 $ 0.07 --
Exercised on February 6, 2007 (548,866) $ 0.07 --
----------
Outstanding at September 30, 2007 --
==========
|
F-19
STRASBAUGH AND SUBSIDIARY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2007 (UNAUDITED)
NOTE 8 - STOCK COMPENSATION PLANS (CONTINUED)
2000 STOCK OPTION AGREEMENT - R. H. STRASBAUGH (CONTINUED)
The 548,866 options outstanding as of January 1, 2006 expired on January 31,
2006. On April 10, 2006, the board of directors approved the re-granting of
these options with a revised expiration date of December 31, 2007 and immediate
vesting. In accordance with SFAS No. 123(R), this re-grant was treated as a new
issuance effective on that date, based on the fair value of the options on that
date, and resulted in $7,000 of share-based compensation expense for the nine
months ended September 30, 2006.
2007 SHARE INCENTIVE PLAN
In February 2007, the Company established the 2007 Share Incentive Plan (the
"2007 Plan"), under which 2,000,000 shares of the Company's common stock are
available for issuance. The 2007 Plan is administered by the Compensation
Committee of the Company's Board of Directors.
The 2007 Plan provides for the granting of options, restricted stock awards,
restricted stock units, stock appreciation rights, direct stock issuances and
other stock-based awards, or equity awards, made to executive officers and
non-employee board members, as well as to all other eligible individuals.
Under the 2007 Plan, stock options will have an exercise price per share
determined by the plan administrator, provided that the exercise price will not
be less than 85% or 100% of the fair market value of a share on the grant date
in the case of non-statutory or incentive options, respectively. No granted
option will have a term in excess of ten years. Options generally will become
exercisable in one or more installments over a specified period of service
measured from the grant date. However, options may be structured so that they
will be immediately exercisable for any or all of the option shares.
On May 24, 2007, the Compensation Committee granted stock options to purchase an
aggregate of 1,375,000 shares of common stock with an exercise price of $1.71
per share. The options expire ten years from the date of issuance and vest over
a period of three years. The Company uses the Black-Scholes option pricing model
to calculate the grant-date fair value of an award. The fair values of options
granted were calculated using the following estimated weighted-average
assumptions for the nine months ended September 30, 2007:
Options granted 1,375,000
Weighted-average exercise prices of stock options $ 1.71
Assumptions:
Weighted-average expected volatility 48.1%
Weighted-average expected term (in years) 6.5 years
Risk-free interest rate 4.81%
Expected dividend yield 0%
|
F-20
STRASBAUGH AND SUBSIDIARY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2007 (UNAUDITED)
NOTE 8 - STOCK COMPENSATION PLANS (CONTINUED)
2007 SHARE INCENTIVE PLAN (CONTINUED)
The $1.71 exercise price of the options was determined based on the market price
of the Company's stock on the date of the grant. The fair value per share of the
common stock on the date of grant was deemed to be equal to the closing selling
price per share of the Company's common stock at the close of regular hours
trading on the Pink Sheets(R) on that date, as the price was reported by the
National Association of Securities Dealers, multiplied by 31 to reflect the
1-for-31 reverse stock split that occurred on the same date. The volatility for
options granted in 2007 has been determined based on an analysis of reported
data for a peer group of companies that issued options with substantially
similar terms. The expected volatility of options granted has been determined
using an average of the historical volatility measures of this peer group of
companies for a period equal to the expected life of the option. The expected
life of the options has been determined utilizing the "simplified" method as
prescribed by SAB No. 107, "Share-Based Payment."
The risk-free interest rate is based on United States treasury instruments whose
terms are consistent with the expected life of the stock options. The Company
does not anticipate paying cash dividends on its shares of common stock;
therefore, the expected dividend yield is assumed to be zero. In addition, SFAS
No. 123(R) requires companies to utilize an estimated forfeiture rate when
calculating the expense for the period. As a result, the Company applied an
estimated forfeiture rate, based on its historical forfeiture experience during
previous years, of 12.5%.
The status of the options under the 2007 Plan is summarized below:
AGGREGATE
AVERAGE INTRINSIC
SHARES PRICE VALUE
----------- ------------ ------------
Outstanding at January 1, 2007 --
Granted 1,375,000 $ 1.71 $ 674,000
Forfeited (36,000) $ 1.71
-----------
Outstanding at September 30, 2007 1,339,000 $ 1.71 $ 656,000
-----------
Exercisable at September 30, 2007 --
===========
|
The remaining contractual term on the above options is 9.6 years as of September
30, 2007. The weighted average grant-date fair value of options granted during
the nine months ended September 30, 2007 was $0.39. None of the shares under the
2007 Plan were vested as of September 30, 2007.
As of September 30, 2007, a total of 661,000 common shares were available for
future grants under the Company's 2007 Plan.
The share based compensation expense was $60,000 and $0 for the nine months
ended September 30, 2007 and 2006, respectively. As of September 30, 2007, there
was $484,000 of total unrecognized compensation cost related to nonvested
share-based compensation arrangements. The cost is expected to be recognized
over a weighted-average period of 2.7 years.
F-21
STRASBAUGH AND SUBSIDIARY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2007 (UNAUDITED)
NOTE 9 - CONDITIONALLY REDEEMABLE CONVERTIBLE SERIES A PREFERRED STOCK
SERIES A PREFERRED STOCK FINANCING
On May 24, 2007, immediately after the closing of the Share Exchange
Transaction, the Company entered into an agreement with 21 accredited investors
for the sale by it in a private offering of 5,909,089 shares of its Series A
Preferred Stock at a purchase price of $2.20 per share for gross proceeds of $13
million.
The Series A Preferred Stock ranks senior in liquidation and dividend
preferences to the Company's common stock. Each share of Series A Preferred
Stock is convertible by the holder at any time after its initial issuance at an
initial conversion price of $2.20 per share such that one share of common stock
would be issued for each share of Series A Preferred Stock. Subject to certain
exceptions, the conversion ratio is subject to customary antidilution
adjustments and antidilution adjustments if the Company subsequently issues
certain equity securities at a price equivalent of less than $2.20 per share.
The Company has no present intention to issue equity securities at a price
equivalent of less than $2.20 per share. The shares of Series A Preferred Stock
are also subject to forced conversion, at a conversion price as last adjusted,
anytime after May 24, 2008, if the closing price of our common stock exceeds
200% of the conversion price then in effect for 20 consecutive trading days. The
holders of Series A Preferred Stock vote together as a single class with the
holders of the Company's other classes and series of voting stock on all actions
to be taken by its shareholders. Each share of Series A Preferred Stock entitles
the holder to the number of votes equal to the number of shares of our common
stock into which each share of Series A Preferred Stock is convertible. In
addition, the holders of Series A Preferred Stock are afforded numerous
customary protective provisions with respect to certain actions that may only be
approved by holders of a majority of the shares of Series A Preferred Stock. The
Company is also required at all times to reserve and keep available out of its
authorized but unissued shares of Common Stock, such number of shares of Common
Stock sufficient to effect the conversion of all outstanding shares of Series A
Preferred Stock. On or after May 24, 2012 the holders of then outstanding shares
of our Series A Preferred Stock will be entitled to redemption rights. The
redemption price is equal to the per-share purchase price of the Series A
Preferred Stock, which is subject to adjustment as discussed above and in our
articles of incorporation, plus any accrued but unpaid dividends. The Series A
Preferred Stock contain provisions prohibiting certain conversions of the Series
A Preferred Stock.
The initial carrying amount of the Series A Preferred Stock was its fair value
at the issuance date of $11,122,000. The fair value at the issuance date was the
gross proceeds from the sale of the securities less issuance costs of
$1,878,000. The issuance costs included $1,354,000 of direct incremental costs
of the issuance including legal, investment banking commissions, registration
fees, as well as the fair value of warrants issued in connection with the
financing.
The changes in the redemption value of the Series A Preferred Stock are accreted
over the period from the date of issuance to the earliest redemption date (May
24, 2012) using the interest method. The accretion of unpaid dividends and
issuance costs for the nine months ended September 30, 2007 was approximately
$479,000.
F-22
STRASBAUGH AND SUBSIDIARY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2007 (UNAUDITED)
NOTE 9 - CONDITIONALLY REDEEMABLE, CONVERTIBLE SERIES A PREFERRED STOCK
(CONTINUED)
SERIES A PREFERRED STOCK FINANCING (CONTINUED)
SFAS No. 150 requires an issuer to classify the following instruments as
liabilities (or assets in some circumstances): A financial instrument issued in
the form of shares that is mandatorily redeemable--that embodies an
unconditional obligation requiring the issuer to redeem it by transferring its
assets at a specified or determinable date (or dates) or upon an event that is
certain to occur. Management of the Company has determined the redemption
feature of the Series A Preferred Stock has a "condition" to redemption which
means it is not mandatorily redeemable and is not within the scope of SFAS No.
150 for the first 5 years, and should be treated as "temporary equity," outside
of permanent equity and below liabilities and in accordance with EITF Abstracts,
Topic D-98, "Classification and Measurement of Redeemable Securities." Under the
terms of the Series A Preferred Stock, the holders have the right, but not the
obligation to convert their shares into common stock, whether or not registered,
and because the redemption is conditional, contingent upon the holder's not
exercising its option to convert into common shares, the Series A Preferred
Stock does not meet the definition of mandatorily redeemable in accordance with
SFAS No. 150. Recent guidance from the Commission states the staff will no
longer accept liability classification for financial instruments (or host
contracts) that meet the conditions for temporary equity classification under
ASR 268 and Topic D-98. Consistent with Commission Regulation S-X, Articles
5-02, 7-03, and 9-03, these financial instruments should be classified on the
balance sheet between captions for liabilities and shareholder's equity.
The Company also evaluated the conversion and redemption features for potential
embedded derivatives in accordance with SFAS No. 133 and determined that
accounting for potential embedded derivatives is not required with respect to
its Series A Preferred Stock. The redemption feature is considered clearly and
closely related to the host contract, and the conversion feature is considered
to be (i) indexed to the Company's stock and (ii) classified in shareholders
equity in its statement of financial position. In each case SFAS No. 133 does
not require separation of the feature as an embedded derivative. SFAS No. 133
defines derivative instruments as a financial instrument or other contract with
all three of the following characteristics:
(i) It has (a) one or more underlyings and (b) one or more notional
amounts or payment provisions or both. Those terms determine the
amount of the settlement or settlements, and, in some cases, whether
or not a settlement is required.
(ii) It requires no initial net investment or an initial net investment
that is smaller than would be required for other types of contracts
that would be expected to have a similar response to changes in
market factors.
(iii) Its terms require or permit net settlement, it can readily be settled
net by a means outside the contract, or it provides for delivery of
an asset that puts the recipient in a position not substantially
different from net settlement.
F-23
STRASBAUGH AND SUBSIDIARY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2007 (UNAUDITED)
NOTE 9 - CONDITIONALLY REDEEMABLE, CONVERTIBLE SERIES A PREFERRED STOCK
(CONTINUED)
SERIES A PREFERRED STOCK FINANCING (CONTINUED)
SFAS No. 133 provides guidance on derivative instruments and contracts that do
not in their entirety meet the definition of a derivative instrument but may
contain "embedded" derivative instruments. The Statement requires that an
embedded derivative instrument be separated from the host contract and accounted
for as a derivative instrument if specified criteria are met. The Statement also
indicates the necessary criteria for bifurcation including (i) that the economic
characteristics and risks of the embedded derivative instrument are not clearly
and closely related to the economic characteristics and risks of the host
contract, as well as (ii) that a separate instrument with the same terms as the
embedded derivative instrument would be a derivative instrument subject to the
requirements of the Statement.
The Company has evaluated the redemption feature and determined that the
economic characteristics and risks are clearly and closely related to the host
primarily because the host contract contains no residual equity interest and is
therefore considered more akin to debt.
The Company believes that the conversion feature in its Series A Preferred Stock
meets the conditions specified in paragraphs 6-10 of SFAS No. 133 to be
considered a potential embedded derivative instrument. However, the Company
believes the conversion feature should not be considered a derivative instrument
based on the guidance in paragraph 11 of SFAS No. 133 regarding contracts that
should not be considered and accounted for as derivative instruments including
contracts issued or held by that reporting entity that are both (i) indexed to
its own stock and (ii) classified in stockholders' equity in its statement of
financial position.
EITF Issue No. 00-19 provides guidance in determining whether an embedded
derivative would be classified in stockholders' equity in accordance with SFAS
No. 133 if it were freestanding. In analyzing the conditions necessary for
equity classification in paragraphs 12-32 of EITF Issue No. 00-19, the Company
considered that there are no provisions in the Series A Preferred Stock that
could require net-cash settlement, the Company may settle the contract in
unregistered shares, the number of shares issuable under the conversion option
are fixed, and there are sufficient authorized and unissued shares available to
settle the contract after consideration of all other commitments that may
require the issuance of stock during the maximum period the contract could
remain outstanding, there are no provisions in the conversion option indicating
rights that rank higher than those of the common stockholders, and there is no
requirement to post collateral.
F-24
STRASBAUGH AND SUBSIDIARY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2007 (UNAUDITED)
NOTE 9 - CONDITIONALLY REDEEMABLE, CONVERTIBLE SERIES A PREFERRED STOCK
(CONTINUED)
SERIES A PREFERRED STOCK FINANCING (CONTINUED)
The Company also considered that the Series A Preferred Stock contains standard
antidilution provisions and provisions that are solely within the control of the
Company. EITF Issue No. 00-19, states that instruments that contain "standard"
antidilution provisions would not preclude a conclusion that the instrument is
convertible into a fixed number of shares. Standard antidilution provisions are
those that result in adjustments to the conversion ratio in the event of an
equity restructuring transaction (as defined) that are designed to maintain the
value of the conversion option. The Series A Preferred Stock also contains a
provision that if the Company makes certain equity offerings in the future at a
price lower than the conversion price, the conversion ratio would also be
adjusted for dilution. However, the Company is required at all times to maintain
adequate authorized and unissued common shares to effect conversion of its
convertible securities and warrants and must control the number of shares
issuable on conversion, additionally, the Company has no plans to make such
future equity offerings. The Series A Preferred also contains a buy-in provision
that in the event the Company fails to deliver to the holder the required number
of shares upon exercise the Company may be required to pay the difference
between the market value of the shares at the exercise date and the conversion
price. This provision effectively gives the Company the option to settle in
shares or in cash, as the Company may settle the conversion shares at any time
with authorized and unregistered shares.
Accordingly, the Company believes it controls the actions or events necessary to
issue the maximum number of shares that could be required to be delivered under
share settlement of the conversion feature and meets the conditions necessary
for equity classification in accordance with EITF Issue No. 00-19 and qualifies
for the paragraph 11 scope exception in SFAS No. 133. Therefore, the embedded
conversion option is not bifurcated from the host and accounted for as a
derivative instrument.
WARRANTS
In connection with the Series A Preferred Stock Financing, the Company issued to
the investors five-year warrants ("Investor Warrants") to purchase an aggregate
of 886,363 shares of common stock and issued to its placement agent, B. Riley
and Co. Inc. and its assignees, five-year warrants ("Placement Warrants") to
purchase an aggregate of 385,434 shares of common stock. The Investor Warrants
and the Placement Warrants are collectively referred to as the "Warrants." The
Investor Warrants and the Placement Warrants have an exercise price of $2.42 per
share. The Investor Warrants are exercisable beginning 180 days after May 24,
2007 and became immediately exercisable upon issuance on May 24, 2007. The
Company determined the $350,000 fair value of the Warrants, using the
Black-Scholes option-pricing model, utilizing a volatility factor of 48%,
risk-free interest rate of 4.81%, an expected life of five years and a fair
value per share of the Company's common stock of $1.71 on the date issued.
The Warrants contain cashless exercise features which could require the Company
to issue fewer shares to the holder, but without cash payment, under a net-share
settlement formula. The number of shares issuable under the cashless exercise
feature is based on a formula that considers the excess of the market value of
the Company's common stock on the exercise date over the stated exercise price,
as defined in the Warrant. In accordance with paragraph 8 of EITF Issue No.
00-19, contracts with no net-cash settlement feature that require that the
Company deliver shares as part of a physical settlement or a net-share
settlement should be initially measured at fair value and reported in permanent
equity, assuming additional conditions for equity classification are met.
F-25
STRASBAUGH AND SUBSIDIARY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2007 (UNAUDITED)
NOTE 9 - CONDITIONALLY REDEEMABLE, CONVERTIBLE SERIES A PREFERRED STOCK
(CONTINUED)
WARRANTS (CONTINUED)
The exercise price and number of Warrant Shares issuable upon exercise of the
Warrants are subject to adjustment from time to time for (i) stock dividends and
splits, and (ii) "fundamental transactions" including a merger or consolidation,
any sale of all or substantially all of the Company's assets, any tender offer
or exchange offer is completed pursuant to which holders of the Company's common
stock are permitted to tender or exchange their shares for other securities,
cash or property, or any reclassification of the Company's common stock or any
compulsory share exchange pursuant to which the Company's common stock is
effectively converted into or exchanged for other securities, cash or property.
In the case of a fundamental transaction, the Warrant holders will be entitled
to rights equivalent to the common shareholders as if the Warrant Shares were
issued immediately prior to the fundamental transaction. The Investor Warrants
also provide that if the Company offers or sells stock in subsequent equity
sales at a price below the Warrant exercise price then in effect, then the
number of Warrant Shares issuable will be increased such that the aggregate
exercise price of the Warrants, after taking into account an equivalent price
decrease, shall be equal to the aggregate exercise price prior to such
adjustment (the "Reset Provisions").
The Placement Warrants include "piggyback" registration rights. In addition,
each holder of the Placement Warrants is either an "accredited investor" as
defined in Rule 501(a) under the Securities Act or a "qualified institutional
buyer" as defined in Rule 144A(a) under the Securities Act. The Warrants may be
transferred by the original holder to any other Person provided such Person is
an "accredited investor" as defined in Rule 501(a).
Prior to exercise of the Warrants, the holders are not entitled to any rights of
a shareholder with respect to the Warrant Shares. In addition, under the terms
of the Warrants, the Company is required at all times to reserve and keep
available out of the aggregate of its authorized but unissued and otherwise
unreserved common stock, adequate shares for the purpose of enabling it to issue
Warrant Shares upon exercise of the Warrants.
In order to assess the accounting treatment of the Warrants, management analyzed
the terms of the Warrants and considered the provisions of paragraphs 10 through
32 of EITF Issue No. 00-19 which discuss the conditions necessary for a
derivative indexed to, and potentially settled in, a company's own stock to be
classified in shareholders' equity. Management's determination that the Warrants
are appropriately classified as shareholders' equity included the following
principal considerations:
o The Company can settle the Warrants in unregistered shares
(although under the registration rights agreement,
commercially reasonable efforts are to be made to register the
shares and maintain the effectiveness of the registration
statement for a stated period of time);
o The Company has sufficient authorized but unissued shares of
common stock available to settle the Warrants after
considering all other commitments that may require the
issuance of shares of common stock during the period the
Warrants could remain outstanding;
o There is no requirement in the Warrants to post collateral at
any point or for any reason;
o There are no required cash payments to the Warrant holders;
o There are no provisions in the Warrants that indicate the
Warrant holders have rights that rank higher than those of the
shareholders of the common stock underlying the Warrants; and
F-26
STRASBAUGH AND SUBSIDIARY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2007 (UNAUDITED)
NOTE 9 - CONDITIONALLY REDEEMABLE, CONVERTIBLE SERIES A PREFERRED STOCK
(CONTINUED)
WARRANTS (CONTINUED)
o The change in control provision included in the Warrants
requires that the Warrant holders receive or deliver upon
settlement the same form of consideration as holders of the
shares of common stock underlying the Warrants.
The cashless, net-share settlement features were analyzed under EITF Issue 00-19
guidelines and because the maximum number of shares that could be required to be
delivered under the features is limited to the total number of shares under the
warrants (886,363 shares under the Investor Warrants and 385,434 shares under
the Placement Warrants), and since the Company has sufficient available
authorized and unissued shares to settle the total number of shares under
warrant, it was determined that the Company controls the net-share settlement,
and thus equity treatment is appropriate if other requirements are met.
Management also considered that the Warrants contain standard antidilution
provisions and provisions that are solely within the control of the Company.
EITF Issue No. 00-19 states that instruments that contain "standard"
antidilution provisions would not preclude a conclusion that the instrument is
convertible into a fixed number of shares. Standard antidilution provisions are
those that result in adjustments to the conversion ratio in the event of an
equity restructuring transaction (as defined) that are designed to maintain the
value of the conversion option. The Investor Warrant Reset Provision could
increase the number of shares issuable in the event of certain equity offerings
in the future. However, the Company is required at all times to maintain
adequate authorized and unissued common shares to effect the exercise of its
convertible securities and warrants and must control the number of shares
issuable on conversion, additionally, the Company has no plans to make such
future equity offerings. The Warrants also contain a buy-in provision that in
the event the Company fails to deliver to the Warrant holder the required number
of shares upon exercise, the Company may be required to pay the difference
between the market value of the shares at the exercise date and the conversion
price. This provision is similar to giving the Company the option to settle in
shares or in cash, as the Company may settle the warrant shares at any time with
authorized and unregistered shares and delivery is solely in the control of the
Company.
Accordingly, management believes it controls the actions or events necessary to
issue the maximum number of shares that could be required to be delivered under
share settlement of the Warrants and meets the conditions necessary for equity
classification in accordance with EITF Issue No. 00-19.
Management determined there is no beneficial conversion feature related to the
Series A Preferred Stock. Consistent with guidance in EITF Issue No. 00-27,
"Application of Issue No. 98-5 to Certain Convertible Instruments" and EITF
Issue No. 98-5, "Accounting for Convertible Securities with Beneficial
Conversion Features or Contingently Adjustable Conversion Ratios," management
determined there is no beneficial conversion feature as the fair value of the
underlying common stock was less than the conversion price.
F-27
STRASBAUGH AND SUBSIDIARY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2007 (UNAUDITED)
NOTE 10 - EQUITY
REPURCHASE OF PREFERRED STOCK
In May 2007, R. H. Strasbaugh repurchased all of its issued and outstanding
participating preferred stock owned by Lam Research, Inc. for $3,000,000. The
participating preferred stock had a carrying value of $8,595,000 at the
repurchase date. The excess of the carrying value over the cash paid at
repurchase was recorded to additional paid in capital.
REPURCHASE OF COMMON STOCK
In May 2007, R. H. Strasbaugh repurchased 771,327 shares of outstanding common
stock held by Agility for a cash payment of $750,000.
REGISTRATION RIGHTS AGREEMENT
The Company is obligated under a registration rights agreement related to the
Series A Preferred Stock Financing to file a registration statement with the
Commission, registering for resale shares of common stock underlying the Series
A Preferred Stock and shares of common stock underlying Investor Warrants,
issued in connection with the Series A Preferred Stock Financing. The
registration obligations require, among other things, that a registration
statement be declared effective by the Commission on or before October 6, 2007.
As the Company was unable to meet this obligation in accordance with the
requirements contained in the registration rights agreement the Company entered
into with the investors, then the Company is required to pay to each investor
liquidated damages equal to 1% per month of the amount paid by the investor for
the common shares still owned by the investor on the date of the default and 1%
of the amount paid by the investor for the common shares still owned by the
investor on each monthly anniversary of the date of the default that occurs
prior to the cure of the default. The maximum aggregate liquidated damages
payable to any investor will be equal to 10% of the aggregate amount paid by the
investor for the shares of the Company's Series A Preferred Stock. Accordingly,
the maximum aggregate liquidation damages that we would be required to pay under
this provision is $1.3 million. The Company anticipates that it will have
sufficient cash available to pay these liquidated damages, if required. However,
the Company will not be obligated to pay any liquidated damages with respect to
any shares of common stock not included on the registration statement as a
result of limitations imposed by the SEC relating to Rule 415 under the
Securities Act.
In accordance with FSP EITF Issue No. 00-19-2, on the date of the private
offering the Company reviewed the terms of the registration rights agreements,
and as of that date, management believed that the Company would meet all of the
required deadlines under the agreement. However, as of September 30, 2007,
management believes it is probable that penalties under the agreement will be
incurred and accrued $62,000 of expense related to the Company's registration
rights agreement calculated based on the terms of the agreement and the number
of shares included in this filing. Management is unable to determine if any
additional penalties may be incurred under the terms of the registration rights
agreement due to the restrictions imposed upon the Company by the SEC relating
to Rule 415 under the Securities Act.
F-28
STRASBAUGH AND SUBSIDIARY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2007 (UNAUDITED)
NOTE 11 - INCOME TAXES
The Company estimates its income tax expense for interim periods using an
estimated annual effective tax rate. Tax expense for the nine months ended
September 30, 2007 and 2006 was lower than tax expense calculated at the
expected U.S. federal tax rate of 34% mainly as a result of a reduction in the
valuation allowance relating to the realization of net operating loss
carryforwards. The Company has a valuation allowance covering its deferred tax
assets, including its net operating loss carryforwards, because management
believes that it is more likely than not that all, or some portion of, such
deferred tax assets will not be realized.
The Company has federal and state net operating loss carryforwards of
approximately $22,252,000 and $6,853,000, respectively, at September 30, 2007,
which will begin to expire in 2019 for federal purposes. Annual utilization of
the federal net operating loss carryforward may be limited for federal tax
purposes as a result of an Internal Revenue Code Section 382 change in ownership
rules. The state net operating loss carryforwards expire at various dates
through 2013.
The Company adopted the provisions of FASB Interpretation No. 48, Accounting for
Uncertainty in Income Taxes, on January 1, 2007. As a result of the
implementation of Interpretation 48, the Company recognized approximately $0
increase in the liability for unrecognized tax benefits. The amount of
unrecognized tax benefits as of January 1, 2007, and September 30, 2007, are $0
and $0, respectively.
Included in the balance at January 1, 2007, are $0 of tax positions for which
the ultimate deductibility is highly certain but for which there is uncertainty
about the timing of such deductibility. Because of the impact of deferred tax
accounting, other than interest and penalties, the disallowance of the shorter
deductibility period would not affect the annual effective tax rate but would
accelerate the payment of cash to taxing authorities to an earlier period. Also
included in the balance at January 1, 2007, are $0 of unrecognized tax benefits
that, if recognized, would impact the effective tax rate. The Company expects no
adjustment to its amount of unrecognized tax benefits during 2007.
The Company recognizes interest and penalties accrued related to unrecognized
tax benefits in income tax expense. The Company had no amount accrued for the
payment of interest and penalties at September 30, 2007.
NOTE 12 - RELATED-PARTY ACTIVITY
Through the Company's former affiliation with SCST as a sales representative and
former customer, the Company has entered into an agreement to run and maintain a
sales office in Tokyo, Japan. The contract began in April 2005 and is effective
for five years. In connection with the agreement, SCST paid the Company 83
million yen (approximately $750,000) to operate the office over the contract
term. The Company has established a deferred liability and is amortizing the
amount on a monthly basis as a reduction of the operating expenses for the sales
office. In turn, for every sale originating from the Tokyo office, SCST will
receive a commission of 20% of the sale price, not to exceed 83 million yen.
There were no commissionable sales in Japan or to SCST during the nine months
ended September 30, 2007 or 2006, respectively. The Company had accounts
receivable from SCST of $0 and $8,000 at September 30, 2007 and 2006,
respectively.
F-29
STRASBAUGH AND SUBSIDIARY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2007 (UNAUDITED)
NOTE 13 - RESTATEMENT OF FINANCIAL STATEMENTS
Subsequent to the original issuance of the Company's financial statements as of
and for the nine months ended September 30, 2007 and 2006, management determined
that certain liabilities derecognized under the application of SFAS No. 140,
"Accounting Transfers and Servicing of Financial Assets and Extinguishments of
Liabilities, a replacement of FASB Statement 125" which had deemed to have run
the statute of limitations under California law had, in fact, not run their
respective statutes of limitations as of December 31, 2005 because they were
actually notes either subject to a the laws of other states with varying
statutes of limitations or were notes that were subject to a longer statute of
limitations under California law.
The Company had recorded $100,236 and $379,178 in income from the derecognition
of these liabilities and accrued royalties, respectively, during the year ended
December 31, 2005. Accordingly, upon restatement, the Company eliminated
$479,414 of income from the cancellation of these liabilities and royalties.
In addition, the Company incorrectly amortized and understated its employee
stock option compensation expense by $52,000 for the nine months ended September
30, 2007 as required under SFAS 123R.
The effect of these restatements as of and for the nine months ended September
30, 2007 is as follows:
AS PREVIOUSLY AS RESTATED
REPORTED
------------- -------------
Condensed Consolidated Balance Sheets
Notes payable, current portion $ -- $ 100,000
Accrued expenses $ 1,964,000 $ 2,343,000
Additional paid in capital $ 28,194,000 $ 28,246,000
Accumulated deficit $(26,276,000) $(26,807,000)
Condensed Consolidated Statement of Income
Operating expenses $ 6,127,000 $ 6,179,000
Net income $ 146,000 $ 94,000
Basic income per share $ 0.37 $ 0.36
Diluted income per share $ 0.29 $ 0.29
Condensed Consolidated Statement of Cash Flows
Net income $ 146,000 $ 94,000
Stock based compensation $ 8,000 $ 60,000
|
NOTE 14 - SUBSEQUENT EVENTS
On December 4, 2007, the Company entered into two Loan and Security Agreements
with Silicon Valley Bank providing for a credit facility in the aggregate amount
of $7.5 million (the "SVB Credit Facilities"). The first component , the "EXIM
Facility" provides for a two-year $2.5 million revolving line of credit, secured
by substantially all of the Company's assets, that requires the Company to
obtain a guarantee from the Export Import Bank of the United States of the
credit extensions under the agreement before a credit extension will be made.
The second component of the SVB Credit Facility (the "Non-EXIM Facility") is a
two-year, revolving line of credit secured by substantially all of the Company's
assets pursuant to which the Company can borrow up to $7.5 million dollars less
the principal balance borrowed under the EXIM Facility. The guarantee from
Export Import Bank of the United States must be in full force and effect
throughout the term of the EXIM Facility and so long as any credit extensions
under the EXIM Facility are outstanding. The Company will be in default under
the EXIM Facility if the EXIM guaranty ceases to be in full force and effect as
required by the Loan and Security Agreement applicable to the EXIM Facility.
Events of default under either of the SVB Credit Facilities will constitute an
event of default on the other SVB Credit Facility.
The SVB Credit Facilities are subject to various financial covenants, applicable
to the Company and its subsidiary, R.H. Strasbaugh, on a consolidated basis,
including the following: the ratio of certain assets to current liabilities,
measured on a monthly basis, must not be less than 1.0:1.0; and the ratio of
total liabilities less subordinated debt to tangible net worth plus subordinated
debt, measured on a monthly basis, must be not more than 0.60:1.0.
F-30
STRASBAUGH AND SUBSIDIARY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2007 (UNAUDITED)
NOTE 14 - SUBSEQUENT EVENTS (CONTINUED)
The Non-EXIM Facility is formula-based which generally provides that the
outstanding borrowings under the line of credit may not exceed an aggregate of
85% of eligible accounts receivable and 30% of eligible inventory. The EXIM
Facility is also formula-based and provides that the outstanding borrowings
under the line of credit may not exceed an aggregate of 90% of eligible accounts
receivable and 50% of eligible inventory.
Interest on the SVB Credit Facilities is payable monthly. The interest rate
applicable to the SVB Credit Facilities is a variable per annum rate equal to
0.75 percentage points above the prime rate as published by Silicon Valley Bank.
Upon the occurrence and during the continuation of an event of default, the
interest rate applicable to the outstanding balance under the SVB Credit
Facilities will increase by five percentage points above the per annum interest
rate that would otherwise be applicable. Both the EXIM Facility and the Non-EXIM
Facility are subject to an unused line fee of 0.25% per annum, payable monthly,
on any unused portion of the respective revolving credit facility.
F-31
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and
Shareholders of Strasbaugh
We have audited the accompanying balance sheet of Strasbaugh (a California
corporation) as of December 31, 2006, and the related statements of operations,
changes in shareholders' equity, and cash flows for each of the two years in the
period ended December 31, 2006. These financial statements are the
responsibility of the Company's management. Our responsibility is to express an
opinion on these financial statements based on our audits.
We conducted our audits in accordance with the standards of the Public Company
Accounting Oversight Board (United States). Those standards require that we plan
and perform the audit to obtain reasonable assurance about whether the financial
statements are free of material misstatement. The Company is not required to
have, nor were we engaged to perform, an audit of its internal control over
financial reporting. Our audit included consideration of internal control over
financial reporting as a basis for designing audit procedures that are
appropriate in the circumstances, but not for the purpose of expressing an
opinion on the effectiveness of the Company's internal control over financial
reporting. Accordingly we express no such opinion. An audit also includes
examining, on a test basis, evidence supporting the amounts and disclosures in
the financial statements. An audit also includes assessing the accounting
principles used and significant estimates made by management, as well as
evaluating the overall financial statement presentation. We believe that our
audits provide a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly, in
all material respects, the financial position of Strasbaugh as of December 31,
2006, and the results of its operations and its cash flows for each of the two
years in the period ended December 31, 2006, in conformity with accounting
principles generally accepted in the United States of America.
As discussed in Note 15 to the financial statements, the Company has restated
its financial statements for the years ended December 31, 2006 and 2005.
/S/ WINDES & McCLAUGHRY
Long Beach, California
May 7, 2007, except for the fifth, sixth and seventh paragraphs of Note 15, as
to which the date is December 5, 2007, and the eighth, ninth, tenth, and
eleventh paragraphs of Note 15, as to which the date is January 24, 2008.
|
F-32
STRASBAUGH
BALANCE SHEET
AS OF DECEMBER 31, 2006
ASSETS
DECEMBER 31,
2006
(AS RESTATED)
------------
CURRENT ASSETS
Cash and cash equivalents $ 1,205,007
Accounts receivable, net of allowance for doubtful accounts 4,251,180
of $70,000
Inventories 7,113,784
Prepaid expenses 337,769
Short-term deposits 48,024
------------
12,955,764
------------
PROPERTY, PLANT, AND EQUIPMENT 1,948,967
------------
OTHER ASSETS
Capitalized intellectual property net of amortization $10,625 in 2006 192,606
Long-term deposits 88,000
------------
280,606
------------
TOTAL ASSETS $ 15,185,337
============
LIABILITIES AND SHAREHOLDERS' EQUITY
CURRENT LIABILITIES
Line of credit $ 2,650,311
Notes payable, current portion 1,785,599
Accounts payable 1,038,128
Accrued expenses 2,941,230
Deferred revenue 1,200,689
------------
9,615,957
------------
NONCURRENT LIABILITIES
Accrued warrant 450,000
------------
450,000
------------
COMMITMENTS AND CONTINGENCIES (Notes 7, 8 and 10)
SHAREHOLDERS' EQUITY
Preferred stock 8,594,777
Common stock 17,163
Additional paid-in capital 23,408,661
Accumulated deficit (26,901,221)
------------
5,119,380
------------
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY $ 15,185,337
============
The accompanying notes are an integral part of these statements.
F-33
|
STRASBAUGH
STATEMENTS OF INCOME
FOR THE YEARS ENDED DECEMBER 31, 2006 AND 2005
YEAR ENDED
DECEMBER 31,
------------------------------
2006 2005
(AS RESTATED) (AS RESTATED)
------------ ------------
REVENUES
Tools $ 11,268,579 $ 7,673,102
Parts and Service 11,766,388 8,481,700
------------ ------------
NET REVENUES 23,034,967 16,154,802
------------ ------------
COST OF SALES
Tools 6,441,257 5,863,340
Parts and Service 8,029,765 3,960,713
------------ ------------
TOTAL COST OF SALES 14,471,022 9,824,053
------------ ------------
GROSS PROFIT 8,563,945 6,330,749
------------ ------------
OPERATING EXPENSES
Selling, general and administrative expenses 4,492,678 5,008,523
Research and development 2,070,689 2,322,000
Loss on sale of property and equipment -- 8,596
Gain from extinguishment of debt -- (1,092,265)
------------ ------------
6,563,367 6,246,854
------------ ------------
INCOME FROM OPERATIONS 2,000,578 83,895
------------ ------------
OTHER INCOME (EXPENSE)
Rental income 163,763 116,923
Interest income 527 902
Interest expense (840,787) (490,920)
Other (expense) income, net (77,197) (46,383)
------------ ------------
(753,694) (419,478)
------------ ------------
INCOME BEFORE PROVISION FOR INCOME TAXES 1,246,884 (335,583)
PROVISION FOR INCOME TAXES 78,500 29,015
------------ ------------
NET INCOME $ 1,168,384 $ (364,598)
============ ============
NET INCOME PER COMMON SHARE
Basic $ 0.08 $ (0.03)
============ ============
Diluted $ 0.06 $ (0.03)
============ ============
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING
Basic 13,992,828 13,992,828
============ ============
Diluted 18,572,556 13,992,828
============ ============
The accompanying notes are an integral part of these statements.
F-34
|
STRASBAUGH
STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY
FOR THE YEARS ENDED DECEMBER 31, 2006 AND 2005
PREFERRED STOCK COMMON STOCK ADDITIONAL
----------------------- ------------------------ PAID-IN ACCUMULATED
SHARES AMOUNT SHARES AMOUNT CAPITAL DEFICIT TOTAL
--------- ---------- ----------- -------- ------------ ------------ -----------
BALANCE, JANUARY 1, 2005 4,087,980 $8,594,777 16,351,868 $ 20,057 $ 23,400,789 $(27,705,007) $ 4,310,616
Repurchase of common stock -- -- (2,333,205) (2,862) 862 -- (2,000)
Cancellation of common stock -- -- (797,162) (978) 295 -- (683)
Issuance of common stock -- -- 771,327 946 (285) -- 661
Net loss (as restated) -- -- -- -- -- (364,598) (364,598)
--------- ---------- ----------- -------- ------------ ------------ -----------
BALANCE, DECEMBER 31, 2005 4,087,980 8,594,777 13,992,828 17,163 23,401,661 (28,069,605) 3,943,996
Stock compensation expense -- -- -- -- 7,000 -- 7,000
Net income -- -- -- -- -- 1,168,384 1,168,384
--------- ---------- ----------- -------- ------------ ------------ -----------
BALANCE, DECEMBER 31, 2006 4,087,980 $8,594,777 13,992,828 $ 17,163 $ 23,408,661 $(26,901,221) $ 5,119,380
========= ========== =========== ======== ============ ============ ===========
The accompanying notes are an integral part of
these statements.
F-35
|
STRASBAUGH
STATEMENTS OF CASH FLOWS
FOR THE YEARS ENDED DECEMBER 31, 2006 AND 2005
FOR THE YEAR ENDED
DECEMBER 31,
----------------------------
2006 2005
(AS RESTATED) (AS RESTATED)
----------- -----------
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss) $ 1,168,384 $ (364,598)
Adjustments to reconcile net income (loss)
to net cash from operating activities:
Depreciation and amortization 373,208 485,470
Loss on sale of property and equipment -- 8,596
Noncash gain from extinguishment of debt -- (1,092,265)
Noncash interest expense 216,275 61,545
Noncash stock compensation expense 7,000 --
Changes in assets and liabilities:
Accounts receivable (795,541) 1,303,603
Inventories (1,284,995) 1,496,846
Prepaid expenses (148,943) (62,099)
Short-term deposits -- (48,024)
Other assets (68,728) (19,272)
Accounts payable 390,126 (1,650,819)
Accrued expenses 458,531 507,360
Deferred revenue 477,503 476,916
Accrued warrant 52,002 7,014
----------- -----------
Net Cash Provided By Operating Activities 844,822 1,110,273
----------- -----------
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property and equipment (119,971) (81,653)
Capitalized cost for intellectual property (203,231) --
Proceeds from sale of property and equipment -- 200
----------- -----------
Net Cash Used In Investing Activities (323,202) (81,453)
----------- -----------
CASH FLOWS FROM FINANCING ACTIVITIES
Net change in line of credit 499,073 (809,973)
Repayment of notes payable (746,444) (327,303)
Borrowings on notes payable 250,000 389,000
Repurchase of common stock -- (2,000)
----------- -----------
Net Cash Provided By (Used In) Financing Activities 2,629 (750,276)
----------- -----------
NET CHANGE IN CASH AND CASH EQUIVALENTS 524,249 278,544
CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR 680,758 402,214
----------- -----------
CASH AND CASH EQUIVALENTS, END OF YEAR $ 1,205,007 $ 680,758
=========== ===========
CASH PAID FOR
Interest $ 572,510 $ 447,279
=========== ===========
Income taxes $ 78,700 $ 29,015
=========== ===========
The accompanying notes are an integral part of these statements.
F-36
|
STRASBAUGH
NOTES TO FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2006 AND 2005
NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
The following significant accounting policies are in conformity with accounting
principles generally accepted in the United States of America. Such policies are
consistently followed by Strasbaugh, a California corporation (the "Company"),
in preparation of its financial statements.
DESCRIPTION OF BUSINESS
The Company designs and manufactures precision surfacing systems and solutions
for the global semiconductor, electronics, precision optics, and aerospace
industries. Products are sold to customers throughout the United States, Europe,
and Asia and Pacific Rim countries.
ESTIMATES AND ASSUMPTIONS
The preparation of financial statements in accordance with accounting principles
generally accepted in the United States of America requires management to make
estimates and assumptions that affect the reported amounts of assets and
liabilities, the disclosure of contingent assets and liabilities at the date of
the financial statements, and the reported amounts of increases and decreases in
net assets from operations during the reporting period. Actual results could
differ from those estimates, and those differences could be material.
CONCENTRATIONS OF CREDIT RISK
Financial instruments that subject the Company to credit risk consist primarily
of cash and trade accounts receivable. With regard to cash and cash equivalents,
we maintain our excess cash balances in checking and money market accounts at
high-credit quality financial institution(s). We have not experienced any losses
in any of the short-term investment instruments we have used for excess cash
balances. We do not require collateral on our trade receivables. Historically,
we have not suffered significant losses with respect to trade accounts
receivable.
The Company sells its products on credit terms, performs ongoing credit
evaluations of its customers, and maintains an allowance for potential credit
losses. During the years ended December 31, 2006 and 2005, the Company's top 10
customers accounted for 64% and 66% of net revenues, respectively. Sales to
major customers (over 10%) as a percentage of net revenues were 29.9% and 34.5%
for the years ended December 31, 2006 and 2005, respectively.
A decision by a significant customer to substantially decrease or delay
purchases from the Company, or the Company's inability to collect receivables
from these customers, could have a material adverse effect on the Company's
financial condition and results of operations. As of December 31, 2006 and 2005,
the amount due from the major customers (over 10%) discussed above represented
20.4% and 16.2%, respectively, of total accounts receivable.
F-37
STRASBAUGH
NOTES TO FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2006 AND 2005
NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
PRODUCT WARRANTIES
The Company provides limited warranty for the replacement or repair of defective
product at no cost to its customers within a specified time period after the
sale. The Company makes no other guarantees or warranties, expressed or implied,
of any nature whatsoever as to the goods including without limitation,
warranties to merchantability, fit for a particular purpose or non-infringement
of patent or the like unless agreed upon in writing. The Company estimates the
costs that may be incurred under its limited warranty and reserve based on
actual historical warranty claims coupled with an analysis of unfulfilled claims
at the balance sheet date. Warranty claims costs are not material given the
nature of the Company's products and services which normally result in repairs
and returns in the same accounting period.
FAIR VALUE OF FINANCIAL INSTRUMENTS
The carrying value of financial instruments approximate their fair values. The
carrying values of cash, receivables, accounts payable and accrued expenses
approximate fair value because of the short-term maturity of these instruments.
The carrying values of the line of credit and notes payable approximate fair
value because the interest rates on these instruments approximate market
interest rates currently available to the Company.
SEGMENT INFORMATION
The Company's results of operations for the years ended December 31, 2006 and
2005, represent a single segment referred to as global semiconductor,
electronics, precision optics, and aerospace industries. Export sales represent
approximately 35% and 39% of sales for the years ended December 31, 2006 and
2005, respectively.
The geographic breakdown of the Company's sales was as follows:
FOR THE YEAR ENDED
DECEMBER 31,
2006 2005
---------- ----------
United States 65% 61%
Europe 8% 4%
Asia and Pacific Rim countries 27% 35%
|
The geographic breakdown of the Company's accounts receivable was as follows:
DECEMBER 31, 2006
United States 58%
Europe 14%
Asia and Pacific Rim countries 28%
|
F-38
STRASBAUGH
NOTES TO FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2006 AND 2005
NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
CASH AND CASH EQUIVALENTS
For purposes of the statements of cash flows, the Company considers all highly
liquid debt instruments purchased with a maturity of three months or less to be
cash equivalents.
At December 31, 2006 and throughout the year, the Company maintained cash
balances in excess of federally insured limits.
ACCOUNTS RECEIVABLE
Accounts receivable are due from companies operating primarily in the global
semiconductor, electronics, precision optics, and aerospace industries located
throughout the United States, Europe, and Asia and Pacific Rim countries. Credit
is extended to both domestic and international customers based on an evaluation
of the customer's financial condition, and, generally collateral is usually not
required. For international customers, additional evaluation steps are
performed, where required, and more stringent terms, such as letters of credit,
are used as necessary.
The Company estimates an allowance for uncollectible accounts receivable. The
allowance for probable uncollectible receivables is based on a combination of
historical data, cash payment trends, specific customer issues, write-off
trends, general economic conditions and other factors. These factors are
continuously monitored by management to arrive at the estimate for the amount of
accounts receivable that may be ultimately uncollectible. In circumstances where
the Company is aware of a specific customer's inability to meet its financial
obligations, the Company records a specific allowance for doubtful accounts
against amounts due, to reduce the net recognized receivable to the amount it
reasonably believes will be collected. Management believes that the allowance
for doubtful accounts at December 31, 2006 and 2005 is reasonably stated.
INVENTORIES
Inventories are maintained on the first-in, first-out method and are stated at
the lower of cost or market based on the lower of replacement cost or net
realizable value. Costs include material, labor and overhead required in the
warehousing and production of the Company's products. Inventory reserves are
maintained for the estimated value of the inventory that may have a lower value
than stated or quantities in excess of estimated future production needs.
PROPERTY, PLANT, AND EQUIPMENT
Property, plant, and equipment items are stated at cost, less accumulated
depreciation. Additions, improvements, and major renewals are capitalized, while
maintenance, repairs, and minor renewals are expensed as incurred. When assets
are retired or disposed of, the assets and related accumulated depreciation are
removed from the accounts and the resulting gain or loss is reflected in
operations. Depreciation is computed principally using straight-line and
accelerated methods over their estimated useful lives of three to thirty years.
Amortization of leasehold improvements is computed using straight-line and
accelerated methods over the shorter of the terms of the leases or their
estimated useful lives. Periodically, the Company may transfer a completed tool
from inventory to property, plant and equipment for use as a laboratory tool, or
for customer demonstration purposes. The tools are transferred at the lower of
cost or market and then depreciated over its estimated useful life. If the tool
is subsequently sold to an end user, it may be transferred back to inventory at
net book value and shipped to that customer.
F-39
STRASBAUGH
NOTES TO FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2006 AND 2005
NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
INTELLECTUAL PROPERTY
During the year ended December 31, 2006, the Company changed its policy of
expensing direct legal costs associated with the application and successful
defense of patents as incurred, and began capitalizing those costs. These costs
will be expensed over the life of the patents, not to exceed 15 years.
Approximately $203,000 of such costs were capitalized in the year ended December
31, 2006. Amortization expense for these patent costs totaled $10,625 during the
year ended December 31, 2006.
IMPAIRMENT OF LONG-LIVED ASSETS
Long-lived assets, such as property, plant, and equipment, are reviewed for
impairment whenever events or changes in circumstances indicate that the
carrying amount of an asset may not be recoverable. Recoverability of assets to
be held and used is measured by a comparison of the carrying amount of an asset
to estimated undiscounted future cash flows expected to be generated by the
asset. If the carrying amount of an asset exceeds its estimated future cash
flows, an impairment charge is recognized by the amount by which the carrying
amount of the asset exceeds the fair value of the asset. Management has
evaluated its long-lived assets and has not identified any impairment at
December 31, 2006 and 2005.
DEFERRED REVENUE
Deferred revenue represents service contract revenue which is deferred and
recognized ratably over the life of the service contract, which is generally one
year.
REVENUE RECOGNITION
The Company derives revenues principally from the sale of tools, parts and
services. The Company has evaluated its revenue recognition under Emerging
Issues Task Force ("EITF") Issue No. 00-21, Accounting for Revenue Arrangements
with Multiple Deliverables, and determined that its components of revenue are
separate units of accounting. Each unit has value to the customer on a
standalone basis, there is objective and reliable evidence of the fair value of
each unit, and there is no right to cancel, return or refuse an order. Since
each component is a separate unit of accounting pursuant to EITF Issue No.
00-21, the Company recognizes its revenue pursuant to Staff Accounting Bulletin
("SAB") No. 104, "Revenue Recognition." Under SAB No. 104, revenue is recognized
when the following criteria are met: (i) persuasive evidence of an arrangement,
such as a purchase order, exists, (ii) delivery has occurred or services have
been rendered, (iii) our price to the customer is fixed or determinable, and
(iv) collection is reasonably assured.
The Company's revenue recognition policies for its specific units of accounting
are as follows:
o Tools - The Company recognizes revenue once a customer has
visited the plant, signed off on the tool and the tool is
completed and shipped. A provision for the estimated future
cost of warranty is recorded when revenue is recognized.
o Parts - The Company recognizes revenue when the parts are
shipped.
F-40
STRASBAUGH
NOTES TO FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2006 AND 2005
NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
REVENUE RECOGNITION (CONTINUED)
o Service - Revenue from maintenance contracts is deferred and
recognized over the life of the contract, which is generally
one to three years. Maintenance contracts are separate
components of revenue and not bundled with our tools. If a
customer does not have a maintenance contract, then the
customer is billed for time and material and the Company
recognizes revenue the after the service has been completed.
o Installation - The Company does not charge for installation as
it is an inconsequential or perfunctory obligation and not
considered a separate element of the sales contract. All sales
contract fees are payable 60 days after delivery or upon
installation, and payment is not contingent upon installation.
Management considers Question 3 of SAB No. 104 Topic 13A3(c)
in its revenue recognition policy. This question considers a
unit of accounting that includes both equipment and
installation because the two deliverables do not meet the
separation criteria under EITF Issue No. 00-21. The following
examples of indicators that installation is not essential to
the functionality of the equipment are all present with
respect to the Company: (i) the equipment is a standard
product; (ii) installation does not significantly alter the
equipment's capabilities; and (iii) other companies are
available to perform the installation.
o Upgrades - The Company offers a suite of products known as
"Enhancements" which are generally comprised of one-time parts
and/or software upgrades to existing Strasbaugh and
non-Strasbaugh tools. These enhancements are not required for
the tools to function, are not part of the original contract
and do not include any obligation to provide any future
upgrades. The Company recognizes revenue once these upgrades
and enhancements are complete. Revenue is recognized on
equipment upgrades when the Company completes the installation
of the upgrade parts and/or software on the customer's
equipment and the equipment is accepted by the customer. The
upgrade contracts cover a one-time upgrade of a customer's
equipment with new or modified parts and/or software. After
installation of the upgrade, the Company has no further
obligation on the contracts, other than standard warranty
provisions. The revenue recognition requirements of Statement
of Position ("SOP") 97-2, "Software Revenue Recognition," are
met upon delivery and acceptance of the equipment, including
the parts and/or software upgrades, to the customer.
o Right of Return and/or Cancellation - The Company's tool sales
have no right of return, or cancellation rights. Tools are
typically modified to some degree to fit the needs of the
customer and, therefore, once a purchase order has been
accepted by the Company and the manufacturing process has
begun, there is no right to cancel, return or refuse the
order.
o Non-refundable fees - Generally, the Company obtains a
non-refundable down-payment from the customer. These fees are
deferred and recognized as the tool is shipped in accordance
with the policy for revenue recognition under tool sales
discussed above.
F-41
STRASBAUGH
NOTES TO FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2006 AND 2005
NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
REVENUE RECOGNITION (CONTINUED)
The AICPA issued SOP 97-2, "Software Revenue Recognition," which established
four basic requirements for revenue recognition for software arrangements that
are not subject to contract accounting: (i) persuasive evidence of an
arrangements exists, (ii) delivery has occurred, (iii) the vendor's fee is fixed
or determinable, and (iv) collectibility is probable.
The Company installs software into it tools. The software is used solely in
connection with operating the tools and is not sold or marketed separately. Once
installed, the software is not updated for new versions that may be subsequently
developed. However, software modifications may be included in tool upgrade
contracts.
Accordingly, revenue from the sale of the tools, including the software
component is recognized when there is a written contract, the customer has
accepted the tool, the tool is completed and shipped, the price is fixed or
determinable and collection is reasonably assured. Similarly, if a software
modification is sold in an upgrade contract, revenue is recognized when the
upgrade is complete, the customer accepts the upgraded equipment, the price is
fixed or determinable and collection is reasonable assured.
RESEARCH AND DEVELOPMENT
Costs related to designing and developing new products are expensed as research
and product development expenses as incurred. Research and development expenses
totaled approximately $2,071,000 and $2,322,000 for the years ended December 31,
2006 and 2005, respectively.
SHIPPING COSTS
During the years ended December 31, 2006 and 2005, freight and handling amounts
incurred by the Company totaled approximately $60,000 and $73,000, respectively,
and are included in the cost of sales. Freight and handling fees billed to
customers of approximately $15,000 and $43,000 are included in revenues for the
years ended December 31, 2006 and 2005, respectively.
STOCK-BASED COMPENSATION
Historically the Company's stock-based compensation was accounted for using the
intrinsic value method, under which no compensation expense is recognized when
the exercise price of the employee's stock option equals or exceeds the market
price of the underlying stock on the date of grant. Required pro forma
information has been presented under the fair value method using a Black-Scholes
option-pricing model pursuant to Statement of Financial Accounting Standard
("SFAS") No. 123, "Accounting for Stock-Based Compensation."
In December 2004, the Financial Accounting Standards Board ("FASB") issued SFAS
No. 123 (revised 2004), "Share-Based Payment," ("SFAS No. 123(R)"), which is a
revision of SFAS No. 123. SFAS No. 123(R) supersedes Accounting Principles Board
Opinion No. 25, "Accounting for Stock Issued to Employees" and amends SFAS No.
95, "Statement of Cash Flows." Generally, the approach in SFAS No.123(R) is
similar to the approach described in SFAS No. 123. However, SFAS No. 123(R)
requires all share-based payments to employees, including grants of employee
stock options, to be recognized in the income statement based on their fair
values. Pro forma disclosure is no longer an alternative.
F-42
STRASBAUGH
NOTES TO FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2006 AND 2005
NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
STOCK-BASED COMPENSATION
SFAS No. 123(R) also establishes accounting requirements for measuring,
recognizing and reporting share-based compensation, including income tax
considerations. One such change was the elimination of the minimum-value method,
which under SFAS No. 123 permitted the use of zero volatility when performing
Black-Scholes valuations. Under SFAS No. 123(R), companies are required to use
expected volatilities derived from the historical volatility of the company's
stock, implied volatilities from traded options on the company's stock and other
factors. SFAS No. 123(R) also requires the benefits of tax deductions in excess
of recognized compensation cost to be reported as a financing cash flow, rather
than as an operating cash flow as required under current accounting literature.
The provisions of SFAS No. 123(R) were effective for and adopted by the Company
as of January 1, 2006. As the Company was using the intrinsic-value accounting
for stock based compensation pursuant to Accounting Principles Board ("APB")
Opinion No. 25, "Accounting for Stock Issued to Employees," the adoption of SFAS
No. 123(R) was made using the prospective method. Under the prospective
application, the cost of new awards and awards modified, if any, repurchased or
cancelled after the required effective date will be recognized as the requisite
service is rendered on or after the required effective date.
Although the Company had previously recorded stock compensation expense under
the intrinsic-value method, the adoption of SFAS No. 123(R) did not have any
impact on the Company's results of operations, income taxes or earnings per
share as all previous options were fully vested.
DETACHABLE STOCK WARRANTS
The Company accounts for detachable stock warrants under EITF Issue No. 00-19,
"Accounting for Derivative Financial Instruments Indexed to, and Potentially
Settled in, a Company's Own Stock," and APB No. 14, "Accounting for Convertible
Debt Issued with Stock Purchase Warrants."
Original issue discounts are recorded as deferred charges and are amortized to
interest expense over the term of the associated debt instrument using the
effective-interest method.
FOREIGN CURRENCY TRANSACTIONS
The accounts of the Company are maintained in U.S. dollars. Transactions
denominated in foreign currencies are recorded at the rate of exchange in effect
on the dates of the transactions. Balances payable in foreign currencies are
translated at the current rate of exchange when settled.
F-43
STRASBAUGH
NOTES TO FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2006 AND 2005
NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
EARNINGS PER SHARE
Basic net income (loss) per share is computed by dividing net income (loss)
available to common stockholders by the weighted-average number of outstanding
common shares for the period. Diluted net income per share is computed by using
the treasury stock method and dividing net income (loss) available to common
stockholders, plus the effect of assumed conversions (if applicable), by the
weighted-average number of outstanding common shares after giving effect to all
potential dilutive common stock, including options, warrants, common stock
subject to repurchase, and convertible preferred stock, if any.
Reconciliations of the numerator and denominator used in the calculation of
basic net income (loss) per common share are as follows:
FOR THE YEAR ENDED
DECEMBER 31,
--------------------------
2005
2006 (as restated)
----------- -----------
Numerator:
Net income (loss) $ 1,168,384 $ (364,598)
Preferred stock accretion -- --
Preferred stock dividend -- --
---------- -----------
Net income (loss)available to common shareholders - basic 1,168,384 (364,598)
Adjustment to net income for assumed conversions 52,002 --
----------- -----------
Net income (loss) available to common shareholders - diluted $ 1,220,386 $ (364,598)
=========== ===========
Denominator:
Shares outstanding, beginning 13,992,828 13,992,828
Weighted-average shares issued -- --
----------- -----------
Weighted-average shares outstanding - basic 13,992,828 13,992,828
Effect of dilutive securities
Preferred stock (Note 11) 4,087,980 --
Warrant (Note 7) 491,748 --
----------- -----------
4,579,728 --
----------- -----------
Weighted-average shares outstanding - diluted 18,572,556 13,992,828
=========== ===========
|
Diluted earnings per share is computed similar to basic earnings per share
except that the denominator is increased to include the number of additional
common shares that would have been outstanding if the potential common shares
had been issued and if the additional common shares were dilutive. Stock options
to purchase approximately 843,886 and 845,336 shares of common stock as of
December 31, 2006 and 2005, respectively, were outstanding but not included in
the computation of diluted earnings per common share because the option exercise
price was greater than the average market price of the common stock and,
therefore, the effect on dilutive earnings per common share would have been
anti-dilutive. Common stock equivalents, representing convertible preferred
stock, options and warrants totaling approximately 4,579,728 shares are not
included in diluted loss per share for the year ended December 31, 2005 since
they would be anti-dilutive. Accordingly, diluted and basic loss per share are
the same for the year ended December 31, 2005.
F-44
STRASBAUGH
NOTES TO FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2006 AND 2005
NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
INCOME TAXES AND DEFERRED INCOME TAXES
Income taxes are provided for the effects of transactions reported in the
financial statements and consist of taxes currently due plus deferred taxes
related primarily to differences between the basis of certain assets and
liabilities for financial and income tax reporting. Deferred taxes are
classified as current or noncurrent depending on the classification of the
assets and liabilities to which they relate. Deferred taxes arising from
temporary differences that are not related to an asset or liability are
classified as current or noncurrent, depending on the periods in which the
temporary differences are expected to reverse. A valuation allowance is
established when necessary to reduce deferred tax assets if it is more likely
than not that all, or some portion of, such deferred tax assets will not be
realized.
NEW ACCOUNTING PRONOUNCEMENTS
In February 2007, the FASB issued SFAS No. 159, "The Fair Value Option for
Financial Assets and Financial Liabilities" which permits entities to choose to
measure many financial instruments and certain other items at fair value that
are not currently required to be measured at fair value. SFAS No. 159 will be
effective for the Company on January 1, 2008. The Company is currently
evaluating the impact of adopting SFAS No. 159 on its financial position, cash
flows, and results of operations.
In December 2006, the FASB issued FASB Staff Position ("FSP") EITF Issue No.
00-19-2, "Accounting for Registration Payment Arrangements." This FSP specifies
that the contingent obligation to make future payments or otherwise transfer
consideration under a registration payment arrangement, whether issued as a
separate agreement or included as a provision of a financial instrument or other
agreement, should be separately recognized and measured in accordance with FASB
Statement No. 5, "Accounting for Contingencies." The adoption of FSP EITF Issue
No. 00-19-2 is not expected to have a material effect on the Company's financial
position, cash flows, or results of operations.
In September 2006, the Securities and Exchange Commission issued SAB No. 108,
"Considering the Effects of Prior Year Misstatements When Quantifying
Misstatements in Current Year Financial Statements," which provides interpretive
guidance on how the effects of the carryover or reversal of prior year
misstatements should be considered in quantifying a current year misstatement.
SAB No. 108 is effective for the Company's fiscal year ended December 31, 2006.
The adoption of SAB No. 108 has not had a material impact on the Company's
financial position, cash flows, or results of operations.
In September 2006, the FASB issued SFAS No. 157, "Fair Value Measurements." SFAS
No. 157 establishes a common definition for fair value to be applied to U.S.
GAAP guidance requiring use of fair value, establishes a framework for measuring
fair value, and expands disclosure about such fair value measurements. SFAS No.
157 is effective for fiscal years beginning after November 15, 2007. The Company
is currently assessing the impact that SFAS No. 157 may have on its financial
position, cash flows, and results of operations.
F-45
STRASBAUGH
NOTES TO FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2006 AND 2005
NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
NEW ACCOUNTING PRONOUNCEMENTS (CONTINUED)
In July 2006, the FASB released FASB Interpretation No. 48 ("FIN 48")
"Accounting for Uncertainty in Income Taxes." FIN 48 provides guidance for how
uncertain tax positions should be recognized, measured, presented, and disclosed
in the financial statements. FIN 48 requires the evaluation of tax positions
taken in the course of preparing the Company's tax returns to determine whether
the tax positions are "more-likely-than-not" of being sustained by the
applicable tax authority. Tax benefits of positions not deemed to meet the
"more-likely-than-not" threshold would be booked as a tax expense in the current
year and recognized as: a liability for unrecognized tax benefits; a reduction
of an income tax refund receivable; a reduction of deferred tax asset; an
increase in deferred tax liability; or a combination thereof. Adoption of FIN 48
is required for fiscal years beginning after December 15, 2006. At this time,
management is evaluating the implication of FIN 48, and its impact on the
financial statements has not yet been determined.
In February 2006, the FASB issued SFAS No. 155, "Accounting for Certain Hybrid
Financial Instruments," an amendment of SFAS No. 133, "Accounting for Derivative
Instruments and Hedging Activities," and SFAS No. 140, "Accounting for Transfers
and Servicing of Financial Assets and Extinguishments of Liabilities." This
Statement permits fair value re-measurement for any hybrid financial instrument
that contains an embedded derivative that otherwise would require bifurcation.
This Statement is effective for the Company for all financial instruments
acquired or issued after July 1, 2007. The adoption of SFAS No. 155 is not
expected to have a material effect on the Company's consolidated financial
position, results of operations or cash flows.
In May 2005, the FASB issued SFAS No. 154, "Accounting Changes and Error
Corrections" which replaces Accounting Principles Board Opinions No. 20
"Accounting Changes" and SFAS No. 3, "Reporting Accounting Changes in Interim
Financial Statements-An Amendment of APB Opinion No. 28." SFAS No. 154 provides
guidance on the accounting for and reporting of accounting changes and error
corrections. It establishes retrospective application, or the latest practicable
date, as the required method for reporting a change in accounting principle and
the reporting of a correction of an error. SFAS No. 154 is effective for
accounting changes and corrections of errors made in fiscal years beginning
after December 15, 2005.
RECLASSIFICATIONS
Certain reclassifications have been made in the prior year financial statements
to conform to the current year's presentation.
NOTE 2 - MANAGEMENT'S PLANS
The Company has an accumulated deficit of approximately $26,901,000 at December
31, 2006. The Company has invested substantial resources in product development,
which has negatively impacted its cost structure and contributed to a
significant portion of its recent losses.
F-46
STRASBAUGH
NOTES TO FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2006 AND 2005
NOTE 2 - MANAGEMENT'S PLANS (CONTINUED)
Management's plans with respect to these matters include efforts to increase
revenues through the sale of existing products and new technology, continuing to
reduce certain operating expenses, and potentially re-financing its long-term
debt and/or raising additional capital. Management believes that the Company's
current backlog and working capital is sufficient to maintain operations in the
near term and that product development can be reduced or curtailed in the future
to further manage cash expenditures. Potential sources of additional financing
include the issuance of notes payable, the sale of equity securities and/or the
sale and/or licensing of certain technology. There are no assurances that the
Company will achieve profitable operations in the future or that additional
capital will be raised or obtained by the Company if cash generated from
operations is insufficient to pay current liabilities.
NOTE 3 - INVENTORIES
Inventories consist of the following:
DECEMBER 31, 2006
Raw materials $ 6,180,899
Work-in-process 3,918,477
Finished goods 81,470
-----------------
10,180,846
Inventory Reserves (3,067,062)
-----------------
$ 7,113,784
=================
|
NOTE 4 - PROPERTY, PLANT, AND EQUIPMENT
Property, plant, and equipment consist of the following:
DECEMBER 31, 2006
Buildings and improvements $ 2,197,849
Shop and lab equipment 5,688,941
Transportation equipment 165,501
Furniture and fixtures 1,111,227
Computer equipment 2,308,137
-----------------
11,471,655
Less: accumulated depreciation and amortization 9,522,688
-----------------
$ 1,948,967
=================
|
During the year ended December 31, 2006, the Company transferred approximately
$9,000 of shop and lab equipment and computer equipment from inventory to
property and equipment. During the year ended December 31, 2005, the Company
transferred approximately $197,000 of shop and lab equipment and computer
equipment to inventory for resale, which was subsequently sold during the year
ended December 31, 2005. Depreciation expense totaled approximately $363,000 and
$485,000 for the years ended December 31, 2006 and 2005, respectively.
F-47
STRASBAUGH
NOTES TO FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2006 AND 2005
NOTE 5 - LINE OF CREDIT
In November 2006, the Company renewed its line of credit agreement ("Loan
Agreement") and guaranty agreement ("Exim Agreement") with a bank through
February 2007. The agreements are secured by substantially all of the Company's
assets. The borrowing amount under the agreements is based on eligible accounts
receivable. The agreements allow the Company to borrow up to $3 million at the
prime rate (8.25% at December 31, 2006) plus 3.5% under the Loan Agreement and
$500,000 at the prime rate plus 4% under the Exim Agreement. In addition, the
Company must pay the bank an administrative fee of 0.5% of the face amount of
each receivable when first financed under both of the agreements. Both
agreements include affirmative, negative and financial covenants. The notes
payable to the majority stockholder are subordinated in connection with these
agreements. (See Note 6.) In February 2007, the Company renewed the agreements
through April 18, 2007. Subsequent to year-end, the Company renewed the
agreements through May 18, 2007.
NOTE 6 - NOTES PAYABLE
Notes payable consists of the following:
DECEMBER 31, 2006
-----------------
Note payable to Agility Capital, LLC ("Agility"), secured by substantially all
of the Company's assets, payable in monthly installments of $55,000 including
interest at 12%, lump-sum payment of $150,000 due March 1, 2007, and remaining
balance due September 2007 (amount due of $1,076,727 less unamortized discount
allocated to warrant issued totaling $113,164) $ 963,563
Subordinated unsecured note payable to majority stockholder, payable in monthly
interest-only payments at the prime rate plus 1%, was due February 2007 and
subsequently extended until June 2007 721,800
Other unsecured notes payable 100,236
-----------------
1,785,599
Less: current portion 1,785,599
-----------------
Noncurrent portion $ --
=================
|
During the year ended December 31, 2005, the Company entered a settlement
agreement with several of its previous lenders, Comdisco and a credit
association, and obtained financing from a new institution, Agility. The Company
borrowed $1,650,000 from Agility, of which $1,186,000 was paid directly by
Agility to Comdisco and the credit association based on the settlement
agreement. The remainder consisted of a loan fee of $75,000 and cash for
operations of $389,000.
According to EITF Issue No. 96-19, "Debtor's Accounting for a Modification or
Exchange of Debt Instruments," an exchange of debt instruments with
substantially different terms is an "extinguishment" and pursuant to SFAS No.
140, "Accounting for Transfers and Servicing of Financial Assets and
Extinguishments of Liabilities," any resulting gain or loss must be recognized
on the transaction. Because the new debt had substantially different terms, the
Company recorded a gain from the extinguishment totaling approximately
$1,092,000. Of this amount, approximately $894,000 represented the difference
between the carrying amount of various notes payable and the amount paid, and
$273,000 represented accrued expenses that were forgiven, net of a $75,000 loan
fee for the new debt.
F-48
STRASBAUGH
NOTES TO FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2006 AND 2005
NOTE 6 - NOTES PAYABLE (CONTINUED)
In connection with the exchange of debt instruments, the Company cancelled
797,162 shares of common stock held by the credit association and issued 771,327
shares to Agility (Note 11). The Company also issued Agility a warrant (Note 7).
The fair value of the warrant has been allocated as a discount to the new debt.
The values for each security were determined separately, based on their values
at the time of issuance, and the debt discount was computed by comparing the
value attributed to the debt securities with the face value of the debt. The
discount was initially recorded at its fair value of $390,984. Amortization of
the discount totaled $216,275 and $61,545 for the years ended December 31, 2006
and 2005, respectively.
Maturities of notes payable are as follows as of December 31, 2006:
YEAR ENDING
DECEMBER 31,
2007 $ 1,898,763
NOTE 7 - STOCK WARRANT
As a condition for obtaining financing (Note 6), the Company issued Agility a
warrant to purchase up to 4.1% of the Company's equity on a fully diluted basis
at $0.01 per share. If the Company had repaid the note payable prior to June 17,
2006, the warrant would have decreased to 2.1% of the Company's equity on a
fully diluted basis. The agreement also allowed the Company to call the warrant
for $225,000 on or before June 17, 2006, which was not done. If the Company has
not received at least $5 million of net proceeds from the sale or issuance of
its equity securities on or before September 16, 2007, Agility may require the
Company to purchase the warrant in cash for $450,000. The shares underlying the
warrant vested upon issuance and the warrant expires September 2017.
The Company has accounted for this warrant under EITF Issue No. 00-19 and APB
No. 14. As such, the Company has classified this warrant as a liability. The
warrant was initially recorded at its fair value of $390,984, discounted using
the prime rate over its estimated life considering the various put and call
options, as a liability and a discount to the new debt (Note 6).
The warrant is carried at its estimated fair value. As of December 31, 2005, the
carrying amount of the warrant totaled approximately $397,998 and was included
in noncurrent accrued expenses. The change in the fair value of the warrant
during the years ended December 31, 2006 and 2005 totaling $52,002 and $7,014,
respectively, were included in other expenses.
F-49
STRASBAUGH
NOTES TO FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2006 AND 2005
NOTE 8 - COMMITMENTS AND CONTINGENCIES
LEASE COMMITMENTS
As of December 31, 2004, the Company was committed under a lease for its
manufacturing and sales facility, which is owned by the chairman of the Company,
who is the majority stockholder, and his former spouse. This 15-year lease
agreement commenced on May 1, 1990 and ended on April 30, 2005. Under the
original terms of the lease, the Company paid monthly lease payments and was
liable for all property taxes, insurance, repairs, and maintenance. The lease
also provided for periodic adjustments in minimum lease payments based upon the
CPI.
Effective May 1, 2005, the Company exercised the holdover provision within the
lease agreement for its manufacturing and sales facility when it did not elect
to execute an automatic five-year extension but remained in possession of the
premises. The holdover provision within the lease agreement allows the Company
to remain the tenant on a month-to-month basis under the terms that existed at
the end of the original lease term, as defined. The holdover provision remains
valid as long as the Company remains in possession and makes timely monthly rent
payments.
Lease expense under the Company's operating leases for facilities totaled
approximately $1,020,000 and $1,022,000 for the years ended December 31, 2006
and 2005, respectively, of which approximately $1,000,000 and $956,000,
respectively, was related to the stockholder lease. Sublease income totaled
approximately $164,000 and $117,000 for the years ended December 31, 2006 and
2005, respectively.
The Company leases a postal mailing system under a noncancelable operating
lease, which expires in December 2008. The Company also leases a sales facility
in Tokyo, Japan, through April 2007. In April 2007, the Company extended the
lease on a month-to-month basis. The following is a schedule by years of future
minimum payments required under these operating leases with unrelated third
parties that have a term in excess of one year as of December 31, 2006:
YEAR ENDING
DECEMBER 31,
2007 $ 27,471
2008 6,346
2009 3,000
-------------
$ 36,817
=============
|
SUBLEASE AGREEMENT
In March 2005, the Company entered into a sublease agreement with a previously
unrelated third party to lease approximately 9,000 square feet of office space
and 11,200 square feet of warehouse space. The lease commenced in April 2005 and
terminates in March 2008. The rent under the sublease totals $16,220 per month
through March 31, 2006, $16,707 per month through March 31, 2007, and $17,208
through March 31, 2008. The sublease also includes an option to extend for three
years. The Company is required to pay the majority of the applicable operating
expenses, except for certain telecommunications services, as defined. The
Company agreed to release the tenant and the sublease was terminated in November
2006.
F-50
STRASBAUGH
NOTES TO FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2006 AND 2005
NOTE 8 - COMMITMENTS AND CONTINGENCIES (CONTINUED)
LITIGATION
During the year ended December 31, 2006, the Company entered into a legal
dispute with the co-landlord of its current facility, who is the former spouse
of the major stockholder, regarding the Company's potential liability for
capital repairs. The Company is presently unable to evaluate the likelihood of
an unfavorable result in this dispute or the range of potential loss. However,
management intends to vigorously defend against this case and believes that all
of its defenses are meritorious.
On or about August 15, 2006, John Rzezuski filed a complaint in the Commonwealth
of Massachusetts Superior Court against R. H. Strasbaugh alleging negligence and
breach of implied warranty. Mr. Rzezuski alleges that he was injured while using
a product we designed, manufactured and sold to Mr. Rzezuski's employer. Mr.
Rzezuski demands a judgment in an amount sufficient to compensate him for his
losses and damages but does not allege with specificity his injuries or the
relief sought. As of the date of these financial statements, management is
unable to reasonably estimate a potential range of loss and, further, believes
that the possibility of any payment is remote. The Company's insurance carrier
has assumed the defense of this action.
The Company is subject to various lawsuits and claims with respect to such
matters as product liabilities, employment matters and other actions arising out
of the normal course of business. While the effect on future financial results
is not subject to reasonable estimation because considerable uncertainty exists,
in the opinion of Company counsel, the ultimate liabilities resulting from such
lawsuits and claims will not materially affect the financial condition or
results of operations.
NOTE 9 - PROFIT SHARING PLAN
The Company's profit sharing plan covers substantially all employees and
includes a savings plan under Section 401(k) of the Internal Revenue Code. The
plan allows participants to make pre-tax contributions from 1% to 15% of their
annual compensation, subject to maximum annual limits as established by the
Internal Revenue Service. The Company made matching contributions totaling
approximately $59,000 and $88,000 for the years ended December 31, 2006 and
2005, respectively. The Company's board of directors may also elect to make
additional discretionary contributions. There were no additional discretionary
contributions made during the years ended December 31, 2006 and 2005.
NOTE 10 - STOCK COMPENSATION PLANS
STOCK-BASED COMPENSATION PLANS
As of January 1, 2006, the Company adopted SFAS No. 123(R), which requires the
measurement and recognition of compensation expense for all share-based payment
awards made to employees and directors including employee stock options based on
estimated fair values, ratably over the requisite service period of the award.
Net income will be reduced as a result of the recognition of the fair value of
all newly issued stock options, which is contingent upon the number of future
options granted and other variables. SFAS 123(R) supersedes the Company's
previous accounting under APB No. 25.
F-51
STRASBAUGH
NOTES TO FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2006 AND 2005
NOTE 10 - STOCK COMPENSATION PLANS (CONTINUED)
STOCK-BASED COMPENSATION PLANS (CONTINUED)
The Company adopted SFAS No. 123(R) using the prospective transition method,
which requires the application of the accounting standard as of January 1, 2006,
the first day of the Company's fiscal year ending December 31, 2006. The
Company's audited Financial Statements as of and for the twelve months ended
December 31, 2006 reflect the impact of SFAS No. 123(R). In accordance with the
prospective transition method, the Company's audited financial statements for
periods prior to January 1, 2006 have not been restated to reflect, and do not
include, the impact of SFAS No. 123(R).
Prior to the adoption of SFAS No. 123(R), the Company accounted for stock-based
awards to employees and directors using the intrinsic value method in accordance
with APB No. 25 as allowed under SFAS No. 123, "Accounting for Stock-Based
Compensation." Generally, no compensation expense was recognized by the Company
in its financial statements in connection with the awarding of stock option
grants to employees provided that, as of the grant date, all terms associated
with the award are fixed and the fair value of our stock, as of the grant date,
is equal to or less than the amount an employee must pay to acquire the stock.
The Company would have recognized compensation expense in situations where the
fair value of our common stock on the grant date was greater than the amount an
employee must pay to acquire the stock.
1998 AMENDED RESTATED STOCK OPTION PLAN
Under the Company's 1998 Amended Restated Stock Option Plan (the "1998 Plan"),
as amended, 1,400,000 shares of the Company's common stock are available for
issuance, pursuant to which employees are eligible to receive stock options. The
1998 Plan is administered by the Board of Directors (the "Board"). No
compensation expense has been recorded in the accompanying consolidated
financial statements related to the 1998 Plan.
The status of the 1998 Plan is summarized below:
AVERAGE INTRINSIC
SHARES PRICE VALUE
------------ ---------- ---------
Outstanding at January 1, 2005 715,514 $3.21 $ 0.00
Forfeited (419,044) $1.58 $ 0.00
-----------
Outstanding at December 31, 2005 296,470 $5.50 $ 0.00
Forfeited (1,450) $5.50 $ 0.00
-----------
Outstanding at December 31, 2006 295,020 $5.50 $ 0.00
===========
Exercisable at December 31, 2006 295,020 $5.50 $ 0.00
===========
|
The remaining options under the 1998 Plan expire in 2008.
F-52
STRASBAUGH
NOTES TO FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2006 AND 2005
NOTE 10 - STOCK COMPENSATION PLANS (CONTINUED)
2000 STOCK OPTION AGREEMENT
During 2000, the board granted options to purchase 1,646,557 shares of common
stock at an exercise price of $.07 per share to four vice presidents. The
options are subject to a number of restrictions as defined in the agreement,
including a buy-sell provision with the Company. The options expire ten years
from the date of issuance and automatically cancel 30 days after termination, as
defined in the agreements.
The status of the options under this plan is summarized below:
AVERAGE INTRINSIC
SHARES PRICE VALUE
------------ ---------- ---------
Outstanding at January 1, 2005 548,866 $ 0.07 $ 0.00
Forfeited --
-----------
Outstanding at December 31, 2005 548,866 $ 0.07 $ 0.00
Forfeited --
-----------
Outstanding at December 31, 2006 548,866 $ 0.07 $ 0.00
===========
Exercisable at December 31, 2006 548,866 $ 0.07 $ 0.00
===========
|
The remaining 548,866 options outstanding as of December 31, 2005 expired on
January 31, 2006. On April 10, 2006, the board of directors approved the
re-granting of these options with a revised expiration date of December 31, 2007
and immediate vesting resulting in $7,000 of total compensation expense. In
accordance with SFAS No. 123(R), this re-grant is treated a new issuance
effective on that date.
During the year ended December 31, 2006, there was $7,000 of total compensation
expense related to vested share-based compensation arrangements granted under
the Plan.
The Company used the Black-Scholes option-pricing model to value option grants
and determine the related compensation expense under the fair-value method. The
assumptions used in calculating the fair value of stock-based payment awards
represent management's best estimates.
The following table provides the assumptions used in determining the fair value
of the share-based awards for the year ended 2006.
APRIL 10,
GRANT/MODIFICATION DATE 2006
-------------
Stock price $ 0.07
Exercise price $ 0.07
Expected life 1.75 years
Risk-free interest rate 4.6%
Volatility 55.0%
Forfeiture rate 0.0%
Expected dividend yield 0.0%
|
F-53
STRASBAUGH
NOTES TO FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2006 AND 2005
NOTE 10 - STOCK COMPENSATION PLANS (CONTINUED)
2000 STOCK OPTION AGREEMENT (CONTINUED)
The expected term of the options granted was determined based upon review of the
period that the Company's share-based awards are expected to be outstanding and
is estimated based on historical experience of similar awards, giving
consideration to the contractual term of the awards, vesting schedules, and
expectations of employee exercise behavior.
The risk-free interest rate used for each grant is equal to the U.S. Treasury
yield curve in effect at the time of grant for instruments with a similar
expected life.
The Company estimates expected volatility based on that of the Company's
publicly traded peer companies and expects to continue to do so until such time
as the Company has adequate historical data from our traded share price.
Management believes that the historical volatility of the Company's stock price
does not best represent the expected volatility of the stock price. The Company
has historically been a private company and, therefore, lacks company-specific
historical and implied volatility information. The Company intends to continue
to consistently use the same group of publicly-traded peer companies to
determine volatility in the future until such time that sufficient information
regarding the volatility of our share price becomes available, or that the
selected companies are no longer suitable for this purpose.
SFAS No. 123(R) also requires that the Company recognize compensation expense
for only the portion of options that are expected to vest. Therefore, the
Company has estimated expected forfeitures of stock options with the adoption of
SFAS No. 123(R). In developing a forfeiture rate estimate, the Company
considered its historical experience, its growing employee base, and the limited
liquidity of its common stock. Forfeitures are considered separately for
managers and employees. If the actual number of forfeitures differs from those
estimated by management, additional adjustments to compensation expense may be
required in future periods. Prior to the adoption of SFAS No. 123(R),
forfeitures were recorded as they occurred.
Compensation expense related to the adoption of SFAS 123(R) amounted to $7,000,
which is included in the statements of operations for the twelve months ended
December 31, 2006, and is based on awards ultimately expected to vest and
reflects an estimate of awards that will be forfeited.
NOTE 11 - STOCKHOLDERS' EQUITY
COMMON STOCK
The Company is authorized to issue up to 50,000,000 shares of common stock, no
par value, of which 13,992,828 were outstanding as of December 31, 2006 and
2005. The holders of common stock are entitled to one vote per share on all
matters submitted to a vote of stockholders. The holders of common stock are
also entitled to ratably receive dividends declared by the board out of legally
available funds. The holders of common stock have no rights to convert their
common stock into any other securities.
During the year ended December 31, 2005, the Company repurchased 2,333,205
shares of common stock from the principals of Dalton Partners for $2,000. The
difference between the deemed par value of the common stock of $0.001226 per
share and the purchase price of $0.008572 per share totaling $862 was credited
to additional paid-in capital.
F-54
STRASBAUGH
NOTES TO FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2006 AND 2005
NOTE 11 - STOCKHOLDERS' EQUITY (CONTINUED)
COMMON STOCK (CONTINUED)
In connection with the exchange of debt instruments (Note 6), the Company
cancelled 797,162 shares of common stock held by the credit association and
issued 771,327 shares to Agility. The Company used the deemed fair value of
$0.008572 per share. The difference between the deemed fair value and the deemed
par value of the common stock was credited to additional paid-in capital.
During 2000, the Company voluntarily formed a Committee of Unsecured Creditors
of Strasbaugh (the Creditor's Committee) to facilitate the repayment of its
unsecured debt. The resulting agreement includes an anti-dilution provision with
respect to certain issuances of the Company's stock, as defined in the
agreement. No stock was issued to the Creditor's Committee during the years
ended December 31, 2006 and 2005.
PREFERRED STOCK
The Company is authorized to issue up to 5,769,736 shares of Series A preferred
stock, no par value, of which 4,087,980 shares are issued to one investor. The
holder of Series A preferred stock is entitled to receive dividends out of
legally available funds, if declared by the board, prior and in preference to
any declaration or payment of any dividend on the common stock of the Company,
at the rate of 8% per share per annum. Each share of Series A preferred stock is
convertible to common stock on a one-to-one basis, at the option of the holder,
into such number of shares as defined in the agreement. The holder of each share
of Series A preferred stock has full voting rights to one vote for each share of
common stock into which each share of preferred stock could be converted.
This agreement also includes an anti-dilution provision with respect to certain
issuances of the Company's stock, as defined in the agreement, which is in the
control of the Company. No preferred stock was issued during the years ended
December 31, 2006 and 2005.
NOTE 12 - INCOME TAXES
The provision for income taxes consists of the following:
FOR THE YEAR ENDED
DECEMBER 31,
2006 2005
--------- --------
Current:
Federal $ 16,300 --
State 6,200 $ 2,165
Foreign 56,000 26,850
--------- --------
78,500 29,015
--------- --------
Deferred:
Federal -- --
State -- --
Foreign -- --
--------- --------
-- --
--------- --------
$ 78,500 $ 29,015
========= ========
|
F-55
STRASBAUGH
NOTES TO FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2006 AND 2005
NOTE 12 - INCOME TAXES (CONTINUED)
The reconciliation of the Company's expected tax rate to the effective tax rate
is as follows:
FOR THE YEAR ENDED
DECEMBER 31,
2005
2006 (as restated)
--------- --------
Statutory federal rate $ 468,075 $(114,098)
State income taxes, net of federal benefit 118,112 (25,584)
Nondeductible expenses 4,579 14,810
Change in valuation allowance (517,300) 151,140
Other 5,034 2,747
--------- --------
$ 78,500 $ 29,015
========= ========
|
Deferred taxes consists of the following:
DECEMBER 31,
2006 2005
(as restated) (as restated)
----------- ---------
Deferred tax assets:
Accrued vacation $ 143,000 $ 119,400
Allowance for doubtful accounts 27,800 3,100
Accrued warranty 148,000 125,400
Inventory reserve 899,600 830,100
Additional inventory costs 135,400 109,400
Deferred revenue 64,800 304,600
Federal net operating losses 8,187,100 8,586,300
State net operating losses 752,700 836,300
Federal tax credits 258,700 187,000
Other -- 32,800
----------- ----------
10,617,100 11,134,400
Valuation allowance (10,617,100) (11,134,400)
------------ ----------
-- --
=========== ==========
|
The Company had federal and state net operating losses of approximately
$23,879,000 and $8,454,000, respectively, at December 31, 2006, which begin to
expire in 2019 for federal purposes. Annual utilization of the federal net
operating loss may be limited for federal tax purposes as a result of Internal
Revenue Code Section 382 change of ownership rules. The state net operating
losses expire at various dates through 2013.
The Company has a foreign tax credit and alternative minimum tax credit
carryforwards of approximately $259,000 as of December 31, 2006. The valuation
allowance decreased by approximately $517,300 during the year ended December 31,
2006.
F-56
STRASBAUGH
NOTES TO FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2006 AND 2005
NOTE 13 - RELATED-PARTY ACTIVITY
In the ordinary course of business, the Company sells inventory to SCST from
time to time. No sales were made to SCST during the year ended December 31,
2006. Sales to SCST totaled approximately $87,000 for the year ended December
31, 2005. Accounts receivable from SCST totaled approximately $8,000 as of
December 31, 2005.
Through the Company's affiliation with SCST, the Company has entered into an
agreement to run and maintain a sales office in Tokyo, Japan. The contract began
in April 2005 and is effective for five years. In connection with the agreement,
SCST paid the Company 83 million yen (approximately $750,000) to operate the
office over the contract term. The Company has established a deferred liability
and is amortizing the amount on a monthly basis as a reduction of the operating
expenses for the sales office. In turn, for every sale originating from the
Tokyo office, SCST will receive a commission of 20% of the sale price, not to
exceed 83 million yen. During the year ended December 31, 2005, one sale was
made from the Tokyo office. As such, commissions payable to SCST totaling
approximately $135,000 have been accrued at year-end. No tool sales occurred
during the year ended December 31, 2006.
NOTE 14 - SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Additional information to the statements of cash flows with regard to certain
noncash investing and financing transactions approximated the following:
FOR THE YEAR ENDED
DECEMBER 31,
2006 2005
----------- -----------
NONCASH TRANSACTIONS:
Inventory transferred to property and equipment $ 8,911 $ --
Equipment transferred to inventory for resale $ -- $ 197,000
NOTE 15 - RESTATEMENT OF FINANCIAL STATEMENTS
Subsequent to the original issuance of the Company's financial statements as of
and for the year ended December 31, 2005, management determined that the Company
did not properly record the warrant issued to Agility in connection with the
debt financing (Notes 6 and 7). The Company originally recorded the fair value
of the warrant as expense rather than as a discount to the debt which will be
amortized over the life of the debt. Accordingly, the Company has restated its
2005 financial statements to properly record the warrant as a debt discount.
The Company recorded the warrant as a liability and calculated its fair value at
the date of the initial investment. Upon restatement, the initial value of the
warrant of approximately $391,000 has been reclassified from expense and
recorded as a debt discount, and approximately $62,000 of the debt discount has
been charged to interest expense during the year ended December 31, 2005.
F-57
|
STRASBAUGH
NOTES TO FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2006 AND 2005
NOTE 15 - RESTATEMENT OF FINANCIAL STATEMENTS (CONTINUED)
The effect of this restatement on the statements of operations and cash flows
for the year ended December 31, 2005, is as follows:
AS PREVIOUSLY
REPORTED AS RESTATED
---------------- ---------------
Statement of Operations and Accumulated Deficit
Gain from extinguishment of debt $ (694,245) $ (1,092,265)
Interest expense $ (429,375) $ (490,920)
Other (expense) income, net $ (39,369) $ (46,383)
Net income (loss) $ (214,645) $ 114,816
Basic income (loss) per share $ (0.01) $ 0.01
Diluted income (loss) per share $ (0.01) $ 0.01
Statement of Cash Flows
Net income (loss) $ (214,645) $ 114,816
Noncash gain on extinguishment of debt $ (694,245) $ (1,092,265)
Noncash interest expense $ -- $ 68,559
|
The Company also reclassified certain line items on the balance sheet as of
December 31, 2005 and statement of operations and accumulated deficit for the
year then ended.
Subsequent to the original issuance of the Company's financial statements as of
and for the years ended December 31, 2006 and 2005, an initial restatement for
the year ended December 31, 2005, management determined that the Company did not
properly classify shipping and handling charges. The Company originally netted
these charged in selling, general and administrative expenses. The proper
treatment is to include costs billed to customers in revenues and the related
shipping and handling costs incurred by the Company should be included in Cost
of Sales.
The effect of this restatement for the period ended December 31, 2006 is as
follows:
AS PREVIOUSLY
REPORTED AS RESTATED
---------------- ---------------
Statement of Operations
Revenues--Parts and services $ 23,016,101 $ 23,034,967
Cost of sales--Parts and services $ 14,412,047 $ 14,471,022
Gross Profit $ 8,604,054 $ 8,563,945
Selling, general and administrative expenses $ 4,532,787 $ 4,492,678
The effect of this restatement for the period ended December 31, 2005 is as
follows:
AS PREVIOUSLY
REPORTED AS RESTATED
---------------- ---------------
Statement of Operations
Revenues--Parts and services $ 16,120,879 $ 16,154,802
Cost of sales--Parts and services $ 9,750,906 $ 9,824,053
Gross Profit $ 6,369,973 $ 6,330,749
Selling, general and administrative expenses $ 5,047,747 $ 5,008,523
Subsequent to the issuance of the Company's RESTATED financial statements as of
and for the years ended December 31, 2006 and 2005, management determined that
certain liabilities derecognized under the application of SFAS No. 140,
"Accounting Transfers and Servicing of Financial Assets and Extinguishments of
Liabilities, a replacement of FASB Statement 125" which had deemed to have run
the statute of limitations under California law had, in fact, not run their
respective statutes of limitations as of December 31, 2005 because they were
actually notes either subject to a the laws of other states with varying
statutes of limitations or were notes that were subject to a longer statute of
limitations under California law.
F-58
|
STRASBAUGH
NOTES TO FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2006 AND 2005
NOTE 15 - RESTATEMENT OF FINANCIAL STATEMENTS (CONTINUED)
The Company had recorded $100,236 and $379,178 in income from the derecognition
of these liabilities and accrued royalties, respectively, during the year ended
December 31, 2005. Accordingly, upon restatement, the Company eliminated
$479,414 of income from the cancellation of these liabilities and royalties.
The effect of this restatement for the period ended December 31, 2006 is as
follows:
AS PREVIOUSLY
REPORTED AS RESTATED
---------------- ---------------
Balance Sheet
Notes payable, current portion $ 1,685,363 $ 1,785,599
Accrued expenses $ 2,562,052 $ 2,941,230
Accumulated deficit $ (26,421,807) $ (26,901,221)
The effect of this restatement on the statements of operations and cash flows
for the year ended December 31, 2005, is as follows:
AS PREVIOUSLY
STATED AND
RESTATED AS RESTATED
---------------- ---------------
Statement of Operations
Income from cancellation of liabilities $ (100,236) $ --
Income from cancellation of accrued royalties $ (379,178) $ --
Income from operations $ 563,309 $ 83,895
Net income (loss) (as previously restated) $ 114,816 $ (364,598)
Basic income (loss) per share $ 0.01 $ (0.03)
Diluted income (loss) per share $ 0.01 $ (0.03)
Statement of Cash Flows
Net income (loss) (as previously restated) $ 114,816 $ (364,598)
Non-cash income from cancellation of liabilities $ (100,236) $ --
Non-cash income from cancellation of accrued royalties $ (379,178) $ --
|
NOTE 16 - SUBSEQUENT EVENTS
SHARE EXCHANGE AGREEMENT
Effective January 31, 2007, the Company entered into a share exchange agreement
to be acquired by CTK Windup Corporation ("CTK") (formerly Celeritek, Inc.), in
a stock for stock transaction. Upon consummation of the share exchange, the
Company will become a wholly owned subsidiary of CTK. CTK will issue 14,201,897
shares of its common stock (calculated on a post-reverse-split basis) to acquire
the Company. The current shareholders of CTK would own approximately 3% of CTK
common stock outstanding immediately following the share exchange, and the
Company's shareholders would own approximately 97% of the CTK common stock
immediately following the share exchange.
In March 2007, CTK shareholders approved the share exchange and related
transactions, which include the amendment and restatement of its articles of
incorporation to effectuate, immediately preceding the closing of the share
exchange, (i) a 1- for-31 reverse stock split, (ii) a change in the name of CTK
to the Company, and (iii) an increase in CTK's authorized common stock from 50
million shares to 100 million shares, and an increase in CTK's authorized
preferred stock from 2 million shares to 15 million shares.
F-59
STRASBAUGH
NOTES TO FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2006 AND 2005
NOTE 16 - SUBSEQUENT EVENTS (CONTINUED)
SHARE EXCHANGE AGREEMENT (CONTINUED)
The proposed share exchange, and related transactions, are subject to
satisfaction of due diligence investigations by all of the parties, the Company
(through CTK) completing an equity financing in the amount of approximately $13
million, or up to $20 million immediately following the closing of the share
exchange, execution of the share exchange agreement by all of the shareholders
of the Company, approval by CTK's shareholders holding a majority of the
outstanding shares of CTK common stock, and certain other additional conditions
to closing. As a further condition to the completion of the acquisition, the
current board of directors of CTK will resign and the current management and
certain of the current members of the board of the Company will assume
management of CTK. After the closing of the share exchange, CTK plans to file
with the Securities and Exchange Commission a registration statement under the
Securities Exchange Act of 1934 to register its common stock under the Exchange
Act and thereby become a reporting company.
REPURCHASE OF PREFERRED STOCK
During February 2007, the Company and its preferred stockholder agreed in
principle for the Company to repurchase all of its issued and outstanding
preferred stock for $3,000,000. The proposed transaction is subject to the
completion of the Share Exchange Agreement with CTK and the Company's ability to
raise sufficient funds.
DEBT MODIFICATION
During February 2007, the Company and Agility agreed in principle for the
Company to satisfy its note payable (Note 6), repurchase the outstanding common
stock held by Agility (Notes 6 and 11) and repurchase the warrant held by
Agility (Note 7) for $1,200,000. The proposed transaction is subject to the
completion of the Share Exchange Agreement with CTK and the Company's ability to
raise sufficient funds.
F-60
STRASBAUGH
PROSPECTUS
, 2008
WE HAVE NOT AUTHORIZED ANY DEALER, SALESMAN OR OTHER PERSON TO GIVE ANY
INFORMATION OR TO MAKE ANY REPRESENTATION OTHER THAN THOSE CONTAINED IN THIS
PROSPECTUS AND ANY ACCOMPANYING SUPPLEMENT TO THIS PROSPECTUS. YOU MUST NOT RELY
UPON ANY INFORMATION OR REPRESENTATION NOT CONTAINED IN THIS PROSPECTUS OR ANY
ACCOMPANYING PROSPECTUS SUPPLEMENT. THIS PROSPECTUS AND ANY ACCOMPANYING
SUPPLEMENT TO THIS PROSPECTUS DO NOT CONSTITUTE AN OFFER TO SELL OR THE
SOLICITATION OF AN OFFER TO BUY ANY SECURITIES OTHER THAN THE REGISTERED
SECURITIES TO WHICH THEY RELATE, NOR DO THIS PROSPECTUS AND ANY ACCOMPANYING
SUPPLEMENT TO THIS PROSPECTUS CONSTITUTE AN OFFER TO SELL OR THE SOLICITATION OF
AN OFFER TO BUY SECURITIES IN ANY JURISDICTION TO ANY PERSON TO WHOM IT IS
UNLAWFUL TO MAKE SUCH OFFER OR SOLICITATION IN SUCH JURISDICTION. THE
INFORMATION CONTAINED IN THIS PROSPECTUS AND ANY ACCOMPANYING SUPPLEMENT TO THIS
PROSPECTUS IS ACCURATE AS OF THE DATES ON THEIR COVERS. WHEN WE DELIVER THIS
PROSPECTUS OR A SUPPLEMENT OR MAKE A SALE PURSUANT TO THIS PROSPECTUS OR A
SUPPLEMENT, WE ARE NOT IMPLYING THAT THE INFORMATION IS CURRENT AS OF THE DATE
OF THE DELIVERY OR SALE.
PART II
INFORMATION NOT REQUIRED IN PROSPECTUS
ITEM 24. INDEMNIFICATION OF DIRECTORS AND OFFICERS
Our articles of incorporation provide that the liability of our
directors for monetary damages shall be eliminated to the fullest extent
permissible under California law. This is intended to eliminate the personal
liability of a director for monetary damages in an action brought by or in the
right of Strasbaugh for breach of a director's duties to Strasbaugh or our
shareholders except for liability:
o for acts or omissions that involve intentional misconduct or a
knowing and culpable violation of law;
o for acts or omissions that a director believes to be contrary
to the best interests of Strasbaugh or our shareholders or
that involve the absence of good faith on the part of the
director;
o for any transaction for which a director derived an improper
personal benefit;
o for acts or omissions that show a reckless disregard for the
director's duty to Strasbaugh or our shareholders in
circumstances in which the director was aware, or should have
been aware, in the ordinary course of performing a director's
duties, of a risk of serious injury to Strasbaugh or our
shareholders;
o for acts or omissions that constitute an unexcused pattern of
inattention that amounts to an abdication of the director's
duty to Strasbaugh or our shareholders; and
o for engaging in transactions described in the California
Corporations Code or California case law that result in
liability, or approving the same kinds of transactions.
Our articles of incorporation also provide that we are authorized to
provide indemnification to our agents, as defined in Section 317 of the
California Corporations Code, through our bylaws or through agreements with such
agents or both, for breach of duty to us and our shareholders, in excess of the
indemnification otherwise permitted by Section 317 of the California
Corporations Code, subject to the limits on such excess indemnification set
forth in Section 204 of the California Corporations Code. Our bylaws also
authorize us to purchase and maintain insurance on behalf of any of our
directors or officers against any liability asserted against that person in that
capacity, whether or not we would have the power to indemnify that person under
the provisions of the California Corporations Code. We have entered and expect
to continue to enter into agreements to indemnify our directors and officers as
determined by our board of directors. These agreements provide for
indemnification of related expenses including attorneys' fees, judgments, fines
and settlement amounts incurred by any of these individuals in any action or
proceeding. We believe that these bylaw provisions and indemnification
agreements are necessary to attract any retain qualified persons as directors
and officers. We also maintain directors' and officers' liability insurance.
Our bylaws provide for indemnification of our officers, directors,
employees, and other agents to the extent and under the circumstances permitted
by California law. In all cases where indemnification is permitted by the
bylaws, a determination to indemnify such person must be made when ordered by a
court and must be made in a specific case upon a determination that
indemnification is required or proper in the circumstances. Such determination
must be made:
II-1
o by our board of directors by a majority vote of a quorum
consisting of directors who were not parties to the action,
suit or proceeding which is the subject of the request for
indemnification; or
o if such a quorum is not obtainable, or, even if obtainable, a
majority vote of a quorum of disinterested directors so
directs, by independent legal counsel in a written opinion; or
o by a majority of our shareholders.
The limitation of liability and indemnification provisions in our
articles of incorporation and bylaws may discourage shareholders from bringing a
lawsuit against our directors for breach of their fiduciary duty. They may also
reduce the likelihood of derivative litigation against our directors and
officers, even though an action, if successful, might benefit us and other
shareholders. Furthermore, a shareholder's investment may be adversely affected
to the extent that we pay the costs of settlement and damage awards against
directors and officers as required by these indemnification provisions. At
present, there is no pending litigation or proceeding involving any of our
directors, officers or employees regarding which indemnification is sought, and
we are not aware of any threatened litigation that may result in claims for
indemnification.
INSOFAR AS THE PROVISIONS OF OUR ARTICLES OF INCORPORATION OR BYLAWS PROVIDE FOR
INDEMNIFICATION OF DIRECTORS OR OFFICERS FOR LIABILITIES ARISING UNDER THE
SECURITIES ACT, WE HAVE BEEN INFORMED THAT IN THE OPINION OF THE SEC THIS
INDEMNIFICATION IS AGAINST PUBLIC POLICY AS EXPRESSED IN THE SECURITIES ACT AND
IS THEREFORE UNENFORCEABLE.
II-2
ITEM 25. OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION
The following table sets forth all expenses to be paid by us in
connection with this offering. All amounts shown are estimates except for the
SEC registration fee.
SEC Registration $ 970
NASD Fees --
Accounting Fees and Expenses 95,000
Legal Fees and Expenses 400,000
Blue Sky Fees and Expenses 750
Placement Agent Fees and Expenses 1,100,000
Printing Costs 8,500
Miscellaneous Expenses 5,000
-------------
Total $ 1,610,220
=============
|
ITEM 26. RECENT SALES OF UNREGISTERED SECURITIES.
On May 24, 2007, we completed a Share Exchange Transaction, with the
shareholders of R. H. Strasbaugh pursuant to which we issued an aggregate of
13,770,366 shares of our common stock to the shareholders of R. H. Strasbaugh
and, in exchange, we acquired all of the issued and outstanding shares of
capital stock of R. H. Strasbaugh.
On May 24, 2007, immediately after the closing of the Share Exchange
Transaction, we entered into an agreement with 21 accredited investors for the
sale by us of 5,909,089 shares of our Series A Preferred Stock at a purchase
price of $2.20 per share for total aggregate proceeds of $13 million.
Additionally, in connection with the Series A Preferred Stock Financing, we
issued to the investors five-year warrants to purchase an aggregate of 886,363
shares of common stock and we issued to our placement agent, B. Riley and Co.
Inc. and its assignees, five-year warrants to purchase an aggregate of 385,434
shares of common stock.
On May 24, 2007, we issued options to purchase 1,375,000 shares of our
common stock pursuant to our 2007 Share Incentive Plan.
The issuances of our securities described above were made in reliance
upon the exemption from registration available under Section 4(2) of the
Securities Act, among others, as transactions not involving a public offering.
This exemption was claimed on the basis that these transactions did not involve
any public offering and the purchasers in each offering were accredited or
sophisticated and had sufficient access to the kind of information registration
would provide. In each case, appropriate investment representations were
obtained and certificates representing the securities were issued with
restrictive legends.
II-3
ITEM 27. EXHIBITS.
(a) EXHIBITS.
EXHIBIT
NUMBER DESCRIPTION
------ -----------
2.1 Share Exchange Agreement by and between the Registrant and R. H.
Strasbaugh dated January 31, 2007 (1)
2.2 Amendment No. 1 to Share Exchange Agreement between the
Registrant and R. H. Strasbaugh dated April 30, 2007 (1)
3.1 Amended and Restated Articles of Incorporation of the Registrant
(1)
3.2 Amended and Restated Bylaws of the Registrant (1)
4.1 Securities Purchase Agreement dated May 24, 2007 by and among the
Registrant and the investors who are parties thereto (1)
4.2 Registration Rights Agreement dated May 24, 2007 by and among the
Registrant and the investors who are parties thereto (1)
4.3 Specimen Common Stock Certificate (1)
4.4 Specimen Preferred Stock Certificate (1)
4.5 Form of Warrant dated May 24, 2007 issued by the Registrant to
certain investors pursuant to the Securities Purchase Agreement
filed as Exhibit 4.1 hereto (1)
4.6 Form of Placement Agent Warrant dated effective May 24, 2007
issued by the Registrant to B. Riley and Co. Inc. Inc. and its
assignees (1)
4.7 Article IV of Amended and Restated Articles of Incorporation of
Registrant (contained in Exhibit 3.1 to this Registration
Statement) (1)
5.1 Opinion of Rutan & Tucker, LLP *
10.1 Strasbaugh 2007 Share Incentive Plan (#)(1)
10.2 Form of the Strasbaugh 2007 Share Incentive Plan Stock Option
Grant Notice and Stock Option Agreement (#)(1)
10.3 Form of Indemnification Agreement for officers and directors
(#)(1)
10.4 Executive Employment Agreement by and between the Registrant and
Chuck Schillings (#)(1)
10.5 Executive Employment Agreement by and between the Registrant and
Richard Nance (#)(1)
10.6 Employment Agreement by and between the Registrant and Alan
Strasbaugh (#)(1)
10.7 License Agreement by and between Lam Research Corporation and R.
H. Strasbaugh dated December 20, 2000 (1)
10.8 Loan and Security Agreement by and between Silicon Valley Bank
and R. H. Strasbaugh dated August 23, 2004 (1)
10.9 Amendment to Loan Documents by and between Silicon Valley Bank
and R. H. Strasbaugh dated February 28, 2007 (1)
10.10 Amendment to Loan and Security Agreement by and between Silicon
Valley Bank and R. H. Strasbaugh dated May 22, 2007 (1)
10.11 Amendment to Loan and Security Agreement by and between Silicon
Valley Bank and R. H. Strasbaugh dated September 6, 2007 (2)
II-4
|
EXHIBIT
NUMBER DESCRIPTION
------ -----------
10.12 Standard Industrial Lease by and between Larry and Alan
Strasbaugh and R. H. Strasbaugh dated as of May 1, 1990 (1)
10.13 Assignment dated April 14, 1995 by Larry Strasbaugh of his
interest in the Standard Industrial Lease by and between Larry
and Alan Strasbaugh and R.H. Strasbaugh dated as of May 1, 1990
to Alan and April Strasbaugh (1)
10.14 Agreement dated October 18, 2007 by and between B. Riley and Co.
Inc. and R. H. Strasbaugh (2)
10.15 Assignment and Assumption Agreement dated May 24, 2007 by and
among the Registrant, R. H. Strasbaugh and B. Riley and Co.
Inc.(2)
10.16 Loan and Security Agreement dated December 3, 2007 by and among
Silicon Valley Bank, the Registrant and R. H. Strasbaugh (3)
10.17 Loan and Security Agreement (EXIM Facility) dated December 3,
2007 by and among Silicon Valley Bank, the Registrant and R. H.
Strasbaugh (3)
10.18 Memorandum of Understanding dated December 1, 2006 by and between
the Registrant and the 45th Research Institute of China
Electronic Technology Corporation (3)
14.1 Code of Ethics (1)
16.1 Letter on Change in Certifying Accountant (1)
21 Subsidiaries of the Registrant (1)
23.1 Consent of Rutan & Tucker, LLP (contained in Exhibit 5.1)*
23.2 Consent of Windes & McClaughry Accountancy Corporation,
Independent Registered Public Accounting Firm*
24.1 Power of Attorney (included on signature page to the initial
filing of this Registration Statement)
99.1 Consent of Laredo Technologies (3)
_________________________
|
* Filed herewith.
(#) This exhibit is a management contract or a compensatory plan or
arrangement.
(1) Filed as an exhibit to the initial filing of the Registrant's registration
statement on Form SB-2 (Registration Statement No.: 333-144787) and
incorporated herein by reference.
(2) Filed as an exhibit to Amendment No. 1 to the Registrant's registration
statement on Form SB-2 (Registration Statement No.: 333-144787) filed on
September 17, 2007 and incorporated herein by reference.
(3) Filed as an exhibit to Amendment No. 2 to the Registrant's registration
statement on Form SB-2 (Registration Statement No.: 333-144787) filed on
December 14, 2007 and incorporated herein by reference.
II-5
ITEM 28. UNDERTAKINGS
The undersigned Registrant hereby undertakes:
(1) To file, during any period in which offers or sales are being made,
a post-effective amendment to this Registration Statement to:
(i) include any prospectus required by Section 10(a)(3) of the
Securities Act of 1933 (the "Securities Act");
(ii) reflect in the prospectus any facts or events which,
individually or together, represent a fundamental change in the
information in the Registration Statement. Notwithstanding the
foregoing, any increase or decrease in volume of securities offered (if
the total dollar value of securities offered would not exceed that
which was registered) and any deviation from the low or high end of the
estimated maximum offering range may be reflected in the form of
prospectus filed with the Commission pursuant to Rule 424(b) if, in the
aggregate, the changes in volume and price represent no more than a 20%
change in the maximum aggregate offering price set forth in the
"Calculation of Registration Fee" table in the effective registration
statement; and
(iii) include any additional or changed material information
on the plan of distribution.
(2) That, for determining liability under the Securities Act, each such
post-effective amendment shall be treated as a new registration statement
relating to the securities offered therein, and the offering of such securities
at that time shall be deemed to be the initial bona fide offering thereof.
(3) To file a post-effective amendment to remove from registration any
of the securities being registered that remain unsold at the end of the
offering.
(4) For determining liability of the undersigned small business issuer
under the Securities Act to any purchaser in the initial distribution of the
securities, the undersigned undertakes that in a primary offering of securities
of the undersigned small business issuer pursuant to this registration
statement, regardless of the underwriting method used to sell the securities to
the purchaser, if the securities are offered or sold to such purchaser by means
of any of the following communications, the undersigned small business issuer
will be a seller to the purchaser and will be considered to offer or sell such
securities to such purchaser:
(i) any preliminary prospectus or prospectus of the
undersigned small business issuer relating to the offering required to
be filed pursuant to Rule 424;
(ii) any free writing prospectus relating to the offering
prepared by or on behalf of the undersigned small business issuer or
used or referred to by the undersigned small business issuer;
(iii) the portion of any other free writing prospectus
relating to the offering containing material information about the
undersigned small business issuer or its securities provided by or on
behalf of the undersigned small business issuer; and
(iv) any other communication that is an offer in the offering
made by the undersigned small business issuer or the purchaser.
II-6
The undersigned Registrant hereby undertakes that for the purpose of
determining liability under the Securities Act to any purchaser, if the
Registrant is subject to Rule 430C, each prospectus filed pursuant to Rule
424(b) as part of a registration statement relating to an offering, other than
registration statements relying on Rule 430B or other than prospectuses filed in
reliance on Rule 430A, shall be deemed to be part of and included in the
registration statement as of the date it is first used after effectiveness.
PROVIDED, HOWEVER, that no statement made in a registration statement or
prospectus that is part of the registration statement or made in a document
incorporated or deemed incorporated by reference into the registration statement
or prospectus that is part of the registration statement will, as to a purchaser
with a time of contract of sale prior to such first use, supersede or modify any
statement that was made in the registration statement or prospectus that was
part of the registration statement or made in any such document immediately
prior to such date of first use.
Insofar as indemnification for liabilities arising under the Securities
Act may be permitted to directors, officers and controlling persons of the
Registrant pursuant to the foregoing provisions, or otherwise, the Registrant
has been advised that in the opinion of the Securities and Exchange Commission
such indemnification is against public policy as expressed in the Securities Act
and is, therefore, unenforceable.
In the event that a claim for indemnification against such liabilities
(other than the payment by the Registrant of expenses incurred or paid by a
director, officer or controlling person of the Registrant in the successful
defense of any action, suit or proceeding) is asserted by such director, officer
or controlling person in connection with the securities being registered, the
Registrant will, unless in the opinion of its counsel the matter has been
settled by controlling precedent, submit to a court of appropriate jurisdiction
the question whether such indemnification by it is against public policy as
expressed in the Securities Act and will be governed by the final adjudication
of such issue.
II-7
SIGNATURES
In accordance with the requirements of the Securities Act of 1933, the
registrant certifies that it has reasonable grounds to believe that it meets all
of the requirements for filing on Form SB-2 and authorized this registration
statement to be signed on its behalf by the undersigned, in the city of San Luis
Obispo, State of California, on February 4, 2008.
STRASBAUGH
By: /s/ CHUCK SCHILLINGS
-------------------------------------
Chuck Schillings
President and Chief Executive Officer
|
Pursuant to the requirements of the Securities Act of 1933, this
registration statement has been signed by the following persons in the
capacities and on the dates indicated.
Name Title Date
------------------------------- ------------------------------------- -----------------
/s/ CHUCK SCHILLINGS President and Chief Executive February 4, 2008
------------------------------- Officer (principal executive officer)
Chuck Schillings
/s/ RICHARD NANCE Chief Financial Officer (principal February 4, 2008
------------------------------- financial officer and principal
Richard Nance accounting officer)
/s/ * Chairman of the Board and Director February 4, 2008
-------------------------------
Alan Strasbaugh
/s/ * Director February 4, 2008
-------------------------------
Wesley Cummings
/s/ * Director February 4, 2008
-------------------------------
David Porter
Director ----------------
-------------------------------
John Givens
*/s/ CHUCK SCHILLINGS February 4, 2008
-------------------------------
Chuck Schillings,
Attorney-In-Fact
|
II-8
INDEX TO EXHIBITS
EXHIBIT
NUMBER DESCRIPTION
------ -----------
5.1 Opinion of Rutan & Tucker, LLP
23.1 Consent of Rutan & Tucker, LLP (contained in Exhibit 5.1)
23.2 Consent of Windes & McClaughry Accountancy Corporation,
Independent Registered Public Accounting Firm
|
Strasbaugh (CE) (USOTC:STRB)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Strasbaugh (CE) (USOTC:STRB)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024